id	sid	tid	token	lemma	pos
ajlm-1964	1	1	abstract	abstract	ADJ
ajlm-1964	1	2	introduction	introduction	NOUN
ajlm-1964	1	3	immunity	immunity	NOUN
ajlm-1964	1	4	to	to	ADP
ajlm-1964	1	5	covid-19	covid-19	PROPN
ajlm-1964	1	6	disease	disease	NOUN
ajlm-1964	1	7	dynamics	dynamic	NOUN
ajlm-1964	1	8	of	of	ADP
ajlm-1964	1	9	covid-19	covid-19	PROPN
ajlm-1964	1	10	in	in	ADP
ajlm-1964	1	11	sub	sub	ADJ
ajlm-1964	1	12	-	-	ADJ
ajlm-1964	1	13	saharan	saharan	ADJ
ajlm-1964	1	14	african	african	ADJ
ajlm-1964	1	15	countries	country	NOUN
ajlm-1964	1	16	infectious	infectious	ADJ
ajlm-1964	1	17	diseases	disease	NOUN
ajlm-1964	1	18	in	in	ADP
ajlm-1964	1	19	sub	sub	ADJ
ajlm-1964	1	20	-	-	ADJ
ajlm-1964	1	21	saharan	saharan	ADJ
ajlm-1964	1	22	africa	africa	PROPN
ajlm-1964	1	23	immune	immune	ADJ
ajlm-1964	1	24	response	response	NOUN
ajlm-1964	1	25	to	to	ADP
ajlm-1964	1	26	microbial	microbial	ADJ
ajlm-1964	1	27	infections	infection	NOUN
ajlm-1964	1	28	possible	possible	ADJ
ajlm-1964	1	29	reasons	reason	NOUN
ajlm-1964	1	30	for	for	ADP
ajlm-1964	1	31	a	a	DET
ajlm-1964	1	32	presumed	presume	VERB
ajlm-1964	1	33	immune	immune	ADJ
ajlm-1964	1	34	sufficiency	sufficiency	NOUN
ajlm-1964	1	35	in	in	ADP
ajlm-1964	1	36	sub	sub	ADJ
ajlm-1964	1	37	-	-	ADJ
ajlm-1964	1	38	saharan	saharan	ADJ
ajlm-1964	1	39	africa	africa	PROPN
ajlm-1964	1	40	projections	projection	NOUN
ajlm-1964	1	41	into	into	ADP
ajlm-1964	1	42	the	the	DET
ajlm-1964	1	43	future	future	NOUN
ajlm-1964	1	44	of	of	ADP
ajlm-1964	1	45	covid-19	covid-19	PROPN
ajlm-1964	1	46	and	and	CCONJ
ajlm-1964	1	47	disease	disease	NOUN
ajlm-1964	1	48	processes	process	VERB
ajlm-1964	1	49	conclusion	conclusion	NOUN
ajlm-1964	1	50	acknowledgements	acknowledgement	NOUN
ajlm-1964	1	51	references	reference	NOUN
ajlm-1964	1	52	about	about	ADP
ajlm-1964	1	53	the	the	DET
ajlm-1964	1	54	author(s	author(s	NOUN
ajlm-1964	1	55	)	)	PUNCT
ajlm-1964	1	56	abel	abel	PROPN
ajlm-1964	1	57	o.	o.	PROPN
ajlm-1964	1	58	idowu	idowu	PROPN
ajlm-1964	1	59	department	department	PROPN
ajlm-1964	1	60	of	of	ADP
ajlm-1964	1	61	pharmaceutical	pharmaceutical	NOUN
ajlm-1964	1	62	microbiology	microbiology	NOUN
ajlm-1964	1	63	and	and	CCONJ
ajlm-1964	1	64	biotechnology	biotechnology	NOUN
ajlm-1964	1	65	,	,	PUNCT
ajlm-1964	1	66	faculty	faculty	NOUN
ajlm-1964	1	67	of	of	ADP
ajlm-1964	1	68	pharmacy	pharmacy	NOUN
ajlm-1964	1	69	,	,	PUNCT
ajlm-1964	1	70	college	college	NOUN
ajlm-1964	1	71	of	of	ADP
ajlm-1964	1	72	medicine	medicine	NOUN
ajlm-1964	1	73	,	,	PUNCT
ajlm-1964	1	74	university	university	NOUN
ajlm-1964	1	75	of	of	ADP
ajlm-1964	1	76	lagos	lago	NOUN
ajlm-1964	1	77	,	,	PUNCT
ajlm-1964	1	78	lagos	lago	NOUN
ajlm-1964	1	79	,	,	PUNCT
ajlm-1964	1	80	nigeria	nigeria	PROPN
ajlm-1964	1	81	yusuf	yusuf	PROPN
ajlm-1964	1	82	o.	o.	PROPN
ajlm-1964	1	83	omosun	omosun	PROPN
ajlm-1964	1	84	department	department	PROPN
ajlm-1964	1	85	of	of	ADP
ajlm-1964	1	86	microbiology	microbiology	NOUN
ajlm-1964	1	87	,	,	PUNCT
ajlm-1964	1	88	biochemistry	biochemistry	NOUN
ajlm-1964	1	89	and	and	CCONJ
ajlm-1964	1	90	immunology	immunology	NOUN
ajlm-1964	1	91	,	,	PUNCT
ajlm-1964	1	92	morehouse	morehouse	PROPN
ajlm-1964	1	93	school	school	NOUN
ajlm-1964	1	94	of	of	ADP
ajlm-1964	1	95	medicine	medicine	NOUN
ajlm-1964	1	96	,	,	PUNCT
ajlm-1964	1	97	atlanta	atlanta	PROPN
ajlm-1964	1	98	,	,	PUNCT
ajlm-1964	1	99	georgia	georgia	PROPN
ajlm-1964	1	100	,	,	PUNCT
ajlm-1964	1	101	united	united	PROPN
ajlm-1964	1	102	states	states	PROPN
ajlm-1964	1	103	joseph	joseph	PROPN
ajlm-1964	1	104	u.	u.	PROPN
ajlm-1964	1	105	igietseme	igietseme	PROPN
ajlm-1964	1	106	department	department	PROPN
ajlm-1964	1	107	of	of	ADP
ajlm-1964	1	108	microbiology	microbiology	NOUN
ajlm-1964	1	109	,	,	PUNCT
ajlm-1964	1	110	biochemistry	biochemistry	NOUN
ajlm-1964	1	111	and	and	CCONJ
ajlm-1964	1	112	immunology	immunology	NOUN
ajlm-1964	1	113	,	,	PUNCT
ajlm-1964	1	114	morehouse	morehouse	PROPN
ajlm-1964	1	115	school	school	NOUN
ajlm-1964	1	116	of	of	ADP
ajlm-1964	1	117	medicine	medicine	NOUN
ajlm-1964	1	118	,	,	PUNCT
ajlm-1964	1	119	atlanta	atlanta	PROPN
ajlm-1964	1	120	,	,	PUNCT
ajlm-1964	1	121	georgia	georgia	PROPN
ajlm-1964	1	122	,	,	PUNCT
ajlm-1964	1	123	united	united	PROPN
ajlm-1964	1	124	states	states	PROPN
ajlm-1964	1	125	centers	center	NOUN
ajlm-1964	1	126	for	for	ADP
ajlm-1964	1	127	disease	disease	NOUN
ajlm-1964	1	128	control	control	NOUN
ajlm-1964	1	129	and	and	CCONJ
ajlm-1964	1	130	prevention	prevention	NOUN
ajlm-1964	1	131	(	(	PUNCT
ajlm-1964	1	132	cdc	cdc	PROPN
ajlm-1964	1	133	)	)	PUNCT
ajlm-1964	1	134	,	,	PUNCT
ajlm-1964	1	135	atlanta	atlanta	PROPN
ajlm-1964	1	136	,	,	PUNCT
ajlm-1964	1	137	georgia	georgia	PROPN
ajlm-1964	1	138	,	,	PUNCT
ajlm-1964	1	139	united	united	PROPN
ajlm-1964	1	140	states	states	PROPN
ajlm-1964	1	141	anthony	anthony	PROPN
ajlm-1964	1	142	a.	a.	PROPN
ajlm-1964	1	143	azenabor	azenabor	PROPN
ajlm-1964	1	144	department	department	PROPN
ajlm-1964	1	145	of	of	ADP
ajlm-1964	1	146	pharmaceutical	pharmaceutical	NOUN
ajlm-1964	1	147	microbiology	microbiology	NOUN
ajlm-1964	1	148	and	and	CCONJ
ajlm-1964	1	149	biotechnology	biotechnology	NOUN
ajlm-1964	1	150	,	,	PUNCT
ajlm-1964	1	151	faculty	faculty	NOUN
ajlm-1964	1	152	of	of	ADP
ajlm-1964	1	153	pharmacy	pharmacy	NOUN
ajlm-1964	1	154	,	,	PUNCT
ajlm-1964	1	155	college	college	NOUN
ajlm-1964	1	156	of	of	ADP
ajlm-1964	1	157	medicine	medicine	NOUN
ajlm-1964	1	158	,	,	PUNCT
ajlm-1964	1	159	university	university	NOUN
ajlm-1964	1	160	of	of	ADP
ajlm-1964	1	161	lagos	lago	NOUN
ajlm-1964	1	162	,	,	PUNCT
ajlm-1964	1	163	lagos	lago	NOUN
ajlm-1964	1	164	,	,	PUNCT
ajlm-1964	1	165	nigeria	nigeria	PROPN
ajlm-1964	1	166	citation	citation	NOUN
ajlm-1964	1	167	idowu	idowu	PROPN
ajlm-1964	1	168	ao	ao	PROPN
ajlm-1964	1	169	,	,	PUNCT
ajlm-1964	1	170	omosun	omosun	PROPN
ajlm-1964	1	171	yo	yo	PROPN
ajlm-1964	1	172	,	,	PUNCT
ajlm-1964	1	173	igietseme	igietseme	PROPN
ajlm-1964	1	174	ju	ju	PROPN
ajlm-1964	1	175	,	,	PUNCT
ajlm-1964	1	176	azenabor	azenabor	PROPN
ajlm-1964	1	177	aa	aa	PROPN
ajlm-1964	1	178	.	.	PUNCT
ajlm-1964	2	1	the	the	DET
ajlm-1964	2	2	covid-19	covid-19	PROPN
ajlm-1964	2	3	pandemic	pandemic	NOUN
ajlm-1964	2	4	in	in	ADP
ajlm-1964	2	5	sub	sub	ADJ
ajlm-1964	2	6	-	-	ADJ
ajlm-1964	2	7	saharan	saharan	ADJ
ajlm-1964	2	8	africa	africa	PROPN
ajlm-1964	2	9	:	:	PUNCT
ajlm-1964	2	10	the	the	DET
ajlm-1964	2	11	significance	significance	NOUN
ajlm-1964	2	12	of	of	ADP
ajlm-1964	2	13	presumed	presume	VERB
ajlm-1964	2	14	immune	immune	ADJ
ajlm-1964	2	15	sufficiency	sufficiency	NOUN
ajlm-1964	2	16	.	.	PUNCT
ajlm-1964	3	1	afr	afr	PROPN
ajlm-1964	3	2	j	j	PROPN
ajlm-1964	3	3	lab	lab	PROPN
ajlm-1964	3	4	med	med	PROPN
ajlm-1964	3	5	.	.	PUNCT
ajlm-1964	4	1	2023;12(1	2023;12(1	NUM
ajlm-1964	4	2	)	)	PUNCT
ajlm-1964	4	3	,	,	PUNCT
ajlm-1964	4	4	a1964	a1964	PROPN
ajlm-1964	4	5	.	.	PUNCT
ajlm-1964	4	6	https://doi.org/10.4102/ajlm.v12i1.1964	https://doi.org/10.4102/ajlm.v12i1.1964	X
ajlm-1964	4	7	review	review	NOUN
ajlm-1964	4	8	article	article	NOUN
ajlm-1964	4	9	the	the	DET
ajlm-1964	4	10	covid-19	covid-19	PROPN
ajlm-1964	4	11	pandemic	pandemic	NOUN
ajlm-1964	4	12	in	in	ADP
ajlm-1964	4	13	sub	sub	ADJ
ajlm-1964	4	14	-	-	ADJ
ajlm-1964	4	15	saharan	saharan	ADJ
ajlm-1964	4	16	africa	africa	PROPN
ajlm-1964	4	17	:	:	PUNCT
ajlm-1964	4	18	the	the	DET
ajlm-1964	4	19	significance	significance	NOUN
ajlm-1964	4	20	of	of	ADP
ajlm-1964	4	21	presumed	presume	VERB
ajlm-1964	4	22	immune	immune	ADJ
ajlm-1964	4	23	sufficiency	sufficiency	NOUN
ajlm-1964	4	24	abel	abel	PROPN
ajlm-1964	4	25	o.	o.	PROPN
ajlm-1964	4	26	idowu	idowu	PROPN
ajlm-1964	4	27	,	,	PUNCT
ajlm-1964	4	28	yusuf	yusuf	PROPN
ajlm-1964	4	29	o.	o.	PROPN
ajlm-1964	4	30	omosun	omosun	PROPN
ajlm-1964	4	31	,	,	PUNCT
ajlm-1964	4	32	joseph	joseph	PROPN
ajlm-1964	4	33	u.	u.	PROPN
ajlm-1964	4	34	igietseme	igietseme	PROPN
ajlm-1964	4	35	,	,	PUNCT
ajlm-1964	4	36	anthony	anthony	PROPN
ajlm-1964	4	37	a.	a.	PROPN
ajlm-1964	4	38	azenabor	azenabor	PROPN
ajlm-1964	4	39	received	receive	VERB
ajlm-1964	4	40	:	:	PUNCT
ajlm-1964	4	41	01	01	NUM
ajlm-1964	4	42	june	june	PROPN
ajlm-1964	4	43	2022	2022	NUM
ajlm-1964	4	44	;	;	PUNCT
ajlm-1964	4	45	accepted	accept	VERB
ajlm-1964	4	46	:	:	PUNCT
ajlm-1964	4	47	24	24	NUM
ajlm-1964	4	48	oct	oct	PROPN
ajlm-1964	4	49	.	.	PROPN
ajlm-1964	4	50	2022	2022	NUM
ajlm-1964	4	51	;	;	PUNCT
ajlm-1964	4	52	published	publish	VERB
ajlm-1964	4	53	:	:	PUNCT
ajlm-1964	4	54	30	30	NUM
ajlm-1964	4	55	jan	jan	PROPN
ajlm-1964	4	56	.	.	PROPN
ajlm-1964	5	1	2023	2023	NUM
ajlm-1964	5	2	copyright	copyright	NOUN
ajlm-1964	5	3	:	:	PUNCT
ajlm-1964	5	4	©	©	PROPN
ajlm-1964	5	5	2023	2023	NUM
ajlm-1964	5	6	.	.	PUNCT
ajlm-1964	6	1	the	the	DET
ajlm-1964	6	2	author(s	author(s	NOUN
ajlm-1964	6	3	)	)	PUNCT
ajlm-1964	6	4	.	.	PUNCT
ajlm-1964	7	1	licensee	licensee	NOUN
ajlm-1964	7	2	:	:	PUNCT
ajlm-1964	7	3	aosis	aosis	NOUN
ajlm-1964	7	4	.	.	PUNCT
ajlm-1964	8	1	this	this	PRON
ajlm-1964	8	2	is	be	AUX
ajlm-1964	8	3	an	an	DET
ajlm-1964	8	4	open	open	ADJ
ajlm-1964	8	5	access	access	NOUN
ajlm-1964	8	6	article	article	NOUN
ajlm-1964	8	7	distributed	distribute	VERB
ajlm-1964	8	8	under	under	ADP
ajlm-1964	8	9	the	the	DET
ajlm-1964	8	10	terms	term	NOUN
ajlm-1964	8	11	of	of	ADP
ajlm-1964	8	12	the	the	DET
ajlm-1964	8	13	creative	creative	ADJ
ajlm-1964	8	14	commons	common	NOUN
ajlm-1964	8	15	attribution	attribution	NOUN
ajlm-1964	8	16	license	license	NOUN
ajlm-1964	8	17	,	,	PUNCT
ajlm-1964	8	18	which	which	PRON
ajlm-1964	8	19	permits	permit	VERB
ajlm-1964	8	20	unrestricted	unrestricted	ADJ
ajlm-1964	8	21	use	use	NOUN
ajlm-1964	8	22	,	,	PUNCT
ajlm-1964	8	23	distribution	distribution	NOUN
ajlm-1964	8	24	,	,	PUNCT
ajlm-1964	8	25	and	and	CCONJ
ajlm-1964	8	26	reproduction	reproduction	NOUN
ajlm-1964	8	27	in	in	ADP
ajlm-1964	8	28	any	any	DET
ajlm-1964	8	29	medium	medium	NOUN
ajlm-1964	8	30	,	,	PUNCT
ajlm-1964	8	31	provided	provide	VERB
ajlm-1964	8	32	the	the	DET
ajlm-1964	8	33	original	original	ADJ
ajlm-1964	8	34	work	work	NOUN
ajlm-1964	8	35	is	be	AUX
ajlm-1964	8	36	properly	properly	ADV
ajlm-1964	8	37	cited	cite	VERB
ajlm-1964	8	38	.	.	PUNCT
ajlm-1964	9	1	abstract	abstract	ADJ
ajlm-1964	9	2	a	a	DET
ajlm-1964	9	3	novel	novel	ADJ
ajlm-1964	9	4	coronavirus	coronavirus	NOUN
ajlm-1964	9	5	known	know	VERB
ajlm-1964	9	6	as	as	ADP
ajlm-1964	9	7	severe	severe	ADJ
ajlm-1964	9	8	acute	acute	ADJ
ajlm-1964	9	9	respiratory	respiratory	ADJ
ajlm-1964	9	10	syndrome	syndrome	NOUN
ajlm-1964	9	11	coronavirus	coronavirus	NOUN
ajlm-1964	9	12	2	2	NUM
ajlm-1964	9	13	(	(	PUNCT
ajlm-1964	9	14	sars	sar	NOUN
ajlm-1964	9	15	-	-	PUNCT
ajlm-1964	9	16	cov-2	cov-2	NOUN
ajlm-1964	9	17	)	)	PUNCT
ajlm-1964	9	18	was	be	AUX
ajlm-1964	9	19	first	first	ADV
ajlm-1964	9	20	reported	report	VERB
ajlm-1964	9	21	in	in	ADP
ajlm-1964	9	22	china	china	PROPN
ajlm-1964	9	23	in	in	ADP
ajlm-1964	9	24	2019	2019	NUM
ajlm-1964	9	25	and	and	CCONJ
ajlm-1964	9	26	later	later	ADV
ajlm-1964	9	27	ignited	ignite	VERB
ajlm-1964	9	28	a	a	DET
ajlm-1964	9	29	global	global	ADJ
ajlm-1964	9	30	pandemic	pandemic	NOUN
ajlm-1964	9	31	.	.	PUNCT
ajlm-1964	10	1	contrary	contrary	ADJ
ajlm-1964	10	2	to	to	ADP
ajlm-1964	10	3	expectations	expectation	NOUN
ajlm-1964	10	4	,	,	PUNCT
ajlm-1964	10	5	the	the	DET
ajlm-1964	10	6	effect	effect	NOUN
ajlm-1964	10	7	of	of	ADP
ajlm-1964	10	8	the	the	DET
ajlm-1964	10	9	pandemic	pandemic	NOUN
ajlm-1964	10	10	was	be	AUX
ajlm-1964	10	11	not	not	PART
ajlm-1964	10	12	as	as	ADV
ajlm-1964	10	13	devastating	devastating	ADJ
ajlm-1964	10	14	to	to	ADP
ajlm-1964	10	15	africa	africa	PROPN
ajlm-1964	10	16	and	and	CCONJ
ajlm-1964	10	17	its	its	PRON
ajlm-1964	10	18	young	young	ADJ
ajlm-1964	10	19	population	population	NOUN
ajlm-1964	10	20	compared	compare	VERB
ajlm-1964	10	21	to	to	ADP
ajlm-1964	10	22	the	the	DET
ajlm-1964	10	23	rest	rest	NOUN
ajlm-1964	10	24	of	of	ADP
ajlm-1964	10	25	the	the	DET
ajlm-1964	10	26	world	world	NOUN
ajlm-1964	10	27	.	.	PUNCT
ajlm-1964	11	1	to	to	PART
ajlm-1964	11	2	provide	provide	VERB
ajlm-1964	11	3	insight	insight	NOUN
ajlm-1964	11	4	into	into	ADP
ajlm-1964	11	5	the	the	DET
ajlm-1964	11	6	possible	possible	ADJ
ajlm-1964	11	7	reasons	reason	NOUN
ajlm-1964	11	8	for	for	ADP
ajlm-1964	11	9	the	the	DET
ajlm-1964	11	10	presumed	presume	VERB
ajlm-1964	11	11	immune	immune	ADJ
ajlm-1964	11	12	sufficiency	sufficiency	NOUN
ajlm-1964	11	13	to	to	ADP
ajlm-1964	11	14	coronavirus	coronavirus	NOUN
ajlm-1964	11	15	disease	disease	NOUN
ajlm-1964	11	16	2019	2019	NUM
ajlm-1964	11	17	(	(	PUNCT
ajlm-1964	11	18	covid-19	covid-19	PROPN
ajlm-1964	11	19	)	)	PUNCT
ajlm-1964	11	20	in	in	ADP
ajlm-1964	11	21	africa	africa	PROPN
ajlm-1964	11	22	,	,	PUNCT
ajlm-1964	11	23	this	this	DET
ajlm-1964	11	24	review	review	NOUN
ajlm-1964	11	25	critically	critically	ADV
ajlm-1964	11	26	examines	examine	VERB
ajlm-1964	11	27	literature	literature	NOUN
ajlm-1964	11	28	published	publish	VERB
ajlm-1964	11	29	from	from	ADP
ajlm-1964	11	30	2020	2020	NUM
ajlm-1964	11	31	onwards	onwards	ADV
ajlm-1964	11	32	on	on	ADP
ajlm-1964	11	33	the	the	DET
ajlm-1964	11	34	dynamics	dynamic	NOUN
ajlm-1964	11	35	of	of	ADP
ajlm-1964	11	36	covid-19	covid-19	PROPN
ajlm-1964	11	37	infection	infection	NOUN
ajlm-1964	11	38	and	and	CCONJ
ajlm-1964	11	39	immunity	immunity	NOUN
ajlm-1964	11	40	and	and	CCONJ
ajlm-1964	11	41	how	how	SCONJ
ajlm-1964	11	42	other	other	ADJ
ajlm-1964	11	43	prevalent	prevalent	ADJ
ajlm-1964	11	44	infectious	infectious	ADJ
ajlm-1964	11	45	diseases	disease	NOUN
ajlm-1964	11	46	in	in	ADP
ajlm-1964	11	47	africa	africa	PROPN
ajlm-1964	11	48	might	might	AUX
ajlm-1964	11	49	have	have	AUX
ajlm-1964	11	50	influenced	influence	VERB
ajlm-1964	11	51	the	the	DET
ajlm-1964	11	52	outcome	outcome	NOUN
ajlm-1964	11	53	of	of	ADP
ajlm-1964	11	54	covid-19	covid-19	PROPN
ajlm-1964	11	55	.	.	PUNCT
ajlm-1964	12	1	studies	study	NOUN
ajlm-1964	12	2	characterising	characterise	VERB
ajlm-1964	12	3	the	the	DET
ajlm-1964	12	4	immune	immune	ADJ
ajlm-1964	12	5	response	response	NOUN
ajlm-1964	12	6	in	in	ADP
ajlm-1964	12	7	patients	patient	NOUN
ajlm-1964	12	8	with	with	ADP
ajlm-1964	12	9	covid-19	covid-19	PROPN
ajlm-1964	12	10	show	show	VERB
ajlm-1964	12	11	that	that	SCONJ
ajlm-1964	12	12	the	the	DET
ajlm-1964	12	13	correlates	correlate	NOUN
ajlm-1964	12	14	of	of	ADP
ajlm-1964	12	15	protection	protection	NOUN
ajlm-1964	12	16	in	in	ADP
ajlm-1964	12	17	infected	infected	ADJ
ajlm-1964	12	18	individuals	individual	NOUN
ajlm-1964	12	19	are	be	AUX
ajlm-1964	12	20	t	t	NOUN
ajlm-1964	12	21	-	-	PUNCT
ajlm-1964	12	22	cell	cell	NOUN
ajlm-1964	12	23	responses	response	NOUN
ajlm-1964	12	24	against	against	ADP
ajlm-1964	12	25	the	the	DET
ajlm-1964	12	26	sars	sar	NOUN
ajlm-1964	12	27	-	-	PUNCT
ajlm-1964	12	28	cov-2	cov-2	NOUN
ajlm-1964	12	29	spike	spike	ADJ
ajlm-1964	12	30	protein	protein	NOUN
ajlm-1964	12	31	and	and	CCONJ
ajlm-1964	12	32	neutralising	neutralise	VERB
ajlm-1964	12	33	titres	titre	NOUN
ajlm-1964	12	34	of	of	ADP
ajlm-1964	12	35	immunoglobin	immunoglobin	PROPN
ajlm-1964	12	36	g	g	PROPN
ajlm-1964	12	37	and	and	CCONJ
ajlm-1964	12	38	immunoglobin	immunoglobin	PROPN
ajlm-1964	12	39	a	a	DET
ajlm-1964	12	40	antibodies	antibody	NOUN
ajlm-1964	12	41	.	.	PUNCT
ajlm-1964	13	1	in	in	ADP
ajlm-1964	13	2	some	some	DET
ajlm-1964	13	3	other	other	ADJ
ajlm-1964	13	4	studies	study	NOUN
ajlm-1964	13	5	,	,	PUNCT
ajlm-1964	13	6	substantial	substantial	ADJ
ajlm-1964	13	7	pre	pre	ADJ
ajlm-1964	13	8	-	-	ADJ
ajlm-1964	13	9	existing	existing	ADJ
ajlm-1964	13	10	t	t	NOUN
ajlm-1964	13	11	-	-	PUNCT
ajlm-1964	13	12	cell	cell	NOUN
ajlm-1964	13	13	reactivity	reactivity	NOUN
ajlm-1964	13	14	to	to	ADP
ajlm-1964	13	15	sars	sar	NOUN
ajlm-1964	13	16	-	-	PUNCT
ajlm-1964	13	17	cov-2	cov-2	PART
ajlm-1964	13	18	was	be	AUX
ajlm-1964	13	19	detected	detect	VERB
ajlm-1964	13	20	in	in	ADP
ajlm-1964	13	21	many	many	ADJ
ajlm-1964	13	22	people	people	NOUN
ajlm-1964	13	23	from	from	ADP
ajlm-1964	13	24	diverse	diverse	ADJ
ajlm-1964	13	25	geographical	geographical	ADJ
ajlm-1964	13	26	locations	location	NOUN
ajlm-1964	13	27	without	without	ADP
ajlm-1964	13	28	a	a	DET
ajlm-1964	13	29	history	history	NOUN
ajlm-1964	13	30	of	of	ADP
ajlm-1964	13	31	exposure	exposure	NOUN
ajlm-1964	13	32	.	.	PUNCT
ajlm-1964	14	1	certain	certain	ADJ
ajlm-1964	14	2	studies	study	NOUN
ajlm-1964	14	3	also	also	ADV
ajlm-1964	14	4	suggest	suggest	VERB
ajlm-1964	14	5	that	that	SCONJ
ajlm-1964	14	6	innate	innate	ADJ
ajlm-1964	14	7	immune	immune	ADJ
ajlm-1964	14	8	memory	memory	NOUN
ajlm-1964	14	9	,	,	PUNCT
ajlm-1964	14	10	which	which	PRON
ajlm-1964	14	11	offers	offer	VERB
ajlm-1964	14	12	protection	protection	NOUN
ajlm-1964	14	13	against	against	ADP
ajlm-1964	14	14	reinfection	reinfection	NOUN
ajlm-1964	14	15	with	with	ADP
ajlm-1964	14	16	the	the	DET
ajlm-1964	14	17	same	same	ADJ
ajlm-1964	14	18	or	or	CCONJ
ajlm-1964	14	19	another	another	DET
ajlm-1964	14	20	pathogen	pathogen	NOUN
ajlm-1964	14	21	,	,	PUNCT
ajlm-1964	14	22	might	might	AUX
ajlm-1964	14	23	influence	influence	VERB
ajlm-1964	14	24	the	the	DET
ajlm-1964	14	25	severity	severity	NOUN
ajlm-1964	14	26	of	of	ADP
ajlm-1964	14	27	covid-19	covid-19	PROPN
ajlm-1964	14	28	.	.	PUNCT
ajlm-1964	15	1	in	in	ADP
ajlm-1964	15	2	addition	addition	NOUN
ajlm-1964	15	3	,	,	PUNCT
ajlm-1964	15	4	an	an	DET
ajlm-1964	15	5	initial	initial	ADJ
ajlm-1964	15	6	analysis	analysis	NOUN
ajlm-1964	15	7	of	of	ADP
ajlm-1964	15	8	epidemiological	epidemiological	ADJ
ajlm-1964	15	9	data	datum	NOUN
ajlm-1964	15	10	showed	show	VERB
ajlm-1964	15	11	that	that	SCONJ
ajlm-1964	15	12	covid‑19	covid‑19	PROPN
ajlm-1964	15	13	cases	case	NOUN
ajlm-1964	15	14	were	be	AUX
ajlm-1964	15	15	not	not	PART
ajlm-1964	15	16	severe	severe	ADJ
ajlm-1964	15	17	in	in	ADP
ajlm-1964	15	18	some	some	DET
ajlm-1964	15	19	countries	country	NOUN
ajlm-1964	15	20	that	that	PRON
ajlm-1964	15	21	implemented	implement	VERB
ajlm-1964	15	22	universal	universal	ADJ
ajlm-1964	15	23	bacillus	bacillus	NOUN
ajlm-1964	15	24	calmette	calmette	NOUN
ajlm-1964	15	25	–	–	PUNCT
ajlm-1964	15	26	guerin	guerin	PROPN
ajlm-1964	15	27	(	(	PUNCT
ajlm-1964	15	28	bcg	bcg	PROPN
ajlm-1964	15	29	)	)	PUNCT
ajlm-1964	15	30	vaccination	vaccination	NOUN
ajlm-1964	15	31	policies	policy	NOUN
ajlm-1964	15	32	,	,	PUNCT
ajlm-1964	15	33	thus	thus	ADV
ajlm-1964	15	34	supporting	support	VERB
ajlm-1964	15	35	the	the	DET
ajlm-1964	15	36	potential	potential	NOUN
ajlm-1964	15	37	of	of	ADP
ajlm-1964	15	38	bcg	bcg	PROPN
ajlm-1964	15	39	vaccination	vaccination	NOUN
ajlm-1964	15	40	to	to	PART
ajlm-1964	15	41	boost	boost	VERB
ajlm-1964	15	42	innate	innate	ADJ
ajlm-1964	15	43	immunity	immunity	NOUN
ajlm-1964	15	44	.	.	PUNCT
ajlm-1964	16	1	the	the	DET
ajlm-1964	16	2	high	high	ADJ
ajlm-1964	16	3	burden	burden	NOUN
ajlm-1964	16	4	of	of	ADP
ajlm-1964	16	5	infectious	infectious	ADJ
ajlm-1964	16	6	diseases	disease	NOUN
ajlm-1964	16	7	and	and	CCONJ
ajlm-1964	16	8	the	the	DET
ajlm-1964	16	9	extensive	extensive	ADJ
ajlm-1964	16	10	vaccination	vaccination	NOUN
ajlm-1964	16	11	campaigns	campaign	NOUN
ajlm-1964	16	12	previously	previously	ADV
ajlm-1964	16	13	conducted	conduct	VERB
ajlm-1964	16	14	in	in	ADP
ajlm-1964	16	15	africa	africa	PROPN
ajlm-1964	16	16	could	could	AUX
ajlm-1964	16	17	have	have	AUX
ajlm-1964	16	18	induced	induce	VERB
ajlm-1964	16	19	specific	specific	ADJ
ajlm-1964	16	20	and	and	CCONJ
ajlm-1964	16	21	non	non	ADJ
ajlm-1964	16	22	-	-	ADJ
ajlm-1964	16	23	specific	specific	ADJ
ajlm-1964	16	24	protective	protective	ADJ
ajlm-1964	16	25	immunity	immunity	NOUN
ajlm-1964	16	26	to	to	ADP
ajlm-1964	16	27	infectious	infectious	ADJ
ajlm-1964	16	28	pathogens	pathogen	NOUN
ajlm-1964	16	29	in	in	ADP
ajlm-1964	16	30	africans	africans	PROPN
ajlm-1964	16	31	.	.	PUNCT
ajlm-1964	17	1	keywords	keyword	NOUN
ajlm-1964	17	2	:	:	PUNCT
ajlm-1964	17	3	covid-19	covid-19	PROPN
ajlm-1964	17	4	;	;	PUNCT
ajlm-1964	17	5	coronavirus	coronaviru	NOUN
ajlm-1964	17	6	;	;	PUNCT
ajlm-1964	17	7	immune	immune	ADJ
ajlm-1964	17	8	response	response	NOUN
ajlm-1964	17	9	;	;	PUNCT
ajlm-1964	17	10	sub	sub	ADJ
ajlm-1964	17	11	-	-	ADJ
ajlm-1964	17	12	saharan	saharan	ADJ
ajlm-1964	17	13	africa	africa	PROPN
ajlm-1964	17	14	;	;	PUNCT
ajlm-1964	17	15	infectious	infectious	ADJ
ajlm-1964	17	16	diseases	disease	NOUN
ajlm-1964	17	17	.	.	PUNCT
ajlm-1964	18	1	introduction	introduction	NOUN
ajlm-1964	18	2	in	in	ADP
ajlm-1964	18	3	december	december	PROPN
ajlm-1964	18	4	2019	2019	NUM
ajlm-1964	18	5	,	,	PUNCT
ajlm-1964	18	6	a	a	DET
ajlm-1964	18	7	group	group	NOUN
ajlm-1964	18	8	of	of	ADP
ajlm-1964	18	9	pneumonia	pneumonia	NOUN
ajlm-1964	18	10	cases	case	NOUN
ajlm-1964	18	11	of	of	ADP
ajlm-1964	18	12	undetermined	undetermined	ADJ
ajlm-1964	18	13	origin	origin	NOUN
ajlm-1964	18	14	where	where	SCONJ
ajlm-1964	18	15	patients	patient	NOUN
ajlm-1964	18	16	presented	present	VERB
ajlm-1964	18	17	with	with	ADP
ajlm-1964	18	18	clinical	clinical	ADJ
ajlm-1964	18	19	signs	sign	NOUN
ajlm-1964	18	20	that	that	PRON
ajlm-1964	18	21	resemble	resemble	VERB
ajlm-1964	18	22	viral	viral	ADJ
ajlm-1964	18	23	pneumonia	pneumonia	NOUN
ajlm-1964	18	24	was	be	AUX
ajlm-1964	18	25	first	first	ADV
ajlm-1964	18	26	described	describe	VERB
ajlm-1964	18	27	in	in	ADP
ajlm-1964	18	28	the	the	DET
ajlm-1964	18	29	city	city	NOUN
ajlm-1964	18	30	of	of	ADP
ajlm-1964	18	31	wuhan	wuhan	PROPN
ajlm-1964	18	32	,	,	PUNCT
ajlm-1964	18	33	hubei	hubei	PROPN
ajlm-1964	18	34	,	,	PUNCT
ajlm-1964	18	35	china.1	china.1	NOUN
ajlm-1964	18	36	analysis	analysis	NOUN
ajlm-1964	18	37	of	of	ADP
ajlm-1964	18	38	samples	sample	NOUN
ajlm-1964	18	39	from	from	ADP
ajlm-1964	18	40	the	the	DET
ajlm-1964	18	41	lower	low	ADJ
ajlm-1964	18	42	respiratory	respiratory	ADJ
ajlm-1964	18	43	tract	tract	NOUN
ajlm-1964	18	44	by	by	ADP
ajlm-1964	18	45	deep	deep	ADJ
ajlm-1964	18	46	sequencing	sequencing	NOUN
ajlm-1964	18	47	implicated	implicate	VERB
ajlm-1964	18	48	a	a	DET
ajlm-1964	18	49	novel	novel	ADJ
ajlm-1964	18	50	coronavirus	coronavirus	NOUN
ajlm-1964	18	51	that	that	PRON
ajlm-1964	18	52	was	be	AUX
ajlm-1964	18	53	named	name	VERB
ajlm-1964	18	54	2019	2019	NUM
ajlm-1964	18	55	-	-	SYM
ajlm-1964	18	56	ncov.1,2	ncov.1,2	NOUN
ajlm-1964	18	57	on	on	ADP
ajlm-1964	18	58	11	11	NUM
ajlm-1964	18	59	march	march	NOUN
ajlm-1964	18	60	2020	2020	NUM
ajlm-1964	18	61	,	,	PUNCT
ajlm-1964	18	62	the	the	DET
ajlm-1964	18	63	world	world	PROPN
ajlm-1964	18	64	health	health	NOUN
ajlm-1964	18	65	organization	organization	NOUN
ajlm-1964	18	66	(	(	PUNCT
ajlm-1964	18	67	who	who	PRON
ajlm-1964	18	68	)	)	PUNCT
ajlm-1964	18	69	declared	declare	VERB
ajlm-1964	18	70	the	the	DET
ajlm-1964	18	71	coronavirus	coronavirus	NOUN
ajlm-1964	18	72	disease	disease	NOUN
ajlm-1964	18	73	2019	2019	NUM
ajlm-1964	18	74	(	(	PUNCT
ajlm-1964	18	75	covid-19	covid-19	PROPN
ajlm-1964	18	76	)	)	PUNCT
ajlm-1964	18	77	,	,	PUNCT
ajlm-1964	18	78	caused	cause	VERB
ajlm-1964	18	79	by	by	ADP
ajlm-1964	18	80	severe	severe	ADJ
ajlm-1964	18	81	acute	acute	ADJ
ajlm-1964	18	82	respiratory	respiratory	ADJ
ajlm-1964	18	83	syndrome	syndrome	NOUN
ajlm-1964	18	84	coronavirus	coronavirus	NOUN
ajlm-1964	18	85	2	2	NUM
ajlm-1964	18	86	(	(	PUNCT
ajlm-1964	18	87	sars	sar	NOUN
ajlm-1964	18	88	-	-	PUNCT
ajlm-1964	18	89	cov-2	cov-2	NOUN
ajlm-1964	18	90	)	)	PUNCT
ajlm-1964	18	91	,	,	PUNCT
ajlm-1964	18	92	a	a	DET
ajlm-1964	18	93	worldwide	worldwide	ADJ
ajlm-1964	18	94	pandemic	pandemic	ADJ
ajlm-1964	18	95	.	.	PUNCT
ajlm-1964	19	1	as	as	ADP
ajlm-1964	19	2	of	of	ADP
ajlm-1964	19	3	07	07	NUM
ajlm-1964	19	4	september	september	PROPN
ajlm-1964	19	5	2021	2021	NUM
ajlm-1964	19	6	,	,	PUNCT
ajlm-1964	19	7	sars	sar	NOUN
ajlm-1964	19	8	-	-	PUNCT
ajlm-1964	19	9	cov-2	cov-2	PART
ajlm-1964	19	10	had	have	AUX
ajlm-1964	19	11	cumulatively	cumulatively	ADV
ajlm-1964	19	12	infected	infect	VERB
ajlm-1964	19	13	over	over	ADP
ajlm-1964	19	14	224	224	NUM
ajlm-1964	19	15	686	686	NUM
ajlm-1964	19	16	497	497	NUM
ajlm-1964	19	17	people	people	NOUN
ajlm-1964	19	18	and	and	CCONJ
ajlm-1964	19	19	caused	cause	VERB
ajlm-1964	19	20	4	4	NUM
ajlm-1964	19	21	566	566	NUM
ajlm-1964	19	22	167	167	NUM
ajlm-1964	19	23	deaths	death	NOUN
ajlm-1964	19	24	in	in	ADP
ajlm-1964	19	25	225	225	NUM
ajlm-1964	19	26	countries	country	NOUN
ajlm-1964	19	27	,	,	PUNCT
ajlm-1964	19	28	with	with	ADP
ajlm-1964	19	29	a	a	DET
ajlm-1964	19	30	case	case	NOUN
ajlm-1964	19	31	fatality	fatality	NOUN
ajlm-1964	19	32	rate	rate	NOUN
ajlm-1964	19	33	of	of	ADP
ajlm-1964	19	34	2.1%.3	2.1%.3	PROPN
ajlm-1964	19	35	the	the	DET
ajlm-1964	19	36	spectrum	spectrum	NOUN
ajlm-1964	19	37	of	of	ADP
ajlm-1964	19	38	covid-19	covid-19	PROPN
ajlm-1964	19	39	manifestation	manifestation	NOUN
ajlm-1964	19	40	may	may	AUX
ajlm-1964	19	41	vary	vary	VERB
ajlm-1964	19	42	from	from	ADP
ajlm-1964	19	43	a	a	DET
ajlm-1964	19	44	self	self	NOUN
ajlm-1964	19	45	-	-	PUNCT
ajlm-1964	19	46	limiting	limit	VERB
ajlm-1964	19	47	mild	mild	ADJ
ajlm-1964	19	48	respiratory	respiratory	ADJ
ajlm-1964	19	49	tract	tract	NOUN
ajlm-1964	19	50	infection	infection	NOUN
ajlm-1964	19	51	to	to	ADP
ajlm-1964	19	52	a	a	DET
ajlm-1964	19	53	severe	severe	ADJ
ajlm-1964	19	54	pneumonia	pneumonia	NOUN
ajlm-1964	19	55	that	that	PRON
ajlm-1964	19	56	could	could	AUX
ajlm-1964	19	57	lead	lead	VERB
ajlm-1964	19	58	to	to	ADP
ajlm-1964	19	59	the	the	DET
ajlm-1964	19	60	failure	failure	NOUN
ajlm-1964	19	61	of	of	ADP
ajlm-1964	19	62	multiple	multiple	ADJ
ajlm-1964	19	63	organs	organ	NOUN
ajlm-1964	19	64	and	and	CCONJ
ajlm-1964	19	65	death.4	death.4	VERB
ajlm-1964	19	66	the	the	DET
ajlm-1964	19	67	common	common	ADJ
ajlm-1964	19	68	symptoms	symptom	NOUN
ajlm-1964	19	69	,	,	PUNCT
ajlm-1964	19	70	including	include	VERB
ajlm-1964	19	71	fever	fever	NOUN
ajlm-1964	19	72	,	,	PUNCT
ajlm-1964	19	73	cough	cough	NOUN
ajlm-1964	19	74	,	,	PUNCT
ajlm-1964	19	75	and	and	CCONJ
ajlm-1964	19	76	difficulty	difficulty	NOUN
ajlm-1964	19	77	in	in	ADP
ajlm-1964	19	78	breathing	breathing	NOUN
ajlm-1964	19	79	,	,	PUNCT
ajlm-1964	19	80	typically	typically	ADV
ajlm-1964	19	81	emerge	emerge	VERB
ajlm-1964	19	82	within	within	ADP
ajlm-1964	19	83	2–14	2–14	NOUN
ajlm-1964	19	84	days	day	NOUN
ajlm-1964	19	85	after	after	SCONJ
ajlm-1964	19	86	exposure.4,5	exposure.4,5	NOUN
ajlm-1964	19	87	certain	certain	ADJ
ajlm-1964	19	88	individuals	individual	NOUN
ajlm-1964	19	89	may	may	AUX
ajlm-1964	19	90	,	,	PUNCT
ajlm-1964	19	91	however	however	ADV
ajlm-1964	19	92	,	,	PUNCT
ajlm-1964	19	93	exhibit	exhibit	VERB
ajlm-1964	19	94	minimal	minimal	ADJ
ajlm-1964	19	95	or	or	CCONJ
ajlm-1964	19	96	no	no	DET
ajlm-1964	19	97	symptoms	symptom	NOUN
ajlm-1964	19	98	even	even	ADV
ajlm-1964	19	99	with	with	ADP
ajlm-1964	19	100	a	a	DET
ajlm-1964	19	101	positive	positive	ADJ
ajlm-1964	19	102	reverse	reverse	NOUN
ajlm-1964	19	103	transcription	transcription	NOUN
ajlm-1964	19	104	polymerase	polymerase	NOUN
ajlm-1964	19	105	chain	chain	NOUN
ajlm-1964	19	106	reaction	reaction	NOUN
ajlm-1964	19	107	test.6,7,8,9	test.6,7,8,9	VERB
ajlm-1964	19	108	the	the	DET
ajlm-1964	19	109	risk	risk	NOUN
ajlm-1964	19	110	of	of	ADP
ajlm-1964	19	111	death	death	NOUN
ajlm-1964	19	112	is	be	AUX
ajlm-1964	19	113	greater	great	ADJ
ajlm-1964	19	114	among	among	ADP
ajlm-1964	19	115	older	old	ADJ
ajlm-1964	19	116	or	or	CCONJ
ajlm-1964	19	117	immunocompromised	immunocompromise	VERB
ajlm-1964	19	118	patients,10	patients,10	NOUN
ajlm-1964	19	119	and	and	CCONJ
ajlm-1964	19	120	the	the	DET
ajlm-1964	19	121	ability	ability	NOUN
ajlm-1964	19	122	of	of	ADP
ajlm-1964	19	123	asymptomatic	asymptomatic	ADJ
ajlm-1964	19	124	individuals	individual	NOUN
ajlm-1964	19	125	to	to	PART
ajlm-1964	19	126	efficiently	efficiently	ADV
ajlm-1964	19	127	transmit	transmit	VERB
ajlm-1964	19	128	the	the	DET
ajlm-1964	19	129	virus11	virus11	NOUN
ajlm-1964	19	130	has	have	AUX
ajlm-1964	19	131	made	make	VERB
ajlm-1964	19	132	it	it	PRON
ajlm-1964	19	133	difficult	difficult	ADJ
ajlm-1964	19	134	to	to	PART
ajlm-1964	19	135	control	control	VERB
ajlm-1964	19	136	the	the	DET
ajlm-1964	19	137	epidemic.6	epidemic.6	PROPN
ajlm-1964	19	138	coronaviruses	coronaviruse	NOUN
ajlm-1964	19	139	are	be	AUX
ajlm-1964	19	140	characteristically	characteristically	ADV
ajlm-1964	19	141	single	single	ADJ
ajlm-1964	19	142	-	-	PUNCT
ajlm-1964	19	143	stranded	strand	VERB
ajlm-1964	19	144	,	,	PUNCT
ajlm-1964	19	145	positive	positive	ADJ
ajlm-1964	19	146	-	-	PUNCT
ajlm-1964	19	147	sense	sense	NOUN
ajlm-1964	19	148	rna	rna	NOUN
ajlm-1964	19	149	viruses	virus	NOUN
ajlm-1964	19	150	that	that	PRON
ajlm-1964	19	151	disseminate	disseminate	VERB
ajlm-1964	19	152	widely	widely	ADV
ajlm-1964	19	153	in	in	ADP
ajlm-1964	19	154	birds	bird	NOUN
ajlm-1964	19	155	,	,	PUNCT
ajlm-1964	19	156	humans	human	NOUN
ajlm-1964	19	157	,	,	PUNCT
ajlm-1964	19	158	and	and	CCONJ
ajlm-1964	19	159	other	other	ADJ
ajlm-1964	19	160	mammals	mammal	NOUN
ajlm-1964	19	161	,	,	PUNCT
ajlm-1964	19	162	and	and	CCONJ
ajlm-1964	19	163	can	can	AUX
ajlm-1964	19	164	cause	cause	VERB
ajlm-1964	19	165	enteric	enteric	NOUN
ajlm-1964	19	166	,	,	PUNCT
ajlm-1964	19	167	respiratory	respiratory	ADJ
ajlm-1964	19	168	,	,	PUNCT
ajlm-1964	19	169	neurological	neurological	ADJ
ajlm-1964	19	170	,	,	PUNCT
ajlm-1964	19	171	and	and	CCONJ
ajlm-1964	19	172	hepatic	hepatic	ADJ
ajlm-1964	19	173	diseases.12,13	diseases.12,13	NOUN
ajlm-1964	19	174	six	six	NUM
ajlm-1964	19	175	species	specie	NOUN
ajlm-1964	19	176	of	of	ADP
ajlm-1964	19	177	coronavirus	coronavirus	NOUN
ajlm-1964	19	178	species	specie	NOUN
ajlm-1964	19	179	cause	cause	VERB
ajlm-1964	19	180	human	human	ADJ
ajlm-1964	19	181	diseases	disease	NOUN
ajlm-1964	19	182	,	,	PUNCT
ajlm-1964	19	183	and	and	CCONJ
ajlm-1964	19	184	four	four	NUM
ajlm-1964	19	185	of	of	ADP
ajlm-1964	19	186	them	they	PRON
ajlm-1964	19	187	,	,	PUNCT
ajlm-1964	19	188	nl63	nl63	PROPN
ajlm-1964	19	189	,	,	PUNCT
ajlm-1964	19	190	hku1	hku1	PROPN
ajlm-1964	19	191	,	,	PUNCT
ajlm-1964	19	192	hcov-229e	hcov-229e	PROPN
ajlm-1964	19	193	,	,	PUNCT
ajlm-1964	19	194	and	and	CCONJ
ajlm-1964	19	195	oc43	oc43	PROPN
ajlm-1964	19	196	,	,	PUNCT
ajlm-1964	19	197	are	be	AUX
ajlm-1964	19	198	predominantly	predominantly	ADV
ajlm-1964	19	199	responsible	responsible	ADJ
ajlm-1964	19	200	for	for	ADP
ajlm-1964	19	201	mild	mild	ADJ
ajlm-1964	19	202	respiratory	respiratory	ADJ
ajlm-1964	19	203	infections.14	infections.14	NOUN
ajlm-1964	19	204	the	the	DET
ajlm-1964	19	205	first	first	ADJ
ajlm-1964	19	206	sars	sars	PROPN
ajlm-1964	19	207	-	-	PUNCT
ajlm-1964	19	208	cov	cov	NOUN
ajlm-1964	19	209	,	,	PUNCT
ajlm-1964	19	210	which	which	PRON
ajlm-1964	19	211	emerged	emerge	VERB
ajlm-1964	19	212	in	in	ADP
ajlm-1964	19	213	2002,15,16,17	2002,15,16,17	NUM
ajlm-1964	19	214	and	and	CCONJ
ajlm-1964	19	215	middle	middle	PROPN
ajlm-1964	19	216	east	east	PROPN
ajlm-1964	19	217	respiratory	respiratory	ADJ
ajlm-1964	19	218	syndrome	syndrome	NOUN
ajlm-1964	19	219	coronavirus	coronavirus	NOUN
ajlm-1964	19	220	,	,	PUNCT
ajlm-1964	19	221	which	which	PRON
ajlm-1964	19	222	became	became	AUX
ajlm-1964	19	223	known	know	VERB
ajlm-1964	19	224	in	in	ADP
ajlm-1964	19	225	2012,18	2012,18	NUM
ajlm-1964	19	226	are	be	AUX
ajlm-1964	19	227	two	two	NUM
ajlm-1964	19	228	deadly	deadly	ADJ
ajlm-1964	19	229	novel	novel	ADJ
ajlm-1964	19	230	coronaviruses	coronaviruse	NOUN
ajlm-1964	19	231	that	that	PRON
ajlm-1964	19	232	cause	cause	VERB
ajlm-1964	19	233	severe	severe	ADJ
ajlm-1964	19	234	pneumonia	pneumonia	NOUN
ajlm-1964	19	235	and	and	CCONJ
ajlm-1964	19	236	have	have	AUX
ajlm-1964	19	237	appeared	appear	VERB
ajlm-1964	19	238	occasionally	occasionally	ADV
ajlm-1964	19	239	in	in	ADP
ajlm-1964	19	240	different	different	ADJ
ajlm-1964	19	241	areas	area	NOUN
ajlm-1964	19	242	.	.	PUNCT
ajlm-1964	20	1	however	however	ADV
ajlm-1964	20	2	,	,	PUNCT
ajlm-1964	20	3	in	in	ADP
ajlm-1964	20	4	contrast	contrast	NOUN
ajlm-1964	20	5	to	to	ADP
ajlm-1964	20	6	sars	sar	NOUN
ajlm-1964	20	7	-	-	PUNCT
ajlm-1964	20	8	cov-2	cov-2	NOUN
ajlm-1964	20	9	,	,	PUNCT
ajlm-1964	20	10	the	the	DET
ajlm-1964	20	11	number	number	NOUN
ajlm-1964	20	12	of	of	ADP
ajlm-1964	20	13	confirmed	confirm	VERB
ajlm-1964	20	14	sars	sars	PROPN
ajlm-1964	20	15	-	-	PUNCT
ajlm-1964	20	16	cov	cov	PROPN
ajlm-1964	20	17	and	and	CCONJ
ajlm-1964	20	18	middle	middle	PROPN
ajlm-1964	20	19	east	east	PROPN
ajlm-1964	20	20	respiratory	respiratory	ADJ
ajlm-1964	20	21	syndrome	syndrome	NOUN
ajlm-1964	20	22	coronavirus	coronavirus	NOUN
ajlm-1964	20	23	cases	case	NOUN
ajlm-1964	20	24	are	be	AUX
ajlm-1964	20	25	smaller	small	ADJ
ajlm-1964	20	26	(	(	PUNCT
ajlm-1964	20	27	8100	8100	NUM
ajlm-1964	20	28	and	and	CCONJ
ajlm-1964	20	29	2500	2500	NUM
ajlm-1964	20	30	)	)	PUNCT
ajlm-1964	20	31	because	because	SCONJ
ajlm-1964	20	32	of	of	ADP
ajlm-1964	20	33	limited	limited	ADJ
ajlm-1964	20	34	transmission	transmission	NOUN
ajlm-1964	20	35	from	from	ADP
ajlm-1964	20	36	person	person	NOUN
ajlm-1964	20	37	to	to	ADP
ajlm-1964	20	38	person	person	NOUN
ajlm-1964	20	39	.	.	PUNCT
ajlm-1964	21	1	the	the	DET
ajlm-1964	21	2	probability	probability	NOUN
ajlm-1964	21	3	of	of	ADP
ajlm-1964	21	4	the	the	DET
ajlm-1964	21	5	periodic	periodic	ADJ
ajlm-1964	21	6	emergence	emergence	NOUN
ajlm-1964	21	7	of	of	ADP
ajlm-1964	21	8	novel	novel	ADJ
ajlm-1964	21	9	coronaviruses	coronaviruse	NOUN
ajlm-1964	21	10	is	be	AUX
ajlm-1964	21	11	high	high	ADJ
ajlm-1964	21	12	as	as	ADP
ajlm-1964	21	13	a	a	DET
ajlm-1964	21	14	result	result	NOUN
ajlm-1964	21	15	of	of	ADP
ajlm-1964	21	16	its	its	PRON
ajlm-1964	21	17	extensive	extensive	ADJ
ajlm-1964	21	18	dissemination	dissemination	NOUN
ajlm-1964	21	19	among	among	ADP
ajlm-1964	21	20	humans	human	NOUN
ajlm-1964	21	21	and	and	CCONJ
ajlm-1964	21	22	animal	animal	NOUN
ajlm-1964	21	23	species	specie	NOUN
ajlm-1964	21	24	,	,	PUNCT
ajlm-1964	21	25	high	high	ADJ
ajlm-1964	21	26	genetic	genetic	ADJ
ajlm-1964	21	27	variability	variability	NOUN
ajlm-1964	21	28	and	and	CCONJ
ajlm-1964	21	29	recurrent	recurrent	ADJ
ajlm-1964	21	30	genomic	genomic	ADJ
ajlm-1964	21	31	recombination	recombination	NOUN
ajlm-1964	21	32	,	,	PUNCT
ajlm-1964	21	33	in	in	ADP
ajlm-1964	21	34	addition	addition	NOUN
ajlm-1964	21	35	to	to	ADP
ajlm-1964	21	36	other	other	ADJ
ajlm-1964	21	37	factors	factor	NOUN
ajlm-1964	21	38	such	such	ADJ
ajlm-1964	21	39	as	as	ADP
ajlm-1964	21	40	growing	grow	VERB
ajlm-1964	21	41	human	human	ADJ
ajlm-1964	21	42	and	and	CCONJ
ajlm-1964	21	43	animal	animal	NOUN
ajlm-1964	21	44	interactions	interaction	NOUN
ajlm-1964	21	45	,	,	PUNCT
ajlm-1964	21	46	regular	regular	ADJ
ajlm-1964	21	47	cross	cross	ADJ
ajlm-1964	21	48	-	-	ADJ
ajlm-1964	21	49	species	species	ADJ
ajlm-1964	21	50	infections	infection	NOUN
ajlm-1964	21	51	,	,	PUNCT
ajlm-1964	21	52	and	and	CCONJ
ajlm-1964	21	53	rare	rare	ADJ
ajlm-1964	21	54	spillover	spillover	VERB
ajlm-1964	21	55	events.19,20	events.19,20	NOUN
ajlm-1964	21	56	the	the	DET
ajlm-1964	21	57	sequencing	sequencing	NOUN
ajlm-1964	21	58	of	of	ADP
ajlm-1964	21	59	the	the	DET
ajlm-1964	21	60	2019	2019	NUM
ajlm-1964	21	61	-	-	PUNCT
ajlm-1964	21	62	ncov	ncov	NOUN
ajlm-1964	21	63	genome	genome	NOUN
ajlm-1964	21	64	showed	show	VERB
ajlm-1964	21	65	that	that	SCONJ
ajlm-1964	21	66	it	it	PRON
ajlm-1964	21	67	is	be	AUX
ajlm-1964	21	68	phylogenetically	phylogenetically	ADV
ajlm-1964	21	69	similar	similar	ADJ
ajlm-1964	21	70	to	to	ADP
ajlm-1964	21	71	particular	particular	ADJ
ajlm-1964	21	72	beta	beta	NOUN
ajlm-1964	21	73	-	-	PUNCT
ajlm-1964	21	74	coronaviruses	coronaviruse	NOUN
ajlm-1964	21	75	found	find	VERB
ajlm-1964	21	76	in	in	ADP
ajlm-1964	21	77	bats	bat	NOUN
ajlm-1964	21	78	that	that	PRON
ajlm-1964	21	79	belong	belong	VERB
ajlm-1964	21	80	to	to	ADP
ajlm-1964	21	81	the	the	DET
ajlm-1964	21	82	sarbecovirus	sarbecovirus	NOUN
ajlm-1964	21	83	subgenus	subgenu	NOUN
ajlm-1964	21	84	in	in	ADP
ajlm-1964	21	85	the	the	DET
ajlm-1964	21	86	coronaviridae	coronaviridae	NOUN
ajlm-1964	21	87	family.2	family.2	NOUN
ajlm-1964	21	88	contrary	contrary	ADV
ajlm-1964	21	89	to	to	ADP
ajlm-1964	21	90	expectations	expectation	NOUN
ajlm-1964	21	91	that	that	SCONJ
ajlm-1964	21	92	the	the	DET
ajlm-1964	21	93	african	african	ADJ
ajlm-1964	21	94	region	region	NOUN
ajlm-1964	21	95	would	would	AUX
ajlm-1964	21	96	quickly	quickly	ADV
ajlm-1964	21	97	succumb	succumb	VERB
ajlm-1964	21	98	to	to	ADP
ajlm-1964	21	99	the	the	DET
ajlm-1964	21	100	devastation	devastation	NOUN
ajlm-1964	21	101	of	of	ADP
ajlm-1964	21	102	the	the	DET
ajlm-1964	21	103	rampaging	rampage	VERB
ajlm-1964	21	104	covid-19	covid-19	PROPN
ajlm-1964	21	105	pandemic	pandemic	ADJ
ajlm-1964	21	106	,	,	PUNCT
ajlm-1964	21	107	fewer	few	ADJ
ajlm-1964	21	108	cases	case	NOUN
ajlm-1964	21	109	,	,	PUNCT
ajlm-1964	21	110	as	as	SCONJ
ajlm-1964	21	111	shown	show	VERB
ajlm-1964	21	112	by	by	ADP
ajlm-1964	21	113	the	the	DET
ajlm-1964	21	114	number	number	NOUN
ajlm-1964	21	115	of	of	ADP
ajlm-1964	21	116	cases	case	NOUN
ajlm-1964	21	117	per	per	ADP
ajlm-1964	21	118	million	million	NUM
ajlm-1964	21	119	people	people	NOUN
ajlm-1964	21	120	,	,	PUNCT
ajlm-1964	21	121	are	be	AUX
ajlm-1964	21	122	being	be	AUX
ajlm-1964	21	123	reported	report	VERB
ajlm-1964	21	124	in	in	ADP
ajlm-1964	21	125	africa	africa	PROPN
ajlm-1964	21	126	compared	compare	VERB
ajlm-1964	21	127	to	to	ADP
ajlm-1964	21	128	other	other	ADJ
ajlm-1964	21	129	parts	part	NOUN
ajlm-1964	21	130	of	of	ADP
ajlm-1964	21	131	the	the	DET
ajlm-1964	21	132	world	world	NOUN
ajlm-1964	21	133	(	(	PUNCT
ajlm-1964	21	134	figure	figure	NOUN
ajlm-1964	21	135	13	13	NUM
ajlm-1964	21	136	)	)	PUNCT
ajlm-1964	21	137	.	.	PUNCT
ajlm-1964	22	1	besides	besides	SCONJ
ajlm-1964	22	2	,	,	PUNCT
ajlm-1964	22	3	a	a	DET
ajlm-1964	22	4	comparison	comparison	NOUN
ajlm-1964	22	5	of	of	ADP
ajlm-1964	22	6	the	the	DET
ajlm-1964	22	7	incidence	incidence	NOUN
ajlm-1964	22	8	of	of	ADP
ajlm-1964	22	9	cases	case	NOUN
ajlm-1964	22	10	and	and	CCONJ
ajlm-1964	22	11	the	the	DET
ajlm-1964	22	12	case	case	NOUN
ajlm-1964	22	13	fatality	fatality	NOUN
ajlm-1964	22	14	ratio	ratio	NOUN
ajlm-1964	22	15	among	among	ADP
ajlm-1964	22	16	some	some	DET
ajlm-1964	22	17	selected	select	VERB
ajlm-1964	22	18	african	african	ADJ
ajlm-1964	22	19	and	and	CCONJ
ajlm-1964	22	20	western	western	ADJ
ajlm-1964	22	21	countries	country	NOUN
ajlm-1964	22	22	(	(	PUNCT
ajlm-1964	22	23	table	table	NOUN
ajlm-1964	22	24	13	13	NUM
ajlm-1964	22	25	)	)	PUNCT
ajlm-1964	22	26	showed	show	VERB
ajlm-1964	22	27	that	that	SCONJ
ajlm-1964	22	28	the	the	DET
ajlm-1964	22	29	case	case	NOUN
ajlm-1964	22	30	fatality	fatality	NOUN
ajlm-1964	22	31	ratio	ratio	NOUN
ajlm-1964	22	32	and	and	CCONJ
ajlm-1964	22	33	number	number	NOUN
ajlm-1964	22	34	of	of	ADP
ajlm-1964	22	35	cases	case	NOUN
ajlm-1964	22	36	in	in	ADP
ajlm-1964	22	37	africa	africa	PROPN
ajlm-1964	22	38	were	be	AUX
ajlm-1964	22	39	relatively	relatively	ADV
ajlm-1964	22	40	low	low	ADJ
ajlm-1964	22	41	.	.	PUNCT
ajlm-1964	23	1	this	this	PRON
ajlm-1964	23	2	suggests	suggest	VERB
ajlm-1964	23	3	that	that	SCONJ
ajlm-1964	23	4	africa	africa	PROPN
ajlm-1964	23	5	was	be	AUX
ajlm-1964	23	6	mildly	mildly	ADV
ajlm-1964	23	7	impacted	impact	VERB
ajlm-1964	23	8	by	by	ADP
ajlm-1964	23	9	the	the	DET
ajlm-1964	23	10	pandemic	pandemic	NOUN
ajlm-1964	23	11	despite	despite	SCONJ
ajlm-1964	23	12	the	the	DET
ajlm-1964	23	13	weak	weak	ADJ
ajlm-1964	23	14	health	health	NOUN
ajlm-1964	23	15	infrastructure	infrastructure	NOUN
ajlm-1964	23	16	.	.	PUNCT
ajlm-1964	24	1	this	this	DET
ajlm-1964	24	2	review	review	NOUN
ajlm-1964	24	3	summarises	summarise	VERB
ajlm-1964	24	4	current	current	ADJ
ajlm-1964	24	5	literature	literature	NOUN
ajlm-1964	24	6	on	on	ADP
ajlm-1964	24	7	the	the	DET
ajlm-1964	24	8	dynamics	dynamic	NOUN
ajlm-1964	24	9	of	of	ADP
ajlm-1964	24	10	infection	infection	NOUN
ajlm-1964	24	11	and	and	CCONJ
ajlm-1964	24	12	immunity	immunity	NOUN
ajlm-1964	24	13	to	to	ADP
ajlm-1964	24	14	sars	sar	NOUN
ajlm-1964	24	15	-	-	PUNCT
ajlm-1964	24	16	cov-2	cov-2	NOUN
ajlm-1964	24	17	and	and	CCONJ
ajlm-1964	24	18	other	other	ADJ
ajlm-1964	24	19	infective	infective	ADJ
ajlm-1964	24	20	diseases	disease	NOUN
ajlm-1964	24	21	in	in	ADP
ajlm-1964	24	22	africa	africa	PROPN
ajlm-1964	24	23	and	and	CCONJ
ajlm-1964	24	24	the	the	DET
ajlm-1964	24	25	unique	unique	ADJ
ajlm-1964	24	26	characteristics	characteristic	NOUN
ajlm-1964	24	27	of	of	ADP
ajlm-1964	24	28	the	the	DET
ajlm-1964	24	29	sub	sub	ADJ
ajlm-1964	24	30	-	-	ADJ
ajlm-1964	24	31	saharan	saharan	ADJ
ajlm-1964	24	32	african	african	ADJ
ajlm-1964	24	33	population	population	NOUN
ajlm-1964	24	34	that	that	PRON
ajlm-1964	24	35	might	might	AUX
ajlm-1964	24	36	have	have	AUX
ajlm-1964	24	37	impacted	impact	VERB
ajlm-1964	24	38	the	the	DET
ajlm-1964	24	39	course	course	NOUN
ajlm-1964	24	40	and	and	CCONJ
ajlm-1964	24	41	severity	severity	NOUN
ajlm-1964	24	42	of	of	ADP
ajlm-1964	24	43	the	the	DET
ajlm-1964	24	44	pandemic	pandemic	NOUN
ajlm-1964	24	45	.	.	PUNCT
ajlm-1964	25	1	we	we	PRON
ajlm-1964	25	2	also	also	ADV
ajlm-1964	25	3	describe	describe	VERB
ajlm-1964	25	4	the	the	DET
ajlm-1964	25	5	host	host	NOUN
ajlm-1964	25	6	immune	immune	ADJ
ajlm-1964	25	7	response	response	NOUN
ajlm-1964	25	8	mechanisms	mechanism	NOUN
ajlm-1964	25	9	to	to	ADP
ajlm-1964	25	10	other	other	ADJ
ajlm-1964	25	11	microbial	microbial	ADJ
ajlm-1964	25	12	infections	infection	NOUN
ajlm-1964	25	13	and	and	CCONJ
ajlm-1964	25	14	the	the	DET
ajlm-1964	25	15	possible	possible	ADJ
ajlm-1964	25	16	reasons	reason	NOUN
ajlm-1964	25	17	for	for	ADP
ajlm-1964	25	18	a	a	DET
ajlm-1964	25	19	presumed	presume	VERB
ajlm-1964	25	20	immune	immune	ADJ
ajlm-1964	25	21	sufficiency	sufficiency	NOUN
ajlm-1964	25	22	to	to	ADP
ajlm-1964	25	23	covid-19	covid-19	PROPN
ajlm-1964	25	24	in	in	ADP
ajlm-1964	25	25	the	the	DET
ajlm-1964	25	26	african	african	ADJ
ajlm-1964	25	27	population	population	NOUN
ajlm-1964	25	28	.	.	PUNCT
ajlm-1964	26	1	figure	figure	VERB
ajlm-1964	26	2	1	1	NUM
ajlm-1964	26	3	:	:	PUNCT
ajlm-1964	26	4	global	global	ADJ
ajlm-1964	26	5	distribution	distribution	NOUN
ajlm-1964	26	6	of	of	ADP
ajlm-1964	26	7	covid-19	covid-19	PROPN
ajlm-1964	26	8	cases	case	NOUN
ajlm-1964	26	9	per	per	ADP
ajlm-1964	26	10	million	million	NUM
ajlm-1964	26	11	people	people	NOUN
ajlm-1964	26	12	as	as	ADP
ajlm-1964	26	13	of	of	ADP
ajlm-1964	26	14	07	07	NUM
ajlm-1964	26	15	september	september	PROPN
ajlm-1964	26	16	2021	2021	NUM
ajlm-1964	26	17	.	.	PUNCT
ajlm-1964	27	1	table	table	NOUN
ajlm-1964	27	2	1	1	NUM
ajlm-1964	27	3	:	:	PUNCT
ajlm-1964	27	4	 	 	SPACE
ajlm-1964	27	5	cumulative	cumulative	ADJ
ajlm-1964	27	6	total	total	ADJ
ajlm-1964	27	7	number	number	NOUN
ajlm-1964	27	8	of	of	ADP
ajlm-1964	27	9	covid-19	covid-19	PROPN
ajlm-1964	27	10	cases	case	NOUN
ajlm-1964	27	11	,	,	PUNCT
ajlm-1964	27	12	deaths	death	NOUN
ajlm-1964	27	13	and	and	CCONJ
ajlm-1964	27	14	case	case	NOUN
ajlm-1964	27	15	fatality	fatality	NOUN
ajlm-1964	27	16	ratio	ratio	NOUN
ajlm-1964	27	17	reported	report	VERB
ajlm-1964	27	18	in	in	ADP
ajlm-1964	27	19	some	some	DET
ajlm-1964	27	20	western	western	ADJ
ajlm-1964	27	21	and	and	CCONJ
ajlm-1964	27	22	african	african	ADJ
ajlm-1964	27	23	countries	country	NOUN
ajlm-1964	27	24	between	between	ADP
ajlm-1964	27	25	05	05	NUM
ajlm-1964	27	26	february	february	NOUN
ajlm-1964	27	27	2020	2020	NUM
ajlm-1964	27	28	and	and	CCONJ
ajlm-1964	27	29	07	07	NUM
ajlm-1964	27	30	september	september	PROPN
ajlm-1964	27	31	2021	2021	NUM
ajlm-1964	27	32	.	.	PUNCT
ajlm-1964	28	1	the	the	DET
ajlm-1964	28	2	terms	term	NOUN
ajlm-1964	28	3	‘	'	PUNCT
ajlm-1964	28	4	epidemiology	epidemiology	NOUN
ajlm-1964	28	5	and	and	CCONJ
ajlm-1964	28	6	immunity	immunity	NOUN
ajlm-1964	28	7	to	to	ADP
ajlm-1964	28	8	covid-19	covid-19	PROPN
ajlm-1964	28	9	’	'	PUNCT
ajlm-1964	28	10	,	,	PUNCT
ajlm-1964	28	11	‘	'	PUNCT
ajlm-1964	28	12	covid-19	covid-19	PROPN
ajlm-1964	28	13	and	and	CCONJ
ajlm-1964	28	14	associated	associated	ADJ
ajlm-1964	28	15	coronaviruses	coronaviruse	NOUN
ajlm-1964	28	16	’	'	PUNCT
ajlm-1964	28	17	,	,	PUNCT
ajlm-1964	28	18	‘	'	PUNCT
ajlm-1964	28	19	prevalent	prevalent	ADJ
ajlm-1964	28	20	infectious	infectious	ADJ
ajlm-1964	28	21	diseases	disease	NOUN
ajlm-1964	28	22	in	in	ADP
ajlm-1964	28	23	africa	africa	PROPN
ajlm-1964	28	24	’	'	PUNCT
ajlm-1964	28	25	,	,	PUNCT
ajlm-1964	28	26	‘	'	PUNCT
ajlm-1964	28	27	host	host	NOUN
ajlm-1964	28	28	immune	immune	ADJ
ajlm-1964	28	29	response	response	NOUN
ajlm-1964	28	30	mechanisms	mechanism	NOUN
ajlm-1964	28	31	to	to	ADP
ajlm-1964	28	32	viral	viral	ADJ
ajlm-1964	28	33	and	and	CCONJ
ajlm-1964	28	34	other	other	ADJ
ajlm-1964	28	35	microbial	microbial	ADJ
ajlm-1964	28	36	infections	infection	NOUN
ajlm-1964	28	37	’	'	PUNCT
ajlm-1964	28	38	,	,	PUNCT
ajlm-1964	28	39	and	and	CCONJ
ajlm-1964	28	40	‘	'	PUNCT
ajlm-1964	28	41	immune	immune	ADJ
ajlm-1964	28	42	sufficiency	sufficiency	NOUN
ajlm-1964	28	43	to	to	ADP
ajlm-1964	28	44	covid-19	covid-19	PROPN
ajlm-1964	28	45	in	in	ADP
ajlm-1964	28	46	the	the	DET
ajlm-1964	28	47	african	african	ADJ
ajlm-1964	28	48	population	population	NOUN
ajlm-1964	28	49	’	'	PUNCT
ajlm-1964	28	50	were	be	AUX
ajlm-1964	28	51	used	use	VERB
ajlm-1964	28	52	to	to	PART
ajlm-1964	28	53	carry	carry	VERB
ajlm-1964	28	54	out	out	ADP
ajlm-1964	28	55	a	a	DET
ajlm-1964	28	56	systematic	systematic	ADJ
ajlm-1964	28	57	search	search	NOUN
ajlm-1964	28	58	on	on	ADP
ajlm-1964	28	59	relevant	relevant	ADJ
ajlm-1964	28	60	search	search	NOUN
ajlm-1964	28	61	engines	engine	NOUN
ajlm-1964	28	62	and	and	CCONJ
ajlm-1964	28	63	websites	website	NOUN
ajlm-1964	28	64	such	such	ADJ
ajlm-1964	28	65	as	as	ADP
ajlm-1964	28	66	google	google	NOUN
ajlm-1964	28	67	,	,	PUNCT
ajlm-1964	28	68	google	google	PROPN
ajlm-1964	28	69	scholar	scholar	NOUN
ajlm-1964	28	70	,	,	PUNCT
ajlm-1964	28	71	pubmed	pubmed	PROPN
ajlm-1964	28	72	,	,	PUNCT
ajlm-1964	28	73	african	african	ADJ
ajlm-1964	28	74	journals	journal	NOUN
ajlm-1964	28	75	online	online	ADV
ajlm-1964	28	76	,	,	PUNCT
ajlm-1964	28	77	world	world	PROPN
ajlm-1964	28	78	health	health	NOUN
ajlm-1964	28	79	organization	organization	NOUN
ajlm-1964	28	80	,	,	PUNCT
ajlm-1964	28	81	center	center	NOUN
ajlm-1964	28	82	for	for	ADP
ajlm-1964	28	83	disease	disease	NOUN
ajlm-1964	28	84	control	control	NOUN
ajlm-1964	28	85	and	and	CCONJ
ajlm-1964	28	86	prevention	prevention	NOUN
ajlm-1964	28	87	,	,	PUNCT
ajlm-1964	28	88	nigeria	nigeria	PROPN
ajlm-1964	28	89	centre	centre	PROPN
ajlm-1964	28	90	for	for	ADP
ajlm-1964	28	91	disease	disease	NOUN
ajlm-1964	28	92	control	control	NOUN
ajlm-1964	28	93	,	,	PUNCT
ajlm-1964	28	94	and	and	CCONJ
ajlm-1964	28	95	africa	africa	PROPN
ajlm-1964	28	96	centre	centre	PROPN
ajlm-1964	28	97	for	for	ADP
ajlm-1964	28	98	disease	disease	NOUN
ajlm-1964	28	99	control	control	NOUN
ajlm-1964	28	100	and	and	CCONJ
ajlm-1964	28	101	prevention	prevention	NOUN
ajlm-1964	28	102	.	.	PUNCT
ajlm-1964	29	1	we	we	PRON
ajlm-1964	29	2	included	include	VERB
ajlm-1964	29	3	all	all	DET
ajlm-1964	29	4	relevant	relevant	ADJ
ajlm-1964	29	5	studies	study	NOUN
ajlm-1964	29	6	published	publish	VERB
ajlm-1964	29	7	in	in	ADP
ajlm-1964	29	8	the	the	DET
ajlm-1964	29	9	english	english	ADJ
ajlm-1964	29	10	language	language	NOUN
ajlm-1964	29	11	between	between	ADP
ajlm-1964	29	12	2000	2000	NUM
ajlm-1964	29	13	and	and	CCONJ
ajlm-1964	29	14	2021	2021	NUM
ajlm-1964	29	15	.	.	PUNCT
ajlm-1964	30	1	immunity	immunity	NOUN
ajlm-1964	30	2	to	to	ADP
ajlm-1964	30	3	covid-19	covid-19	PROPN
ajlm-1964	30	4	the	the	DET
ajlm-1964	30	5	specific	specific	ADJ
ajlm-1964	30	6	aspects	aspect	NOUN
ajlm-1964	30	7	of	of	ADP
ajlm-1964	30	8	immunity	immunity	NOUN
ajlm-1964	30	9	that	that	PRON
ajlm-1964	30	10	define	define	VERB
ajlm-1964	30	11	both	both	CCONJ
ajlm-1964	30	12	the	the	DET
ajlm-1964	30	13	protective	protective	ADJ
ajlm-1964	30	14	and	and	CCONJ
ajlm-1964	30	15	pathogenic	pathogenic	ADJ
ajlm-1964	30	16	reactions	reaction	NOUN
ajlm-1964	30	17	to	to	ADP
ajlm-1964	30	18	sars	sars	PROPN
ajlm-1964	30	19	-	-	PUNCT
ajlm-1964	30	20	cov-2	cov-2	PART
ajlm-1964	30	21	infection	infection	NOUN
ajlm-1964	30	22	are	be	AUX
ajlm-1964	30	23	not	not	PART
ajlm-1964	30	24	clear	clear	ADJ
ajlm-1964	30	25	.	.	PUNCT
ajlm-1964	31	1	though	though	SCONJ
ajlm-1964	31	2	some	some	DET
ajlm-1964	31	3	components	component	NOUN
ajlm-1964	31	4	of	of	ADP
ajlm-1964	31	5	the	the	DET
ajlm-1964	31	6	immune	immune	ADJ
ajlm-1964	31	7	response	response	NOUN
ajlm-1964	31	8	to	to	ADP
ajlm-1964	31	9	sars	sar	NOUN
ajlm-1964	31	10	-	-	PUNCT
ajlm-1964	31	11	cov-2	cov-2	PART
ajlm-1964	31	12	infection	infection	NOUN
ajlm-1964	31	13	appear	appear	VERB
ajlm-1964	31	14	to	to	PART
ajlm-1964	31	15	be	be	AUX
ajlm-1964	31	16	unique	unique	ADJ
ajlm-1964	31	17	,	,	PUNCT
ajlm-1964	31	18	some	some	DET
ajlm-1964	31	19	aspects	aspect	NOUN
ajlm-1964	31	20	are	be	AUX
ajlm-1964	31	21	similar	similar	ADJ
ajlm-1964	31	22	to	to	ADP
ajlm-1964	31	23	the	the	DET
ajlm-1964	31	24	mechanisms	mechanism	NOUN
ajlm-1964	31	25	of	of	ADP
ajlm-1964	31	26	immunity	immunity	NOUN
ajlm-1964	31	27	to	to	ADP
ajlm-1964	31	28	other	other	ADJ
ajlm-1964	31	29	human	human	ADJ
ajlm-1964	31	30	and	and	CCONJ
ajlm-1964	31	31	animal	animal	NOUN
ajlm-1964	31	32	infections	infection	NOUN
ajlm-1964	31	33	.	.	PUNCT
ajlm-1964	32	1	an	an	DET
ajlm-1964	32	2	understanding	understanding	NOUN
ajlm-1964	32	3	of	of	ADP
ajlm-1964	32	4	the	the	DET
ajlm-1964	32	5	protective	protective	ADJ
ajlm-1964	32	6	components	component	NOUN
ajlm-1964	32	7	of	of	ADP
ajlm-1964	32	8	the	the	DET
ajlm-1964	32	9	immune	immune	ADJ
ajlm-1964	32	10	reaction	reaction	NOUN
ajlm-1964	32	11	to	to	ADP
ajlm-1964	32	12	sars	sar	NOUN
ajlm-1964	32	13	-	-	PUNCT
ajlm-1964	32	14	cov-2	cov-2	PART
ajlm-1964	32	15	infections	infection	NOUN
ajlm-1964	32	16	is	be	AUX
ajlm-1964	32	17	important	important	ADJ
ajlm-1964	32	18	for	for	ADP
ajlm-1964	32	19	effective	effective	ADJ
ajlm-1964	32	20	vaccine	vaccine	NOUN
ajlm-1964	32	21	development	development	NOUN
ajlm-1964	32	22	.	.	PUNCT
ajlm-1964	33	1	as	as	SCONJ
ajlm-1964	33	2	is	be	AUX
ajlm-1964	33	3	the	the	DET
ajlm-1964	33	4	case	case	NOUN
ajlm-1964	33	5	with	with	ADP
ajlm-1964	33	6	many	many	ADJ
ajlm-1964	33	7	infectious	infectious	ADJ
ajlm-1964	33	8	diseases	disease	NOUN
ajlm-1964	33	9	,	,	PUNCT
ajlm-1964	33	10	an	an	DET
ajlm-1964	33	11	immune	immune	ADJ
ajlm-1964	33	12	reaction	reaction	NOUN
ajlm-1964	33	13	to	to	ADP
ajlm-1964	33	14	sars	sar	NOUN
ajlm-1964	33	15	-	-	PUNCT
ajlm-1964	33	16	cov-2	cov-2	PART
ajlm-1964	33	17	involves	involve	VERB
ajlm-1964	33	18	both	both	DET
ajlm-1964	33	19	cell	cell	NOUN
ajlm-1964	33	20	-	-	PUNCT
ajlm-1964	33	21	mediated	mediate	VERB
ajlm-1964	33	22	and	and	CCONJ
ajlm-1964	33	23	antibody	antibody	NOUN
ajlm-1964	33	24	-	-	PUNCT
ajlm-1964	33	25	facilitated	facilitate	VERB
ajlm-1964	33	26	responses.21	responses.21	PROPN
ajlm-1964	33	27	t	t	NOUN
ajlm-1964	33	28	-	-	PUNCT
ajlm-1964	33	29	cell	cell	NOUN
ajlm-1964	33	30	responses	response	NOUN
ajlm-1964	33	31	against	against	ADP
ajlm-1964	33	32	the	the	DET
ajlm-1964	33	33	viral	viral	ADJ
ajlm-1964	33	34	spike	spike	ADJ
ajlm-1964	33	35	protein	protein	NOUN
ajlm-1964	33	36	have	have	AUX
ajlm-1964	33	37	been	be	AUX
ajlm-1964	33	38	shown	show	VERB
ajlm-1964	33	39	to	to	PART
ajlm-1964	33	40	correlate	correlate	VERB
ajlm-1964	33	41	well	well	ADV
ajlm-1964	33	42	with	with	ADP
ajlm-1964	33	43	the	the	DET
ajlm-1964	33	44	neutralising	neutralising	ADJ
ajlm-1964	33	45	titres	titre	NOUN
ajlm-1964	33	46	of	of	ADP
ajlm-1964	33	47	immunoglobin	immunoglobin	PROPN
ajlm-1964	33	48	g	g	PROPN
ajlm-1964	33	49	and	and	CCONJ
ajlm-1964	33	50	immunoglobin	immunoglobin	PROPN
ajlm-1964	33	51	a	a	PRON
ajlm-1964	33	52	antibodies.22,23,24	antibodies.22,23,24	ADV
ajlm-1964	33	53	this	this	DET
ajlm-1964	33	54	observation	observation	NOUN
ajlm-1964	33	55	could	could	AUX
ajlm-1964	33	56	have	have	VERB
ajlm-1964	33	57	important	important	ADJ
ajlm-1964	33	58	implications	implication	NOUN
ajlm-1964	33	59	for	for	ADP
ajlm-1964	33	60	vaccine	vaccine	NOUN
ajlm-1964	33	61	design	design	NOUN
ajlm-1964	33	62	and	and	CCONJ
ajlm-1964	33	63	the	the	DET
ajlm-1964	33	64	development	development	NOUN
ajlm-1964	33	65	of	of	ADP
ajlm-1964	33	66	durable	durable	ADJ
ajlm-1964	33	67	immunity	immunity	NOUN
ajlm-1964	33	68	.	.	PUNCT
ajlm-1964	34	1	as	as	ADP
ajlm-1964	34	2	the	the	DET
ajlm-1964	34	3	primary	primary	ADJ
ajlm-1964	34	4	inflammatory	inflammatory	ADJ
ajlm-1964	34	5	cells	cell	NOUN
ajlm-1964	34	6	,	,	PUNCT
ajlm-1964	34	7	the	the	DET
ajlm-1964	34	8	cd8	cd8	PROPN
ajlm-1964	34	9	+	+	PROPN
ajlm-1964	34	10	t	t	PROPN
ajlm-1964	34	11	-	-	PUNCT
ajlm-1964	34	12	cells	cell	NOUN
ajlm-1964	34	13	play	play	VERB
ajlm-1964	34	14	a	a	DET
ajlm-1964	34	15	crucial	crucial	ADJ
ajlm-1964	34	16	function	function	NOUN
ajlm-1964	34	17	in	in	ADP
ajlm-1964	34	18	clearing	clear	VERB
ajlm-1964	34	19	the	the	DET
ajlm-1964	34	20	virus	virus	NOUN
ajlm-1964	34	21	.	.	PUNCT
ajlm-1964	35	1	the	the	DET
ajlm-1964	35	2	level	level	NOUN
ajlm-1964	35	3	of	of	ADP
ajlm-1964	35	4	inflammation	inflammation	NOUN
ajlm-1964	35	5	during	during	ADP
ajlm-1964	35	6	sars	sar	NOUN
ajlm-1964	35	7	-	-	PUNCT
ajlm-1964	35	8	cov-2	cov-2	PART
ajlm-1964	35	9	infection	infection	NOUN
ajlm-1964	35	10	is	be	AUX
ajlm-1964	35	11	significantly	significantly	ADV
ajlm-1964	35	12	reliant	reliant	ADJ
ajlm-1964	35	13	on	on	ADP
ajlm-1964	35	14	the	the	DET
ajlm-1964	35	15	association	association	NOUN
ajlm-1964	35	16	between	between	ADP
ajlm-1964	35	17	the	the	DET
ajlm-1964	35	18	cd4+/cd8	cd4+/cd8	NOUN
ajlm-1964	35	19	+	+	NOUN
ajlm-1964	35	20	ratio	ratio	NOUN
ajlm-1964	35	21	and	and	CCONJ
ajlm-1964	35	22	the	the	DET
ajlm-1964	35	23	total	total	ADJ
ajlm-1964	35	24	lymphocytes	lymphocyte	NOUN
ajlm-1964	35	25	,	,	PUNCT
ajlm-1964	35	26	namely	namely	ADV
ajlm-1964	35	27	cd4	cd4	PROPN
ajlm-1964	35	28	+	+	PROPN
ajlm-1964	35	29	t	t	PROPN
ajlm-1964	35	30	-	-	PUNCT
ajlm-1964	35	31	cells	cell	NOUN
ajlm-1964	35	32	,	,	PUNCT
ajlm-1964	35	33	cd8	cd8	PROPN
ajlm-1964	35	34	+	+	PROPN
ajlm-1964	35	35	t	t	PROPN
ajlm-1964	35	36	-	-	PUNCT
ajlm-1964	35	37	cells	cell	NOUN
ajlm-1964	35	38	,	,	PUNCT
ajlm-1964	35	39	and	and	CCONJ
ajlm-1964	35	40	b	b	X
ajlm-1964	35	41	-	-	PUNCT
ajlm-1964	35	42	cells	cell	NOUN
ajlm-1964	35	43	and	and	CCONJ
ajlm-1964	35	44	natural	natural	ADJ
ajlm-1964	35	45	killer	killer	NOUN
ajlm-1964	35	46	cells.10	cells.10	NOUN
ajlm-1964	35	47	in	in	ADP
ajlm-1964	35	48	both	both	CCONJ
ajlm-1964	35	49	mild	mild	ADJ
ajlm-1964	35	50	and	and	CCONJ
ajlm-1964	35	51	severe	severe	ADJ
ajlm-1964	35	52	cases	case	NOUN
ajlm-1964	35	53	,	,	PUNCT
ajlm-1964	35	54	there	there	PRON
ajlm-1964	35	55	is	be	VERB
ajlm-1964	35	56	a	a	DET
ajlm-1964	35	57	decrease	decrease	NOUN
ajlm-1964	35	58	in	in	ADP
ajlm-1964	35	59	the	the	DET
ajlm-1964	35	60	absolute	absolute	ADJ
ajlm-1964	35	61	numbers	number	NOUN
ajlm-1964	35	62	of	of	ADP
ajlm-1964	35	63	t	t	NOUN
ajlm-1964	35	64	lymphocytes	lymphocyte	NOUN
ajlm-1964	35	65	,	,	PUNCT
ajlm-1964	35	66	cd4	cd4	PROPN
ajlm-1964	35	67	+	+	PROPN
ajlm-1964	35	68	t	t	PROPN
ajlm-1964	35	69	-	-	PUNCT
ajlm-1964	35	70	cells	cell	NOUN
ajlm-1964	35	71	,	,	PUNCT
ajlm-1964	35	72	and	and	CCONJ
ajlm-1964	35	73	cd8	cd8	PROPN
ajlm-1964	35	74	+	+	PROPN
ajlm-1964	35	75	t	t	PROPN
ajlm-1964	35	76	-	-	PUNCT
ajlm-1964	35	77	cells	cell	NOUN
ajlm-1964	35	78	,	,	PUNCT
ajlm-1964	35	79	but	but	CCONJ
ajlm-1964	35	80	the	the	DET
ajlm-1964	35	81	decrease	decrease	NOUN
ajlm-1964	35	82	is	be	AUX
ajlm-1964	35	83	more	more	ADV
ajlm-1964	35	84	in	in	ADP
ajlm-1964	35	85	severe	severe	ADJ
ajlm-1964	35	86	than	than	ADP
ajlm-1964	35	87	in	in	ADP
ajlm-1964	35	88	mild	mild	ADJ
ajlm-1964	35	89	cases.10	cases.10	NOUN
ajlm-1964	35	90	the	the	DET
ajlm-1964	35	91	implication	implication	NOUN
ajlm-1964	35	92	of	of	ADP
ajlm-1964	35	93	the	the	DET
ajlm-1964	35	94	lymphopenia	lymphopenia	NOUN
ajlm-1964	35	95	observed	observe	VERB
ajlm-1964	35	96	is	be	AUX
ajlm-1964	35	97	that	that	SCONJ
ajlm-1964	35	98	it	it	PRON
ajlm-1964	35	99	reduces	reduce	VERB
ajlm-1964	35	100	the	the	DET
ajlm-1964	35	101	ability	ability	NOUN
ajlm-1964	35	102	of	of	ADP
ajlm-1964	35	103	the	the	DET
ajlm-1964	35	104	immune	immune	ADJ
ajlm-1964	35	105	system	system	NOUN
ajlm-1964	35	106	to	to	PART
ajlm-1964	35	107	fight	fight	VERB
ajlm-1964	35	108	the	the	DET
ajlm-1964	35	109	infection	infection	NOUN
ajlm-1964	35	110	and	and	CCONJ
ajlm-1964	35	111	increases	increase	VERB
ajlm-1964	35	112	the	the	DET
ajlm-1964	35	113	chances	chance	NOUN
ajlm-1964	35	114	of	of	ADP
ajlm-1964	35	115	severe	severe	ADJ
ajlm-1964	35	116	illness	illness	NOUN
ajlm-1964	35	117	.	.	PUNCT
ajlm-1964	36	1	multivariate	multivariate	NOUN
ajlm-1964	36	2	data	datum	NOUN
ajlm-1964	36	3	analysis	analysis	NOUN
ajlm-1964	36	4	showed	show	VERB
ajlm-1964	36	5	that	that	SCONJ
ajlm-1964	36	6	a	a	DET
ajlm-1964	36	7	reduction	reduction	NOUN
ajlm-1964	36	8	in	in	ADP
ajlm-1964	36	9	b	b	NOUN
ajlm-1964	36	10	-	-	PUNCT
ajlm-1964	36	11	cells	cell	NOUN
ajlm-1964	36	12	and	and	CCONJ
ajlm-1964	36	13	cd8	cd8	PROPN
ajlm-1964	36	14	+	+	PROPN
ajlm-1964	36	15	t	t	PROPN
ajlm-1964	36	16	-	-	PUNCT
ajlm-1964	36	17	cells	cell	NOUN
ajlm-1964	36	18	,	,	PUNCT
ajlm-1964	36	19	and	and	CCONJ
ajlm-1964	36	20	a	a	DET
ajlm-1964	36	21	rise	rise	NOUN
ajlm-1964	36	22	in	in	ADP
ajlm-1964	36	23	the	the	DET
ajlm-1964	36	24	cd4+/cd8	cd4+/cd8	NOUN
ajlm-1964	36	25	+	+	CCONJ
ajlm-1964	36	26	ratio	ratio	NOUN
ajlm-1964	36	27	can	can	AUX
ajlm-1964	36	28	independently	independently	ADV
ajlm-1964	36	29	predict	predict	VERB
ajlm-1964	36	30	a	a	DET
ajlm-1964	36	31	poor	poor	ADJ
ajlm-1964	36	32	treatment	treatment	NOUN
ajlm-1964	36	33	outcome.10	outcome.10	NOUN
ajlm-1964	36	34	in	in	ADP
ajlm-1964	36	35	the	the	DET
ajlm-1964	36	36	context	context	NOUN
ajlm-1964	36	37	of	of	ADP
ajlm-1964	36	38	the	the	DET
ajlm-1964	36	39	african	african	ADJ
ajlm-1964	36	40	population	population	NOUN
ajlm-1964	36	41	where	where	SCONJ
ajlm-1964	36	42	immune	immune	ADJ
ajlm-1964	36	43	sufficiency	sufficiency	NOUN
ajlm-1964	36	44	is	be	AUX
ajlm-1964	36	45	presumed	presume	VERB
ajlm-1964	36	46	,	,	PUNCT
ajlm-1964	36	47	it	it	PRON
ajlm-1964	36	48	is	be	AUX
ajlm-1964	36	49	expected	expect	VERB
ajlm-1964	36	50	that	that	SCONJ
ajlm-1964	36	51	a	a	DET
ajlm-1964	36	52	reduction	reduction	NOUN
ajlm-1964	36	53	in	in	ADP
ajlm-1964	36	54	the	the	DET
ajlm-1964	36	55	numbers	number	NOUN
ajlm-1964	36	56	of	of	ADP
ajlm-1964	36	57	t	t	NOUN
ajlm-1964	36	58	lymphocytes	lymphocyte	NOUN
ajlm-1964	36	59	would	would	AUX
ajlm-1964	36	60	be	be	AUX
ajlm-1964	36	61	limited	limit	VERB
ajlm-1964	36	62	but	but	CCONJ
ajlm-1964	36	63	this	this	PRON
ajlm-1964	36	64	needs	need	VERB
ajlm-1964	36	65	to	to	PART
ajlm-1964	36	66	be	be	AUX
ajlm-1964	36	67	investigated	investigate	VERB
ajlm-1964	36	68	.	.	PUNCT
ajlm-1964	37	1	interferon	interferon	ADJ
ajlm-1964	37	2	-	-	PUNCT
ajlm-1964	37	3	γ	γ	NOUN
ajlm-1964	37	4	expression	expression	NOUN
ajlm-1964	37	5	by	by	ADP
ajlm-1964	37	6	cd4	cd4	PROPN
ajlm-1964	37	7	+	+	PROPN
ajlm-1964	37	8	t	t	PROPN
ajlm-1964	37	9	-	-	PUNCT
ajlm-1964	37	10	cell	cell	NOUN
ajlm-1964	37	11	induction	induction	NOUN
ajlm-1964	37	12	also	also	ADV
ajlm-1964	37	13	tends	tend	VERB
ajlm-1964	37	14	to	to	PART
ajlm-1964	37	15	reduce	reduce	VERB
ajlm-1964	37	16	in	in	ADP
ajlm-1964	37	17	severe	severe	ADJ
ajlm-1964	37	18	cases	case	NOUN
ajlm-1964	37	19	compared	compare	VERB
ajlm-1964	37	20	to	to	ADP
ajlm-1964	37	21	moderate	moderate	ADJ
ajlm-1964	37	22	cases.4	cases.4	PROPN
ajlm-1964	37	23	it	it	PRON
ajlm-1964	37	24	takes	take	VERB
ajlm-1964	37	25	between	between	ADP
ajlm-1964	37	26	10	10	NUM
ajlm-1964	37	27	and	and	CCONJ
ajlm-1964	37	28	21	21	NUM
ajlm-1964	37	29	days	day	NOUN
ajlm-1964	37	30	after	after	ADP
ajlm-1964	37	31	infection	infection	NOUN
ajlm-1964	37	32	for	for	ADP
ajlm-1964	37	33	antibody	antibody	NOUN
ajlm-1964	37	34	response	response	NOUN
ajlm-1964	37	35	to	to	PART
ajlm-1964	37	36	develop	develop	VERB
ajlm-1964	37	37	in	in	ADP
ajlm-1964	37	38	most	most	ADJ
ajlm-1964	37	39	sars	sar	NOUN
ajlm-1964	37	40	-	-	PUNCT
ajlm-1964	37	41	cov-2	cov-2	ADV
ajlm-1964	37	42	-	-	PUNCT
ajlm-1964	37	43	infected	infect	VERB
ajlm-1964	37	44	persons	person	NOUN
ajlm-1964	37	45	,	,	PUNCT
ajlm-1964	37	46	and	and	CCONJ
ajlm-1964	37	47	it	it	PRON
ajlm-1964	37	48	takes	take	VERB
ajlm-1964	37	49	between	between	ADP
ajlm-1964	37	50	6	6	NUM
ajlm-1964	37	51	and	and	CCONJ
ajlm-1964	37	52	15	15	NUM
ajlm-1964	37	53	days	day	NOUN
ajlm-1964	37	54	after	after	ADP
ajlm-1964	37	55	the	the	DET
ajlm-1964	37	56	onset	onset	NOUN
ajlm-1964	37	57	of	of	ADP
ajlm-1964	37	58	disease	disease	NOUN
ajlm-1964	37	59	for	for	ADP
ajlm-1964	37	60	the	the	DET
ajlm-1964	37	61	immunoglobin	immunoglobin	PROPN
ajlm-1964	37	62	m	m	PROPN
ajlm-1964	37	63	and	and	CCONJ
ajlm-1964	37	64	immunoglobin	immunoglobin	PROPN
ajlm-1964	37	65	g	g	PROPN
ajlm-1964	37	66	antibodies	antibodie	VERB
ajlm-1964	37	67	to	to	ADP
ajlm-1964	37	68	sars	sar	NOUN
ajlm-1964	37	69	-	-	PUNCT
ajlm-1964	37	70	cov-2	cov-2	NOUN
ajlm-1964	37	71	to	to	PART
ajlm-1964	37	72	develop.25,26,27,28,29	develop.25,26,27,28,29	VERB
ajlm-1964	37	73	in	in	ADP
ajlm-1964	37	74	mild	mild	ADJ
ajlm-1964	37	75	cases	case	NOUN
ajlm-1964	37	76	,	,	PUNCT
ajlm-1964	37	77	antibody	antibody	NOUN
ajlm-1964	37	78	development	development	NOUN
ajlm-1964	37	79	can	can	AUX
ajlm-1964	37	80	take	take	VERB
ajlm-1964	37	81	up	up	ADP
ajlm-1964	37	82	to	to	PART
ajlm-1964	37	83	4	4	NUM
ajlm-1964	37	84	weeks	week	NOUN
ajlm-1964	37	85	or	or	CCONJ
ajlm-1964	37	86	longer	long	ADV
ajlm-1964	37	87	and	and	CCONJ
ajlm-1964	37	88	may	may	AUX
ajlm-1964	37	89	even	even	ADV
ajlm-1964	37	90	be	be	AUX
ajlm-1964	37	91	undetectable	undetectable	ADJ
ajlm-1964	37	92	in	in	ADP
ajlm-1964	37	93	a	a	DET
ajlm-1964	37	94	small	small	ADJ
ajlm-1964	37	95	number	number	NOUN
ajlm-1964	37	96	of	of	ADP
ajlm-1964	37	97	cases	case	NOUN
ajlm-1964	37	98	.	.	PUNCT
ajlm-1964	38	1	the	the	DET
ajlm-1964	38	2	basis	basis	NOUN
ajlm-1964	38	3	of	of	ADP
ajlm-1964	38	4	protective	protective	ADJ
ajlm-1964	38	5	immunity	immunity	NOUN
ajlm-1964	38	6	from	from	ADP
ajlm-1964	38	7	a	a	DET
ajlm-1964	38	8	successive	successive	ADJ
ajlm-1964	38	9	infection	infection	NOUN
ajlm-1964	38	10	is	be	AUX
ajlm-1964	38	11	the	the	DET
ajlm-1964	38	12	immune	immune	ADJ
ajlm-1964	38	13	memory	memory	NOUN
ajlm-1964	38	14	derived	derive	VERB
ajlm-1964	38	15	from	from	ADP
ajlm-1964	38	16	either	either	CCONJ
ajlm-1964	38	17	primary	primary	ADJ
ajlm-1964	38	18	infection	infection	NOUN
ajlm-1964	38	19	or	or	CCONJ
ajlm-1964	38	20	immunisation.30,31,32	immunisation.30,31,32	VERB
ajlm-1964	38	21	recently	recently	ADV
ajlm-1964	38	22	,	,	PUNCT
ajlm-1964	38	23	a	a	DET
ajlm-1964	38	24	predominantly	predominantly	ADV
ajlm-1964	38	25	cross	cross	ADJ
ajlm-1964	38	26	-	-	ADJ
ajlm-1964	38	27	sectional	sectional	ADJ
ajlm-1964	38	28	study	study	NOUN
ajlm-1964	38	29	,	,	PUNCT
ajlm-1964	38	30	which	which	PRON
ajlm-1964	38	31	also	also	ADV
ajlm-1964	38	32	included	include	VERB
ajlm-1964	38	33	a	a	DET
ajlm-1964	38	34	longitudinal	longitudinal	ADJ
ajlm-1964	38	35	component	component	NOUN
ajlm-1964	38	36	of	of	ADP
ajlm-1964	38	37	188	188	NUM
ajlm-1964	38	38	recovered	recover	VERB
ajlm-1964	38	39	covid-19	covid-19	PROPN
ajlm-1964	38	40	cases	case	NOUN
ajlm-1964	38	41	,	,	PUNCT
ajlm-1964	38	42	assessed	assess	VERB
ajlm-1964	38	43	the	the	DET
ajlm-1964	38	44	involvement	involvement	NOUN
ajlm-1964	38	45	of	of	ADP
ajlm-1964	38	46	the	the	DET
ajlm-1964	38	47	cd4	cd4	PROPN
ajlm-1964	38	48	+	+	PROPN
ajlm-1964	38	49	t	t	PROPN
ajlm-1964	38	50	-	-	PUNCT
ajlm-1964	38	51	cell	cell	NOUN
ajlm-1964	38	52	,	,	PUNCT
ajlm-1964	38	53	cd8	cd8	PROPN
ajlm-1964	38	54	+	+	PROPN
ajlm-1964	38	55	t	t	PROPN
ajlm-1964	38	56	-	-	PUNCT
ajlm-1964	38	57	cell	cell	NOUN
ajlm-1964	38	58	,	,	PUNCT
ajlm-1964	38	59	and	and	CCONJ
ajlm-1964	38	60	humoral	humoral	ADJ
ajlm-1964	38	61	components	component	NOUN
ajlm-1964	38	62	of	of	ADP
ajlm-1964	38	63	adaptive	adaptive	ADJ
ajlm-1964	38	64	immunity	immunity	NOUN
ajlm-1964	38	65	in	in	ADP
ajlm-1964	38	66	the	the	DET
ajlm-1964	38	67	immune	immune	ADJ
ajlm-1964	38	68	memory	memory	NOUN
ajlm-1964	38	69	.	.	PUNCT
ajlm-1964	39	1	the	the	DET
ajlm-1964	39	2	result	result	NOUN
ajlm-1964	39	3	showed	show	VERB
ajlm-1964	39	4	that	that	SCONJ
ajlm-1964	39	5	covid-19	covid-19	PROPN
ajlm-1964	39	6	infection	infection	NOUN
ajlm-1964	39	7	is	be	AUX
ajlm-1964	39	8	followed	follow	VERB
ajlm-1964	39	9	by	by	ADP
ajlm-1964	39	10	the	the	DET
ajlm-1964	39	11	generation	generation	NOUN
ajlm-1964	39	12	of	of	ADP
ajlm-1964	39	13	considerable	considerable	ADJ
ajlm-1964	39	14	immune	immune	ADJ
ajlm-1964	39	15	memory	memory	NOUN
ajlm-1964	39	16	involving	involve	VERB
ajlm-1964	39	17	all	all	DET
ajlm-1964	39	18	types	type	NOUN
ajlm-1964	39	19	of	of	ADP
ajlm-1964	39	20	adaptive	adaptive	ADJ
ajlm-1964	39	21	immune	immune	ADJ
ajlm-1964	39	22	components,21	components,21	NOUN
ajlm-1964	39	23	thus	thus	ADV
ajlm-1964	39	24	suggesting	suggest	VERB
ajlm-1964	39	25	that	that	DET
ajlm-1964	39	26	activation	activation	NOUN
ajlm-1964	39	27	of	of	ADP
ajlm-1964	39	28	antibodies	antibody	NOUN
ajlm-1964	39	29	or	or	CCONJ
ajlm-1964	39	30	t	t	NOUN
ajlm-1964	39	31	-	-	PUNCT
ajlm-1964	39	32	cell	cell	NOUN
ajlm-1964	39	33	reactivity	reactivity	NOUN
ajlm-1964	39	34	are	be	AUX
ajlm-1964	39	35	correlates	correlate	NOUN
ajlm-1964	39	36	of	of	ADP
ajlm-1964	39	37	protection	protection	NOUN
ajlm-1964	39	38	against	against	ADP
ajlm-1964	39	39	covid-19	covid-19	PROPN
ajlm-1964	39	40	infection	infection	NOUN
ajlm-1964	39	41	.	.	PUNCT
ajlm-1964	40	1	the	the	DET
ajlm-1964	40	2	question	question	NOUN
ajlm-1964	40	3	is	be	AUX
ajlm-1964	40	4	:	:	PUNCT
ajlm-1964	40	5	how	how	SCONJ
ajlm-1964	40	6	long	long	ADV
ajlm-1964	40	7	does	do	AUX
ajlm-1964	40	8	the	the	DET
ajlm-1964	40	9	immune	immune	ADJ
ajlm-1964	40	10	protection	protection	NOUN
ajlm-1964	40	11	last	last	ADJ
ajlm-1964	40	12	?	?	PUNCT
ajlm-1964	41	1	in	in	ADP
ajlm-1964	41	2	other	other	ADJ
ajlm-1964	41	3	coronaviruses	coronaviruse	NOUN
ajlm-1964	41	4	,	,	PUNCT
ajlm-1964	41	5	antibody	antibody	NOUN
ajlm-1964	41	6	levels	level	NOUN
ajlm-1964	41	7	decline	decline	VERB
ajlm-1964	41	8	between	between	ADP
ajlm-1964	41	9	12	12	NUM
ajlm-1964	41	10	and	and	CCONJ
ajlm-1964	41	11	52	52	NUM
ajlm-1964	41	12	weeks	week	NOUN
ajlm-1964	41	13	from	from	ADP
ajlm-1964	41	14	the	the	DET
ajlm-1964	41	15	inception	inception	NOUN
ajlm-1964	41	16	of	of	ADP
ajlm-1964	41	17	symptoms	symptom	NOUN
ajlm-1964	41	18	,	,	PUNCT
ajlm-1964	41	19	resulting	result	VERB
ajlm-1964	41	20	in	in	ADP
ajlm-1964	41	21	homologous	homologous	ADJ
ajlm-1964	41	22	reinfections.33	reinfections.33	NOUN
ajlm-1964	41	23	in	in	ADP
ajlm-1964	41	24	contrast	contrast	NOUN
ajlm-1964	41	25	to	to	ADP
ajlm-1964	41	26	sars	sar	NOUN
ajlm-1964	41	27	-	-	PUNCT
ajlm-1964	41	28	cov-1	cov-1	PART
ajlm-1964	41	29	infections	infection	NOUN
ajlm-1964	41	30	where	where	SCONJ
ajlm-1964	41	31	immunoglobin	immunoglobin	PROPN
ajlm-1964	41	32	g	g	NOUN
ajlm-1964	41	33	antibody	antibody	NOUN
ajlm-1964	41	34	levels	level	NOUN
ajlm-1964	41	35	could	could	AUX
ajlm-1964	41	36	be	be	AUX
ajlm-1964	41	37	sustained	sustain	VERB
ajlm-1964	41	38	for	for	ADP
ajlm-1964	41	39	two	two	NUM
ajlm-1964	41	40	years	year	NOUN
ajlm-1964	41	41	in	in	ADP
ajlm-1964	41	42	90	90	NUM
ajlm-1964	41	43	%	%	NOUN
ajlm-1964	41	44	of	of	ADP
ajlm-1964	41	45	patients	patient	NOUN
ajlm-1964	41	46	and	and	CCONJ
ajlm-1964	41	47	for	for	ADP
ajlm-1964	41	48	three	three	NUM
ajlm-1964	41	49	years	year	NOUN
ajlm-1964	41	50	in	in	ADP
ajlm-1964	41	51	50	50	NUM
ajlm-1964	41	52	%	%	NOUN
ajlm-1964	41	53	of	of	ADP
ajlm-1964	41	54	patients,34	patients,34	PROPN
ajlm-1964	41	55	immunoglobin	immunoglobin	PROPN
ajlm-1964	41	56	m	m	PROPN
ajlm-1964	41	57	and	and	CCONJ
ajlm-1964	41	58	immunoglobulin	immunoglobulin	NOUN
ajlm-1964	41	59	g	g	PROPN
ajlm-1964	41	60	antibody	antibody	NOUN
ajlm-1964	41	61	levels	level	NOUN
ajlm-1964	41	62	in	in	ADP
ajlm-1964	41	63	sars	sar	NOUN
ajlm-1964	41	64	-	-	PUNCT
ajlm-1964	41	65	cov-2	cov-2	NUM
ajlm-1964	41	66	could	could	AUX
ajlm-1964	41	67	only	only	ADV
ajlm-1964	41	68	be	be	AUX
ajlm-1964	41	69	sustained	sustain	VERB
ajlm-1964	41	70	for	for	ADP
ajlm-1964	41	71	over	over	ADP
ajlm-1964	41	72	seven	seven	NUM
ajlm-1964	41	73	weeks35	weeks35	NOUN
ajlm-1964	41	74	or	or	CCONJ
ajlm-1964	41	75	until	until	ADP
ajlm-1964	41	76	day	day	NOUN
ajlm-1964	41	77	49	49	NUM
ajlm-1964	41	78	in	in	ADP
ajlm-1964	41	79	at	at	ADV
ajlm-1964	41	80	least	least	ADV
ajlm-1964	41	81	80	80	NUM
ajlm-1964	41	82	%	%	NOUN
ajlm-1964	41	83	of	of	ADP
ajlm-1964	41	84	the	the	DET
ajlm-1964	41	85	cases.36	cases.36	NOUN
ajlm-1964	41	86	a	a	DET
ajlm-1964	41	87	recent	recent	ADJ
ajlm-1964	41	88	study	study	NOUN
ajlm-1964	41	89	showed	show	VERB
ajlm-1964	41	90	that	that	SCONJ
ajlm-1964	41	91	95	95	NUM
ajlm-1964	41	92	%	%	NOUN
ajlm-1964	41	93	of	of	ADP
ajlm-1964	41	94	study	study	NOUN
ajlm-1964	41	95	subjects	subject	NOUN
ajlm-1964	41	96	retained	retain	VERB
ajlm-1964	41	97	immune	immune	ADJ
ajlm-1964	41	98	memory	memory	NOUN
ajlm-1964	41	99	lasting	last	VERB
ajlm-1964	41	100	approximately	approximately	ADV
ajlm-1964	41	101	six	six	NUM
ajlm-1964	41	102	months	month	NOUN
ajlm-1964	41	103	after	after	ADP
ajlm-1964	41	104	infection.21	infection.21	NOUN
ajlm-1964	41	105	disease	disease	NOUN
ajlm-1964	41	106	dynamics	dynamic	NOUN
ajlm-1964	41	107	of	of	ADP
ajlm-1964	41	108	covid-19	covid-19	PROPN
ajlm-1964	41	109	in	in	ADP
ajlm-1964	41	110	sub	sub	ADJ
ajlm-1964	41	111	-	-	ADJ
ajlm-1964	41	112	saharan	saharan	ADJ
ajlm-1964	41	113	african	african	ADJ
ajlm-1964	41	114	countries	country	NOUN
ajlm-1964	41	115	the	the	DET
ajlm-1964	41	116	incidence	incidence	NOUN
ajlm-1964	41	117	of	of	ADP
ajlm-1964	41	118	sars	sar	NOUN
ajlm-1964	41	119	-	-	PUNCT
ajlm-1964	41	120	cov-2	cov-2	NOUN
ajlm-1964	41	121	infections	infection	NOUN
ajlm-1964	41	122	in	in	ADP
ajlm-1964	41	123	sub	sub	ADJ
ajlm-1964	41	124	-	-	ADJ
ajlm-1964	41	125	saharan	saharan	ADJ
ajlm-1964	41	126	africa	africa	PROPN
ajlm-1964	41	127	was	be	AUX
ajlm-1964	41	128	initially	initially	ADV
ajlm-1964	41	129	low	low	ADJ
ajlm-1964	41	130	but	but	CCONJ
ajlm-1964	41	131	increased	increase	VERB
ajlm-1964	41	132	rapidly	rapidly	ADV
ajlm-1964	41	133	over	over	ADP
ajlm-1964	41	134	time	time	NOUN
ajlm-1964	41	135	until	until	SCONJ
ajlm-1964	41	136	it	it	PRON
ajlm-1964	41	137	became	become	VERB
ajlm-1964	41	138	widespread	widespread	ADJ
ajlm-1964	41	139	in	in	ADP
ajlm-1964	41	140	virtually	virtually	ADV
ajlm-1964	41	141	all	all	DET
ajlm-1964	41	142	countries	country	NOUN
ajlm-1964	41	143	.	.	PUNCT
ajlm-1964	42	1	as	as	ADP
ajlm-1964	42	2	of	of	ADP
ajlm-1964	42	3	07	07	NUM
ajlm-1964	42	4	september	september	PROPN
ajlm-1964	42	5	2021	2021	NUM
ajlm-1964	42	6	,	,	PUNCT
ajlm-1964	42	7	the	the	DET
ajlm-1964	42	8	total	total	ADJ
ajlm-1964	42	9	number	number	NOUN
ajlm-1964	42	10	of	of	ADP
ajlm-1964	42	11	covid-19	covid-19	PROPN
ajlm-1964	42	12	cases	case	NOUN
ajlm-1964	42	13	reported	report	VERB
ajlm-1964	42	14	in	in	ADP
ajlm-1964	42	15	55	55	NUM
ajlm-1964	42	16	african	african	ADJ
ajlm-1964	42	17	countries	country	NOUN
ajlm-1964	42	18	was	be	AUX
ajlm-1964	42	19	7	7	NUM
ajlm-1964	42	20	926	926	NUM
ajlm-1964	42	21	999	999	NUM
ajlm-1964	42	22	,	,	PUNCT
ajlm-1964	42	23	with	with	ADP
ajlm-1964	42	24	200	200	NUM
ajlm-1964	42	25	045	045	NUM
ajlm-1964	42	26	deaths	death	NOUN
ajlm-1964	42	27	and	and	CCONJ
ajlm-1964	42	28	a	a	DET
ajlm-1964	42	29	case	case	NOUN
ajlm-1964	42	30	fatality	fatality	NOUN
ajlm-1964	42	31	ratio	ratio	NOUN
ajlm-1964	42	32	of	of	ADP
ajlm-1964	42	33	2.5%.37	2.5%.37	NUM
ajlm-1964	42	34	this	this	PRON
ajlm-1964	42	35	corresponds	correspond	VERB
ajlm-1964	42	36	to	to	ADP
ajlm-1964	42	37	3.6	3.6	NUM
ajlm-1964	42	38	%	%	NOUN
ajlm-1964	42	39	of	of	ADP
ajlm-1964	42	40	the	the	DET
ajlm-1964	42	41	total	total	ADJ
ajlm-1964	42	42	number	number	NOUN
ajlm-1964	42	43	of	of	ADP
ajlm-1964	42	44	cases	case	NOUN
ajlm-1964	42	45	and	and	CCONJ
ajlm-1964	42	46	4.4	4.4	NUM
ajlm-1964	42	47	%	%	NOUN
ajlm-1964	42	48	of	of	ADP
ajlm-1964	42	49	the	the	DET
ajlm-1964	42	50	total	total	ADJ
ajlm-1964	42	51	number	number	NOUN
ajlm-1964	42	52	of	of	ADP
ajlm-1964	42	53	deaths	death	NOUN
ajlm-1964	42	54	reported	report	VERB
ajlm-1964	42	55	globally	globally	ADV
ajlm-1964	42	56	.	.	PUNCT
ajlm-1964	43	1	within	within	ADP
ajlm-1964	43	2	africa	africa	PROPN
ajlm-1964	43	3	,	,	PUNCT
ajlm-1964	43	4	the	the	DET
ajlm-1964	43	5	total	total	ADJ
ajlm-1964	43	6	number	number	NOUN
ajlm-1964	43	7	of	of	ADP
ajlm-1964	43	8	covid-19	covid-19	PROPN
ajlm-1964	43	9	cases	case	NOUN
ajlm-1964	43	10	and	and	CCONJ
ajlm-1964	43	11	deaths	death	NOUN
ajlm-1964	43	12	have	have	AUX
ajlm-1964	43	13	varied	vary	VERB
ajlm-1964	43	14	between	between	ADP
ajlm-1964	43	15	countries	country	NOUN
ajlm-1964	43	16	and	and	CCONJ
ajlm-1964	43	17	with	with	ADP
ajlm-1964	43	18	time37	time37	NOUN
ajlm-1964	43	19	(	(	PUNCT
ajlm-1964	43	20	figure	figure	NOUN
ajlm-1964	43	21	23	23	NUM
ajlm-1964	43	22	)	)	PUNCT
ajlm-1964	43	23	.	.	PUNCT
ajlm-1964	44	1	as	as	ADP
ajlm-1964	44	2	of	of	ADP
ajlm-1964	44	3	07	07	NUM
ajlm-1964	44	4	september	september	PROPN
ajlm-1964	44	5	2021	2021	NUM
ajlm-1964	44	6	,	,	PUNCT
ajlm-1964	44	7	south	south	PROPN
ajlm-1964	44	8	africa	africa	PROPN
ajlm-1964	44	9	,	,	PUNCT
ajlm-1964	44	10	which	which	PRON
ajlm-1964	44	11	is	be	AUX
ajlm-1964	44	12	the	the	DET
ajlm-1964	44	13	epicentre	epicentre	NOUN
ajlm-1964	44	14	of	of	ADP
ajlm-1964	44	15	the	the	DET
ajlm-1964	44	16	pandemic	pandemic	NOUN
ajlm-1964	44	17	in	in	ADP
ajlm-1964	44	18	africa	africa	PROPN
ajlm-1964	44	19	,	,	PUNCT
ajlm-1964	44	20	had	have	AUX
ajlm-1964	44	21	recorded	record	VERB
ajlm-1964	44	22	the	the	DET
ajlm-1964	44	23	highest	high	ADJ
ajlm-1964	44	24	incidence	incidence	NOUN
ajlm-1964	44	25	of	of	ADP
ajlm-1964	44	26	validated	validate	VERB
ajlm-1964	44	27	covid-19	covid-19	PROPN
ajlm-1964	44	28	infections	infection	NOUN
ajlm-1964	44	29	(	(	PUNCT
ajlm-1964	44	30	2	2	NUM
ajlm-1964	44	31	819	819	NUM
ajlm-1964	44	32	945	945	NUM
ajlm-1964	44	33	)	)	PUNCT
ajlm-1964	44	34	in	in	ADP
ajlm-1964	44	35	sub	sub	ADJ
ajlm-1964	44	36	-	-	ADJ
ajlm-1964	44	37	saharan	saharan	ADJ
ajlm-1964	44	38	africa	africa	PROPN
ajlm-1964	44	39	,	,	PUNCT
ajlm-1964	44	40	followed	follow	VERB
ajlm-1964	44	41	by	by	ADP
ajlm-1964	44	42	ethiopia	ethiopia	PROPN
ajlm-1964	44	43	(	(	PUNCT
ajlm-1964	44	44	314	314	NUM
ajlm-1964	44	45	984	984	NUM
ajlm-1964	44	46	)	)	PUNCT
ajlm-1964	44	47	,	,	PUNCT
ajlm-1964	44	48	kenya	kenya	PROPN
ajlm-1964	44	49	(	(	PUNCT
ajlm-1964	44	50	240	240	NUM
ajlm-1964	44	51	172	172	NUM
ajlm-1964	44	52	)	)	PUNCT
ajlm-1964	44	53	,	,	PUNCT
ajlm-1964	44	54	zambia	zambia	PROPN
ajlm-1964	44	55	(	(	PUNCT
ajlm-1964	44	56	207	207	NUM
ajlm-1964	44	57	114	114	NUM
ajlm-1964	44	58	)	)	PUNCT
ajlm-1964	44	59	,	,	PUNCT
ajlm-1964	44	60	nigeria	nigeria	PROPN
ajlm-1964	44	61	(	(	PUNCT
ajlm-1964	44	62	195	195	NUM
ajlm-1964	44	63	511	511	NUM
ajlm-1964	44	64	)	)	PUNCT
ajlm-1964	44	65	,	,	PUNCT
ajlm-1964	44	66	and	and	CCONJ
ajlm-1964	44	67	botswana	botswana	PROPN
ajlm-1964	44	68	(	(	PUNCT
ajlm-1964	44	69	162	162	NUM
ajlm-1964	44	70	186).37	186).37	NUM
ajlm-1964	44	71	although	although	SCONJ
ajlm-1964	44	72	nigeria	nigeria	PROPN
ajlm-1964	44	73	is	be	AUX
ajlm-1964	44	74	the	the	DET
ajlm-1964	44	75	most	most	ADV
ajlm-1964	44	76	populous	populous	ADJ
ajlm-1964	44	77	african	african	ADJ
ajlm-1964	44	78	nation	nation	NOUN
ajlm-1964	44	79	,	,	PUNCT
ajlm-1964	44	80	it	it	PRON
ajlm-1964	44	81	has	have	VERB
ajlm-1964	44	82	the	the	DET
ajlm-1964	44	83	fifth	fifth	ADJ
ajlm-1964	44	84	largest	large	ADJ
ajlm-1964	44	85	case	case	NOUN
ajlm-1964	44	86	count	count	NOUN
ajlm-1964	44	87	in	in	ADP
ajlm-1964	44	88	sub	sub	ADJ
ajlm-1964	44	89	-	-	ADJ
ajlm-1964	44	90	saharan	saharan	ADJ
ajlm-1964	44	91	africa	africa	PROPN
ajlm-1964	44	92	and	and	CCONJ
ajlm-1964	44	93	the	the	DET
ajlm-1964	44	94	largest	large	ADJ
ajlm-1964	44	95	outbreak	outbreak	NOUN
ajlm-1964	44	96	in	in	ADP
ajlm-1964	44	97	west	west	PROPN
ajlm-1964	44	98	africa.37	africa.37	PROPN
ajlm-1964	44	99	the	the	DET
ajlm-1964	44	100	number	number	NOUN
ajlm-1964	44	101	of	of	ADP
ajlm-1964	44	102	cases	case	NOUN
ajlm-1964	44	103	being	be	AUX
ajlm-1964	44	104	reported	report	VERB
ajlm-1964	44	105	in	in	ADP
ajlm-1964	44	106	africa	africa	PROPN
ajlm-1964	44	107	compared	compare	VERB
ajlm-1964	44	108	to	to	ADP
ajlm-1964	44	109	the	the	DET
ajlm-1964	44	110	other	other	ADJ
ajlm-1964	44	111	regions	region	NOUN
ajlm-1964	44	112	of	of	ADP
ajlm-1964	44	113	the	the	DET
ajlm-1964	44	114	globe	globe	NOUN
ajlm-1964	44	115	may	may	AUX
ajlm-1964	44	116	have	have	AUX
ajlm-1964	44	117	been	be	AUX
ajlm-1964	44	118	partly	partly	ADV
ajlm-1964	44	119	influenced	influence	VERB
ajlm-1964	44	120	by	by	ADP
ajlm-1964	44	121	the	the	DET
ajlm-1964	44	122	low	low	ADJ
ajlm-1964	44	123	level	level	NOUN
ajlm-1964	44	124	of	of	ADP
ajlm-1964	44	125	testing,37	testing,37	NOUN
ajlm-1964	44	126	suggesting	suggest	VERB
ajlm-1964	44	127	a	a	DET
ajlm-1964	44	128	high	high	ADJ
ajlm-1964	44	129	likelihood	likelihood	NOUN
ajlm-1964	44	130	of	of	ADP
ajlm-1964	44	131	many	many	ADJ
ajlm-1964	44	132	undetected	undetected	ADJ
ajlm-1964	44	133	cases	case	NOUN
ajlm-1964	44	134	.	.	PUNCT
ajlm-1964	45	1	the	the	DET
ajlm-1964	45	2	level	level	NOUN
ajlm-1964	45	3	of	of	ADP
ajlm-1964	45	4	testing	testing	NOUN
ajlm-1964	45	5	in	in	ADP
ajlm-1964	45	6	africa	africa	PROPN
ajlm-1964	45	7	has	have	AUX
ajlm-1964	45	8	been	be	AUX
ajlm-1964	45	9	hindered	hinder	VERB
ajlm-1964	45	10	by	by	ADP
ajlm-1964	45	11	factors	factor	NOUN
ajlm-1964	45	12	that	that	PRON
ajlm-1964	45	13	include	include	VERB
ajlm-1964	45	14	limited	limited	ADJ
ajlm-1964	45	15	laboratory	laboratory	NOUN
ajlm-1964	45	16	capacity	capacity	NOUN
ajlm-1964	45	17	,	,	PUNCT
ajlm-1964	45	18	availability	availability	NOUN
ajlm-1964	45	19	and	and	CCONJ
ajlm-1964	45	20	accessibility	accessibility	NOUN
ajlm-1964	45	21	of	of	ADP
ajlm-1964	45	22	testing	testing	NOUN
ajlm-1964	45	23	sites	site	NOUN
ajlm-1964	45	24	,	,	PUNCT
ajlm-1964	45	25	cost	cost	NOUN
ajlm-1964	45	26	of	of	ADP
ajlm-1964	45	27	testing	testing	NOUN
ajlm-1964	45	28	,	,	PUNCT
ajlm-1964	45	29	low	low	ADJ
ajlm-1964	45	30	health	health	NOUN
ajlm-1964	45	31	literacy	literacy	NOUN
ajlm-1964	45	32	,	,	PUNCT
ajlm-1964	45	33	and	and	CCONJ
ajlm-1964	45	34	the	the	DET
ajlm-1964	45	35	stigma	stigma	NOUN
ajlm-1964	45	36	associated	associate	VERB
ajlm-1964	45	37	with	with	ADP
ajlm-1964	45	38	testing	test	VERB
ajlm-1964	45	39	positive.38	positive.38	NOUN
ajlm-1964	45	40	also	also	ADV
ajlm-1964	45	41	,	,	PUNCT
ajlm-1964	45	42	certain	certain	ADJ
ajlm-1964	45	43	characteristics	characteristic	NOUN
ajlm-1964	45	44	peculiar	peculiar	ADJ
ajlm-1964	45	45	to	to	ADP
ajlm-1964	45	46	africa	africa	PROPN
ajlm-1964	45	47	in	in	ADP
ajlm-1964	45	48	terms	term	NOUN
ajlm-1964	45	49	of	of	ADP
ajlm-1964	45	50	age	age	NOUN
ajlm-1964	45	51	,	,	PUNCT
ajlm-1964	45	52	health	health	NOUN
ajlm-1964	45	53	,	,	PUNCT
ajlm-1964	45	54	lifestyle	lifestyle	NOUN
ajlm-1964	45	55	,	,	PUNCT
ajlm-1964	45	56	and	and	CCONJ
ajlm-1964	45	57	previous	previous	ADJ
ajlm-1964	45	58	experiences	experience	NOUN
ajlm-1964	45	59	with	with	ADP
ajlm-1964	45	60	other	other	ADJ
ajlm-1964	45	61	infectious	infectious	ADJ
ajlm-1964	45	62	disease	disease	NOUN
ajlm-1964	45	63	outbreaks	outbreak	NOUN
ajlm-1964	45	64	might	might	AUX
ajlm-1964	45	65	have	have	AUX
ajlm-1964	45	66	impacted	impact	VERB
ajlm-1964	45	67	how	how	SCONJ
ajlm-1964	45	68	the	the	DET
ajlm-1964	45	69	pandemic	pandemic	NOUN
ajlm-1964	45	70	is	be	AUX
ajlm-1964	45	71	playing	play	VERB
ajlm-1964	45	72	out	out	ADP
ajlm-1964	45	73	in	in	ADP
ajlm-1964	45	74	africa	africa	PROPN
ajlm-1964	45	75	.	.	PUNCT
ajlm-1964	46	1	figure	figure	NOUN
ajlm-1964	46	2	2	2	NUM
ajlm-1964	46	3	:	:	PUNCT
ajlm-1964	46	4	cumulative	cumulative	ADJ
ajlm-1964	46	5	total	total	ADJ
ajlm-1964	46	6	number	number	NOUN
ajlm-1964	46	7	of	of	ADP
ajlm-1964	46	8	covid-19	covid-19	PROPN
ajlm-1964	46	9	cases	case	NOUN
ajlm-1964	46	10	and	and	CCONJ
ajlm-1964	46	11	deaths	death	NOUN
ajlm-1964	46	12	reported	report	VERB
ajlm-1964	46	13	in	in	ADP
ajlm-1964	46	14	africa	africa	PROPN
ajlm-1964	46	15	between	between	ADP
ajlm-1964	46	16	05	05	NUM
ajlm-1964	46	17	february	february	PROPN
ajlm-1964	46	18	2020	2020	NUM
ajlm-1964	46	19	and	and	CCONJ
ajlm-1964	46	20	07	07	NUM
ajlm-1964	46	21	september	september	PROPN
ajlm-1964	46	22	2021	2021	NUM
ajlm-1964	46	23	.	.	PUNCT
ajlm-1964	47	1	with	with	ADP
ajlm-1964	47	2	a	a	DET
ajlm-1964	47	3	median	median	ADJ
ajlm-1964	47	4	age	age	NOUN
ajlm-1964	47	5	of	of	ADP
ajlm-1964	47	6	under	under	ADP
ajlm-1964	47	7	20	20	NUM
ajlm-1964	47	8	years	year	NOUN
ajlm-1964	47	9	,	,	PUNCT
ajlm-1964	47	10	africa	africa	PROPN
ajlm-1964	47	11	has	have	VERB
ajlm-1964	47	12	a	a	DET
ajlm-1964	47	13	relatively	relatively	ADV
ajlm-1964	47	14	young	young	ADJ
ajlm-1964	47	15	population	population	NOUN
ajlm-1964	47	16	compared	compare	VERB
ajlm-1964	47	17	to	to	ADP
ajlm-1964	47	18	european	european	PROPN
ajlm-1964	47	19	union	union	PROPN
ajlm-1964	47	20	countries	country	NOUN
ajlm-1964	47	21	(	(	PUNCT
ajlm-1964	47	22	43	43	NUM
ajlm-1964	47	23	years	year	NOUN
ajlm-1964	47	24	)	)	PUNCT
ajlm-1964	47	25	and	and	CCONJ
ajlm-1964	47	26	china	china	PROPN
ajlm-1964	47	27	and	and	CCONJ
ajlm-1964	47	28	the	the	DET
ajlm-1964	47	29	united	united	PROPN
ajlm-1964	47	30	states	states	PROPN
ajlm-1964	47	31	(	(	PUNCT
ajlm-1964	47	32	38	38	NUM
ajlm-1964	47	33	years).39	years).39	NOUN
ajlm-1964	47	34	besides	besides	SCONJ
ajlm-1964	47	35	,	,	PUNCT
ajlm-1964	47	36	only	only	ADV
ajlm-1964	47	37	3	3	NUM
ajlm-1964	47	38	%	%	NOUN
ajlm-1964	47	39	of	of	ADP
ajlm-1964	47	40	the	the	DET
ajlm-1964	47	41	african	african	ADJ
ajlm-1964	47	42	population	population	NOUN
ajlm-1964	47	43	is	be	AUX
ajlm-1964	47	44	above	above	ADP
ajlm-1964	47	45	65	65	NUM
ajlm-1964	47	46	years	year	NOUN
ajlm-1964	47	47	,	,	PUNCT
ajlm-1964	47	48	which	which	PRON
ajlm-1964	47	49	is	be	AUX
ajlm-1964	47	50	the	the	DET
ajlm-1964	47	51	threshold	threshold	NOUN
ajlm-1964	47	52	for	for	ADP
ajlm-1964	47	53	significant	significant	ADJ
ajlm-1964	47	54	chances	chance	NOUN
ajlm-1964	47	55	of	of	ADP
ajlm-1964	47	56	complications	complication	NOUN
ajlm-1964	47	57	and	and	CCONJ
ajlm-1964	47	58	deaths	death	NOUN
ajlm-1964	47	59	due	due	ADJ
ajlm-1964	47	60	to	to	ADP
ajlm-1964	47	61	covid-19.40	covid-19.40	PROPN
ajlm-1964	47	62	in	in	ADP
ajlm-1964	47	63	nigeria	nigeria	PROPN
ajlm-1964	47	64	,	,	PUNCT
ajlm-1964	47	65	the	the	DET
ajlm-1964	47	66	most	most	ADV
ajlm-1964	47	67	populous	populous	ADJ
ajlm-1964	47	68	country	country	NOUN
ajlm-1964	47	69	in	in	ADP
ajlm-1964	47	70	africa	africa	PROPN
ajlm-1964	47	71	,	,	PUNCT
ajlm-1964	47	72	over	over	ADP
ajlm-1964	47	73	44	44	NUM
ajlm-1964	47	74	%	%	NOUN
ajlm-1964	47	75	of	of	ADP
ajlm-1964	47	76	the	the	DET
ajlm-1964	47	77	population	population	NOUN
ajlm-1964	47	78	is	be	AUX
ajlm-1964	47	79	below	below	ADP
ajlm-1964	47	80	the	the	DET
ajlm-1964	47	81	age	age	NOUN
ajlm-1964	47	82	of	of	ADP
ajlm-1964	47	83	15	15	NUM
ajlm-1964	47	84	years	year	NOUN
ajlm-1964	47	85	,	,	PUNCT
ajlm-1964	47	86	the	the	DET
ajlm-1964	47	87	age	age	NOUN
ajlm-1964	47	88	group	group	NOUN
ajlm-1964	47	89	with	with	ADP
ajlm-1964	47	90	the	the	DET
ajlm-1964	47	91	fewest	few	ADJ
ajlm-1964	47	92	number	number	NOUN
ajlm-1964	47	93	of	of	ADP
ajlm-1964	47	94	reported	report	VERB
ajlm-1964	47	95	cases	case	NOUN
ajlm-1964	47	96	and	and	CCONJ
ajlm-1964	47	97	mortality.41	mortality.41	NOUN
ajlm-1964	47	98	however	however	ADV
ajlm-1964	47	99	,	,	PUNCT
ajlm-1964	47	100	there	there	PRON
ajlm-1964	47	101	are	be	VERB
ajlm-1964	47	102	fears	fear	NOUN
ajlm-1964	47	103	that	that	SCONJ
ajlm-1964	47	104	other	other	ADJ
ajlm-1964	47	105	demographic	demographic	ADJ
ajlm-1964	47	106	features	feature	NOUN
ajlm-1964	47	107	peculiar	peculiar	ADJ
ajlm-1964	47	108	to	to	ADP
ajlm-1964	47	109	africa	africa	PROPN
ajlm-1964	47	110	such	such	ADJ
ajlm-1964	47	111	as	as	ADP
ajlm-1964	47	112	frequent	frequent	ADJ
ajlm-1964	47	113	migration	migration	NOUN
ajlm-1964	47	114	across	across	ADP
ajlm-1964	47	115	borders	border	NOUN
ajlm-1964	47	116	,	,	PUNCT
ajlm-1964	47	117	a	a	DET
ajlm-1964	47	118	high	high	ADJ
ajlm-1964	47	119	number	number	NOUN
ajlm-1964	47	120	of	of	ADP
ajlm-1964	47	121	displaced	displace	VERB
ajlm-1964	47	122	persons	person	NOUN
ajlm-1964	47	123	,	,	PUNCT
ajlm-1964	47	124	rapid	rapid	ADJ
ajlm-1964	47	125	urbanisation	urbanisation	NOUN
ajlm-1964	47	126	,	,	PUNCT
ajlm-1964	47	127	and	and	CCONJ
ajlm-1964	47	128	large	large	ADJ
ajlm-1964	47	129	households41	households41	NOUN
ajlm-1964	47	130	could	could	AUX
ajlm-1964	47	131	complicate	complicate	VERB
ajlm-1964	47	132	prevention	prevention	NOUN
ajlm-1964	47	133	and	and	CCONJ
ajlm-1964	47	134	mitigation	mitigation	NOUN
ajlm-1964	47	135	efforts	effort	NOUN
ajlm-1964	47	136	,	,	PUNCT
ajlm-1964	47	137	thereby	thereby	ADV
ajlm-1964	47	138	driving	drive	VERB
ajlm-1964	47	139	up	up	ADP
ajlm-1964	47	140	the	the	DET
ajlm-1964	47	141	case	case	NOUN
ajlm-1964	47	142	count	count	NOUN
ajlm-1964	47	143	and	and	CCONJ
ajlm-1964	47	144	the	the	DET
ajlm-1964	47	145	number	number	NOUN
ajlm-1964	47	146	of	of	ADP
ajlm-1964	47	147	deaths	death	NOUN
ajlm-1964	47	148	.	.	PUNCT
ajlm-1964	48	1	in	in	ADP
ajlm-1964	48	2	addition	addition	NOUN
ajlm-1964	48	3	,	,	PUNCT
ajlm-1964	48	4	factors	factor	NOUN
ajlm-1964	48	5	like	like	ADP
ajlm-1964	48	6	the	the	DET
ajlm-1964	48	7	worsening	worsen	VERB
ajlm-1964	48	8	burden	burden	NOUN
ajlm-1964	48	9	of	of	ADP
ajlm-1964	48	10	existing	exist	VERB
ajlm-1964	48	11	health	health	NOUN
ajlm-1964	48	12	conditions	condition	NOUN
ajlm-1964	48	13	such	such	ADJ
ajlm-1964	48	14	as	as	ADP
ajlm-1964	48	15	tuberculosis	tuberculosis	NOUN
ajlm-1964	48	16	and	and	CCONJ
ajlm-1964	48	17	hiv	hiv	PROPN
ajlm-1964	48	18	/	/	SYM
ajlm-1964	48	19	aids42,43	aids42,43	PROPN
ajlm-1964	48	20	with	with	ADP
ajlm-1964	48	21	their	their	PRON
ajlm-1964	48	22	attendant	attendant	ADJ
ajlm-1964	48	23	effects	effect	NOUN
ajlm-1964	48	24	on	on	ADP
ajlm-1964	48	25	the	the	DET
ajlm-1964	48	26	population	population	NOUN
ajlm-1964	48	27	’s	’s	PART
ajlm-1964	48	28	immune	immune	ADJ
ajlm-1964	48	29	status	status	NOUN
ajlm-1964	48	30	,	,	PUNCT
ajlm-1964	48	31	as	as	ADV
ajlm-1964	48	32	well	well	ADV
ajlm-1964	48	33	as	as	ADP
ajlm-1964	48	34	the	the	DET
ajlm-1964	48	35	high	high	ADJ
ajlm-1964	48	36	incidence	incidence	NOUN
ajlm-1964	48	37	of	of	ADP
ajlm-1964	48	38	non	non	ADJ
ajlm-1964	48	39	-	-	ADJ
ajlm-1964	48	40	communicable	communicable	ADJ
ajlm-1964	48	41	diseases	disease	NOUN
ajlm-1964	48	42	such	such	ADJ
ajlm-1964	48	43	as	as	ADP
ajlm-1964	48	44	hypertension	hypertension	NOUN
ajlm-1964	48	45	and	and	CCONJ
ajlm-1964	48	46	heart	heart	NOUN
ajlm-1964	48	47	diseases	disease	NOUN
ajlm-1964	48	48	,	,	PUNCT
ajlm-1964	48	49	increase	increase	VERB
ajlm-1964	48	50	the	the	DET
ajlm-1964	48	51	chances	chance	NOUN
ajlm-1964	48	52	of	of	ADP
ajlm-1964	48	53	complications	complication	NOUN
ajlm-1964	48	54	from	from	ADP
ajlm-1964	48	55	covid-19	covid-19	PROPN
ajlm-1964	48	56	infections	infection	NOUN
ajlm-1964	48	57	.	.	PUNCT
ajlm-1964	49	1	infectious	infectious	ADJ
ajlm-1964	49	2	diseases	disease	NOUN
ajlm-1964	49	3	in	in	ADP
ajlm-1964	49	4	sub	sub	ADJ
ajlm-1964	49	5	-	-	ADJ
ajlm-1964	49	6	saharan	saharan	ADJ
ajlm-1964	49	7	africa	africa	PROPN
ajlm-1964	49	8	infectious	infectious	ADJ
ajlm-1964	49	9	diseases	disease	NOUN
ajlm-1964	49	10	,	,	PUNCT
ajlm-1964	49	11	responsible	responsible	ADJ
ajlm-1964	49	12	for	for	ADP
ajlm-1964	49	13	a	a	DET
ajlm-1964	49	14	minimum	minimum	NOUN
ajlm-1964	49	15	of	of	ADP
ajlm-1964	49	16	69	69	NUM
ajlm-1964	49	17	%	%	NOUN
ajlm-1964	49	18	of	of	ADP
ajlm-1964	49	19	deaths	death	NOUN
ajlm-1964	49	20	in	in	ADP
ajlm-1964	49	21	africa,44	africa,44	NUM
ajlm-1964	49	22	are	be	AUX
ajlm-1964	49	23	a	a	DET
ajlm-1964	49	24	serious	serious	ADJ
ajlm-1964	49	25	challenge	challenge	NOUN
ajlm-1964	49	26	in	in	ADP
ajlm-1964	49	27	africa	africa	PROPN
ajlm-1964	49	28	due	due	ADP
ajlm-1964	49	29	to	to	ADP
ajlm-1964	49	30	various	various	ADJ
ajlm-1964	49	31	underlying	underlie	VERB
ajlm-1964	49	32	factors	factor	NOUN
ajlm-1964	49	33	such	such	ADJ
ajlm-1964	49	34	as	as	ADP
ajlm-1964	49	35	poverty	poverty	NOUN
ajlm-1964	49	36	,	,	PUNCT
ajlm-1964	49	37	poor	poor	ADJ
ajlm-1964	49	38	environmental	environmental	ADJ
ajlm-1964	49	39	hygiene	hygiene	NOUN
ajlm-1964	49	40	,	,	PUNCT
ajlm-1964	49	41	overcrowded	overcrowded	ADJ
ajlm-1964	49	42	housing	housing	NOUN
ajlm-1964	49	43	,	,	PUNCT
ajlm-1964	49	44	limited	limited	ADJ
ajlm-1964	49	45	access	access	NOUN
ajlm-1964	49	46	to	to	ADP
ajlm-1964	49	47	affordable	affordable	ADJ
ajlm-1964	49	48	healthcare	healthcare	NOUN
ajlm-1964	49	49	,	,	PUNCT
ajlm-1964	49	50	and	and	CCONJ
ajlm-1964	49	51	lack	lack	NOUN
ajlm-1964	49	52	of	of	ADP
ajlm-1964	49	53	basic	basic	ADJ
ajlm-1964	49	54	health	health	NOUN
ajlm-1964	49	55	education.45,46,47	education.45,46,47	PROPN
ajlm-1964	49	56	malaria	malaria	NOUN
ajlm-1964	49	57	,	,	PUNCT
ajlm-1964	49	58	hiv	hiv	PROPN
ajlm-1964	49	59	/	/	SYM
ajlm-1964	49	60	aids	aids	PROPN
ajlm-1964	49	61	,	,	PUNCT
ajlm-1964	49	62	tuberculosis	tuberculosis	NOUN
ajlm-1964	49	63	,	,	PUNCT
ajlm-1964	49	64	ebola	ebola	NOUN
ajlm-1964	49	65	disease	disease	NOUN
ajlm-1964	49	66	,	,	PUNCT
ajlm-1964	49	67	lassa	lassa	ADJ
ajlm-1964	49	68	fever	fever	NOUN
ajlm-1964	49	69	,	,	PUNCT
ajlm-1964	49	70	guinea	guinea	NOUN
ajlm-1964	49	71	worm	worm	NOUN
ajlm-1964	49	72	,	,	PUNCT
ajlm-1964	49	73	elephantiasis	elephantiasis	NOUN
ajlm-1964	49	74	,	,	PUNCT
ajlm-1964	49	75	river	river	NOUN
ajlm-1964	49	76	blindness	blindness	NOUN
ajlm-1964	49	77	,	,	PUNCT
ajlm-1964	49	78	lower	low	ADJ
ajlm-1964	49	79	respiratory	respiratory	ADJ
ajlm-1964	49	80	tract	tract	NOUN
ajlm-1964	49	81	infection	infection	NOUN
ajlm-1964	49	82	,	,	PUNCT
ajlm-1964	49	83	and	and	CCONJ
ajlm-1964	49	84	diarrheal	diarrheal	ADJ
ajlm-1964	49	85	disease	disease	NOUN
ajlm-1964	49	86	are	be	AUX
ajlm-1964	49	87	prevalent	prevalent	ADJ
ajlm-1964	49	88	or	or	CCONJ
ajlm-1964	49	89	have	have	AUX
ajlm-1964	49	90	had	have	VERB
ajlm-1964	49	91	outbreaks	outbreak	NOUN
ajlm-1964	49	92	in	in	ADP
ajlm-1964	49	93	africa.48	africa.48	PROPN
ajlm-1964	49	94	there	there	PRON
ajlm-1964	49	95	are	be	VERB
ajlm-1964	49	96	six	six	NUM
ajlm-1964	49	97	infectious	infectious	ADJ
ajlm-1964	49	98	diseases	disease	NOUN
ajlm-1964	49	99	in	in	ADP
ajlm-1964	49	100	the	the	DET
ajlm-1964	49	101	2019	2019	NUM
ajlm-1964	49	102	who	who	PRON
ajlm-1964	49	103	report	report	VERB
ajlm-1964	49	104	of	of	ADP
ajlm-1964	49	105	the	the	DET
ajlm-1964	49	106	top	top	ADJ
ajlm-1964	49	107	10	10	NUM
ajlm-1964	49	108	causes	cause	NOUN
ajlm-1964	49	109	of	of	ADP
ajlm-1964	49	110	disability	disability	NOUN
ajlm-1964	49	111	-	-	PUNCT
ajlm-1964	49	112	adjusted	adjust	VERB
ajlm-1964	49	113	life	life	NOUN
ajlm-1964	49	114	years	year	NOUN
ajlm-1964	49	115	in	in	ADP
ajlm-1964	49	116	sub	sub	ADJ
ajlm-1964	49	117	-	-	ADJ
ajlm-1964	49	118	saharan	saharan	ADJ
ajlm-1964	49	119	africa.49	africa.49	ADP
ajlm-1964	49	120	these	these	PRON
ajlm-1964	49	121	include	include	VERB
ajlm-1964	49	122	malaria	malaria	NOUN
ajlm-1964	49	123	,	,	PUNCT
ajlm-1964	49	124	aids	aid	NOUN
ajlm-1964	49	125	,	,	PUNCT
ajlm-1964	49	126	lower	low	ADJ
ajlm-1964	49	127	respiratory	respiratory	ADJ
ajlm-1964	49	128	tract	tract	NOUN
ajlm-1964	49	129	infections	infection	NOUN
ajlm-1964	49	130	,	,	PUNCT
ajlm-1964	49	131	diarrheal	diarrheal	NOUN
ajlm-1964	49	132	infections	infection	NOUN
ajlm-1964	49	133	,	,	PUNCT
ajlm-1964	49	134	meningitis	meningitis	NOUN
ajlm-1964	49	135	and	and	CCONJ
ajlm-1964	49	136	tuberculosis.49	tuberculosis.49	NOUN
ajlm-1964	49	137	the	the	DET
ajlm-1964	49	138	spread	spread	NOUN
ajlm-1964	49	139	of	of	ADP
ajlm-1964	49	140	these	these	DET
ajlm-1964	49	141	diseases	disease	NOUN
ajlm-1964	49	142	could	could	AUX
ajlm-1964	49	143	occur	occur	VERB
ajlm-1964	49	144	more	more	ADV
ajlm-1964	49	145	easily	easily	ADV
ajlm-1964	49	146	in	in	ADP
ajlm-1964	49	147	countries	country	NOUN
ajlm-1964	49	148	with	with	ADP
ajlm-1964	49	149	inadequate	inadequate	ADJ
ajlm-1964	49	150	infrastructure	infrastructure	NOUN
ajlm-1964	49	151	and	and	CCONJ
ajlm-1964	49	152	fragile	fragile	ADJ
ajlm-1964	49	153	health	health	NOUN
ajlm-1964	49	154	systems	system	NOUN
ajlm-1964	49	155	.	.	PUNCT
ajlm-1964	50	1	malaria	malaria	NOUN
ajlm-1964	50	2	,	,	PUNCT
ajlm-1964	50	3	caused	cause	VERB
ajlm-1964	50	4	by	by	ADP
ajlm-1964	50	5	plasmodium	plasmodium	NOUN
ajlm-1964	50	6	species	specie	NOUN
ajlm-1964	50	7	,	,	PUNCT
ajlm-1964	50	8	is	be	AUX
ajlm-1964	50	9	a	a	DET
ajlm-1964	50	10	vector	vector	NOUN
ajlm-1964	50	11	-	-	PUNCT
ajlm-1964	50	12	borne	borne	ADJ
ajlm-1964	50	13	parasitic	parasitic	ADJ
ajlm-1964	50	14	disease	disease	NOUN
ajlm-1964	50	15	that	that	PRON
ajlm-1964	50	16	infects	infect	VERB
ajlm-1964	50	17	humans	human	NOUN
ajlm-1964	50	18	via	via	ADP
ajlm-1964	50	19	the	the	DET
ajlm-1964	50	20	bites	bite	NOUN
ajlm-1964	50	21	of	of	ADP
ajlm-1964	50	22	infected	infected	ADJ
ajlm-1964	50	23	female	female	ADJ
ajlm-1964	50	24	anopheles	anophele	NOUN
ajlm-1964	50	25	mosquitoes.50	mosquitoes.50	PROPN
ajlm-1964	50	26	in	in	ADP
ajlm-1964	50	27	2020	2020	NUM
ajlm-1964	50	28	,	,	PUNCT
ajlm-1964	50	29	the	the	PRON
ajlm-1964	50	30	who	who	PRON
ajlm-1964	50	31	estimated	estimate	VERB
ajlm-1964	50	32	that	that	SCONJ
ajlm-1964	50	33	3.2	3.2	NUM
ajlm-1964	50	34	billion	billion	NUM
ajlm-1964	50	35	people	people	NOUN
ajlm-1964	50	36	across	across	ADP
ajlm-1964	50	37	96	96	NUM
ajlm-1964	50	38	countries	country	NOUN
ajlm-1964	50	39	run	run	VERB
ajlm-1964	50	40	the	the	DET
ajlm-1964	50	41	risk	risk	NOUN
ajlm-1964	50	42	of	of	ADP
ajlm-1964	50	43	having	have	VERB
ajlm-1964	50	44	malaria	malaria	NOUN
ajlm-1964	50	45	,	,	PUNCT
ajlm-1964	50	46	with	with	ADP
ajlm-1964	50	47	the	the	DET
ajlm-1964	50	48	highest	high	ADJ
ajlm-1964	50	49	burden	burden	NOUN
ajlm-1964	50	50	being	be	AUX
ajlm-1964	50	51	in	in	ADP
ajlm-1964	50	52	sub	sub	ADJ
ajlm-1964	50	53	-	-	ADJ
ajlm-1964	50	54	saharan	saharan	ADJ
ajlm-1964	50	55	africa	africa	PROPN
ajlm-1964	50	56	.	.	PUNCT
ajlm-1964	51	1	this	this	DET
ajlm-1964	51	2	region	region	NOUN
ajlm-1964	51	3	accounts	account	VERB
ajlm-1964	51	4	for	for	ADP
ajlm-1964	51	5	94	94	NUM
ajlm-1964	51	6	%	%	NOUN
ajlm-1964	51	7	of	of	ADP
ajlm-1964	51	8	global	global	ADJ
ajlm-1964	51	9	cases	case	NOUN
ajlm-1964	51	10	and	and	CCONJ
ajlm-1964	51	11	94	94	NUM
ajlm-1964	51	12	%	%	NOUN
ajlm-1964	51	13	of	of	ADP
ajlm-1964	51	14	deaths	death	NOUN
ajlm-1964	51	15	,	,	PUNCT
ajlm-1964	51	16	67	67	NUM
ajlm-1964	51	17	%	%	NOUN
ajlm-1964	51	18	of	of	ADP
ajlm-1964	51	19	which	which	PRON
ajlm-1964	51	20	are	be	AUX
ajlm-1964	51	21	in	in	ADP
ajlm-1964	51	22	children	child	NOUN
ajlm-1964	51	23	aged	age	VERB
ajlm-1964	51	24	under	under	ADP
ajlm-1964	51	25	five	five	NUM
ajlm-1964	51	26	years.50	years.50	NOUN
ajlm-1964	51	27	the	the	DET
ajlm-1964	51	28	hiv	hiv	PROPN
ajlm-1964	51	29	is	be	AUX
ajlm-1964	51	30	a	a	DET
ajlm-1964	51	31	retrovirus	retrovirus	NOUN
ajlm-1964	51	32	that	that	PRON
ajlm-1964	51	33	progressively	progressively	ADV
ajlm-1964	51	34	destroys	destroy	VERB
ajlm-1964	51	35	and	and	CCONJ
ajlm-1964	51	36	weakens	weaken	VERB
ajlm-1964	51	37	the	the	DET
ajlm-1964	51	38	immune	immune	ADJ
ajlm-1964	51	39	system	system	NOUN
ajlm-1964	51	40	of	of	ADP
ajlm-1964	51	41	an	an	DET
ajlm-1964	51	42	infected	infected	ADJ
ajlm-1964	51	43	person	person	NOUN
ajlm-1964	51	44	until	until	SCONJ
ajlm-1964	51	45	it	it	PRON
ajlm-1964	51	46	becomes	become	VERB
ajlm-1964	51	47	vulnerable	vulnerable	ADJ
ajlm-1964	51	48	to	to	ADP
ajlm-1964	51	49	opportunistic	opportunistic	ADJ
ajlm-1964	51	50	infections	infection	NOUN
ajlm-1964	51	51	.	.	PUNCT
ajlm-1964	52	1	if	if	SCONJ
ajlm-1964	52	2	untreated	untreate	VERB
ajlm-1964	52	3	,	,	PUNCT
ajlm-1964	52	4	the	the	DET
ajlm-1964	52	5	hiv	hiv	PROPN
ajlm-1964	52	6	infection	infection	NOUN
ajlm-1964	52	7	can	can	AUX
ajlm-1964	52	8	progress	progress	VERB
ajlm-1964	52	9	to	to	ADP
ajlm-1964	52	10	the	the	DET
ajlm-1964	52	11	most	most	ADV
ajlm-1964	52	12	complex	complex	ADJ
ajlm-1964	52	13	stage	stage	NOUN
ajlm-1964	52	14	of	of	ADP
ajlm-1964	52	15	the	the	DET
ajlm-1964	52	16	disease	disease	NOUN
ajlm-1964	52	17	referred	refer	VERB
ajlm-1964	52	18	to	to	ADP
ajlm-1964	52	19	as	as	ADP
ajlm-1964	52	20	aids	aids	PROPN
ajlm-1964	52	21	,	,	PUNCT
ajlm-1964	52	22	resulting	result	VERB
ajlm-1964	52	23	in	in	ADP
ajlm-1964	52	24	death.51,52	death.51,52	PROPN
ajlm-1964	52	25	over	over	ADP
ajlm-1964	52	26	37.7	37.7	NUM
ajlm-1964	52	27	million	million	NUM
ajlm-1964	52	28	people	people	NOUN
ajlm-1964	52	29	are	be	AUX
ajlm-1964	52	30	living	live	VERB
ajlm-1964	52	31	with	with	ADP
ajlm-1964	52	32	hiv	hiv	PROPN
ajlm-1964	52	33	globally	globally	ADV
ajlm-1964	52	34	,	,	PUNCT
ajlm-1964	52	35	with	with	SCONJ
ajlm-1964	52	36	680	680	NUM
ajlm-1964	52	37	000	000	NUM
ajlm-1964	52	38	annual	annual	ADJ
ajlm-1964	52	39	deaths.53	deaths.53	NOUN
ajlm-1964	52	40	sub	sub	ADJ
ajlm-1964	52	41	-	-	ADJ
ajlm-1964	52	42	saharan	saharan	ADJ
ajlm-1964	52	43	africa	africa	PROPN
ajlm-1964	52	44	is	be	AUX
ajlm-1964	52	45	the	the	DET
ajlm-1964	52	46	worst	worst	ADV
ajlm-1964	52	47	affected	affect	VERB
ajlm-1964	52	48	,	,	PUNCT
ajlm-1964	52	49	being	be	AUX
ajlm-1964	52	50	home	home	ADV
ajlm-1964	52	51	to	to	ADP
ajlm-1964	52	52	67	67	NUM
ajlm-1964	52	53	%	%	NOUN
ajlm-1964	52	54	of	of	ADP
ajlm-1964	52	55	people	people	NOUN
ajlm-1964	52	56	living	live	VERB
ajlm-1964	52	57	with	with	ADP
ajlm-1964	52	58	hiv	hiv	PROPN
ajlm-1964	52	59	and	and	CCONJ
ajlm-1964	52	60	39	39	NUM
ajlm-1964	52	61	%	%	NOUN
ajlm-1964	52	62	of	of	ADP
ajlm-1964	52	63	new	new	ADJ
ajlm-1964	52	64	hiv	hiv	PROPN
ajlm-1964	52	65	cases.53	cases.53	NOUN
ajlm-1964	52	66	although	although	SCONJ
ajlm-1964	52	67	most	most	ADJ
ajlm-1964	52	68	people	people	NOUN
ajlm-1964	52	69	living	live	VERB
ajlm-1964	52	70	with	with	ADP
ajlm-1964	52	71	hiv	hiv	PROPN
ajlm-1964	52	72	have	have	VERB
ajlm-1964	52	73	higher	high	ADJ
ajlm-1964	52	74	co	co	NOUN
ajlm-1964	52	75	-	-	NOUN
ajlm-1964	52	76	morbidities	morbidity	NOUN
ajlm-1964	52	77	and	and	CCONJ
ajlm-1964	52	78	experience	experience	VERB
ajlm-1964	52	79	more	more	ADV
ajlm-1964	52	80	severe	severe	ADJ
ajlm-1964	52	81	outcomes	outcome	NOUN
ajlm-1964	52	82	from	from	ADP
ajlm-1964	52	83	covid-19	covid-19	PROPN
ajlm-1964	52	84	than	than	ADP
ajlm-1964	52	85	people	people	NOUN
ajlm-1964	52	86	without	without	ADP
ajlm-1964	52	87	hiv	hiv	PROPN
ajlm-1964	52	88	,	,	PUNCT
ajlm-1964	52	89	most	most	ADJ
ajlm-1964	52	90	of	of	ADP
ajlm-1964	52	91	them	they	PRON
ajlm-1964	52	92	did	do	AUX
ajlm-1964	52	93	not	not	PART
ajlm-1964	52	94	have	have	VERB
ajlm-1964	52	95	access	access	NOUN
ajlm-1964	52	96	to	to	ADP
ajlm-1964	52	97	covid-19	covid-19	PROPN
ajlm-1964	52	98	vaccines	vaccine	NOUN
ajlm-1964	52	99	as	as	SCONJ
ajlm-1964	52	100	of	of	ADP
ajlm-1964	52	101	mid-2021.53	mid-2021.53	NOUN
ajlm-1964	52	102	tuberculosis	tuberculosis	NOUN
ajlm-1964	52	103	is	be	AUX
ajlm-1964	52	104	caused	cause	VERB
ajlm-1964	52	105	by	by	ADP
ajlm-1964	52	106	the	the	DET
ajlm-1964	52	107	bacterium	bacterium	NOUN
ajlm-1964	52	108	mycobacterium	mycobacterium	NOUN
ajlm-1964	52	109	tuberculosis	tuberculosis	NOUN
ajlm-1964	52	110	and	and	CCONJ
ajlm-1964	52	111	is	be	AUX
ajlm-1964	52	112	an	an	DET
ajlm-1964	52	113	infectious	infectious	ADJ
ajlm-1964	52	114	disease	disease	NOUN
ajlm-1964	52	115	that	that	PRON
ajlm-1964	52	116	commonly	commonly	ADV
ajlm-1964	52	117	affects	affect	VERB
ajlm-1964	52	118	the	the	DET
ajlm-1964	52	119	lungs	lung	NOUN
ajlm-1964	52	120	and	and	CCONJ
ajlm-1964	52	121	is	be	AUX
ajlm-1964	52	122	transmissible	transmissible	ADJ
ajlm-1964	52	123	from	from	ADP
ajlm-1964	52	124	person	person	NOUN
ajlm-1964	52	125	to	to	ADP
ajlm-1964	52	126	person	person	NOUN
ajlm-1964	52	127	through	through	ADP
ajlm-1964	52	128	coughing	cough	VERB
ajlm-1964	52	129	,	,	PUNCT
ajlm-1964	52	130	sneezing	sneeze	VERB
ajlm-1964	52	131	,	,	PUNCT
ajlm-1964	52	132	or	or	CCONJ
ajlm-1964	52	133	spitting.54,55	spitting.54,55	NOUN
ajlm-1964	52	134	in	in	ADP
ajlm-1964	52	135	2019	2019	NUM
ajlm-1964	52	136	,	,	PUNCT
ajlm-1964	52	137	there	there	PRON
ajlm-1964	52	138	were	be	VERB
ajlm-1964	52	139	10	10	NUM
ajlm-1964	52	140	million	million	NUM
ajlm-1964	52	141	cases	case	NOUN
ajlm-1964	52	142	of	of	ADP
ajlm-1964	52	143	tuberculosis	tuberculosis	NOUN
ajlm-1964	52	144	(	(	PUNCT
ajlm-1964	52	145	208	208	NUM
ajlm-1964	52	146	000	000	NUM
ajlm-1964	52	147	were	be	AUX
ajlm-1964	52	148	in	in	ADP
ajlm-1964	52	149	hiv	hiv	PROPN
ajlm-1964	52	150	-	-	PUNCT
ajlm-1964	52	151	positive	positive	ADJ
ajlm-1964	52	152	people	people	NOUN
ajlm-1964	52	153	)	)	PUNCT
ajlm-1964	52	154	and	and	CCONJ
ajlm-1964	52	155	over	over	ADP
ajlm-1964	52	156	1.2	1.2	NUM
ajlm-1964	52	157	million	million	NUM
ajlm-1964	52	158	deaths	death	NOUN
ajlm-1964	52	159	due	due	ADJ
ajlm-1964	52	160	to	to	ADP
ajlm-1964	52	161	tuberculosis	tuberculosis	NOUN
ajlm-1964	52	162	(	(	PUNCT
ajlm-1964	52	163	15	15	NUM
ajlm-1964	52	164	%	%	NOUN
ajlm-1964	52	165	of	of	ADP
ajlm-1964	52	166	all	all	DET
ajlm-1964	52	167	deaths	death	NOUN
ajlm-1964	52	168	were	be	AUX
ajlm-1964	52	169	related	relate	VERB
ajlm-1964	52	170	to	to	AUX
ajlm-1964	52	171	hiv).56	hiv).56	VERB
ajlm-1964	52	172	africa	africa	PROPN
ajlm-1964	52	173	ranked	rank	VERB
ajlm-1964	52	174	second	second	ADV
ajlm-1964	52	175	in	in	ADP
ajlm-1964	52	176	the	the	DET
ajlm-1964	52	177	global	global	ADJ
ajlm-1964	52	178	burden	burden	NOUN
ajlm-1964	52	179	of	of	ADP
ajlm-1964	52	180	new	new	ADJ
ajlm-1964	52	181	tuberculosis	tuberculosis	NOUN
ajlm-1964	52	182	cases	case	NOUN
ajlm-1964	52	183	(	(	PUNCT
ajlm-1964	52	184	25	25	NUM
ajlm-1964	52	185	%	%	NOUN
ajlm-1964	52	186	)	)	PUNCT
ajlm-1964	52	187	in	in	ADP
ajlm-1964	52	188	2019.56	2019.56	NUM
ajlm-1964	52	189	ebola	ebola	PROPN
ajlm-1964	52	190	virus	virus	NOUN
ajlm-1964	52	191	causes	cause	VERB
ajlm-1964	52	192	an	an	DET
ajlm-1964	52	193	acute	acute	NOUN
ajlm-1964	52	194	,	,	PUNCT
ajlm-1964	52	195	contagious	contagious	ADJ
ajlm-1964	52	196	,	,	PUNCT
ajlm-1964	52	197	and	and	CCONJ
ajlm-1964	52	198	deadly	deadly	ADJ
ajlm-1964	52	199	disease	disease	NOUN
ajlm-1964	52	200	that	that	PRON
ajlm-1964	52	201	is	be	AUX
ajlm-1964	52	202	transmitted	transmit	VERB
ajlm-1964	52	203	from	from	ADP
ajlm-1964	52	204	person	person	NOUN
ajlm-1964	52	205	to	to	ADP
ajlm-1964	52	206	person	person	NOUN
ajlm-1964	52	207	through	through	ADP
ajlm-1964	52	208	close	close	ADJ
ajlm-1964	52	209	contact	contact	NOUN
ajlm-1964	52	210	with	with	ADP
ajlm-1964	52	211	fluids	fluid	NOUN
ajlm-1964	52	212	from	from	ADP
ajlm-1964	52	213	the	the	DET
ajlm-1964	52	214	body	body	NOUN
ajlm-1964	52	215	of	of	ADP
ajlm-1964	52	216	symptomatic	symptomatic	ADJ
ajlm-1964	52	217	and	and	CCONJ
ajlm-1964	52	218	asymptomatic	asymptomatic	ADJ
ajlm-1964	52	219	living	live	VERB
ajlm-1964	52	220	patients	patient	NOUN
ajlm-1964	52	221	or	or	CCONJ
ajlm-1964	52	222	dead	dead	ADJ
ajlm-1964	52	223	victims.57,58	victims.57,58	NOUN
ajlm-1964	52	224	periodic	periodic	NOUN
ajlm-1964	52	225	,	,	PUNCT
ajlm-1964	52	226	remote	remote	ADJ
ajlm-1964	52	227	outbreaks	outbreak	NOUN
ajlm-1964	52	228	of	of	ADP
ajlm-1964	52	229	ebola	ebola	PROPN
ajlm-1964	52	230	have	have	AUX
ajlm-1964	52	231	occurred	occur	VERB
ajlm-1964	52	232	in	in	ADP
ajlm-1964	52	233	many	many	ADJ
ajlm-1964	52	234	central	central	ADJ
ajlm-1964	52	235	african	african	ADJ
ajlm-1964	52	236	countries.59,60	countries.59,60	NOUN
ajlm-1964	52	237	the	the	DET
ajlm-1964	52	238	most	most	ADV
ajlm-1964	52	239	widespread	widespread	ADJ
ajlm-1964	52	240	outbreak	outbreak	NOUN
ajlm-1964	52	241	of	of	ADP
ajlm-1964	52	242	ebola	ebola	PROPN
ajlm-1964	52	243	occurred	occur	VERB
ajlm-1964	52	244	in	in	ADP
ajlm-1964	52	245	guinea	guinea	NOUN
ajlm-1964	52	246	,	,	PUNCT
ajlm-1964	52	247	west	west	PROPN
ajlm-1964	52	248	africa	africa	PROPN
ajlm-1964	52	249	,	,	PUNCT
ajlm-1964	52	250	in	in	ADP
ajlm-1964	52	251	2014	2014	NUM
ajlm-1964	52	252	from	from	ADP
ajlm-1964	52	253	where	where	SCONJ
ajlm-1964	52	254	it	it	PRON
ajlm-1964	52	255	spread	spread	VERB
ajlm-1964	52	256	to	to	ADP
ajlm-1964	52	257	neighbouring	neighbouring	NOUN
ajlm-1964	52	258	sierra	sierra	PROPN
ajlm-1964	52	259	leone	leone	PROPN
ajlm-1964	52	260	and	and	CCONJ
ajlm-1964	52	261	liberia	liberia	NOUN
ajlm-1964	52	262	,	,	PUNCT
ajlm-1964	52	263	killing	kill	VERB
ajlm-1964	52	264	an	an	DET
ajlm-1964	52	265	estimated	estimate	VERB
ajlm-1964	52	266	11	11	NUM
ajlm-1964	52	267	000	000	NUM
ajlm-1964	52	268	people	people	NOUN
ajlm-1964	52	269	by	by	ADP
ajlm-1964	52	270	april	april	PROPN
ajlm-1964	52	271	2016.61,62,63	2016.61,62,63	NUM
ajlm-1964	52	272	immune	immune	ADJ
ajlm-1964	52	273	response	response	NOUN
ajlm-1964	52	274	to	to	ADP
ajlm-1964	52	275	microbial	microbial	ADJ
ajlm-1964	52	276	infections	infection	NOUN
ajlm-1964	52	277	the	the	DET
ajlm-1964	52	278	human	human	ADJ
ajlm-1964	52	279	body	body	NOUN
ajlm-1964	52	280	protects	protect	VERB
ajlm-1964	52	281	itself	itself	PRON
ajlm-1964	52	282	from	from	ADP
ajlm-1964	52	283	microbial	microbial	ADJ
ajlm-1964	52	284	infections	infection	NOUN
ajlm-1964	52	285	through	through	ADP
ajlm-1964	52	286	the	the	DET
ajlm-1964	52	287	immune	immune	ADJ
ajlm-1964	52	288	system	system	NOUN
ajlm-1964	52	289	made	make	VERB
ajlm-1964	52	290	up	up	ADP
ajlm-1964	52	291	of	of	ADP
ajlm-1964	52	292	innate	innate	ADJ
ajlm-1964	52	293	and	and	CCONJ
ajlm-1964	52	294	adaptive	adaptive	ADJ
ajlm-1964	52	295	arms	arm	NOUN
ajlm-1964	52	296	that	that	PRON
ajlm-1964	52	297	are	be	AUX
ajlm-1964	52	298	not	not	PART
ajlm-1964	52	299	only	only	ADV
ajlm-1964	52	300	linked	link	VERB
ajlm-1964	52	301	but	but	CCONJ
ajlm-1964	52	302	consist	consist	VERB
ajlm-1964	52	303	of	of	ADP
ajlm-1964	52	304	an	an	DET
ajlm-1964	52	305	extraordinarily	extraordinarily	ADV
ajlm-1964	52	306	diverse	diverse	ADJ
ajlm-1964	52	307	compilation	compilation	NOUN
ajlm-1964	52	308	of	of	ADP
ajlm-1964	52	309	cells	cell	NOUN
ajlm-1964	52	310	(	(	PUNCT
ajlm-1964	52	311	figure	figure	NOUN
ajlm-1964	52	312	3	3	NUM
ajlm-1964	52	313	;	;	PUNCT
ajlm-1964	52	314	compiled	compile	VERB
ajlm-1964	52	315	in	in	ADP
ajlm-1964	52	316	biorender	biorender	NOUN
ajlm-1964	52	317	,	,	PUNCT
ajlm-1964	52	318	https://biorender.com/	https://biorender.com/	PROPN
ajlm-1964	52	319	)	)	PUNCT
ajlm-1964	52	320	.	.	PUNCT
ajlm-1964	53	1	the	the	DET
ajlm-1964	53	2	innate	innate	ADJ
ajlm-1964	53	3	immune	immune	ADJ
ajlm-1964	53	4	system	system	NOUN
ajlm-1964	53	5	is	be	AUX
ajlm-1964	53	6	the	the	DET
ajlm-1964	53	7	host	host	NOUN
ajlm-1964	53	8	’s	’s	PART
ajlm-1964	53	9	first	first	ADJ
ajlm-1964	53	10	-	-	PUNCT
ajlm-1964	53	11	line	line	NOUN
ajlm-1964	53	12	defence	defence	NOUN
ajlm-1964	53	13	against	against	ADP
ajlm-1964	53	14	invading	invade	VERB
ajlm-1964	53	15	pathogens	pathogen	NOUN
ajlm-1964	53	16	,	,	PUNCT
ajlm-1964	53	17	while	while	SCONJ
ajlm-1964	53	18	adaptive	adaptive	ADJ
ajlm-1964	53	19	immune	immune	ADJ
ajlm-1964	53	20	responses	response	NOUN
ajlm-1964	53	21	are	be	AUX
ajlm-1964	53	22	triggered	trigger	VERB
ajlm-1964	53	23	by	by	ADP
ajlm-1964	53	24	the	the	DET
ajlm-1964	53	25	host	host	NOUN
ajlm-1964	53	26	’s	’s	PART
ajlm-1964	53	27	immune	immune	ADJ
ajlm-1964	53	28	recognition	recognition	NOUN
ajlm-1964	53	29	controls.64	controls.64	VERB
ajlm-1964	53	30	with	with	ADP
ajlm-1964	53	31	the	the	DET
ajlm-1964	53	32	help	help	NOUN
ajlm-1964	53	33	of	of	ADP
ajlm-1964	53	34	molecular	molecular	ADJ
ajlm-1964	53	35	patterns	pattern	NOUN
ajlm-1964	53	36	that	that	PRON
ajlm-1964	53	37	are	be	AUX
ajlm-1964	53	38	pathogen	pathogen	NOUN
ajlm-1964	53	39	-	-	PUNCT
ajlm-1964	53	40	related	relate	VERB
ajlm-1964	53	41	,	,	PUNCT
ajlm-1964	53	42	the	the	DET
ajlm-1964	53	43	innate	innate	ADJ
ajlm-1964	53	44	immune	immune	ADJ
ajlm-1964	53	45	system	system	NOUN
ajlm-1964	53	46	recognises	recognise	VERB
ajlm-1964	53	47	repetitive	repetitive	ADJ
ajlm-1964	53	48	evolutionarily	evolutionarily	ADV
ajlm-1964	53	49	conserved	conserve	VERB
ajlm-1964	53	50	molecules	molecule	NOUN
ajlm-1964	53	51	on	on	ADP
ajlm-1964	53	52	pathogens	pathogen	NOUN
ajlm-1964	53	53	by	by	ADP
ajlm-1964	53	54	using	use	VERB
ajlm-1964	53	55	germline	germline	NOUN
ajlm-1964	53	56	-	-	PUNCT
ajlm-1964	53	57	encoded	encode	VERB
ajlm-1964	53	58	pattern	pattern	NOUN
ajlm-1964	53	59	recognition	recognition	NOUN
ajlm-1964	53	60	receptors	receptor	NOUN
ajlm-1964	53	61	such	such	ADJ
ajlm-1964	53	62	as	as	ADP
ajlm-1964	53	63	c	c	NOUN
ajlm-1964	53	64	-	-	PUNCT
ajlm-1964	53	65	type	type	NOUN
ajlm-1964	53	66	lectin	lectin	ADJ
ajlm-1964	53	67	receptors	receptor	NOUN
ajlm-1964	53	68	,	,	PUNCT
ajlm-1964	53	69	toll	toll	NOUN
ajlm-1964	53	70	-	-	PUNCT
ajlm-1964	53	71	like	like	ADJ
ajlm-1964	53	72	receptors	receptor	NOUN
ajlm-1964	53	73	,	,	PUNCT
ajlm-1964	53	74	nucleotide	nucleotide	NOUN
ajlm-1964	53	75	-	-	PUNCT
ajlm-1964	53	76	binding	bind	VERB
ajlm-1964	53	77	oligomerisation	oligomerisation	NOUN
ajlm-1964	53	78	domain	domain	NOUN
ajlm-1964	53	79	-	-	PUNCT
ajlm-1964	53	80	like	like	ADJ
ajlm-1964	53	81	receptors	receptor	NOUN
ajlm-1964	53	82	,	,	PUNCT
ajlm-1964	53	83	and	and	CCONJ
ajlm-1964	53	84	retinoic	retinoic	ADJ
ajlm-1964	53	85	acid	acid	NOUN
ajlm-1964	53	86	-	-	PUNCT
ajlm-1964	53	87	inducible	inducible	ADJ
ajlm-1964	53	88	gene	gene	NOUN
ajlm-1964	53	89	i	i	NOUN
ajlm-1964	53	90	-	-	PUNCT
ajlm-1964	53	91	like	like	INTJ
ajlm-1964	53	92	receptors.65	receptors.65	ADP
ajlm-1964	53	93	the	the	DET
ajlm-1964	53	94	immune	immune	ADJ
ajlm-1964	53	95	cells	cell	NOUN
ajlm-1964	53	96	that	that	PRON
ajlm-1964	53	97	mediate	mediate	VERB
ajlm-1964	53	98	innate	innate	ADJ
ajlm-1964	53	99	immune	immune	ADJ
ajlm-1964	53	100	defences	defence	NOUN
ajlm-1964	53	101	such	such	ADJ
ajlm-1964	53	102	as	as	ADP
ajlm-1964	53	103	natural	natural	ADJ
ajlm-1964	53	104	killer	killer	NOUN
ajlm-1964	53	105	cells	cell	NOUN
ajlm-1964	53	106	,	,	PUNCT
ajlm-1964	53	107	complement	complement	NOUN
ajlm-1964	53	108	proteins	protein	NOUN
ajlm-1964	53	109	,	,	PUNCT
ajlm-1964	53	110	and	and	CCONJ
ajlm-1964	53	111	phagocytic	phagocytic	ADJ
ajlm-1964	53	112	cells	cell	NOUN
ajlm-1964	53	113	like	like	ADP
ajlm-1964	53	114	monocytes	monocyte	NOUN
ajlm-1964	53	115	,	,	PUNCT
ajlm-1964	53	116	macrophages	macrophage	NOUN
ajlm-1964	53	117	,	,	PUNCT
ajlm-1964	53	118	and	and	CCONJ
ajlm-1964	53	119	neutrophils	neutrophil	NOUN
ajlm-1964	53	120	do	do	AUX
ajlm-1964	53	121	not	not	PART
ajlm-1964	53	122	have	have	VERB
ajlm-1964	53	123	effector	effector	NOUN
ajlm-1964	53	124	mechanisms	mechanism	NOUN
ajlm-1964	53	125	that	that	PRON
ajlm-1964	53	126	induce	induce	VERB
ajlm-1964	53	127	immunological	immunological	ADJ
ajlm-1964	53	128	memory.66	memory.66	NOUN
ajlm-1964	53	129	figure	figure	NOUN
ajlm-1964	53	130	3	3	NUM
ajlm-1964	53	131	:	:	PUNCT
ajlm-1964	53	132	cells	cell	NOUN
ajlm-1964	53	133	involved	involve	VERB
ajlm-1964	53	134	in	in	ADP
ajlm-1964	53	135	innate	innate	ADJ
ajlm-1964	53	136	and	and	CCONJ
ajlm-1964	53	137	adaptive	adaptive	ADJ
ajlm-1964	53	138	immune	immune	ADJ
ajlm-1964	53	139	responses	response	NOUN
ajlm-1964	53	140	against	against	ADP
ajlm-1964	53	141	pathogens	pathogen	NOUN
ajlm-1964	53	142	.	.	PUNCT
ajlm-1964	54	1	the	the	DET
ajlm-1964	54	2	immune	immune	ADJ
ajlm-1964	54	3	cells	cell	NOUN
ajlm-1964	54	4	from	from	ADP
ajlm-1964	54	5	innate	innate	ADJ
ajlm-1964	54	6	immunity	immunity	NOUN
ajlm-1964	54	7	which	which	PRON
ajlm-1964	54	8	provide	provide	VERB
ajlm-1964	54	9	the	the	DET
ajlm-1964	54	10	first	first	ADJ
ajlm-1964	54	11	line	line	NOUN
ajlm-1964	54	12	of	of	ADP
ajlm-1964	54	13	defence	defence	NOUN
ajlm-1964	54	14	are	be	AUX
ajlm-1964	54	15	generated	generate	VERB
ajlm-1964	54	16	by	by	ADP
ajlm-1964	54	17	myeloid	myeloid	ADJ
ajlm-1964	54	18	lineage	lineage	NOUN
ajlm-1964	54	19	cells	cell	NOUN
ajlm-1964	54	20	and	and	CCONJ
ajlm-1964	54	21	they	they	PRON
ajlm-1964	54	22	include	include	VERB
ajlm-1964	54	23	monocytes	monocyte	NOUN
ajlm-1964	54	24	,	,	PUNCT
ajlm-1964	54	25	macrophages	macrophage	NOUN
ajlm-1964	54	26	,	,	PUNCT
ajlm-1964	54	27	erythrocytes	erythrocyte	NOUN
ajlm-1964	54	28	,	,	PUNCT
ajlm-1964	54	29	platelets	platelet	NOUN
ajlm-1964	54	30	,	,	PUNCT
ajlm-1964	54	31	and	and	CCONJ
ajlm-1964	54	32	granulocytes	granulocyte	NOUN
ajlm-1964	54	33	.	.	PUNCT
ajlm-1964	55	1	cells	cell	NOUN
ajlm-1964	55	2	from	from	ADP
ajlm-1964	55	3	the	the	DET
ajlm-1964	55	4	adaptive	adaptive	ADJ
ajlm-1964	55	5	immune	immune	ADJ
ajlm-1964	55	6	system	system	NOUN
ajlm-1964	55	7	are	be	AUX
ajlm-1964	55	8	responsible	responsible	ADJ
ajlm-1964	55	9	for	for	ADP
ajlm-1964	55	10	the	the	DET
ajlm-1964	55	11	second	second	ADJ
ajlm-1964	55	12	line	line	NOUN
ajlm-1964	55	13	of	of	ADP
ajlm-1964	55	14	defence	defence	NOUN
ajlm-1964	55	15	and	and	CCONJ
ajlm-1964	55	16	consist	consist	VERB
ajlm-1964	55	17	of	of	ADP
ajlm-1964	55	18	natural	natural	ADJ
ajlm-1964	55	19	killer	killer	NOUN
ajlm-1964	55	20	cells	cell	NOUN
ajlm-1964	55	21	,	,	PUNCT
ajlm-1964	55	22	b	b	X
ajlm-1964	55	23	-	-	PUNCT
ajlm-1964	55	24	cells	cell	NOUN
ajlm-1964	55	25	,	,	PUNCT
ajlm-1964	55	26	and	and	CCONJ
ajlm-1964	55	27	t	t	NOUN
ajlm-1964	55	28	-	-	PUNCT
ajlm-1964	55	29	cells	cell	NOUN
ajlm-1964	55	30	that	that	PRON
ajlm-1964	55	31	come	come	VERB
ajlm-1964	55	32	from	from	ADP
ajlm-1964	55	33	lymphoid	lymphoid	ADJ
ajlm-1964	55	34	progenitor	progenitor	NOUN
ajlm-1964	55	35	cells	cell	NOUN
ajlm-1964	55	36	.	.	PUNCT
ajlm-1964	56	1	recognition	recognition	NOUN
ajlm-1964	56	2	of	of	ADP
ajlm-1964	56	3	external	external	ADJ
ajlm-1964	56	4	antigens	antigen	NOUN
ajlm-1964	56	5	by	by	ADP
ajlm-1964	56	6	the	the	DET
ajlm-1964	56	7	macrophages	macrophage	NOUN
ajlm-1964	56	8	and	and	CCONJ
ajlm-1964	56	9	dendritic	dendritic	ADJ
ajlm-1964	56	10	cells	cell	NOUN
ajlm-1964	56	11	of	of	ADP
ajlm-1964	56	12	the	the	DET
ajlm-1964	56	13	innate	innate	ADJ
ajlm-1964	56	14	immune	immune	ADJ
ajlm-1964	56	15	system	system	NOUN
ajlm-1964	56	16	triggers	trigger	VERB
ajlm-1964	56	17	the	the	DET
ajlm-1964	56	18	naive	naive	ADJ
ajlm-1964	56	19	cd8	cd8	PROPN
ajlm-1964	56	20	+	+	PROPN
ajlm-1964	56	21	and	and	CCONJ
ajlm-1964	56	22	cd4	cd4	PROPN
ajlm-1964	56	23	+	+	PROPN
ajlm-1964	56	24	t	t	PROPN
ajlm-1964	56	25	-	-	PUNCT
ajlm-1964	56	26	cells	cell	NOUN
ajlm-1964	56	27	of	of	ADP
ajlm-1964	56	28	the	the	DET
ajlm-1964	56	29	adaptive	adaptive	ADJ
ajlm-1964	56	30	immune	immune	ADJ
ajlm-1964	56	31	system	system	NOUN
ajlm-1964	56	32	.	.	PUNCT
ajlm-1964	57	1	adaptive	adaptive	ADJ
ajlm-1964	57	2	immunity	immunity	NOUN
ajlm-1964	57	3	comprises	comprise	VERB
ajlm-1964	57	4	cell	cell	NOUN
ajlm-1964	57	5	-	-	PUNCT
ajlm-1964	57	6	mediated	mediate	VERB
ajlm-1964	57	7	and	and	CCONJ
ajlm-1964	57	8	humoral	humoral	ADJ
ajlm-1964	57	9	immunity	immunity	NOUN
ajlm-1964	57	10	,	,	PUNCT
ajlm-1964	57	11	which	which	PRON
ajlm-1964	57	12	have	have	VERB
ajlm-1964	57	13	a	a	DET
ajlm-1964	57	14	wider	wide	ADJ
ajlm-1964	57	15	and	and	CCONJ
ajlm-1964	57	16	fine	fine	ADV
ajlm-1964	57	17	-	-	PUNCT
ajlm-1964	57	18	tuned	tune	VERB
ajlm-1964	57	19	range	range	NOUN
ajlm-1964	57	20	of	of	ADP
ajlm-1964	57	21	recognition	recognition	NOUN
ajlm-1964	57	22	because	because	SCONJ
ajlm-1964	57	23	of	of	ADP
ajlm-1964	57	24	exposure	exposure	NOUN
ajlm-1964	57	25	to	to	ADP
ajlm-1964	57	26	variable	variable	ADJ
ajlm-1964	57	27	antigens	antigen	NOUN
ajlm-1964	57	28	.	.	PUNCT
ajlm-1964	58	1	the	the	DET
ajlm-1964	58	2	unique	unique	ADJ
ajlm-1964	58	3	traits	trait	NOUN
ajlm-1964	58	4	of	of	ADP
ajlm-1964	58	5	the	the	DET
ajlm-1964	58	6	adaptive	adaptive	ADJ
ajlm-1964	58	7	immune	immune	ADJ
ajlm-1964	58	8	system	system	NOUN
ajlm-1964	58	9	are	be	AUX
ajlm-1964	58	10	pathogen	pathogen	NOUN
ajlm-1964	58	11	-	-	PUNCT
ajlm-1964	58	12	specific	specific	ADJ
ajlm-1964	58	13	immunological	immunological	ADJ
ajlm-1964	58	14	memory	memory	NOUN
ajlm-1964	58	15	,	,	PUNCT
ajlm-1964	58	16	immune	immune	ADJ
ajlm-1964	58	17	effector	effector	NOUN
ajlm-1964	58	18	functions	function	NOUN
ajlm-1964	58	19	,	,	PUNCT
ajlm-1964	58	20	tolerance	tolerance	NOUN
ajlm-1964	58	21	,	,	PUNCT
ajlm-1964	58	22	regulation	regulation	NOUN
ajlm-1964	58	23	of	of	ADP
ajlm-1964	58	24	host	host	NOUN
ajlm-1964	58	25	immune	immune	ADJ
ajlm-1964	58	26	homeostasis	homeostasis	NOUN
ajlm-1964	58	27	,	,	PUNCT
ajlm-1964	58	28	and	and	CCONJ
ajlm-1964	58	29	increased	increase	VERB
ajlm-1964	58	30	production	production	NOUN
ajlm-1964	58	31	of	of	ADP
ajlm-1964	58	32	inflammatory	inflammatory	ADJ
ajlm-1964	58	33	mediators.67	mediators.67	NOUN
ajlm-1964	58	34	when	when	SCONJ
ajlm-1964	58	35	the	the	DET
ajlm-1964	58	36	innate	innate	ADJ
ajlm-1964	58	37	immune	immune	ADJ
ajlm-1964	58	38	system	system	NOUN
ajlm-1964	58	39	is	be	AUX
ajlm-1964	58	40	exposed	expose	VERB
ajlm-1964	58	41	to	to	ADP
ajlm-1964	58	42	invading	invade	VERB
ajlm-1964	58	43	organisms	organism	NOUN
ajlm-1964	58	44	in	in	ADP
ajlm-1964	58	45	the	the	DET
ajlm-1964	58	46	form	form	NOUN
ajlm-1964	58	47	of	of	ADP
ajlm-1964	58	48	vaccines	vaccine	NOUN
ajlm-1964	58	49	(	(	PUNCT
ajlm-1964	58	50	bacillus	bacillus	NOUN
ajlm-1964	58	51	calmette	calmette	NOUN
ajlm-1964	58	52	–	–	PUNCT
ajlm-1964	58	53	guerin	guerin	PROPN
ajlm-1964	59	1	[	[	X
ajlm-1964	59	2	bcg	bcg	X
ajlm-1964	59	3	]	]	PUNCT
ajlm-1964	59	4	vaccine	vaccine	NOUN
ajlm-1964	59	5	,	,	PUNCT
ajlm-1964	59	6	measles	measle	NOUN
ajlm-1964	59	7	vaccine	vaccine	NOUN
ajlm-1964	59	8	,	,	PUNCT
ajlm-1964	59	9	etc	etc	X
ajlm-1964	59	10	.	.	X
ajlm-1964	59	11	)	)	PUNCT
ajlm-1964	59	12	or	or	CCONJ
ajlm-1964	59	13	bacterial	bacterial	ADJ
ajlm-1964	59	14	and	and	CCONJ
ajlm-1964	59	15	fungal	fungal	ADJ
ajlm-1964	59	16	complex	complex	ADJ
ajlm-1964	59	17	biomolecules	biomolecule	NOUN
ajlm-1964	59	18	(	(	PUNCT
ajlm-1964	59	19	lipopolysaccharides	lipopolysaccharide	NOUN
ajlm-1964	59	20	,	,	PUNCT
ajlm-1964	59	21	β	β	X
ajlm-1964	59	22	-	-	PUNCT
ajlm-1964	59	23	glucan	glucan	NOUN
ajlm-1964	59	24	,	,	PUNCT
ajlm-1964	59	25	etc	etc	X
ajlm-1964	59	26	.	.	X
ajlm-1964	59	27	)	)	PUNCT
ajlm-1964	59	28	,	,	PUNCT
ajlm-1964	59	29	the	the	DET
ajlm-1964	59	30	immune	immune	ADJ
ajlm-1964	59	31	cells	cell	NOUN
ajlm-1964	59	32	undergo	undergo	VERB
ajlm-1964	59	33	metabolic	metabolic	NOUN
ajlm-1964	59	34	alteration	alteration	NOUN
ajlm-1964	59	35	or	or	CCONJ
ajlm-1964	59	36	epigenetic	epigenetic	ADJ
ajlm-1964	59	37	reprogramming.68,69	reprogramming.68,69	VERB
ajlm-1964	59	38	these	these	DET
ajlm-1964	59	39	changes	change	NOUN
ajlm-1964	59	40	,	,	PUNCT
ajlm-1964	59	41	described	describe	VERB
ajlm-1964	59	42	as	as	ADP
ajlm-1964	59	43	‘	'	PUNCT
ajlm-1964	59	44	trained	train	VERB
ajlm-1964	59	45	immunity	immunity	NOUN
ajlm-1964	59	46	’	'	PUNCT
ajlm-1964	59	47	,	,	PUNCT
ajlm-1964	59	48	elicit	elicit	VERB
ajlm-1964	59	49	an	an	DET
ajlm-1964	59	50	elevated	elevated	ADJ
ajlm-1964	59	51	response	response	NOUN
ajlm-1964	59	52	when	when	SCONJ
ajlm-1964	59	53	challenged	challenge	VERB
ajlm-1964	59	54	afterwards	afterwards	ADV
ajlm-1964	59	55	by	by	ADP
ajlm-1964	59	56	the	the	DET
ajlm-1964	59	57	first	first	ADJ
ajlm-1964	59	58	trigger	trigger	NOUN
ajlm-1964	59	59	or	or	CCONJ
ajlm-1964	59	60	different	different	ADJ
ajlm-1964	59	61	unrelated	unrelated	ADJ
ajlm-1964	59	62	organisms	organism	NOUN
ajlm-1964	59	63	or	or	CCONJ
ajlm-1964	59	64	molecules	molecule	NOUN
ajlm-1964	59	65	through	through	ADP
ajlm-1964	59	66	tor	tor	NOUN
ajlm-1964	59	67	b	b	NOUN
ajlm-1964	59	68	-	-	PUNCT
ajlm-1964	59	69	cell	cell	NOUN
ajlm-1964	59	70	-	-	PUNCT
ajlm-1964	59	71	independent	independent	ADJ
ajlm-1964	59	72	responses	response	NOUN
ajlm-1964	59	73	,	,	PUNCT
ajlm-1964	59	74	leading	lead	VERB
ajlm-1964	59	75	to	to	ADP
ajlm-1964	59	76	increased	increase	VERB
ajlm-1964	59	77	production	production	NOUN
ajlm-1964	59	78	of	of	ADP
ajlm-1964	59	79	inflammatory	inflammatory	ADJ
ajlm-1964	59	80	mediators.70,71,72	mediators.70,71,72	PROPN
ajlm-1964	59	81	unlike	unlike	ADP
ajlm-1964	59	82	the	the	DET
ajlm-1964	59	83	conventional	conventional	ADJ
ajlm-1964	59	84	,	,	PUNCT
ajlm-1964	59	85	more	more	ADV
ajlm-1964	59	86	precise	precise	ADJ
ajlm-1964	59	87	,	,	PUNCT
ajlm-1964	59	88	epitope	epitope	NOUN
ajlm-1964	59	89	-	-	PUNCT
ajlm-1964	59	90	dependent	dependent	ADJ
ajlm-1964	59	91	adaptive	adaptive	ADJ
ajlm-1964	59	92	immune	immune	ADJ
ajlm-1964	59	93	memory	memory	NOUN
ajlm-1964	59	94	that	that	PRON
ajlm-1964	59	95	is	be	AUX
ajlm-1964	59	96	mediated	mediate	VERB
ajlm-1964	59	97	by	by	ADP
ajlm-1964	59	98	lymphocytes	lymphocyte	NOUN
ajlm-1964	59	99	,	,	PUNCT
ajlm-1964	59	100	the	the	DET
ajlm-1964	59	101	control	control	NOUN
ajlm-1964	59	102	of	of	ADP
ajlm-1964	59	103	trained	train	VERB
ajlm-1964	59	104	immunity	immunity	NOUN
ajlm-1964	59	105	is	be	AUX
ajlm-1964	59	106	facilitated	facilitate	VERB
ajlm-1964	59	107	by	by	ADP
ajlm-1964	59	108	a	a	DET
ajlm-1964	59	109	unique	unique	ADJ
ajlm-1964	59	110	mechanism	mechanism	NOUN
ajlm-1964	59	111	that	that	PRON
ajlm-1964	59	112	is	be	AUX
ajlm-1964	59	113	not	not	PART
ajlm-1964	59	114	very	very	ADV
ajlm-1964	59	115	specific	specific	ADJ
ajlm-1964	59	116	and	and	CCONJ
ajlm-1964	59	117	lasts	last	VERB
ajlm-1964	59	118	only	only	ADV
ajlm-1964	59	119	for	for	ADP
ajlm-1964	59	120	a	a	DET
ajlm-1964	59	121	short	short	ADJ
ajlm-1964	59	122	while.73	while.73	NOUN
ajlm-1964	59	123	nevertheless	nevertheless	ADV
ajlm-1964	59	124	,	,	PUNCT
ajlm-1964	59	125	both	both	PRON
ajlm-1964	59	126	fulfil	fulfil	VERB
ajlm-1964	59	127	the	the	DET
ajlm-1964	59	128	same	same	ADJ
ajlm-1964	59	129	major	major	ADJ
ajlm-1964	59	130	task	task	NOUN
ajlm-1964	59	131	of	of	ADP
ajlm-1964	59	132	eliciting	elicit	VERB
ajlm-1964	59	133	a	a	DET
ajlm-1964	59	134	faster	fast	ADJ
ajlm-1964	59	135	and	and	CCONJ
ajlm-1964	59	136	more	more	ADV
ajlm-1964	59	137	robust	robust	ADJ
ajlm-1964	59	138	response	response	NOUN
ajlm-1964	59	139	that	that	PRON
ajlm-1964	59	140	destroys	destroy	VERB
ajlm-1964	59	141	the	the	DET
ajlm-1964	59	142	pathogens	pathogen	NOUN
ajlm-1964	59	143	and	and	CCONJ
ajlm-1964	59	144	improves	improve	VERB
ajlm-1964	59	145	the	the	DET
ajlm-1964	59	146	survival	survival	NOUN
ajlm-1964	59	147	of	of	ADP
ajlm-1964	59	148	the	the	DET
ajlm-1964	59	149	host	host	NOUN
ajlm-1964	59	150	.	.	PUNCT
ajlm-1964	60	1	trained	train	VERB
ajlm-1964	60	2	immunity	immunity	NOUN
ajlm-1964	60	3	could	could	AUX
ajlm-1964	60	4	be	be	AUX
ajlm-1964	60	5	beneficially	beneficially	ADV
ajlm-1964	60	6	applied	apply	VERB
ajlm-1964	60	7	to	to	PART
ajlm-1964	60	8	develop	develop	VERB
ajlm-1964	60	9	improved	improved	ADJ
ajlm-1964	60	10	vaccines74,75	vaccines74,75	NOUN
ajlm-1964	60	11	and	and	CCONJ
ajlm-1964	60	12	limit	limit	VERB
ajlm-1964	60	13	the	the	DET
ajlm-1964	60	14	adverse	adverse	ADJ
ajlm-1964	60	15	effects	effect	NOUN
ajlm-1964	60	16	of	of	ADP
ajlm-1964	60	17	inflammatory	inflammatory	ADJ
ajlm-1964	60	18	diseases.76	diseases.76	PROPN
ajlm-1964	60	19	possible	possible	ADJ
ajlm-1964	60	20	reasons	reason	NOUN
ajlm-1964	60	21	for	for	ADP
ajlm-1964	60	22	a	a	DET
ajlm-1964	60	23	presumed	presume	VERB
ajlm-1964	60	24	immune	immune	ADJ
ajlm-1964	60	25	sufficiency	sufficiency	NOUN
ajlm-1964	60	26	in	in	ADP
ajlm-1964	60	27	sub	sub	ADJ
ajlm-1964	60	28	-	-	ADJ
ajlm-1964	60	29	saharan	saharan	ADJ
ajlm-1964	60	30	africa	africa	PROPN
ajlm-1964	60	31	adaptive	adaptive	PROPN
ajlm-1964	60	32	immunity	immunity	NOUN
ajlm-1964	60	33	-	-	PUNCT
ajlm-1964	60	34	mediated	mediate	VERB
ajlm-1964	60	35	pre	pre	ADJ
ajlm-1964	60	36	-	-	ADJ
ajlm-1964	60	37	existing	exist	VERB
ajlm-1964	60	38	immunity	immunity	NOUN
ajlm-1964	60	39	to	to	ADP
ajlm-1964	60	40	sars	sar	NOUN
ajlm-1964	60	41	-	-	PUNCT
ajlm-1964	60	42	cov-2	cov-2	NOUN
ajlm-1964	60	43	covid-19	covid-19	PROPN
ajlm-1964	60	44	infections	infection	NOUN
ajlm-1964	60	45	are	be	AUX
ajlm-1964	60	46	often	often	ADV
ajlm-1964	60	47	asymptomatic	asymptomatic	ADJ
ajlm-1964	60	48	or	or	CCONJ
ajlm-1964	60	49	mildly	mildly	ADV
ajlm-1964	60	50	symptomatic	symptomatic	ADJ
ajlm-1964	60	51	but	but	CCONJ
ajlm-1964	60	52	may	may	AUX
ajlm-1964	60	53	be	be	AUX
ajlm-1964	60	54	severe	severe	ADJ
ajlm-1964	60	55	,	,	PUNCT
ajlm-1964	60	56	mostly	mostly	ADV
ajlm-1964	60	57	among	among	ADP
ajlm-1964	60	58	vulnerable	vulnerable	ADJ
ajlm-1964	60	59	patients	patient	NOUN
ajlm-1964	60	60	,	,	PUNCT
ajlm-1964	60	61	presenting	present	VERB
ajlm-1964	60	62	as	as	ADP
ajlm-1964	60	63	acute	acute	ADJ
ajlm-1964	60	64	respiratory	respiratory	ADJ
ajlm-1964	60	65	distress.77	distress.77	VERB
ajlm-1964	60	66	the	the	DET
ajlm-1964	60	67	mild	mild	ADJ
ajlm-1964	60	68	pattern	pattern	NOUN
ajlm-1964	60	69	of	of	ADP
ajlm-1964	60	70	infection	infection	NOUN
ajlm-1964	60	71	in	in	ADP
ajlm-1964	60	72	many	many	ADJ
ajlm-1964	60	73	patients	patient	NOUN
ajlm-1964	60	74	may	may	AUX
ajlm-1964	60	75	be	be	AUX
ajlm-1964	60	76	due	due	ADJ
ajlm-1964	60	77	to	to	ADP
ajlm-1964	60	78	an	an	DET
ajlm-1964	60	79	exposure	exposure	NOUN
ajlm-1964	60	80	-	-	PUNCT
ajlm-1964	60	81	related	relate	VERB
ajlm-1964	60	82	cross	cross	NOUN
ajlm-1964	60	83	-	-	NOUN
ajlm-1964	60	84	immunity	immunity	NOUN
ajlm-1964	60	85	to	to	ADP
ajlm-1964	60	86	other	other	ADJ
ajlm-1964	60	87	endemic	endemic	ADJ
ajlm-1964	60	88	common	common	ADJ
ajlm-1964	60	89	cold	cold	NOUN
ajlm-1964	60	90	coronaviruses.78	coronaviruses.78	VERB
ajlm-1964	60	91	these	these	DET
ajlm-1964	60	92	viruses	virus	NOUN
ajlm-1964	60	93	cause	cause	VERB
ajlm-1964	60	94	mild	mild	ADJ
ajlm-1964	60	95	self	self	NOUN
ajlm-1964	60	96	-	-	PUNCT
ajlm-1964	60	97	limiting	limit	VERB
ajlm-1964	60	98	respiratory	respiratory	ADJ
ajlm-1964	60	99	infections	infection	NOUN
ajlm-1964	60	100	and	and	CCONJ
ajlm-1964	60	101	circulate	circulate	VERB
ajlm-1964	60	102	widely	widely	ADV
ajlm-1964	60	103	in	in	ADP
ajlm-1964	60	104	the	the	DET
ajlm-1964	60	105	human	human	ADJ
ajlm-1964	60	106	population	population	NOUN
ajlm-1964	60	107	where	where	SCONJ
ajlm-1964	60	108	globally	globally	ADV
ajlm-1964	60	109	,	,	PUNCT
ajlm-1964	60	110	more	more	ADJ
ajlm-1964	60	111	than	than	ADP
ajlm-1964	60	112	90	90	NUM
ajlm-1964	60	113	%	%	NOUN
ajlm-1964	60	114	are	be	AUX
ajlm-1964	60	115	seropositive	seropositive	ADJ
ajlm-1964	60	116	for	for	ADP
ajlm-1964	60	117	at	at	ADV
ajlm-1964	60	118	least	least	ADV
ajlm-1964	60	119	three	three	NUM
ajlm-1964	60	120	of	of	ADP
ajlm-1964	60	121	the	the	DET
ajlm-1964	60	122	common	common	ADJ
ajlm-1964	60	123	cold	cold	ADJ
ajlm-1964	60	124	coronaviruses.79	coronaviruses.79	NOUN
ajlm-1964	60	125	there	there	ADV
ajlm-1964	60	126	has	have	AUX
ajlm-1964	60	127	been	be	AUX
ajlm-1964	60	128	evidence	evidence	NOUN
ajlm-1964	60	129	that	that	PRON
ajlm-1964	60	130	supports	support	VERB
ajlm-1964	60	131	the	the	DET
ajlm-1964	60	132	likelihood	likelihood	NOUN
ajlm-1964	60	133	that	that	SCONJ
ajlm-1964	60	134	circulating	circulate	VERB
ajlm-1964	60	135	memory	memory	NOUN
ajlm-1964	60	136	b	b	NOUN
ajlm-1964	60	137	-	-	PUNCT
ajlm-1964	60	138	cells	cell	NOUN
ajlm-1964	60	139	and	and	CCONJ
ajlm-1964	60	140	neutralising	neutralise	VERB
ajlm-1964	60	141	antibodies	antibody	NOUN
ajlm-1964	60	142	developed	develop	VERB
ajlm-1964	60	143	to	to	ADP
ajlm-1964	60	144	one	one	NUM
ajlm-1964	60	145	type	type	NOUN
ajlm-1964	60	146	of	of	ADP
ajlm-1964	60	147	coronavirus	coronavirus	NOUN
ajlm-1964	60	148	may	may	AUX
ajlm-1964	60	149	cross	cross	VERB
ajlm-1964	60	150	-	-	VERB
ajlm-1964	60	151	react	react	ADJ
ajlm-1964	60	152	with	with	ADP
ajlm-1964	60	153	other	other	ADJ
ajlm-1964	60	154	members	member	NOUN
ajlm-1964	60	155	of	of	ADP
ajlm-1964	60	156	the	the	DET
ajlm-1964	60	157	coronavirus	coronavirus	NOUN
ajlm-1964	60	158	family.78	family.78	VERB
ajlm-1964	60	159	emerging	emerge	VERB
ajlm-1964	60	160	data	datum	NOUN
ajlm-1964	60	161	from	from	ADP
ajlm-1964	60	162	studies	study	NOUN
ajlm-1964	60	163	conducted	conduct	VERB
ajlm-1964	60	164	in	in	ADP
ajlm-1964	60	165	unexposed	unexposed	ADJ
ajlm-1964	60	166	donors	donor	NOUN
ajlm-1964	60	167	from	from	ADP
ajlm-1964	60	168	different	different	ADJ
ajlm-1964	60	169	geographical	geographical	ADJ
ajlm-1964	60	170	locations	location	NOUN
ajlm-1964	60	171	revealed	reveal	VERB
ajlm-1964	60	172	that	that	SCONJ
ajlm-1964	60	173	20	20	NUM
ajlm-1964	60	174	%	%	NOUN
ajlm-1964	60	175	–	–	PUNCT
ajlm-1964	60	176	50	50	NUM
ajlm-1964	60	177	%	%	NOUN
ajlm-1964	60	178	had	have	VERB
ajlm-1964	60	179	lymphocytes	lymphocyte	NOUN
ajlm-1964	60	180	with	with	ADP
ajlm-1964	60	181	significant	significant	ADJ
ajlm-1964	60	182	reactivity	reactivity	NOUN
ajlm-1964	60	183	to	to	ADP
ajlm-1964	60	184	pools	pool	NOUN
ajlm-1964	60	185	of	of	ADP
ajlm-1964	60	186	sars	sar	NOUN
ajlm-1964	60	187	-	-	PUNCT
ajlm-1964	60	188	cov-2	cov-2	NOUN
ajlm-1964	60	189	antigen	antigen	NOUN
ajlm-1964	60	190	peptides.22,23,24,80,81	peptides.22,23,24,80,81	NOUN
ajlm-1964	60	191	there	there	PRON
ajlm-1964	60	192	is	be	VERB
ajlm-1964	60	193	also	also	ADV
ajlm-1964	60	194	speculation	speculation	NOUN
ajlm-1964	60	195	that	that	SCONJ
ajlm-1964	60	196	the	the	DET
ajlm-1964	60	197	sars	sar	NOUN
ajlm-1964	60	198	-	-	PUNCT
ajlm-1964	60	199	cov-2	cov-2	NOUN
ajlm-1964	60	200	-	-	PUNCT
ajlm-1964	60	201	specific	specific	ADJ
ajlm-1964	60	202	t	t	NOUN
ajlm-1964	60	203	-	-	PUNCT
ajlm-1964	60	204	cells	cell	NOUN
ajlm-1964	60	205	in	in	ADP
ajlm-1964	60	206	unexposed	unexposed	ADJ
ajlm-1964	60	207	individuals	individual	NOUN
ajlm-1964	60	208	originated	originate	VERB
ajlm-1964	60	209	from	from	ADP
ajlm-1964	60	210	the	the	DET
ajlm-1964	60	211	memory	memory	NOUN
ajlm-1964	60	212	t	t	PROPN
ajlm-1964	60	213	-	-	PUNCT
ajlm-1964	60	214	cells	cell	NOUN
ajlm-1964	60	215	obtained	obtain	VERB
ajlm-1964	60	216	from	from	ADP
ajlm-1964	60	217	contact	contact	NOUN
ajlm-1964	60	218	with	with	ADP
ajlm-1964	60	219	common	common	ADJ
ajlm-1964	60	220	cold	cold	ADJ
ajlm-1964	60	221	coronaviruses.82,83	coronaviruses.82,83	NOUN
ajlm-1964	60	222	in	in	ADP
ajlm-1964	60	223	a	a	DET
ajlm-1964	60	224	study	study	NOUN
ajlm-1964	60	225	conducted	conduct	VERB
ajlm-1964	60	226	in	in	ADP
ajlm-1964	60	227	germany	germany	PROPN
ajlm-1964	60	228	,	,	PUNCT
ajlm-1964	60	229	the	the	DET
ajlm-1964	60	230	highest	high	ADJ
ajlm-1964	60	231	t	t	NOUN
ajlm-1964	60	232	-	-	PUNCT
ajlm-1964	60	233	cell	cell	NOUN
ajlm-1964	60	234	reactivity	reactivity	NOUN
ajlm-1964	60	235	occurred	occur	VERB
ajlm-1964	60	236	against	against	ADP
ajlm-1964	60	237	a	a	DET
ajlm-1964	60	238	pool	pool	NOUN
ajlm-1964	60	239	of	of	ADP
ajlm-1964	60	240	sars	sar	NOUN
ajlm-1964	60	241	-	-	PUNCT
ajlm-1964	60	242	cov-2	cov-2	NOUN
ajlm-1964	60	243	spike	spike	ADJ
ajlm-1964	60	244	peptides	peptide	NOUN
ajlm-1964	60	245	that	that	PRON
ajlm-1964	60	246	are	be	AUX
ajlm-1964	60	247	homologous	homologous	ADJ
ajlm-1964	60	248	to	to	ADP
ajlm-1964	60	249	common	common	ADJ
ajlm-1964	60	250	cold	cold	ADJ
ajlm-1964	60	251	coronavirus	coronavirus	NOUN
ajlm-1964	60	252	spike	spike	ADJ
ajlm-1964	60	253	proteins.24	proteins.24	NOUN
ajlm-1964	60	254	the	the	DET
ajlm-1964	60	255	occurrence	occurrence	NOUN
ajlm-1964	60	256	of	of	ADP
ajlm-1964	60	257	sars	sar	NOUN
ajlm-1964	60	258	-	-	PUNCT
ajlm-1964	60	259	cov-2	cov-2	PART
ajlm-1964	60	260	pre	pre	ADJ
ajlm-1964	60	261	-	-	ADJ
ajlm-1964	60	262	existing	exist	VERB
ajlm-1964	60	263	primed	prime	VERB
ajlm-1964	60	264	t	t	NOUN
ajlm-1964	60	265	-	-	PUNCT
ajlm-1964	60	266	cells	cell	NOUN
ajlm-1964	60	267	and	and	CCONJ
ajlm-1964	60	268	neutralising	neutralise	VERB
ajlm-1964	60	269	antibodies	antibody	NOUN
ajlm-1964	60	270	acquired	acquire	VERB
ajlm-1964	60	271	through	through	ADP
ajlm-1964	60	272	previous	previous	ADJ
ajlm-1964	60	273	exposure	exposure	NOUN
ajlm-1964	60	274	to	to	ADP
ajlm-1964	60	275	endemic	endemic	ADJ
ajlm-1964	60	276	coronaviruses	coronaviruse	NOUN
ajlm-1964	60	277	could	could	AUX
ajlm-1964	60	278	slow	slow	VERB
ajlm-1964	60	279	down	down	ADP
ajlm-1964	60	280	disease	disease	NOUN
ajlm-1964	60	281	transmission	transmission	NOUN
ajlm-1964	60	282	and	and	CCONJ
ajlm-1964	60	283	limit	limit	VERB
ajlm-1964	60	284	the	the	DET
ajlm-1964	60	285	number	number	NOUN
ajlm-1964	60	286	of	of	ADP
ajlm-1964	60	287	cases	case	NOUN
ajlm-1964	60	288	and	and	CCONJ
ajlm-1964	60	289	mortality.78,84	mortality.78,84	ADJ
ajlm-1964	60	290	individuals	individual	NOUN
ajlm-1964	60	291	with	with	ADP
ajlm-1964	60	292	a	a	DET
ajlm-1964	60	293	high	high	ADJ
ajlm-1964	60	294	level	level	NOUN
ajlm-1964	60	295	of	of	ADP
ajlm-1964	60	296	pre	pre	ADJ
ajlm-1964	60	297	-	-	ADJ
ajlm-1964	60	298	existing	exist	VERB
ajlm-1964	60	299	cd4	cd4	PROPN
ajlm-1964	60	300	+	+	PROPN
ajlm-1964	60	301	t	t	PROPN
ajlm-1964	60	302	-	-	PUNCT
ajlm-1964	60	303	cells	cell	NOUN
ajlm-1964	60	304	with	with	ADP
ajlm-1964	60	305	sars	sar	NOUN
ajlm-1964	60	306	-	-	PUNCT
ajlm-1964	60	307	cov-2	cov-2	PART
ajlm-1964	60	308	recognition	recognition	NOUN
ajlm-1964	60	309	memory	memory	NOUN
ajlm-1964	60	310	may	may	AUX
ajlm-1964	60	311	elicit	elicit	VERB
ajlm-1964	60	312	a	a	DET
ajlm-1964	60	313	faster	fast	ADJ
ajlm-1964	60	314	and	and	CCONJ
ajlm-1964	60	315	more	more	ADV
ajlm-1964	60	316	robust	robust	ADJ
ajlm-1964	60	317	immune	immune	ADJ
ajlm-1964	60	318	response	response	NOUN
ajlm-1964	60	319	upon	upon	SCONJ
ajlm-1964	60	320	exposure	exposure	NOUN
ajlm-1964	60	321	,	,	PUNCT
ajlm-1964	60	322	thus	thus	ADV
ajlm-1964	60	323	limiting	limit	VERB
ajlm-1964	60	324	the	the	DET
ajlm-1964	60	325	severity	severity	NOUN
ajlm-1964	60	326	of	of	ADP
ajlm-1964	60	327	the	the	DET
ajlm-1964	60	328	disease	disease	NOUN
ajlm-1964	60	329	.	.	PUNCT
ajlm-1964	61	1	in	in	ADP
ajlm-1964	61	2	such	such	ADJ
ajlm-1964	61	3	individuals	individual	NOUN
ajlm-1964	61	4	,	,	PUNCT
ajlm-1964	61	5	t	t	PROPN
ajlm-1964	61	6	follicular	follicular	ADJ
ajlm-1964	61	7	helper	helper	NOUN
ajlm-1964	61	8	cd4	cd4	PROPN
ajlm-1964	61	9	+	+	PROPN
ajlm-1964	61	10	t	t	PROPN
ajlm-1964	61	11	-	-	PUNCT
ajlm-1964	61	12	cells	cell	NOUN
ajlm-1964	61	13	have	have	VERB
ajlm-1964	61	14	a	a	DET
ajlm-1964	61	15	memory	memory	NOUN
ajlm-1964	61	16	that	that	PRON
ajlm-1964	61	17	could	could	AUX
ajlm-1964	61	18	potentially	potentially	ADV
ajlm-1964	61	19	enhance	enhance	VERB
ajlm-1964	61	20	the	the	DET
ajlm-1964	61	21	antibody	antibody	NOUN
ajlm-1964	61	22	-	-	PUNCT
ajlm-1964	61	23	neutralising	neutralise	VERB
ajlm-1964	61	24	response	response	NOUN
ajlm-1964	61	25	against	against	ADP
ajlm-1964	61	26	sars	sar	NOUN
ajlm-1964	61	27	-	-	PUNCT
ajlm-1964	61	28	cov-2	cov-2	NOUN
ajlm-1964	61	29	.	.	PUNCT
ajlm-1964	62	1	the	the	DET
ajlm-1964	62	2	memory	memory	NOUN
ajlm-1964	62	3	of	of	ADP
ajlm-1964	62	4	cd4	cd4	PROPN
ajlm-1964	62	5	+	+	PROPN
ajlm-1964	62	6	and	and	CCONJ
ajlm-1964	62	7	cd8	cd8	PROPN
ajlm-1964	62	8	+	+	PROPN
ajlm-1964	62	9	t	t	PROPN
ajlm-1964	62	10	-	-	PUNCT
ajlm-1964	62	11	cells	cell	NOUN
ajlm-1964	62	12	might	might	AUX
ajlm-1964	62	13	also	also	ADV
ajlm-1964	62	14	enhance	enhance	VERB
ajlm-1964	62	15	direct	direct	ADJ
ajlm-1964	62	16	antiviral	antiviral	ADJ
ajlm-1964	62	17	immunity	immunity	NOUN
ajlm-1964	62	18	in	in	ADP
ajlm-1964	62	19	the	the	DET
ajlm-1964	62	20	lungs	lung	NOUN
ajlm-1964	62	21	and	and	CCONJ
ajlm-1964	62	22	nasopharynx	nasopharynx	NOUN
ajlm-1964	62	23	early	early	ADV
ajlm-1964	62	24	after	after	ADP
ajlm-1964	62	25	exposure	exposure	NOUN
ajlm-1964	62	26	,	,	PUNCT
ajlm-1964	62	27	consistent	consistent	ADJ
ajlm-1964	62	28	with	with	ADP
ajlm-1964	62	29	previous	previous	ADJ
ajlm-1964	62	30	knowledge	knowledge	NOUN
ajlm-1964	62	31	that	that	SCONJ
ajlm-1964	62	32	cd4	cd4	PROPN
ajlm-1964	62	33	+	+	PROPN
ajlm-1964	62	34	t	t	PROPN
ajlm-1964	62	35	-	-	PUNCT
ajlm-1964	62	36	cells	cell	NOUN
ajlm-1964	62	37	in	in	ADP
ajlm-1964	62	38	the	the	DET
ajlm-1964	62	39	lungs	lung	NOUN
ajlm-1964	62	40	have	have	VERB
ajlm-1964	62	41	antiviral	antiviral	ADJ
ajlm-1964	62	42	activity	activity	NOUN
ajlm-1964	62	43	against	against	ADP
ajlm-1964	62	44	the	the	DET
ajlm-1964	62	45	associated	associated	ADJ
ajlm-1964	62	46	sars	sars	PROPN
ajlm-1964	62	47	-	-	PUNCT
ajlm-1964	62	48	cov85	cov85	PROPN
ajlm-1964	62	49	and	and	CCONJ
ajlm-1964	62	50	that	that	DET
ajlm-1964	62	51	memory	memory	NOUN
ajlm-1964	62	52	cd8	cd8	PROPN
ajlm-1964	62	53	+	+	PROPN
ajlm-1964	62	54	t	t	PROPN
ajlm-1964	62	55	-	-	PUNCT
ajlm-1964	62	56	cells	cell	NOUN
ajlm-1964	62	57	protect	protect	VERB
ajlm-1964	62	58	against	against	ADP
ajlm-1964	62	59	viral	viral	ADJ
ajlm-1964	62	60	infections	infection	NOUN
ajlm-1964	62	61	.	.	PUNCT
ajlm-1964	63	1	a	a	DET
ajlm-1964	63	2	recent	recent	ADJ
ajlm-1964	63	3	study	study	NOUN
ajlm-1964	63	4	that	that	PRON
ajlm-1964	63	5	used	use	VERB
ajlm-1964	63	6	samples	sample	NOUN
ajlm-1964	63	7	collected	collect	VERB
ajlm-1964	63	8	before	before	ADP
ajlm-1964	63	9	the	the	DET
ajlm-1964	63	10	pandemic	pandemic	NOUN
ajlm-1964	63	11	in	in	ADP
ajlm-1964	63	12	africa	africa	PROPN
ajlm-1964	63	13	,	,	PUNCT
ajlm-1964	63	14	europe	europe	PROPN
ajlm-1964	63	15	,	,	PUNCT
ajlm-1964	63	16	and	and	CCONJ
ajlm-1964	63	17	south	south	NOUN
ajlm-1964	63	18	and	and	CCONJ
ajlm-1964	63	19	north	north	PROPN
ajlm-1964	63	20	america	america	PROPN
ajlm-1964	63	21	showed	show	VERB
ajlm-1964	63	22	the	the	DET
ajlm-1964	63	23	occurrence	occurrence	NOUN
ajlm-1964	63	24	of	of	ADP
ajlm-1964	63	25	pre	pre	ADJ
ajlm-1964	63	26	-	-	ADJ
ajlm-1964	63	27	existing	exist	VERB
ajlm-1964	63	28	humoral	humoral	ADJ
ajlm-1964	63	29	immunity	immunity	NOUN
ajlm-1964	63	30	against	against	ADP
ajlm-1964	63	31	the	the	DET
ajlm-1964	63	32	spike	spike	ADJ
ajlm-1964	63	33	(	(	PUNCT
ajlm-1964	63	34	s	s	NOUN
ajlm-1964	63	35	)	)	PUNCT
ajlm-1964	63	36	and	and	CCONJ
ajlm-1964	63	37	nucleocapsid	nucleocapsid	ADJ
ajlm-1964	63	38	(	(	PUNCT
ajlm-1964	63	39	n	n	CCONJ
ajlm-1964	63	40	)	)	PUNCT
ajlm-1964	63	41	proteins	protein	NOUN
ajlm-1964	63	42	of	of	ADP
ajlm-1964	63	43	sars‑cov‑2	sars‑cov‑2	NOUN
ajlm-1964	63	44	.	.	PUNCT
ajlm-1964	64	1	although	although	SCONJ
ajlm-1964	64	2	antibodies	antibody	NOUN
ajlm-1964	64	3	specific	specific	ADJ
ajlm-1964	64	4	to	to	ADP
ajlm-1964	64	5	the	the	DET
ajlm-1964	64	6	sars	sar	NOUN
ajlm-1964	64	7	-	-	PUNCT
ajlm-1964	64	8	cov-2	cov-2	NOUN
ajlm-1964	64	9	s	s	PART
ajlm-1964	64	10	and	and	CCONJ
ajlm-1964	64	11	n	n	NUM
ajlm-1964	64	12	proteins	protein	NOUN
ajlm-1964	64	13	were	be	AUX
ajlm-1964	64	14	not	not	PART
ajlm-1964	64	15	common	common	ADJ
ajlm-1964	64	16	in	in	ADP
ajlm-1964	64	17	all	all	DET
ajlm-1964	64	18	populations	population	NOUN
ajlm-1964	64	19	,	,	PUNCT
ajlm-1964	64	20	the	the	DET
ajlm-1964	64	21	prevalence	prevalence	NOUN
ajlm-1964	64	22	of	of	ADP
ajlm-1964	64	23	n	n	CCONJ
ajlm-1964	64	24	-	-	PUNCT
ajlm-1964	64	25	specific	specific	ADJ
ajlm-1964	64	26	antibodies	antibody	NOUN
ajlm-1964	64	27	was	be	AUX
ajlm-1964	64	28	higher	high	ADJ
ajlm-1964	64	29	in	in	ADP
ajlm-1964	64	30	the	the	DET
ajlm-1964	64	31	two	two	NUM
ajlm-1964	64	32	african	african	ADJ
ajlm-1964	64	33	study	study	NOUN
ajlm-1964	64	34	locations	location	NOUN
ajlm-1964	64	35	,	,	PUNCT
ajlm-1964	64	36	gabon	gabon	NOUN
ajlm-1964	64	37	and	and	CCONJ
ajlm-1964	64	38	senegal	senegal	ADJ
ajlm-1964	64	39	,	,	PUNCT
ajlm-1964	64	40	than	than	ADP
ajlm-1964	64	41	in	in	ADP
ajlm-1964	64	42	europe	europe	PROPN
ajlm-1964	64	43	and	and	CCONJ
ajlm-1964	64	44	south	south	ADJ
ajlm-1964	64	45	and	and	CCONJ
ajlm-1964	64	46	north	north	NOUN
ajlm-1964	64	47	america.86	america.86	NOUN
ajlm-1964	64	48	in	in	ADP
ajlm-1964	64	49	separate	separate	ADJ
ajlm-1964	64	50	studies	study	NOUN
ajlm-1964	64	51	conducted	conduct	VERB
ajlm-1964	64	52	with	with	ADP
ajlm-1964	64	53	samples	sample	NOUN
ajlm-1964	64	54	from	from	ADP
ajlm-1964	64	55	gabon	gabon	PROPN
ajlm-1964	64	56	(	(	PUNCT
ajlm-1964	64	57	central	central	PROPN
ajlm-1964	64	58	africa	africa	PROPN
ajlm-1964	64	59	)	)	PUNCT
ajlm-1964	64	60	,	,	PUNCT
ajlm-1964	64	61	nigeria	nigeria	PROPN
ajlm-1964	64	62	,	,	PUNCT
ajlm-1964	64	63	ghana	ghana	PROPN
ajlm-1964	64	64	,	,	PUNCT
ajlm-1964	64	65	benin	benin	PROPN
ajlm-1964	64	66	(	(	PUNCT
ajlm-1964	64	67	west	west	PROPN
ajlm-1964	64	68	africa	africa	PROPN
ajlm-1964	64	69	)	)	PUNCT
ajlm-1964	64	70	,	,	PUNCT
ajlm-1964	64	71	tanzania	tanzania	PROPN
ajlm-1964	64	72	(	(	PUNCT
ajlm-1964	64	73	east	east	PROPN
ajlm-1964	64	74	africa	africa	PROPN
ajlm-1964	64	75	)	)	PUNCT
ajlm-1964	64	76	,	,	PUNCT
ajlm-1964	64	77	and	and	CCONJ
ajlm-1964	64	78	zambia	zambia	PROPN
ajlm-1964	64	79	(	(	PUNCT
ajlm-1964	64	80	southern	southern	PROPN
ajlm-1964	64	81	africa	africa	PROPN
ajlm-1964	64	82	)	)	PUNCT
ajlm-1964	64	83	,	,	PUNCT
ajlm-1964	64	84	the	the	DET
ajlm-1964	64	85	pre	pre	ADJ
ajlm-1964	64	86	-	-	ADJ
ajlm-1964	64	87	existing	exist	VERB
ajlm-1964	64	88	immunity	immunity	NOUN
ajlm-1964	64	89	was	be	AUX
ajlm-1964	64	90	high	high	ADJ
ajlm-1964	64	91	against	against	ADP
ajlm-1964	64	92	the	the	DET
ajlm-1964	64	93	sars	sar	NOUN
ajlm-1964	64	94	-	-	PUNCT
ajlm-1964	64	95	cov-2	cov-2	NOUN
ajlm-1964	64	96	n	n	NOUN
ajlm-1964	64	97	and	and	CCONJ
ajlm-1964	64	98	,	,	PUNCT
ajlm-1964	64	99	to	to	ADP
ajlm-1964	64	100	a	a	DET
ajlm-1964	64	101	lower	low	ADJ
ajlm-1964	64	102	extent	extent	NOUN
ajlm-1964	64	103	,	,	PUNCT
ajlm-1964	64	104	s	s	VERB
ajlm-1964	64	105	proteins,87,88,89,90	proteins,87,88,89,90	NOUN
ajlm-1964	64	106	which	which	PRON
ajlm-1964	64	107	suggests	suggest	VERB
ajlm-1964	64	108	that	that	SCONJ
ajlm-1964	64	109	high	high	ADJ
ajlm-1964	64	110	sars	sar	NOUN
ajlm-1964	64	111	-	-	PUNCT
ajlm-1964	64	112	cov-2	cov-2	PART
ajlm-1964	64	113	pre	pre	ADJ
ajlm-1964	64	114	-	-	ADJ
ajlm-1964	64	115	existing	exist	VERB
ajlm-1964	64	116	immunity	immunity	NOUN
ajlm-1964	64	117	is	be	AUX
ajlm-1964	64	118	widespread	widespread	ADJ
ajlm-1964	64	119	in	in	ADP
ajlm-1964	64	120	africa	africa	PROPN
ajlm-1964	64	121	.	.	PUNCT
ajlm-1964	65	1	in	in	ADP
ajlm-1964	65	2	addition	addition	NOUN
ajlm-1964	65	3	,	,	PUNCT
ajlm-1964	65	4	previous	previous	ADJ
ajlm-1964	65	5	studies	study	NOUN
ajlm-1964	65	6	conducted	conduct	VERB
ajlm-1964	65	7	in	in	ADP
ajlm-1964	65	8	france	france	PROPN
ajlm-1964	65	9	,	,	PUNCT
ajlm-1964	65	10	england	england	PROPN
ajlm-1964	65	11	,	,	PUNCT
ajlm-1964	65	12	and	and	CCONJ
ajlm-1964	65	13	the	the	DET
ajlm-1964	65	14	united	united	PROPN
ajlm-1964	65	15	states	states	PROPN
ajlm-1964	65	16	have	have	AUX
ajlm-1964	65	17	also	also	ADV
ajlm-1964	65	18	reported	report	VERB
ajlm-1964	65	19	low	low	ADJ
ajlm-1964	65	20	levels	level	NOUN
ajlm-1964	65	21	of	of	ADP
ajlm-1964	65	22	pre	pre	ADJ
ajlm-1964	65	23	-	-	ADJ
ajlm-1964	65	24	existing	existing	ADJ
ajlm-1964	65	25	sars	sar	NOUN
ajlm-1964	65	26	-	-	PUNCT
ajlm-1964	65	27	cov-2	cov-2	NOUN
ajlm-1964	65	28	s	s	PART
ajlm-1964	65	29	protein	protein	NOUN
ajlm-1964	65	30	cross	cross	ADJ
ajlm-1964	65	31	-	-	ADJ
ajlm-1964	65	32	reactive	reactive	ADJ
ajlm-1964	65	33	antibodies	antibody	NOUN
ajlm-1964	65	34	in	in	ADP
ajlm-1964	65	35	uninfected	uninfected	ADJ
ajlm-1964	65	36	individuals.91,92,93	individuals.91,92,93	PUNCT
ajlm-1964	65	37	although	although	SCONJ
ajlm-1964	65	38	the	the	DET
ajlm-1964	65	39	reason	reason	NOUN
ajlm-1964	65	40	for	for	ADP
ajlm-1964	65	41	the	the	DET
ajlm-1964	65	42	underlying	underlie	VERB
ajlm-1964	65	43	sars	sar	NOUN
ajlm-1964	65	44	-	-	PUNCT
ajlm-1964	65	45	cov-2	cov-2	NOUN
ajlm-1964	65	46	high	high	ADJ
ajlm-1964	65	47	seropositivity	seropositivity	NOUN
ajlm-1964	65	48	in	in	ADP
ajlm-1964	65	49	african	african	ADJ
ajlm-1964	65	50	populations	population	NOUN
ajlm-1964	65	51	has	have	AUX
ajlm-1964	65	52	not	not	PART
ajlm-1964	65	53	been	be	AUX
ajlm-1964	65	54	established	establish	VERB
ajlm-1964	65	55	,	,	PUNCT
ajlm-1964	65	56	some	some	PRON
ajlm-1964	65	57	have	have	AUX
ajlm-1964	65	58	postulated	postulate	VERB
ajlm-1964	65	59	that	that	SCONJ
ajlm-1964	65	60	the	the	DET
ajlm-1964	65	61	immune	immune	ADJ
ajlm-1964	65	62	system	system	NOUN
ajlm-1964	65	63	could	could	AUX
ajlm-1964	65	64	be	be	AUX
ajlm-1964	65	65	stimulated	stimulate	VERB
ajlm-1964	65	66	to	to	PART
ajlm-1964	65	67	develop	develop	VERB
ajlm-1964	65	68	cross	cross	ADJ
ajlm-1964	65	69	-	-	ADJ
ajlm-1964	65	70	reactive	reactive	ADJ
ajlm-1964	65	71	antibodies	antibody	NOUN
ajlm-1964	65	72	against	against	ADP
ajlm-1964	65	73	sars	sar	NOUN
ajlm-1964	65	74	-	-	PUNCT
ajlm-1964	65	75	cov-2	cov-2	NOUN
ajlm-1964	65	76	as	as	ADP
ajlm-1964	65	77	a	a	DET
ajlm-1964	65	78	result	result	NOUN
ajlm-1964	65	79	of	of	ADP
ajlm-1964	65	80	infections	infection	NOUN
ajlm-1964	65	81	with	with	ADP
ajlm-1964	65	82	the	the	DET
ajlm-1964	65	83	common	common	ADJ
ajlm-1964	65	84	human	human	ADJ
ajlm-1964	65	85	coronaviruses87,88	coronaviruses87,88	PROPN
ajlm-1964	65	86	due	due	ADP
ajlm-1964	65	87	to	to	ADP
ajlm-1964	65	88	the	the	DET
ajlm-1964	65	89	wide	wide	ADJ
ajlm-1964	65	90	distribution	distribution	NOUN
ajlm-1964	65	91	of	of	ADP
ajlm-1964	65	92	the	the	DET
ajlm-1964	65	93	common	common	ADJ
ajlm-1964	65	94	human	human	ADJ
ajlm-1964	65	95	coronaviruses	coronaviruse	NOUN
ajlm-1964	65	96	throughout	throughout	ADP
ajlm-1964	65	97	the	the	DET
ajlm-1964	65	98	globe.14	globe.14	NOUN
ajlm-1964	65	99	in	in	ADP
ajlm-1964	65	100	this	this	DET
ajlm-1964	65	101	regard	regard	NOUN
ajlm-1964	65	102	,	,	PUNCT
ajlm-1964	65	103	samples	sample	NOUN
ajlm-1964	65	104	collected	collect	VERB
ajlm-1964	65	105	from	from	ADP
ajlm-1964	65	106	africa	africa	PROPN
ajlm-1964	65	107	,	,	PUNCT
ajlm-1964	65	108	europe	europe	PROPN
ajlm-1964	65	109	,	,	PUNCT
ajlm-1964	65	110	and	and	CCONJ
ajlm-1964	65	111	south	south	PROPN
ajlm-1964	65	112	africa	africa	PROPN
ajlm-1964	65	113	were	be	AUX
ajlm-1964	65	114	used	use	VERB
ajlm-1964	65	115	in	in	ADP
ajlm-1964	65	116	a	a	DET
ajlm-1964	65	117	recent	recent	ADJ
ajlm-1964	65	118	serological	serological	ADJ
ajlm-1964	65	119	study	study	NOUN
ajlm-1964	65	120	to	to	PART
ajlm-1964	65	121	demonstrate	demonstrate	VERB
ajlm-1964	65	122	the	the	DET
ajlm-1964	65	123	existence	existence	NOUN
ajlm-1964	65	124	of	of	ADP
ajlm-1964	65	125	antibodies	antibody	NOUN
ajlm-1964	65	126	that	that	SCONJ
ajlm-1964	65	127	cross	cross	NOUN
ajlm-1964	65	128	-	-	ADJ
ajlm-1964	65	129	react	react	ADJ
ajlm-1964	65	130	against	against	ADP
ajlm-1964	65	131	the	the	DET
ajlm-1964	65	132	n	n	PRON
ajlm-1964	65	133	protein	protein	NOUN
ajlm-1964	65	134	of	of	ADP
ajlm-1964	65	135	common	common	ADJ
ajlm-1964	65	136	human	human	ADJ
ajlm-1964	65	137	coronaviruses	coronaviruse	NOUN
ajlm-1964	65	138	,	,	PUNCT
ajlm-1964	65	139	but	but	CCONJ
ajlm-1964	65	140	their	their	PRON
ajlm-1964	65	141	presence	presence	NOUN
ajlm-1964	65	142	did	do	AUX
ajlm-1964	65	143	not	not	PART
ajlm-1964	65	144	show	show	VERB
ajlm-1964	65	145	any	any	DET
ajlm-1964	65	146	correlation	correlation	NOUN
ajlm-1964	65	147	with	with	ADP
ajlm-1964	65	148	the	the	DET
ajlm-1964	65	149	sars	sar	NOUN
ajlm-1964	65	150	-	-	PUNCT
ajlm-1964	65	151	cov-2	cov-2	NOUN
ajlm-1964	65	152	n	n	PRON
ajlm-1964	65	153	protein	protein	NOUN
ajlm-1964	65	154	cross	cross	ADJ
ajlm-1964	65	155	-	-	ADJ
ajlm-1964	65	156	reactive	reactive	ADJ
ajlm-1964	65	157	antibodies.88	antibodies.88	NOUN
ajlm-1964	65	158	this	this	PRON
ajlm-1964	65	159	suggests	suggest	VERB
ajlm-1964	65	160	the	the	DET
ajlm-1964	65	161	possibility	possibility	NOUN
ajlm-1964	65	162	that	that	SCONJ
ajlm-1964	65	163	the	the	DET
ajlm-1964	65	164	high	high	ADJ
ajlm-1964	65	165	cross	cross	ADJ
ajlm-1964	65	166	-	-	ADJ
ajlm-1964	65	167	reactive	reactive	ADJ
ajlm-1964	65	168	immunity	immunity	NOUN
ajlm-1964	65	169	reported	report	VERB
ajlm-1964	65	170	by	by	ADP
ajlm-1964	65	171	the	the	DET
ajlm-1964	65	172	african	african	ADJ
ajlm-1964	65	173	population	population	NOUN
ajlm-1964	65	174	is	be	AUX
ajlm-1964	65	175	being	be	AUX
ajlm-1964	65	176	driven	drive	VERB
ajlm-1964	65	177	by	by	ADP
ajlm-1964	65	178	other	other	ADJ
ajlm-1964	65	179	main	main	ADJ
ajlm-1964	65	180	contributors	contributor	NOUN
ajlm-1964	65	181	besides	besides	SCONJ
ajlm-1964	65	182	the	the	DET
ajlm-1964	65	183	common	common	ADJ
ajlm-1964	65	184	human	human	ADJ
ajlm-1964	65	185	coronaviruses	coronaviruse	NOUN
ajlm-1964	65	186	.	.	PUNCT
ajlm-1964	66	1	high	high	ADJ
ajlm-1964	66	2	seropositivity	seropositivity	NOUN
ajlm-1964	66	3	against	against	ADP
ajlm-1964	66	4	sars	sar	NOUN
ajlm-1964	66	5	-	-	PUNCT
ajlm-1964	66	6	cov-2	cov-2	NOUN
ajlm-1964	66	7	n	n	NOUN
ajlm-1964	66	8	in	in	ADP
ajlm-1964	66	9	samples	sample	NOUN
ajlm-1964	66	10	collected	collect	VERB
ajlm-1964	66	11	before	before	ADP
ajlm-1964	66	12	the	the	DET
ajlm-1964	66	13	pandemic	pandemic	NOUN
ajlm-1964	66	14	could	could	AUX
ajlm-1964	66	15	also	also	ADV
ajlm-1964	66	16	be	be	AUX
ajlm-1964	66	17	an	an	DET
ajlm-1964	66	18	indication	indication	NOUN
ajlm-1964	66	19	of	of	ADP
ajlm-1964	66	20	the	the	DET
ajlm-1964	66	21	circulation	circulation	NOUN
ajlm-1964	66	22	of	of	ADP
ajlm-1964	66	23	other	other	ADJ
ajlm-1964	66	24	coronaviruses	coronaviruse	NOUN
ajlm-1964	66	25	that	that	PRON
ajlm-1964	66	26	have	have	AUX
ajlm-1964	66	27	not	not	PART
ajlm-1964	66	28	yet	yet	ADV
ajlm-1964	66	29	been	be	AUX
ajlm-1964	66	30	recognised	recognise	VERB
ajlm-1964	66	31	.	.	PUNCT
ajlm-1964	67	1	the	the	DET
ajlm-1964	67	2	limited	limited	ADJ
ajlm-1964	67	3	number	number	NOUN
ajlm-1964	67	4	of	of	ADP
ajlm-1964	67	5	cases	case	NOUN
ajlm-1964	67	6	and	and	CCONJ
ajlm-1964	67	7	mortality	mortality	NOUN
ajlm-1964	67	8	due	due	ADP
ajlm-1964	67	9	to	to	ADP
ajlm-1964	67	10	sars	sar	NOUN
ajlm-1964	67	11	-	-	PUNCT
ajlm-1964	67	12	cov-2	cov-2	PART
ajlm-1964	67	13	infection	infection	NOUN
ajlm-1964	67	14	in	in	ADP
ajlm-1964	67	15	africa	africa	PROPN
ajlm-1964	67	16	may	may	AUX
ajlm-1964	67	17	be	be	AUX
ajlm-1964	67	18	attributed	attribute	VERB
ajlm-1964	67	19	to	to	ADP
ajlm-1964	67	20	a	a	DET
ajlm-1964	67	21	high	high	ADJ
ajlm-1964	67	22	cross	cross	ADJ
ajlm-1964	67	23	-	-	ADJ
ajlm-1964	67	24	reactive	reactive	ADJ
ajlm-1964	67	25	immunity	immunity	NOUN
ajlm-1964	67	26	background	background	NOUN
ajlm-1964	67	27	as	as	SCONJ
ajlm-1964	67	28	observed	observe	VERB
ajlm-1964	67	29	in	in	ADP
ajlm-1964	67	30	sera	sera	NOUN
ajlm-1964	67	31	from	from	ADP
ajlm-1964	67	32	african	african	ADJ
ajlm-1964	67	33	populations	population	NOUN
ajlm-1964	67	34	.	.	PUNCT
ajlm-1964	68	1	large	large	ADJ
ajlm-1964	68	2	studies	study	NOUN
ajlm-1964	68	3	are	be	AUX
ajlm-1964	68	4	needed	need	VERB
ajlm-1964	68	5	to	to	PART
ajlm-1964	68	6	measure	measure	VERB
ajlm-1964	68	7	and	and	CCONJ
ajlm-1964	68	8	demonstrate	demonstrate	VERB
ajlm-1964	68	9	the	the	DET
ajlm-1964	68	10	correlation	correlation	NOUN
ajlm-1964	68	11	between	between	ADP
ajlm-1964	68	12	pre	pre	ADJ
ajlm-1964	68	13	-	-	ADJ
ajlm-1964	68	14	existing	exist	VERB
ajlm-1964	68	15	immunity	immunity	NOUN
ajlm-1964	68	16	,	,	PUNCT
ajlm-1964	68	17	prospective	prospective	ADJ
ajlm-1964	68	18	infection	infection	NOUN
ajlm-1964	68	19	and	and	CCONJ
ajlm-1964	68	20	disease	disease	NOUN
ajlm-1964	68	21	severity	severity	NOUN
ajlm-1964	68	22	as	as	ADP
ajlm-1964	68	23	a	a	DET
ajlm-1964	68	24	way	way	NOUN
ajlm-1964	68	25	to	to	PART
ajlm-1964	68	26	define	define	VERB
ajlm-1964	68	27	the	the	DET
ajlm-1964	68	28	possible	possible	ADJ
ajlm-1964	68	29	function	function	NOUN
ajlm-1964	68	30	of	of	ADP
ajlm-1964	68	31	pre	pre	ADJ
ajlm-1964	68	32	-	-	ADJ
ajlm-1964	68	33	existing	existing	ADJ
ajlm-1964	68	34	t	t	NOUN
ajlm-1964	68	35	-	-	PUNCT
ajlm-1964	68	36	cell	cell	NOUN
ajlm-1964	68	37	memory	memory	NOUN
ajlm-1964	68	38	in	in	ADP
ajlm-1964	68	39	sars	sar	NOUN
ajlm-1964	68	40	-	-	PUNCT
ajlm-1964	68	41	cov-2	cov-2	PART
ajlm-1964	68	42	infection	infection	NOUN
ajlm-1964	68	43	.	.	PUNCT
ajlm-1964	69	1	innate	innate	ADJ
ajlm-1964	69	2	immunity	immunity	NOUN
ajlm-1964	69	3	-	-	PUNCT
ajlm-1964	69	4	mediated	mediate	VERB
ajlm-1964	69	5	trained	train	VERB
ajlm-1964	69	6	immunity	immunity	NOUN
ajlm-1964	69	7	and	and	CCONJ
ajlm-1964	69	8	immune	immune	ADJ
ajlm-1964	69	9	tolerance	tolerance	NOUN
ajlm-1964	69	10	in	in	ADP
ajlm-1964	69	11	addition	addition	NOUN
ajlm-1964	69	12	to	to	ADP
ajlm-1964	69	13	adaptive	adaptive	ADJ
ajlm-1964	69	14	immunity	immunity	NOUN
ajlm-1964	69	15	-	-	PUNCT
ajlm-1964	69	16	mediated	mediate	VERB
ajlm-1964	69	17	cross	cross	NOUN
ajlm-1964	69	18	-	-	NOUN
ajlm-1964	69	19	immunity	immunity	NOUN
ajlm-1964	69	20	,	,	PUNCT
ajlm-1964	69	21	trained	train	VERB
ajlm-1964	69	22	immunity	immunity	NOUN
ajlm-1964	69	23	and	and	CCONJ
ajlm-1964	69	24	immune	immune	ADJ
ajlm-1964	69	25	tolerance	tolerance	NOUN
ajlm-1964	69	26	mediated	mediate	VERB
ajlm-1964	69	27	by	by	ADP
ajlm-1964	69	28	the	the	DET
ajlm-1964	69	29	innate	innate	ADJ
ajlm-1964	69	30	immune	immune	ADJ
ajlm-1964	69	31	system	system	NOUN
ajlm-1964	69	32	could	could	AUX
ajlm-1964	69	33	also	also	ADV
ajlm-1964	69	34	considerably	considerably	ADV
ajlm-1964	69	35	modify	modify	VERB
ajlm-1964	69	36	the	the	DET
ajlm-1964	69	37	clinical	clinical	ADJ
ajlm-1964	69	38	spectrum	spectrum	NOUN
ajlm-1964	69	39	and	and	CCONJ
ajlm-1964	69	40	mortality	mortality	NOUN
ajlm-1964	69	41	of	of	ADP
ajlm-1964	69	42	covid-19	covid-19	PROPN
ajlm-1964	69	43	infection	infection	NOUN
ajlm-1964	69	44	.	.	PUNCT
ajlm-1964	70	1	trained	train	VERB
ajlm-1964	70	2	immunity	immunity	NOUN
ajlm-1964	70	3	is	be	AUX
ajlm-1964	70	4	the	the	DET
ajlm-1964	70	5	memory	memory	NOUN
ajlm-1964	70	6	characteristic	characteristic	NOUN
ajlm-1964	70	7	in	in	ADP
ajlm-1964	70	8	the	the	DET
ajlm-1964	70	9	innate	innate	ADJ
ajlm-1964	70	10	immune	immune	ADJ
ajlm-1964	70	11	system	system	NOUN
ajlm-1964	70	12	of	of	ADP
ajlm-1964	70	13	vertebrates	vertebrate	NOUN
ajlm-1964	70	14	that	that	PRON
ajlm-1964	70	15	elicits	elicit	VERB
ajlm-1964	70	16	an	an	DET
ajlm-1964	70	17	increased	increase	VERB
ajlm-1964	70	18	reaction	reaction	NOUN
ajlm-1964	70	19	to	to	ADP
ajlm-1964	70	20	secondary	secondary	ADJ
ajlm-1964	70	21	infections	infection	NOUN
ajlm-1964	70	22	or	or	CCONJ
ajlm-1964	70	23	sterile	sterile	ADJ
ajlm-1964	70	24	activation	activation	NOUN
ajlm-1964	70	25	of	of	ADP
ajlm-1964	70	26	inflammation.65,94	inflammation.65,94	NOUN
ajlm-1964	70	27	besides	besides	SCONJ
ajlm-1964	70	28	trained	train	VERB
ajlm-1964	70	29	immunity	immunity	NOUN
ajlm-1964	70	30	,	,	PUNCT
ajlm-1964	70	31	the	the	DET
ajlm-1964	70	32	cells	cell	NOUN
ajlm-1964	70	33	of	of	ADP
ajlm-1964	70	34	the	the	DET
ajlm-1964	70	35	innate	innate	ADJ
ajlm-1964	70	36	immune	immune	ADJ
ajlm-1964	70	37	system	system	NOUN
ajlm-1964	70	38	could	could	AUX
ajlm-1964	70	39	also	also	ADV
ajlm-1964	70	40	reach	reach	VERB
ajlm-1964	70	41	a	a	DET
ajlm-1964	70	42	status	status	NOUN
ajlm-1964	70	43	of	of	ADP
ajlm-1964	70	44	immune	immune	ADJ
ajlm-1964	70	45	tolerance	tolerance	NOUN
ajlm-1964	70	46	or	or	CCONJ
ajlm-1964	70	47	hypo	hypo	NOUN
ajlm-1964	70	48	-	-	PUNCT
ajlm-1964	70	49	responsiveness	responsiveness	NOUN
ajlm-1964	70	50	,	,	PUNCT
ajlm-1964	70	51	wherein	wherein	SCONJ
ajlm-1964	70	52	there	there	PRON
ajlm-1964	70	53	is	be	VERB
ajlm-1964	70	54	a	a	DET
ajlm-1964	70	55	decrease	decrease	NOUN
ajlm-1964	70	56	in	in	ADP
ajlm-1964	70	57	the	the	DET
ajlm-1964	70	58	production	production	NOUN
ajlm-1964	70	59	of	of	ADP
ajlm-1964	70	60	pro	pro	ADJ
ajlm-1964	70	61	-	-	ADJ
ajlm-1964	70	62	inflammatory	inflammatory	ADJ
ajlm-1964	70	63	mediators	mediator	NOUN
ajlm-1964	70	64	when	when	SCONJ
ajlm-1964	70	65	these	these	DET
ajlm-1964	70	66	cells	cell	NOUN
ajlm-1964	70	67	encounter	encounter	VERB
ajlm-1964	70	68	secondary	secondary	ADJ
ajlm-1964	70	69	heterologous	heterologous	ADJ
ajlm-1964	70	70	stimuli.70,71,72	stimuli.70,71,72	NOUN
ajlm-1964	70	71	for	for	ADP
ajlm-1964	70	72	example	example	NOUN
ajlm-1964	70	73	,	,	PUNCT
ajlm-1964	70	74	epidemiological	epidemiological	ADJ
ajlm-1964	70	75	data	datum	NOUN
ajlm-1964	70	76	,	,	PUNCT
ajlm-1964	70	77	as	as	ADV
ajlm-1964	70	78	well	well	ADV
ajlm-1964	70	79	as	as	ADP
ajlm-1964	70	80	in	in	ADP
ajlm-1964	70	81	vivo	vivo	NOUN
ajlm-1964	70	82	and	and	CCONJ
ajlm-1964	70	83	in	in	ADP
ajlm-1964	70	84	vitro	vitro	X
ajlm-1964	70	85	studies	study	NOUN
ajlm-1964	70	86	with	with	ADP
ajlm-1964	70	87	bcg	bcg	PROPN
ajlm-1964	70	88	vaccines	vaccine	NOUN
ajlm-1964	70	89	conducted	conduct	VERB
ajlm-1964	70	90	among	among	ADP
ajlm-1964	70	91	humans	human	NOUN
ajlm-1964	70	92	and	and	CCONJ
ajlm-1964	70	93	in	in	ADP
ajlm-1964	70	94	murine	murine	ADJ
ajlm-1964	70	95	-	-	PUNCT
ajlm-1964	70	96	derived	derive	VERB
ajlm-1964	70	97	peripheral	peripheral	ADJ
ajlm-1964	70	98	blood	blood	NOUN
ajlm-1964	70	99	mononuclear	mononuclear	ADJ
ajlm-1964	70	100	cells	cell	NOUN
ajlm-1964	70	101	subjected	subject	VERB
ajlm-1964	70	102	to	to	ADP
ajlm-1964	70	103	immune	immune	NOUN
ajlm-1964	70	104	-	-	PUNCT
ajlm-1964	70	105	stimulatory	stimulatory	ADJ
ajlm-1964	70	106	agents	agent	NOUN
ajlm-1964	70	107	such	such	ADJ
ajlm-1964	70	108	as	as	ADP
ajlm-1964	70	109	lipopolysaccharide	lipopolysaccharide	ADJ
ajlm-1964	70	110	,	,	PUNCT
ajlm-1964	70	111	β	β	NOUN
ajlm-1964	70	112	-	-	NOUN
ajlm-1964	70	113	glucan	glucan	NOUN
ajlm-1964	70	114	,	,	PUNCT
ajlm-1964	70	115	and	and	CCONJ
ajlm-1964	70	116	flagellin	flagellin	NOUN
ajlm-1964	70	117	,	,	PUNCT
ajlm-1964	70	118	provided	provide	VERB
ajlm-1964	70	119	evidence	evidence	NOUN
ajlm-1964	70	120	of	of	ADP
ajlm-1964	70	121	either	either	CCONJ
ajlm-1964	70	122	increased	increase	VERB
ajlm-1964	70	123	or	or	CCONJ
ajlm-1964	70	124	decreased	decrease	VERB
ajlm-1964	70	125	inflammatory	inflammatory	ADJ
ajlm-1964	70	126	reaction	reaction	NOUN
ajlm-1964	70	127	to	to	ADP
ajlm-1964	70	128	secondary	secondary	ADJ
ajlm-1964	70	129	stimuli	stimulus	NOUN
ajlm-1964	70	130	that	that	PRON
ajlm-1964	70	131	corroborates	corroborate	VERB
ajlm-1964	70	132	the	the	DET
ajlm-1964	70	133	concept	concept	NOUN
ajlm-1964	70	134	of	of	ADP
ajlm-1964	70	135	trained	train	VERB
ajlm-1964	70	136	immunity	immunity	NOUN
ajlm-1964	70	137	and	and	CCONJ
ajlm-1964	70	138	immune	immune	ADJ
ajlm-1964	70	139	tolerance.70,71,72	tolerance.70,71,72	NOUN
ajlm-1964	70	140	in	in	ADP
ajlm-1964	70	141	addition	addition	NOUN
ajlm-1964	70	142	,	,	PUNCT
ajlm-1964	70	143	animal	animal	NOUN
ajlm-1964	70	144	studies	study	NOUN
ajlm-1964	70	145	have	have	AUX
ajlm-1964	70	146	shown	show	VERB
ajlm-1964	70	147	that	that	SCONJ
ajlm-1964	70	148	immunisation	immunisation	NOUN
ajlm-1964	70	149	with	with	ADP
ajlm-1964	70	150	the	the	DET
ajlm-1964	70	151	bcg	bcg	PROPN
ajlm-1964	70	152	vaccine	vaccine	NOUN
ajlm-1964	70	153	can	can	AUX
ajlm-1964	70	154	protect	protect	VERB
ajlm-1964	70	155	against	against	ADP
ajlm-1964	70	156	subsequent	subsequent	ADJ
ajlm-1964	70	157	infections	infection	NOUN
ajlm-1964	70	158	by	by	ADP
ajlm-1964	70	159	candida	candida	PROPN
ajlm-1964	70	160	albicans	albican	NOUN
ajlm-1964	70	161	and	and	CCONJ
ajlm-1964	70	162	m.	m.	NOUN
ajlm-1964	70	163	tuberculosis.95,96	tuberculosis.95,96	NOUN
ajlm-1964	70	164	immunisation	immunisation	NOUN
ajlm-1964	70	165	with	with	ADP
ajlm-1964	70	166	the	the	DET
ajlm-1964	70	167	bcg	bcg	PROPN
ajlm-1964	70	168	vaccine	vaccine	NOUN
ajlm-1964	70	169	can	can	AUX
ajlm-1964	70	170	also	also	ADV
ajlm-1964	70	171	protect	protect	VERB
ajlm-1964	70	172	against	against	ADP
ajlm-1964	70	173	a	a	DET
ajlm-1964	70	174	controlled	control	VERB
ajlm-1964	70	175	version	version	NOUN
ajlm-1964	70	176	of	of	ADP
ajlm-1964	70	177	human	human	ADJ
ajlm-1964	70	178	yellow	yellow	ADJ
ajlm-1964	70	179	fever	fever	NOUN
ajlm-1964	70	180	infection97	infection97	NOUN
ajlm-1964	70	181	or	or	CCONJ
ajlm-1964	70	182	malaria98	malaria98	VERB
ajlm-1964	70	183	by	by	ADP
ajlm-1964	70	184	augmenting	augment	VERB
ajlm-1964	70	185	the	the	DET
ajlm-1964	70	186	pro	pro	ADJ
ajlm-1964	70	187	-	-	ADJ
ajlm-1964	70	188	inflammatory	inflammatory	ADJ
ajlm-1964	70	189	activity	activity	NOUN
ajlm-1964	70	190	of	of	ADP
ajlm-1964	70	191	monocytes	monocyte	NOUN
ajlm-1964	70	192	.	.	PUNCT
ajlm-1964	71	1	it	it	PRON
ajlm-1964	71	2	is	be	AUX
ajlm-1964	71	3	reasonable	reasonable	ADJ
ajlm-1964	71	4	to	to	PART
ajlm-1964	71	5	argue	argue	VERB
ajlm-1964	71	6	that	that	SCONJ
ajlm-1964	71	7	the	the	DET
ajlm-1964	71	8	non	non	ADJ
ajlm-1964	71	9	-	-	ADJ
ajlm-1964	71	10	specific	specific	ADJ
ajlm-1964	71	11	nature	nature	NOUN
ajlm-1964	71	12	of	of	ADP
ajlm-1964	71	13	this	this	DET
ajlm-1964	71	14	type	type	NOUN
ajlm-1964	71	15	of	of	ADP
ajlm-1964	71	16	cross	cross	NOUN
ajlm-1964	71	17	-	-	NOUN
ajlm-1964	71	18	protection	protection	NOUN
ajlm-1964	71	19	is	be	AUX
ajlm-1964	71	20	not	not	PART
ajlm-1964	71	21	consistent	consistent	ADJ
ajlm-1964	71	22	with	with	ADP
ajlm-1964	71	23	mediation	mediation	NOUN
ajlm-1964	71	24	by	by	ADP
ajlm-1964	71	25	adaptive	adaptive	ADJ
ajlm-1964	71	26	immunity	immunity	NOUN
ajlm-1964	71	27	,	,	PUNCT
ajlm-1964	71	28	but	but	CCONJ
ajlm-1964	71	29	it	it	PRON
ajlm-1964	71	30	demonstrates	demonstrate	VERB
ajlm-1964	71	31	that	that	SCONJ
ajlm-1964	71	32	the	the	DET
ajlm-1964	71	33	host	host	NOUN
ajlm-1964	71	34	defence	defence	NOUN
ajlm-1964	71	35	can	can	AUX
ajlm-1964	71	36	develop	develop	VERB
ajlm-1964	71	37	innate	innate	ADJ
ajlm-1964	71	38	-	-	PUNCT
ajlm-1964	71	39	like	like	ADJ
ajlm-1964	71	40	immune	immune	ADJ
ajlm-1964	71	41	adaptation	adaptation	NOUN
ajlm-1964	71	42	mechanisms	mechanism	NOUN
ajlm-1964	71	43	.	.	PUNCT
ajlm-1964	72	1	several	several	ADJ
ajlm-1964	72	2	countries	country	NOUN
ajlm-1964	72	3	have	have	AUX
ajlm-1964	72	4	used	use	VERB
ajlm-1964	72	5	the	the	DET
ajlm-1964	72	6	bcg	bcg	PROPN
ajlm-1964	72	7	vaccine	vaccine	NOUN
ajlm-1964	72	8	to	to	PART
ajlm-1964	72	9	protect	protect	VERB
ajlm-1964	72	10	against	against	ADP
ajlm-1964	72	11	tuberculosis	tuberculosis	NOUN
ajlm-1964	72	12	caused	cause	VERB
ajlm-1964	72	13	by	by	ADP
ajlm-1964	72	14	m.	m.	NOUN
ajlm-1964	72	15	tuberculosis	tuberculosis	NOUN
ajlm-1964	72	16	by	by	ADP
ajlm-1964	72	17	exposing	expose	VERB
ajlm-1964	72	18	individuals	individual	NOUN
ajlm-1964	72	19	to	to	ADP
ajlm-1964	72	20	a	a	DET
ajlm-1964	72	21	live	live	ADJ
ajlm-1964	72	22	,	,	PUNCT
ajlm-1964	72	23	attenuated	attenuated	ADJ
ajlm-1964	72	24	strain	strain	NOUN
ajlm-1964	72	25	of	of	ADP
ajlm-1964	72	26	mycobacterium	mycobacterium	NOUN
ajlm-1964	72	27	bovis	bovis	NOUN
ajlm-1964	72	28	.	.	PUNCT
ajlm-1964	73	1	apart	apart	ADV
ajlm-1964	73	2	from	from	ADP
ajlm-1964	73	3	the	the	DET
ajlm-1964	73	4	partial	partial	ADJ
ajlm-1964	73	5	and	and	CCONJ
ajlm-1964	73	6	possibly	possibly	ADV
ajlm-1964	73	7	variable	variable	VERB
ajlm-1964	73	8	immunity	immunity	NOUN
ajlm-1964	73	9	the	the	DET
ajlm-1964	73	10	bcg	bcg	PROPN
ajlm-1964	73	11	vaccine	vaccine	NOUN
ajlm-1964	73	12	offers	offer	VERB
ajlm-1964	73	13	against	against	ADP
ajlm-1964	73	14	tuberculosis	tuberculosis	NOUN
ajlm-1964	73	15	,	,	PUNCT
ajlm-1964	73	16	it	it	PRON
ajlm-1964	73	17	also	also	ADV
ajlm-1964	73	18	protects	protect	VERB
ajlm-1964	73	19	in	in	ADP
ajlm-1964	73	20	an	an	DET
ajlm-1964	73	21	off	off	ADJ
ajlm-1964	73	22	-	-	PUNCT
ajlm-1964	73	23	target	target	NOUN
ajlm-1964	73	24	manner	manner	NOUN
ajlm-1964	73	25	against	against	ADP
ajlm-1964	73	26	other	other	ADJ
ajlm-1964	73	27	non‑tuberculosis	non‑tuberculosis	PROPN
ajlm-1964	73	28	infectious	infectious	ADJ
ajlm-1964	73	29	diseases.99	diseases.99	NOUN
ajlm-1964	73	30	for	for	ADP
ajlm-1964	73	31	example	example	NOUN
ajlm-1964	73	32	,	,	PUNCT
ajlm-1964	73	33	bcg	bcg	PROPN
ajlm-1964	73	34	vaccination	vaccination	NOUN
ajlm-1964	73	35	-	-	PUNCT
ajlm-1964	73	36	induced	induce	VERB
ajlm-1964	73	37	trained	train	VERB
ajlm-1964	73	38	immunity	immunity	NOUN
ajlm-1964	73	39	offers	offer	VERB
ajlm-1964	73	40	protection	protection	NOUN
ajlm-1964	73	41	against	against	ADP
ajlm-1964	73	42	infections	infection	NOUN
ajlm-1964	73	43	with	with	ADP
ajlm-1964	73	44	rna	rna	NOUN
ajlm-1964	73	45	and	and	CCONJ
ajlm-1964	73	46	dna	dna	PROPN
ajlm-1964	73	47	viruses	virus	NOUN
ajlm-1964	73	48	such	such	ADJ
ajlm-1964	73	49	as	as	ADP
ajlm-1964	73	50	herpes	herpe	NOUN
ajlm-1964	73	51	and	and	CCONJ
ajlm-1964	73	52	influenza	influenza	NOUN
ajlm-1964	73	53	,	,	PUNCT
ajlm-1964	73	54	reduces	reduce	VERB
ajlm-1964	73	55	yellow	yellow	ADJ
ajlm-1964	73	56	fever	fever	NOUN
ajlm-1964	73	57	viraemia	viraemia	NOUN
ajlm-1964	73	58	,	,	PUNCT
ajlm-1964	73	59	and	and	CCONJ
ajlm-1964	73	60	protects	protect	VERB
ajlm-1964	73	61	against	against	ADP
ajlm-1964	73	62	respiratory	respiratory	ADJ
ajlm-1964	73	63	tract	tract	NOUN
ajlm-1964	73	64	infections.97,100,101,102,103	infections.97,100,101,102,103	ADJ
ajlm-1964	73	65	data	datum	NOUN
ajlm-1964	73	66	from	from	ADP
ajlm-1964	73	67	a	a	DET
ajlm-1964	73	68	randomised	randomised	ADJ
ajlm-1964	73	69	,	,	PUNCT
ajlm-1964	73	70	double	double	ADJ
ajlm-1964	73	71	-	-	PUNCT
ajlm-1964	73	72	blind	blind	ADJ
ajlm-1964	73	73	,	,	PUNCT
ajlm-1964	73	74	clinical	clinical	ADJ
ajlm-1964	73	75	trial	trial	NOUN
ajlm-1964	73	76	conducted	conduct	VERB
ajlm-1964	73	77	recently	recently	ADV
ajlm-1964	73	78	showed	show	VERB
ajlm-1964	73	79	that	that	SCONJ
ajlm-1964	73	80	there	there	PRON
ajlm-1964	73	81	was	be	VERB
ajlm-1964	73	82	a	a	DET
ajlm-1964	73	83	reduction	reduction	NOUN
ajlm-1964	73	84	in	in	ADP
ajlm-1964	73	85	the	the	DET
ajlm-1964	73	86	incidence	incidence	NOUN
ajlm-1964	73	87	of	of	ADP
ajlm-1964	73	88	respiratory	respiratory	ADJ
ajlm-1964	73	89	tract	tract	NOUN
ajlm-1964	73	90	infections	infection	NOUN
ajlm-1964	73	91	in	in	ADP
ajlm-1964	73	92	bcg	bcg	NOUN
ajlm-1964	73	93	-	-	PUNCT
ajlm-1964	73	94	vaccinated	vaccinate	VERB
ajlm-1964	73	95	patients	patient	NOUN
ajlm-1964	73	96	65	65	NUM
ajlm-1964	73	97	years	year	NOUN
ajlm-1964	73	98	and	and	CCONJ
ajlm-1964	73	99	older.104	older.104	PRON
ajlm-1964	73	100	this	this	DET
ajlm-1964	73	101	protection	protection	NOUN
ajlm-1964	73	102	against	against	ADP
ajlm-1964	73	103	a	a	DET
ajlm-1964	73	104	variety	variety	NOUN
ajlm-1964	73	105	of	of	ADP
ajlm-1964	73	106	pathogens	pathogen	NOUN
ajlm-1964	73	107	is	be	AUX
ajlm-1964	73	108	achieved	achieve	VERB
ajlm-1964	73	109	through	through	ADP
ajlm-1964	73	110	trained	train	VERB
ajlm-1964	73	111	immunity.97	immunity.97	NOUN
ajlm-1964	73	112	most	most	ADJ
ajlm-1964	73	113	countries	country	NOUN
ajlm-1964	73	114	with	with	ADP
ajlm-1964	73	115	a	a	DET
ajlm-1964	73	116	high	high	ADJ
ajlm-1964	73	117	incidence	incidence	NOUN
ajlm-1964	73	118	of	of	ADP
ajlm-1964	73	119	tuberculosis	tuberculosis	NOUN
ajlm-1964	73	120	have	have	AUX
ajlm-1964	73	121	implemented	implement	VERB
ajlm-1964	73	122	a	a	DET
ajlm-1964	73	123	comprehensive	comprehensive	ADJ
ajlm-1964	73	124	bcg	bcg	NOUN
ajlm-1964	73	125	vaccination	vaccination	NOUN
ajlm-1964	73	126	policy	policy	NOUN
ajlm-1964	73	127	that	that	PRON
ajlm-1964	73	128	encourages	encourage	VERB
ajlm-1964	73	129	children	child	NOUN
ajlm-1964	73	130	to	to	PART
ajlm-1964	73	131	get	get	VERB
ajlm-1964	73	132	the	the	DET
ajlm-1964	73	133	bcg	bcg	PROPN
ajlm-1964	73	134	vaccine	vaccine	NOUN
ajlm-1964	73	135	in	in	ADP
ajlm-1964	73	136	early	early	ADJ
ajlm-1964	73	137	childhood	childhood	NOUN
ajlm-1964	73	138	.	.	PUNCT
ajlm-1964	74	1	the	the	DET
ajlm-1964	74	2	protection	protection	NOUN
ajlm-1964	74	3	offered	offer	VERB
ajlm-1964	74	4	by	by	ADP
ajlm-1964	74	5	the	the	DET
ajlm-1964	74	6	bcg	bcg	PROPN
ajlm-1964	74	7	vaccine	vaccine	NOUN
ajlm-1964	74	8	may	may	AUX
ajlm-1964	74	9	persist	persist	VERB
ajlm-1964	74	10	for	for	ADP
ajlm-1964	74	11	up	up	ADP
ajlm-1964	74	12	to	to	PART
ajlm-1964	74	13	30–40	30–40	NUM
ajlm-1964	74	14	years	year	NOUN
ajlm-1964	74	15	after	after	ADP
ajlm-1964	74	16	inoculation	inoculation	NOUN
ajlm-1964	74	17	as	as	SCONJ
ajlm-1964	74	18	described	describe	VERB
ajlm-1964	74	19	in	in	ADP
ajlm-1964	74	20	a	a	DET
ajlm-1964	74	21	study	study	NOUN
ajlm-1964	74	22	in	in	ADP
ajlm-1964	74	23	norway,105	norway,105	NOUN
ajlm-1964	74	24	or	or	CCONJ
ajlm-1964	74	25	up	up	ADP
ajlm-1964	74	26	to	to	ADP
ajlm-1964	74	27	50–60	50–60	NUM
ajlm-1964	74	28	years	year	NOUN
ajlm-1964	74	29	as	as	SCONJ
ajlm-1964	74	30	shown	show	VERB
ajlm-1964	74	31	in	in	ADP
ajlm-1964	74	32	a	a	DET
ajlm-1964	74	33	bcg	bcg	NOUN
ajlm-1964	74	34	vaccine	vaccine	NOUN
ajlm-1964	74	35	trial	trial	NOUN
ajlm-1964	74	36	among	among	ADP
ajlm-1964	74	37	american	american	ADJ
ajlm-1964	74	38	indians	indians	PROPN
ajlm-1964	74	39	and	and	CCONJ
ajlm-1964	74	40	alaska	alaska	PROPN
ajlm-1964	74	41	natives.106	natives.106	INTJ
ajlm-1964	74	42	however	however	ADV
ajlm-1964	74	43	,	,	PUNCT
ajlm-1964	74	44	data	datum	NOUN
ajlm-1964	74	45	from	from	ADP
ajlm-1964	74	46	these	these	PRON
ajlm-1964	74	47	and	and	CCONJ
ajlm-1964	74	48	some	some	DET
ajlm-1964	74	49	other	other	ADJ
ajlm-1964	74	50	studies	study	NOUN
ajlm-1964	74	51	have	have	AUX
ajlm-1964	74	52	also	also	ADV
ajlm-1964	74	53	shown	show	VERB
ajlm-1964	74	54	that	that	SCONJ
ajlm-1964	74	55	bcg	bcg	PROPN
ajlm-1964	74	56	vaccination	vaccination	NOUN
ajlm-1964	74	57	-	-	PUNCT
ajlm-1964	74	58	induced	induce	VERB
ajlm-1964	74	59	protection	protection	NOUN
ajlm-1964	74	60	could	could	AUX
ajlm-1964	74	61	also	also	ADV
ajlm-1964	74	62	wane	wane	VERB
ajlm-1964	74	63	over	over	ADP
ajlm-1964	74	64	time.107	time.107	NOUN
ajlm-1964	74	65	apart	apart	ADV
ajlm-1964	74	66	from	from	ADP
ajlm-1964	74	67	its	its	PRON
ajlm-1964	74	68	reported	report	VERB
ajlm-1964	74	69	prospect	prospect	NOUN
ajlm-1964	74	70	to	to	PART
ajlm-1964	74	71	enhance	enhance	VERB
ajlm-1964	74	72	innate	innate	ADJ
ajlm-1964	74	73	immunity	immunity	NOUN
ajlm-1964	74	74	,	,	PUNCT
ajlm-1964	74	75	preliminary	preliminary	ADJ
ajlm-1964	74	76	epidemiological	epidemiological	ADJ
ajlm-1964	74	77	analyses	analysis	NOUN
ajlm-1964	74	78	have	have	AUX
ajlm-1964	74	79	also	also	ADV
ajlm-1964	74	80	shown	show	VERB
ajlm-1964	74	81	a	a	DET
ajlm-1964	74	82	reduction	reduction	NOUN
ajlm-1964	74	83	in	in	ADP
ajlm-1964	74	84	covid-19	covid-19	PROPN
ajlm-1964	74	85	severity	severity	NOUN
ajlm-1964	74	86	in	in	ADP
ajlm-1964	74	87	countries	country	NOUN
ajlm-1964	74	88	that	that	PRON
ajlm-1964	74	89	are	be	AUX
ajlm-1964	74	90	implementing	implement	VERB
ajlm-1964	74	91	the	the	DET
ajlm-1964	74	92	policy	policy	NOUN
ajlm-1964	74	93	of	of	ADP
ajlm-1964	74	94	widespread	widespread	ADJ
ajlm-1964	74	95	bcg	bcg	NOUN
ajlm-1964	74	96	vaccination.108	vaccination.108	NOUN
ajlm-1964	74	97	these	these	DET
ajlm-1964	74	98	observations	observation	NOUN
ajlm-1964	74	99	suggest	suggest	VERB
ajlm-1964	74	100	that	that	SCONJ
ajlm-1964	74	101	the	the	DET
ajlm-1964	74	102	bcg	bcg	PROPN
ajlm-1964	74	103	vaccine	vaccine	NOUN
ajlm-1964	74	104	may	may	AUX
ajlm-1964	74	105	protect	protect	VERB
ajlm-1964	74	106	against	against	ADP
ajlm-1964	74	107	sars	sar	NOUN
ajlm-1964	74	108	-	-	PUNCT
ajlm-1964	74	109	cov-2	cov-2	PART
ajlm-1964	74	110	infection	infection	NOUN
ajlm-1964	74	111	.	.	PUNCT
ajlm-1964	75	1	consequently	consequently	ADV
ajlm-1964	75	2	,	,	PUNCT
ajlm-1964	75	3	in	in	ADP
ajlm-1964	75	4	2020	2020	NUM
ajlm-1964	75	5	,	,	PUNCT
ajlm-1964	75	6	bcg	bcg	NOUN
ajlm-1964	75	7	vaccination	vaccination	NOUN
ajlm-1964	75	8	was	be	AUX
ajlm-1964	75	9	proposed	propose	VERB
ajlm-1964	75	10	as	as	ADP
ajlm-1964	75	11	a	a	DET
ajlm-1964	75	12	strategy	strategy	NOUN
ajlm-1964	75	13	to	to	PART
ajlm-1964	75	14	prevent	prevent	VERB
ajlm-1964	75	15	infection	infection	NOUN
ajlm-1964	75	16	and	and	CCONJ
ajlm-1964	75	17	combat	combat	VERB
ajlm-1964	75	18	the	the	DET
ajlm-1964	75	19	covid‑19	covid‑19	NOUN
ajlm-1964	75	20	outbreak.108	outbreak.108	NUM
ajlm-1964	75	21	although	although	SCONJ
ajlm-1964	75	22	bcg	bcg	NOUN
ajlm-1964	75	23	vaccination	vaccination	NOUN
ajlm-1964	75	24	is	be	AUX
ajlm-1964	75	25	linked	link	VERB
ajlm-1964	75	26	to	to	ADP
ajlm-1964	75	27	a	a	DET
ajlm-1964	75	28	reduction	reduction	NOUN
ajlm-1964	75	29	in	in	ADP
ajlm-1964	75	30	the	the	DET
ajlm-1964	75	31	number	number	NOUN
ajlm-1964	75	32	of	of	ADP
ajlm-1964	75	33	covid-19	covid-19	PROPN
ajlm-1964	75	34	cases	case	NOUN
ajlm-1964	75	35	and	and	CCONJ
ajlm-1964	75	36	mortality,109,110,111	mortality,109,110,111	ADJ
ajlm-1964	75	37	many	many	ADJ
ajlm-1964	75	38	of	of	ADP
ajlm-1964	75	39	the	the	DET
ajlm-1964	75	40	assessments	assessment	NOUN
ajlm-1964	75	41	do	do	AUX
ajlm-1964	75	42	not	not	PART
ajlm-1964	75	43	consider	consider	VERB
ajlm-1964	75	44	likely	likely	ADJ
ajlm-1964	75	45	confounding	confound	VERB
ajlm-1964	75	46	factors	factor	NOUN
ajlm-1964	75	47	such	such	ADJ
ajlm-1964	75	48	as	as	ADP
ajlm-1964	75	49	testing	testing	NOUN
ajlm-1964	75	50	rate	rate	NOUN
ajlm-1964	75	51	,	,	PUNCT
ajlm-1964	75	52	socio	socio	NOUN
ajlm-1964	75	53	-	-	PUNCT
ajlm-1964	75	54	economic	economic	ADJ
ajlm-1964	75	55	factors	factor	NOUN
ajlm-1964	75	56	,	,	PUNCT
ajlm-1964	75	57	and	and	CCONJ
ajlm-1964	75	58	co	co	NOUN
ajlm-1964	75	59	-	-	NOUN
ajlm-1964	75	60	morbidities	morbidity	NOUN
ajlm-1964	75	61	.	.	PUNCT
ajlm-1964	76	1	one	one	NUM
ajlm-1964	76	2	epidemiological	epidemiological	ADJ
ajlm-1964	76	3	study	study	NOUN
ajlm-1964	76	4	that	that	PRON
ajlm-1964	76	5	corrected	correct	VERB
ajlm-1964	76	6	for	for	ADP
ajlm-1964	76	7	confounding	confound	VERB
ajlm-1964	76	8	variables	variable	NOUN
ajlm-1964	76	9	,	,	PUNCT
ajlm-1964	76	10	particularly	particularly	ADV
ajlm-1964	76	11	the	the	DET
ajlm-1964	76	12	testing	testing	NOUN
ajlm-1964	76	13	rate	rate	NOUN
ajlm-1964	76	14	,	,	PUNCT
ajlm-1964	76	15	did	do	AUX
ajlm-1964	76	16	not	not	PART
ajlm-1964	76	17	find	find	VERB
ajlm-1964	76	18	evidence	evidence	NOUN
ajlm-1964	76	19	that	that	SCONJ
ajlm-1964	76	20	the	the	DET
ajlm-1964	76	21	overall	overall	ADJ
ajlm-1964	76	22	bcg	bcg	PROPN
ajlm-1964	76	23	vaccination	vaccination	NOUN
ajlm-1964	76	24	policy	policy	NOUN
ajlm-1964	76	25	correlated	correlate	VERB
ajlm-1964	76	26	with	with	ADP
ajlm-1964	76	27	the	the	DET
ajlm-1964	76	28	spread	spread	NOUN
ajlm-1964	76	29	of	of	ADP
ajlm-1964	76	30	sars	sar	NOUN
ajlm-1964	76	31	-	-	PUNCT
ajlm-1964	76	32	cov-2	cov-2	NOUN
ajlm-1964	76	33	and	and	CCONJ
ajlm-1964	76	34	its	its	PRON
ajlm-1964	76	35	associated	associate	VERB
ajlm-1964	76	36	mortality.112	mortality.112	NOUN
ajlm-1964	76	37	available	available	ADJ
ajlm-1964	76	38	information	information	NOUN
ajlm-1964	76	39	as	as	ADP
ajlm-1964	76	40	of	of	ADP
ajlm-1964	76	41	2020	2020	NUM
ajlm-1964	76	42	on	on	ADP
ajlm-1964	76	43	the	the	DET
ajlm-1964	76	44	bcg	bcg	PROPN
ajlm-1964	76	45	atlas	atlas	PROPN
ajlm-1964	76	46	(	(	PUNCT
ajlm-1964	76	47	www.bcgatlas.org	www.bcgatlas.org	PROPN
ajlm-1964	76	48	)	)	PUNCT
ajlm-1964	76	49	showed	show	VERB
ajlm-1964	76	50	that	that	SCONJ
ajlm-1964	76	51	all	all	DET
ajlm-1964	76	52	african	african	ADJ
ajlm-1964	76	53	countries	country	NOUN
ajlm-1964	76	54	except	except	SCONJ
ajlm-1964	76	55	south	south	PROPN
ajlm-1964	76	56	sudan	sudan	PROPN
ajlm-1964	76	57	have	have	VERB
ajlm-1964	76	58	an	an	DET
ajlm-1964	76	59	existing	exist	VERB
ajlm-1964	76	60	universal	universal	ADJ
ajlm-1964	76	61	bcg	bcg	NOUN
ajlm-1964	76	62	vaccination	vaccination	NOUN
ajlm-1964	76	63	policy	policy	NOUN
ajlm-1964	76	64	.	.	PUNCT
ajlm-1964	77	1	if	if	SCONJ
ajlm-1964	77	2	it	it	PRON
ajlm-1964	77	3	is	be	AUX
ajlm-1964	77	4	proven	prove	VERB
ajlm-1964	77	5	that	that	SCONJ
ajlm-1964	77	6	bcg	bcg	PROPN
ajlm-1964	77	7	vaccination	vaccination	NOUN
ajlm-1964	77	8	does	do	AUX
ajlm-1964	77	9	indeed	indeed	ADV
ajlm-1964	77	10	offer	offer	VERB
ajlm-1964	77	11	protection	protection	NOUN
ajlm-1964	77	12	against	against	ADP
ajlm-1964	77	13	sars	sar	NOUN
ajlm-1964	77	14	-	-	PUNCT
ajlm-1964	77	15	cov-2	cov-2	NOUN
ajlm-1964	77	16	,	,	PUNCT
ajlm-1964	77	17	the	the	DET
ajlm-1964	77	18	relatively	relatively	ADV
ajlm-1964	77	19	low	low	ADJ
ajlm-1964	77	20	number	number	NOUN
ajlm-1964	77	21	of	of	ADP
ajlm-1964	77	22	cases	case	NOUN
ajlm-1964	77	23	and	and	CCONJ
ajlm-1964	77	24	deaths	death	NOUN
ajlm-1964	77	25	could	could	AUX
ajlm-1964	77	26	be	be	AUX
ajlm-1964	77	27	attributed	attribute	VERB
ajlm-1964	77	28	to	to	ADP
ajlm-1964	77	29	the	the	DET
ajlm-1964	77	30	long	long	ADV
ajlm-1964	77	31	-	-	PUNCT
ajlm-1964	77	32	standing	stand	VERB
ajlm-1964	77	33	universal	universal	ADJ
ajlm-1964	77	34	bcg	bcg	PROPN
ajlm-1964	77	35	vaccination	vaccination	NOUN
ajlm-1964	77	36	policy	policy	NOUN
ajlm-1964	77	37	in	in	ADP
ajlm-1964	77	38	african	african	ADJ
ajlm-1964	77	39	countries	country	NOUN
ajlm-1964	77	40	rather	rather	ADV
ajlm-1964	77	41	than	than	ADP
ajlm-1964	77	42	under	under	ADP
ajlm-1964	77	43	-	-	PUNCT
ajlm-1964	77	44	reporting	reporting	NOUN
ajlm-1964	77	45	or	or	CCONJ
ajlm-1964	77	46	diagnostic	diagnostic	ADJ
ajlm-1964	77	47	limitations	limitation	NOUN
ajlm-1964	77	48	.	.	PUNCT
ajlm-1964	78	1	the	the	DET
ajlm-1964	78	2	determinant	determinant	NOUN
ajlm-1964	78	3	of	of	ADP
ajlm-1964	78	4	whether	whether	SCONJ
ajlm-1964	78	5	the	the	DET
ajlm-1964	78	6	innate	innate	ADJ
ajlm-1964	78	7	immune	immune	ADJ
ajlm-1964	78	8	system	system	NOUN
ajlm-1964	78	9	exhibits	exhibit	VERB
ajlm-1964	78	10	either	either	CCONJ
ajlm-1964	78	11	trained	train	VERB
ajlm-1964	78	12	immunity	immunity	NOUN
ajlm-1964	78	13	or	or	CCONJ
ajlm-1964	78	14	immune	immune	ADJ
ajlm-1964	78	15	tolerance	tolerance	NOUN
ajlm-1964	78	16	is	be	AUX
ajlm-1964	78	17	not	not	PART
ajlm-1964	78	18	known	know	VERB
ajlm-1964	78	19	but	but	CCONJ
ajlm-1964	78	20	is	be	AUX
ajlm-1964	78	21	thought	think	VERB
ajlm-1964	78	22	to	to	PART
ajlm-1964	78	23	be	be	AUX
ajlm-1964	78	24	related	relate	VERB
ajlm-1964	78	25	to	to	ADP
ajlm-1964	78	26	the	the	DET
ajlm-1964	78	27	dose	dose	NOUN
ajlm-1964	78	28	and	and	CCONJ
ajlm-1964	78	29	duration	duration	NOUN
ajlm-1964	78	30	of	of	ADP
ajlm-1964	78	31	the	the	DET
ajlm-1964	78	32	primary	primary	ADJ
ajlm-1964	78	33	trigger.72,113	trigger.72,113	NOUN
ajlm-1964	78	34	trained	train	VERB
ajlm-1964	78	35	immunity	immunity	NOUN
ajlm-1964	78	36	and	and	CCONJ
ajlm-1964	78	37	immune	immune	ADJ
ajlm-1964	78	38	tolerance	tolerance	NOUN
ajlm-1964	78	39	have	have	AUX
ajlm-1964	78	40	been	be	AUX
ajlm-1964	78	41	demonstrated	demonstrate	VERB
ajlm-1964	78	42	in	in	ADP
ajlm-1964	78	43	studies	study	NOUN
ajlm-1964	78	44	that	that	PRON
ajlm-1964	78	45	focused	focus	VERB
ajlm-1964	78	46	on	on	ADP
ajlm-1964	78	47	circulating	circulate	VERB
ajlm-1964	78	48	mononuclear	mononuclear	ADJ
ajlm-1964	78	49	cells	cell	NOUN
ajlm-1964	78	50	with	with	ADP
ajlm-1964	78	51	a	a	DET
ajlm-1964	78	52	short	short	ADJ
ajlm-1964	78	53	lifespan	lifespan	NOUN
ajlm-1964	78	54	,	,	PUNCT
ajlm-1964	78	55	as	as	ADV
ajlm-1964	78	56	well	well	ADV
ajlm-1964	78	57	as	as	ADP
ajlm-1964	78	58	progenitor	progenitor	NOUN
ajlm-1964	78	59	stem	stem	NOUN
ajlm-1964	78	60	cells	cell	NOUN
ajlm-1964	78	61	of	of	ADP
ajlm-1964	78	62	the	the	DET
ajlm-1964	78	63	bone	bone	NOUN
ajlm-1964	78	64	marrow	marrow	NOUN
ajlm-1964	78	65	,	,	PUNCT
ajlm-1964	78	66	epithelial	epithelial	ADJ
ajlm-1964	78	67	cells	cell	NOUN
ajlm-1964	78	68	,	,	PUNCT
ajlm-1964	78	69	and	and	CCONJ
ajlm-1964	78	70	resident	resident	ADJ
ajlm-1964	78	71	tissue	tissue	NOUN
ajlm-1964	78	72	macrophages	macrophage	NOUN
ajlm-1964	78	73	with	with	ADP
ajlm-1964	78	74	long	long	ADJ
ajlm-1964	78	75	lifespans.70,71	lifespans.70,71	NOUN
ajlm-1964	78	76	this	this	PRON
ajlm-1964	78	77	may	may	AUX
ajlm-1964	78	78	imply	imply	VERB
ajlm-1964	78	79	that	that	SCONJ
ajlm-1964	78	80	the	the	DET
ajlm-1964	78	81	host	host	NOUN
ajlm-1964	78	82	’s	’s	PART
ajlm-1964	78	83	innate	innate	ADJ
ajlm-1964	78	84	immune	immune	ADJ
ajlm-1964	78	85	response	response	NOUN
ajlm-1964	78	86	to	to	ADP
ajlm-1964	78	87	different	different	ADJ
ajlm-1964	78	88	pathogens	pathogen	NOUN
ajlm-1964	78	89	could	could	AUX
ajlm-1964	78	90	last	last	VERB
ajlm-1964	78	91	longer	long	ADV
ajlm-1964	78	92	.	.	PUNCT
ajlm-1964	79	1	trained	train	VERB
ajlm-1964	79	2	immunity	immunity	NOUN
ajlm-1964	79	3	and	and	CCONJ
ajlm-1964	79	4	immune	immune	ADJ
ajlm-1964	79	5	tolerance	tolerance	NOUN
ajlm-1964	79	6	may	may	AUX
ajlm-1964	79	7	have	have	VERB
ajlm-1964	79	8	significant	significant	ADJ
ajlm-1964	79	9	implications	implication	NOUN
ajlm-1964	79	10	for	for	ADP
ajlm-1964	79	11	covid-19	covid-19	PROPN
ajlm-1964	79	12	infection	infection	NOUN
ajlm-1964	79	13	.	.	PUNCT
ajlm-1964	80	1	in	in	ADP
ajlm-1964	80	2	sub	sub	ADJ
ajlm-1964	80	3	-	-	ADJ
ajlm-1964	80	4	saharan	saharan	ADJ
ajlm-1964	80	5	africa	africa	PROPN
ajlm-1964	80	6	,	,	PUNCT
ajlm-1964	80	7	vast	vast	ADJ
ajlm-1964	80	8	portions	portion	NOUN
ajlm-1964	80	9	of	of	ADP
ajlm-1964	80	10	the	the	DET
ajlm-1964	80	11	population	population	NOUN
ajlm-1964	80	12	live	live	VERB
ajlm-1964	80	13	under	under	ADP
ajlm-1964	80	14	unfavourable	unfavourable	ADJ
ajlm-1964	80	15	conditions	condition	NOUN
ajlm-1964	80	16	such	such	ADJ
ajlm-1964	80	17	as	as	ADP
ajlm-1964	80	18	crowded	crowded	ADJ
ajlm-1964	80	19	and	and	CCONJ
ajlm-1964	80	20	unhygienic	unhygienic	ADJ
ajlm-1964	80	21	environments	environment	NOUN
ajlm-1964	80	22	,	,	PUNCT
ajlm-1964	80	23	leading	lead	VERB
ajlm-1964	80	24	to	to	ADP
ajlm-1964	80	25	recurrent	recurrent	ADJ
ajlm-1964	80	26	infections	infection	NOUN
ajlm-1964	80	27	with	with	ADP
ajlm-1964	80	28	bacteria	bacteria	NOUN
ajlm-1964	80	29	,	,	PUNCT
ajlm-1964	80	30	viruses	virus	NOUN
ajlm-1964	80	31	,	,	PUNCT
ajlm-1964	80	32	and	and	CCONJ
ajlm-1964	80	33	eukaryotic	eukaryotic	ADJ
ajlm-1964	80	34	parasites	parasite	NOUN
ajlm-1964	80	35	,	,	PUNCT
ajlm-1964	80	36	and	and	CCONJ
ajlm-1964	80	37	thus	thus	ADV
ajlm-1964	80	38	making	make	VERB
ajlm-1964	80	39	it	it	PRON
ajlm-1964	80	40	possible	possible	ADJ
ajlm-1964	80	41	to	to	PART
ajlm-1964	80	42	attain	attain	VERB
ajlm-1964	80	43	immune	immune	ADJ
ajlm-1964	80	44	tolerance	tolerance	NOUN
ajlm-1964	80	45	against	against	ADP
ajlm-1964	80	46	a	a	DET
ajlm-1964	80	47	novel	novel	ADJ
ajlm-1964	80	48	pathogen	pathogen	NOUN
ajlm-1964	80	49	like	like	ADP
ajlm-1964	80	50	sars	sar	NOUN
ajlm-1964	80	51	-	-	PUNCT
ajlm-1964	80	52	cov-2	cov-2	NOUN
ajlm-1964	80	53	.	.	NOUN
ajlm-1964	80	54	immune	immune	ADJ
ajlm-1964	80	55	tolerance	tolerance	NOUN
ajlm-1964	80	56	could	could	AUX
ajlm-1964	80	57	prevent	prevent	VERB
ajlm-1964	80	58	the	the	DET
ajlm-1964	80	59	innate	innate	ADJ
ajlm-1964	80	60	immune	immune	ADJ
ajlm-1964	80	61	system	system	NOUN
ajlm-1964	80	62	from	from	ADP
ajlm-1964	80	63	reaching	reach	VERB
ajlm-1964	80	64	a	a	DET
ajlm-1964	80	65	hyper	hyper	ADJ
ajlm-1964	80	66	-	-	ADJ
ajlm-1964	80	67	inflammatory	inflammatory	ADJ
ajlm-1964	80	68	state	state	NOUN
ajlm-1964	80	69	or	or	CCONJ
ajlm-1964	80	70	a	a	DET
ajlm-1964	80	71	‘	'	PUNCT
ajlm-1964	80	72	cytokine	cytokine	ADJ
ajlm-1964	80	73	storm	storm	NOUN
ajlm-1964	80	74	’	'	PUNCT
ajlm-1964	80	75	,	,	PUNCT
ajlm-1964	80	76	which	which	PRON
ajlm-1964	80	77	is	be	AUX
ajlm-1964	80	78	generally	generally	ADV
ajlm-1964	80	79	associated	associate	VERB
ajlm-1964	80	80	with	with	ADP
ajlm-1964	80	81	the	the	DET
ajlm-1964	80	82	ultimate	ultimate	ADJ
ajlm-1964	80	83	fatality	fatality	NOUN
ajlm-1964	80	84	of	of	ADP
ajlm-1964	80	85	covid-19	covid-19	PROPN
ajlm-1964	80	86	disease	disease	NOUN
ajlm-1964	80	87	.	.	PUNCT
ajlm-1964	81	1	people	people	NOUN
ajlm-1964	81	2	living	live	VERB
ajlm-1964	81	3	in	in	ADP
ajlm-1964	81	4	developed	develop	VERB
ajlm-1964	81	5	countries	country	NOUN
ajlm-1964	81	6	with	with	ADP
ajlm-1964	81	7	better	well	ADJ
ajlm-1964	81	8	sanitary	sanitary	NOUN
ajlm-1964	81	9	conditions	condition	NOUN
ajlm-1964	81	10	are	be	AUX
ajlm-1964	81	11	less	less	ADV
ajlm-1964	81	12	exposed	expose	VERB
ajlm-1964	81	13	to	to	ADP
ajlm-1964	81	14	multiple	multiple	ADJ
ajlm-1964	81	15	pathogens	pathogen	NOUN
ajlm-1964	81	16	during	during	ADP
ajlm-1964	81	17	their	their	PRON
ajlm-1964	81	18	lifetime	lifetime	NOUN
ajlm-1964	81	19	and	and	CCONJ
ajlm-1964	81	20	thus	thus	ADV
ajlm-1964	81	21	less	less	ADV
ajlm-1964	81	22	likely	likely	ADJ
ajlm-1964	81	23	to	to	PART
ajlm-1964	81	24	attain	attain	VERB
ajlm-1964	81	25	immune	immune	ADJ
ajlm-1964	81	26	tolerance	tolerance	NOUN
ajlm-1964	81	27	.	.	PUNCT
ajlm-1964	82	1	this	this	PRON
ajlm-1964	82	2	may	may	AUX
ajlm-1964	82	3	be	be	AUX
ajlm-1964	82	4	partially	partially	ADV
ajlm-1964	82	5	responsible	responsible	ADJ
ajlm-1964	82	6	for	for	ADP
ajlm-1964	82	7	the	the	DET
ajlm-1964	82	8	clinical	clinical	ADJ
ajlm-1964	82	9	spectrum	spectrum	NOUN
ajlm-1964	82	10	and	and	CCONJ
ajlm-1964	82	11	the	the	DET
ajlm-1964	82	12	heightened	heighten	VERB
ajlm-1964	82	13	vulnerability	vulnerability	NOUN
ajlm-1964	82	14	to	to	PART
ajlm-1964	82	15	novel	novel	VERB
ajlm-1964	82	16	pathogens	pathogen	NOUN
ajlm-1964	82	17	like	like	ADP
ajlm-1964	82	18	sars	sar	NOUN
ajlm-1964	82	19	-	-	PUNCT
ajlm-1964	82	20	cov-2	cov-2	NOUN
ajlm-1964	82	21	observed	observe	VERB
ajlm-1964	82	22	in	in	ADP
ajlm-1964	82	23	such	such	ADJ
ajlm-1964	82	24	populations	population	NOUN
ajlm-1964	82	25	.	.	PUNCT
ajlm-1964	83	1	projections	projection	NOUN
ajlm-1964	83	2	into	into	ADP
ajlm-1964	83	3	the	the	DET
ajlm-1964	83	4	future	future	NOUN
ajlm-1964	83	5	of	of	ADP
ajlm-1964	83	6	covid-19	covid-19	PROPN
ajlm-1964	83	7	and	and	CCONJ
ajlm-1964	83	8	disease	disease	NOUN
ajlm-1964	83	9	processes	process	NOUN
ajlm-1964	83	10	against	against	ADP
ajlm-1964	83	11	the	the	DET
ajlm-1964	83	12	background	background	NOUN
ajlm-1964	83	13	of	of	ADP
ajlm-1964	83	14	increasing	increase	VERB
ajlm-1964	83	15	population	population	NOUN
ajlm-1964	83	16	immunity	immunity	NOUN
ajlm-1964	83	17	due	due	ADP
ajlm-1964	83	18	to	to	ADP
ajlm-1964	83	19	vaccination	vaccination	NOUN
ajlm-1964	83	20	and	and	CCONJ
ajlm-1964	83	21	high	high	ADJ
ajlm-1964	83	22	rates	rate	NOUN
ajlm-1964	83	23	of	of	ADP
ajlm-1964	83	24	natural	natural	ADJ
ajlm-1964	83	25	infection	infection	NOUN
ajlm-1964	83	26	,	,	PUNCT
ajlm-1964	83	27	many	many	ADJ
ajlm-1964	83	28	new	new	ADJ
ajlm-1964	83	29	variants	variant	NOUN
ajlm-1964	83	30	of	of	ADP
ajlm-1964	83	31	sars	sar	NOUN
ajlm-1964	83	32	-	-	PUNCT
ajlm-1964	83	33	cov-2	cov-2	PART
ajlm-1964	83	34	have	have	AUX
ajlm-1964	83	35	emerged	emerge	VERB
ajlm-1964	83	36	and	and	CCONJ
ajlm-1964	83	37	have	have	AUX
ajlm-1964	83	38	been	be	AUX
ajlm-1964	83	39	designated	designate	VERB
ajlm-1964	83	40	by	by	ADP
ajlm-1964	83	41	the	the	DET
ajlm-1964	83	42	who	who	PRON
ajlm-1964	83	43	as	as	SCONJ
ajlm-1964	83	44	either	either	DET
ajlm-1964	83	45	variants	variant	NOUN
ajlm-1964	83	46	of	of	ADP
ajlm-1964	83	47	concern	concern	NOUN
ajlm-1964	83	48	or	or	CCONJ
ajlm-1964	83	49	variants	variant	NOUN
ajlm-1964	83	50	of	of	ADP
ajlm-1964	83	51	interest.114	interest.114	NUM
ajlm-1964	83	52	these	these	DET
ajlm-1964	83	53	variants	variant	NOUN
ajlm-1964	83	54	pose	pose	VERB
ajlm-1964	83	55	a	a	DET
ajlm-1964	83	56	greater	great	ADJ
ajlm-1964	83	57	risk	risk	NOUN
ajlm-1964	83	58	to	to	ADP
ajlm-1964	83	59	public	public	ADJ
ajlm-1964	83	60	health	health	NOUN
ajlm-1964	83	61	because	because	SCONJ
ajlm-1964	83	62	they	they	PRON
ajlm-1964	83	63	may	may	AUX
ajlm-1964	83	64	be	be	AUX
ajlm-1964	83	65	more	more	ADV
ajlm-1964	83	66	transmissible	transmissible	ADJ
ajlm-1964	83	67	or	or	CCONJ
ajlm-1964	83	68	produce	produce	VERB
ajlm-1964	83	69	more	more	ADJ
ajlm-1964	83	70	severe	severe	ADJ
ajlm-1964	83	71	disease	disease	NOUN
ajlm-1964	83	72	,	,	PUNCT
ajlm-1964	83	73	escape	escape	VERB
ajlm-1964	83	74	immune	immune	ADJ
ajlm-1964	83	75	response	response	NOUN
ajlm-1964	83	76	,	,	PUNCT
ajlm-1964	83	77	cause	cause	VERB
ajlm-1964	83	78	diagnostic	diagnostic	ADJ
ajlm-1964	83	79	or	or	CCONJ
ajlm-1964	83	80	treatment	treatment	NOUN
ajlm-1964	83	81	failure	failure	NOUN
ajlm-1964	83	82	,	,	PUNCT
ajlm-1964	83	83	or	or	CCONJ
ajlm-1964	83	84	reduce	reduce	VERB
ajlm-1964	83	85	the	the	DET
ajlm-1964	83	86	efficacy	efficacy	NOUN
ajlm-1964	83	87	of	of	ADP
ajlm-1964	83	88	vaccines.114,115	vaccines.114,115	PROPN
ajlm-1964	83	89	the	the	DET
ajlm-1964	83	90	five	five	NUM
ajlm-1964	83	91	main	main	ADJ
ajlm-1964	83	92	variants	variant	NOUN
ajlm-1964	83	93	of	of	ADP
ajlm-1964	83	94	concern	concern	NOUN
ajlm-1964	83	95	are	be	AUX
ajlm-1964	83	96	:	:	PUNCT
ajlm-1964	83	97	b.1.1.7	b.1.1.7	PROPN
ajlm-1964	83	98	(	(	PUNCT
ajlm-1964	83	99	alpha	alpha	NOUN
ajlm-1964	83	100	)	)	PUNCT
ajlm-1964	83	101	,	,	PUNCT
ajlm-1964	83	102	first	first	ADV
ajlm-1964	83	103	described	describe	VERB
ajlm-1964	83	104	in	in	ADP
ajlm-1964	83	105	the	the	DET
ajlm-1964	83	106	united	united	ADJ
ajlm-1964	83	107	kingdom	kingdom	PROPN
ajlm-1964	83	108	;	;	PUNCT
ajlm-1964	83	109	b.1.351	b.1.351	NOUN
ajlm-1964	83	110	(	(	PUNCT
ajlm-1964	83	111	beta	beta	NOUN
ajlm-1964	83	112	)	)	PUNCT
ajlm-1964	83	113	,	,	PUNCT
ajlm-1964	83	114	first	first	ADV
ajlm-1964	83	115	reported	report	VERB
ajlm-1964	83	116	in	in	ADP
ajlm-1964	83	117	south	south	PROPN
ajlm-1964	83	118	africa	africa	PROPN
ajlm-1964	83	119	;	;	PUNCT
ajlm-1964	83	120	p.1	p.1	PROPN
ajlm-1964	83	121	(	(	PUNCT
ajlm-1964	83	122	gamma	gamma	NOUN
ajlm-1964	83	123	)	)	PUNCT
ajlm-1964	83	124	,	,	PUNCT
ajlm-1964	83	125	originated	originate	VERB
ajlm-1964	83	126	from	from	ADP
ajlm-1964	83	127	brazil	brazil	PROPN
ajlm-1964	83	128	;	;	PUNCT
ajlm-1964	83	129	b.1.617.2	b.1.617.2	PROPN
ajlm-1964	83	130	(	(	PUNCT
ajlm-1964	83	131	delta	delta	PROPN
ajlm-1964	83	132	)	)	PUNCT
ajlm-1964	83	133	,	,	PUNCT
ajlm-1964	83	134	first	first	ADV
ajlm-1964	83	135	described	describe	VERB
ajlm-1964	83	136	in	in	ADP
ajlm-1964	83	137	india	india	PROPN
ajlm-1964	83	138	;	;	PUNCT
ajlm-1964	83	139	and	and	CCONJ
ajlm-1964	83	140	b.1.1.529	b.1.1.529	ADV
ajlm-1964	83	141	(	(	PUNCT
ajlm-1964	83	142	omicron	omicron	PROPN
ajlm-1964	83	143	)	)	PUNCT
ajlm-1964	83	144	,	,	PUNCT
ajlm-1964	83	145	first	first	ADV
ajlm-1964	83	146	detected	detect	VERB
ajlm-1964	83	147	in	in	ADP
ajlm-1964	83	148	south	south	PROPN
ajlm-1964	83	149	africa	africa	PROPN
ajlm-1964	83	150	.	.	PUNCT
ajlm-1964	84	1	the	the	DET
ajlm-1964	84	2	alpha	alpha	NOUN
ajlm-1964	84	3	,	,	PUNCT
ajlm-1964	84	4	beta	beta	NOUN
ajlm-1964	84	5	,	,	PUNCT
ajlm-1964	84	6	and	and	CCONJ
ajlm-1964	84	7	gamma	gamma	PROPN
ajlm-1964	84	8	variants	variant	NOUN
ajlm-1964	84	9	share	share	VERB
ajlm-1964	84	10	the	the	DET
ajlm-1964	84	11	n501y	n501y	PROPN
ajlm-1964	84	12	mutation	mutation	NOUN
ajlm-1964	84	13	,	,	PUNCT
ajlm-1964	84	14	which	which	PRON
ajlm-1964	84	15	likely	likely	ADV
ajlm-1964	84	16	makes	make	VERB
ajlm-1964	84	17	them	they	PRON
ajlm-1964	84	18	more	more	ADV
ajlm-1964	84	19	transmissible	transmissible	ADJ
ajlm-1964	84	20	.	.	PUNCT
ajlm-1964	85	1	the	the	DET
ajlm-1964	85	2	e484k	e484k	PROPN
ajlm-1964	85	3	and	and	CCONJ
ajlm-1964	85	4	k417n	k417n	PROPN
ajlm-1964	85	5	mutations	mutation	NOUN
ajlm-1964	85	6	displayed	display	VERB
ajlm-1964	85	7	by	by	ADP
ajlm-1964	85	8	both	both	CCONJ
ajlm-1964	85	9	the	the	DET
ajlm-1964	85	10	beta	beta	NOUN
ajlm-1964	85	11	and	and	CCONJ
ajlm-1964	85	12	gamma	gamma	NOUN
ajlm-1964	85	13	variants	variant	NOUN
ajlm-1964	85	14	decrease	decrease	VERB
ajlm-1964	85	15	the	the	DET
ajlm-1964	85	16	binding	binding	NOUN
ajlm-1964	85	17	of	of	ADP
ajlm-1964	85	18	neutralising	neutralise	VERB
ajlm-1964	85	19	antibodies	antibody	NOUN
ajlm-1964	85	20	,	,	PUNCT
ajlm-1964	85	21	thus	thus	ADV
ajlm-1964	85	22	causing	cause	VERB
ajlm-1964	85	23	partial	partial	ADJ
ajlm-1964	85	24	immune	immune	ADJ
ajlm-1964	85	25	escape	escape	NOUN
ajlm-1964	85	26	,	,	PUNCT
ajlm-1964	85	27	favouring	favour	VERB
ajlm-1964	85	28	reinfections	reinfection	NOUN
ajlm-1964	85	29	,	,	PUNCT
ajlm-1964	85	30	and	and	CCONJ
ajlm-1964	85	31	reducing	reduce	VERB
ajlm-1964	85	32	the	the	DET
ajlm-1964	85	33	in	in	ADV
ajlm-1964	85	34	vitro	vitro	X
ajlm-1964	85	35	efficacy	efficacy	NOUN
ajlm-1964	85	36	of	of	ADP
ajlm-1964	85	37	some	some	DET
ajlm-1964	85	38	antibody	antibody	NOUN
ajlm-1964	85	39	therapies	therapy	NOUN
ajlm-1964	85	40	or	or	CCONJ
ajlm-1964	85	41	vaccines.116,117	vaccines.116,117	VERB
ajlm-1964	85	42	the	the	DET
ajlm-1964	85	43	frequent	frequent	ADJ
ajlm-1964	85	44	emergence	emergence	NOUN
ajlm-1964	85	45	of	of	ADP
ajlm-1964	85	46	these	these	DET
ajlm-1964	85	47	variants	variant	NOUN
ajlm-1964	85	48	globally	globally	ADV
ajlm-1964	85	49	challenges	challenge	VERB
ajlm-1964	85	50	the	the	DET
ajlm-1964	85	51	use	use	NOUN
ajlm-1964	85	52	of	of	ADP
ajlm-1964	85	53	herd	herd	NOUN
ajlm-1964	85	54	immunity	immunity	NOUN
ajlm-1964	85	55	as	as	ADP
ajlm-1964	85	56	an	an	DET
ajlm-1964	85	57	approach	approach	NOUN
ajlm-1964	85	58	to	to	ADP
ajlm-1964	85	59	managing	manage	VERB
ajlm-1964	85	60	the	the	DET
ajlm-1964	85	61	pandemic	pandemic	NOUN
ajlm-1964	85	62	and	and	CCONJ
ajlm-1964	85	63	has	have	AUX
ajlm-1964	85	64	been	be	AUX
ajlm-1964	85	65	responsible	responsible	ADJ
ajlm-1964	85	66	for	for	ADP
ajlm-1964	85	67	new	new	ADJ
ajlm-1964	85	68	waves	wave	NOUN
ajlm-1964	85	69	of	of	ADP
ajlm-1964	85	70	the	the	DET
ajlm-1964	85	71	pandemic	pandemic	ADJ
ajlm-1964	85	72	and	and	CCONJ
ajlm-1964	85	73	thousands	thousand	NOUN
ajlm-1964	85	74	of	of	ADP
ajlm-1964	85	75	deaths	death	NOUN
ajlm-1964	85	76	globally.114	globally.114	VERB
ajlm-1964	85	77	the	the	DET
ajlm-1964	85	78	alpha	alpha	ADJ
ajlm-1964	85	79	variant	variant	NOUN
ajlm-1964	85	80	was	be	AUX
ajlm-1964	85	81	quickly	quickly	ADV
ajlm-1964	85	82	replaced	replace	VERB
ajlm-1964	85	83	by	by	ADP
ajlm-1964	85	84	the	the	DET
ajlm-1964	85	85	highly	highly	ADV
ajlm-1964	85	86	contagious	contagious	ADJ
ajlm-1964	85	87	delta	delta	NOUN
ajlm-1964	85	88	variant	variant	NOUN
ajlm-1964	85	89	,	,	PUNCT
ajlm-1964	85	90	which	which	PRON
ajlm-1964	85	91	was	be	AUX
ajlm-1964	85	92	soon	soon	ADV
ajlm-1964	85	93	outcompeted	outcompete	VERB
ajlm-1964	85	94	by	by	ADP
ajlm-1964	85	95	the	the	DET
ajlm-1964	85	96	omicron	omicron	PROPN
ajlm-1964	85	97	variant	variant	NOUN
ajlm-1964	85	98	to	to	PART
ajlm-1964	85	99	become	become	VERB
ajlm-1964	85	100	the	the	DET
ajlm-1964	85	101	dominant	dominant	ADJ
ajlm-1964	85	102	circulating	circulate	VERB
ajlm-1964	85	103	variant	variant	NOUN
ajlm-1964	85	104	.	.	PUNCT
ajlm-1964	86	1	the	the	DET
ajlm-1964	86	2	omicron	omicron	PROPN
ajlm-1964	86	3	variant	variant	NOUN
ajlm-1964	86	4	is	be	AUX
ajlm-1964	86	5	more	more	ADV
ajlm-1964	86	6	highly	highly	ADV
ajlm-1964	86	7	transmissible	transmissible	ADJ
ajlm-1964	86	8	than	than	ADP
ajlm-1964	86	9	the	the	DET
ajlm-1964	86	10	other	other	ADJ
ajlm-1964	86	11	variants	variant	NOUN
ajlm-1964	86	12	,	,	PUNCT
ajlm-1964	86	13	being	be	AUX
ajlm-1964	86	14	able	able	ADJ
ajlm-1964	86	15	to	to	PART
ajlm-1964	86	16	infect	infect	VERB
ajlm-1964	86	17	3–6	3–6	NUM
ajlm-1964	86	18	times	time	NOUN
ajlm-1964	86	19	more	more	ADJ
ajlm-1964	86	20	people	people	NOUN
ajlm-1964	86	21	than	than	ADP
ajlm-1964	86	22	the	the	DET
ajlm-1964	86	23	delta	delta	NOUN
ajlm-1964	86	24	variant	variant	NOUN
ajlm-1964	86	25	,	,	PUNCT
ajlm-1964	86	26	including	include	VERB
ajlm-1964	86	27	individuals	individual	NOUN
ajlm-1964	86	28	immune	immune	ADJ
ajlm-1964	86	29	to	to	ADP
ajlm-1964	86	30	the	the	DET
ajlm-1964	86	31	other	other	ADJ
ajlm-1964	86	32	variants.117,118	variants.117,118	NOUN
ajlm-1964	86	33	the	the	DET
ajlm-1964	86	34	omicron	omicron	PROPN
ajlm-1964	86	35	variant	variant	NOUN
ajlm-1964	86	36	has	have	AUX
ajlm-1964	86	37	been	be	AUX
ajlm-1964	86	38	detected	detect	VERB
ajlm-1964	86	39	in	in	ADP
ajlm-1964	86	40	77	77	NUM
ajlm-1964	86	41	countries	country	NOUN
ajlm-1964	86	42	as	as	ADP
ajlm-1964	86	43	of	of	ADP
ajlm-1964	86	44	december	december	PROPN
ajlm-1964	86	45	2021.119,120	2021.119,120	PUNCT
ajlm-1964	86	46	although	although	SCONJ
ajlm-1964	86	47	several	several	ADJ
ajlm-1964	86	48	aspects	aspect	NOUN
ajlm-1964	86	49	of	of	ADP
ajlm-1964	86	50	the	the	DET
ajlm-1964	86	51	behaviour	behaviour	NOUN
ajlm-1964	86	52	of	of	ADP
ajlm-1964	86	53	the	the	DET
ajlm-1964	86	54	omicron	omicron	PROPN
ajlm-1964	86	55	variant	variant	NOUN
ajlm-1964	86	56	and	and	CCONJ
ajlm-1964	86	57	how	how	SCONJ
ajlm-1964	86	58	it	it	PRON
ajlm-1964	86	59	will	will	AUX
ajlm-1964	86	60	impact	impact	VERB
ajlm-1964	86	61	the	the	DET
ajlm-1964	86	62	course	course	NOUN
ajlm-1964	86	63	of	of	ADP
ajlm-1964	86	64	the	the	DET
ajlm-1964	86	65	pandemic	pandemic	NOUN
ajlm-1964	86	66	have	have	AUX
ajlm-1964	86	67	not	not	PART
ajlm-1964	86	68	been	be	AUX
ajlm-1964	86	69	well	well	ADV
ajlm-1964	86	70	defined	define	VERB
ajlm-1964	86	71	,	,	PUNCT
ajlm-1964	86	72	current	current	ADJ
ajlm-1964	86	73	data	datum	NOUN
ajlm-1964	86	74	indicate	indicate	VERB
ajlm-1964	86	75	that	that	SCONJ
ajlm-1964	86	76	immunisation	immunisation	NOUN
ajlm-1964	86	77	with	with	ADP
ajlm-1964	86	78	existing	exist	VERB
ajlm-1964	86	79	vaccines	vaccine	NOUN
ajlm-1964	86	80	could	could	AUX
ajlm-1964	86	81	reduce	reduce	VERB
ajlm-1964	86	82	the	the	DET
ajlm-1964	86	83	risk	risk	NOUN
ajlm-1964	86	84	of	of	ADP
ajlm-1964	86	85	serious	serious	ADJ
ajlm-1964	86	86	illness	illness	NOUN
ajlm-1964	86	87	,	,	PUNCT
ajlm-1964	86	88	hospitalisation	hospitalisation	NOUN
ajlm-1964	86	89	,	,	PUNCT
ajlm-1964	86	90	and	and	CCONJ
ajlm-1964	86	91	death.119,121	death.119,121	VERB
ajlm-1964	86	92	however	however	ADV
ajlm-1964	86	93	,	,	PUNCT
ajlm-1964	86	94	in	in	ADP
ajlm-1964	86	95	vitro	vitro	X
ajlm-1964	86	96	studies	study	NOUN
ajlm-1964	86	97	indicate	indicate	VERB
ajlm-1964	86	98	that	that	SCONJ
ajlm-1964	86	99	the	the	DET
ajlm-1964	86	100	neutralisation	neutralisation	NOUN
ajlm-1964	86	101	efficacy	efficacy	NOUN
ajlm-1964	86	102	of	of	ADP
ajlm-1964	86	103	vaccine	vaccine	NOUN
ajlm-1964	86	104	sera	sera	NOUN
ajlm-1964	86	105	against	against	ADP
ajlm-1964	86	106	omicron	omicron	PROPN
ajlm-1964	86	107	reduces	reduce	VERB
ajlm-1964	86	108	greatly	greatly	ADV
ajlm-1964	86	109	compared	compare	VERB
ajlm-1964	86	110	to	to	ADP
ajlm-1964	86	111	the	the	DET
ajlm-1964	86	112	previously	previously	ADV
ajlm-1964	86	113	circulating	circulate	VERB
ajlm-1964	86	114	delta	delta	NOUN
ajlm-1964	86	115	variant.122	variant.122	NOUN
ajlm-1964	86	116	if	if	SCONJ
ajlm-1964	86	117	more	more	ADJ
ajlm-1964	86	118	data	datum	NOUN
ajlm-1964	86	119	confirm	confirm	VERB
ajlm-1964	86	120	that	that	SCONJ
ajlm-1964	86	121	the	the	DET
ajlm-1964	86	122	omicron	omicron	PROPN
ajlm-1964	86	123	variant	variant	NOUN
ajlm-1964	86	124	indeed	indeed	ADV
ajlm-1964	86	125	produces	produce	VERB
ajlm-1964	86	126	milder	mild	ADJ
ajlm-1964	86	127	forms	form	NOUN
ajlm-1964	86	128	of	of	ADP
ajlm-1964	86	129	the	the	DET
ajlm-1964	86	130	disease	disease	NOUN
ajlm-1964	86	131	,	,	PUNCT
ajlm-1964	86	132	it	it	PRON
ajlm-1964	86	133	may	may	AUX
ajlm-1964	86	134	suggest	suggest	VERB
ajlm-1964	86	135	a	a	DET
ajlm-1964	86	136	trend	trend	NOUN
ajlm-1964	86	137	that	that	SCONJ
ajlm-1964	86	138	the	the	DET
ajlm-1964	86	139	pandemic	pandemic	NOUN
ajlm-1964	86	140	is	be	AUX
ajlm-1964	86	141	on	on	ADP
ajlm-1964	86	142	its	its	PRON
ajlm-1964	86	143	way	way	NOUN
ajlm-1964	86	144	out	out	ADV
ajlm-1964	86	145	but	but	CCONJ
ajlm-1964	86	146	the	the	DET
ajlm-1964	86	147	world	world	NOUN
ajlm-1964	86	148	may	may	AUX
ajlm-1964	86	149	have	have	VERB
ajlm-1964	86	150	to	to	PART
ajlm-1964	86	151	come	come	VERB
ajlm-1964	86	152	to	to	ADP
ajlm-1964	86	153	terms	term	NOUN
ajlm-1964	86	154	with	with	ADP
ajlm-1964	86	155	living	live	VERB
ajlm-1964	86	156	with	with	ADP
ajlm-1964	86	157	the	the	DET
ajlm-1964	86	158	virus	virus	NOUN
ajlm-1964	86	159	.	.	PUNCT
ajlm-1964	87	1	it	it	PRON
ajlm-1964	87	2	may	may	AUX
ajlm-1964	87	3	require	require	VERB
ajlm-1964	87	4	occasional	occasional	ADJ
ajlm-1964	87	5	vaccination	vaccination	NOUN
ajlm-1964	87	6	like	like	ADP
ajlm-1964	87	7	in	in	ADP
ajlm-1964	87	8	the	the	DET
ajlm-1964	87	9	case	case	NOUN
ajlm-1964	87	10	of	of	ADP
ajlm-1964	87	11	the	the	DET
ajlm-1964	87	12	flu	flu	PROPN
ajlm-1964	87	13	virus	virus	NOUN
ajlm-1964	87	14	to	to	PART
ajlm-1964	87	15	prevent	prevent	VERB
ajlm-1964	87	16	infection	infection	NOUN
ajlm-1964	87	17	.	.	PUNCT
ajlm-1964	88	1	the	the	DET
ajlm-1964	88	2	background	background	NOUN
ajlm-1964	88	3	of	of	ADP
ajlm-1964	88	4	previous	previous	ADJ
ajlm-1964	88	5	exposure	exposure	NOUN
ajlm-1964	88	6	to	to	ADP
ajlm-1964	88	7	multiple	multiple	ADJ
ajlm-1964	88	8	pathogens	pathogen	NOUN
ajlm-1964	88	9	in	in	ADP
ajlm-1964	88	10	the	the	DET
ajlm-1964	88	11	african	african	ADJ
ajlm-1964	88	12	population	population	NOUN
ajlm-1964	88	13	may	may	AUX
ajlm-1964	88	14	provide	provide	VERB
ajlm-1964	88	15	a	a	DET
ajlm-1964	88	16	further	further	ADJ
ajlm-1964	88	17	advantage	advantage	NOUN
ajlm-1964	88	18	in	in	ADP
ajlm-1964	88	19	conferring	confer	VERB
ajlm-1964	88	20	protection	protection	NOUN
ajlm-1964	88	21	against	against	ADP
ajlm-1964	88	22	the	the	DET
ajlm-1964	88	23	severe	severe	ADJ
ajlm-1964	88	24	form	form	NOUN
ajlm-1964	88	25	of	of	ADP
ajlm-1964	88	26	the	the	DET
ajlm-1964	88	27	disease	disease	NOUN
ajlm-1964	88	28	.	.	PUNCT
ajlm-1964	89	1	in	in	ADP
ajlm-1964	89	2	africa	africa	PROPN
ajlm-1964	89	3	,	,	PUNCT
ajlm-1964	89	4	the	the	DET
ajlm-1964	89	5	prospect	prospect	NOUN
ajlm-1964	89	6	that	that	SCONJ
ajlm-1964	89	7	new	new	ADJ
ajlm-1964	89	8	diseases	disease	NOUN
ajlm-1964	89	9	may	may	AUX
ajlm-1964	89	10	emerge	emerge	VERB
ajlm-1964	89	11	is	be	AUX
ajlm-1964	89	12	high	high	ADJ
ajlm-1964	89	13	due	due	ADP
ajlm-1964	89	14	to	to	ADP
ajlm-1964	89	15	the	the	DET
ajlm-1964	89	16	existing	exist	VERB
ajlm-1964	89	17	burden	burden	NOUN
ajlm-1964	89	18	of	of	ADP
ajlm-1964	89	19	infectious	infectious	ADJ
ajlm-1964	89	20	diseases	disease	NOUN
ajlm-1964	89	21	and	and	CCONJ
ajlm-1964	89	22	conducive	conducive	ADJ
ajlm-1964	89	23	environmental	environmental	ADJ
ajlm-1964	89	24	conditions	condition	NOUN
ajlm-1964	89	25	such	such	ADJ
ajlm-1964	89	26	as	as	ADP
ajlm-1964	89	27	high	high	ADJ
ajlm-1964	89	28	population	population	NOUN
ajlm-1964	89	29	growth	growth	NOUN
ajlm-1964	89	30	,	,	PUNCT
ajlm-1964	89	31	rapid	rapid	ADJ
ajlm-1964	89	32	economic	economic	ADJ
ajlm-1964	89	33	development	development	NOUN
ajlm-1964	89	34	,	,	PUNCT
ajlm-1964	89	35	increased	increase	VERB
ajlm-1964	89	36	exploitation	exploitation	NOUN
ajlm-1964	89	37	of	of	ADP
ajlm-1964	89	38	previously	previously	ADV
ajlm-1964	89	39	untapped	untapped	ADJ
ajlm-1964	89	40	natural	natural	ADJ
ajlm-1964	89	41	resources	resource	NOUN
ajlm-1964	89	42	,	,	PUNCT
ajlm-1964	89	43	and	and	CCONJ
ajlm-1964	89	44	increasing	increase	VERB
ajlm-1964	89	45	interactions	interaction	NOUN
ajlm-1964	89	46	between	between	ADP
ajlm-1964	89	47	humans	human	NOUN
ajlm-1964	89	48	and	and	CCONJ
ajlm-1964	89	49	wildlife	wildlife	NOUN
ajlm-1964	89	50	.	.	PUNCT
ajlm-1964	90	1	a	a	DET
ajlm-1964	90	2	prompt	prompt	ADJ
ajlm-1964	90	3	and	and	CCONJ
ajlm-1964	90	4	coordinated	coordinated	ADJ
ajlm-1964	90	5	global	global	ADJ
ajlm-1964	90	6	health	health	NOUN
ajlm-1964	90	7	response	response	NOUN
ajlm-1964	90	8	would	would	AUX
ajlm-1964	90	9	be	be	AUX
ajlm-1964	90	10	required	require	VERB
ajlm-1964	90	11	to	to	PART
ajlm-1964	90	12	quickly	quickly	ADV
ajlm-1964	90	13	control	control	VERB
ajlm-1964	90	14	outbreaks	outbreak	NOUN
ajlm-1964	90	15	either	either	CCONJ
ajlm-1964	90	16	at	at	ADP
ajlm-1964	90	17	the	the	DET
ajlm-1964	90	18	local	local	ADJ
ajlm-1964	90	19	or	or	CCONJ
ajlm-1964	90	20	regional	regional	ADJ
ajlm-1964	90	21	level	level	NOUN
ajlm-1964	90	22	as	as	SCONJ
ajlm-1964	90	23	exemplified	exemplify	VERB
ajlm-1964	90	24	by	by	ADP
ajlm-1964	90	25	the	the	DET
ajlm-1964	90	26	global	global	ADJ
ajlm-1964	90	27	response	response	NOUN
ajlm-1964	90	28	to	to	ADP
ajlm-1964	90	29	the	the	DET
ajlm-1964	90	30	2014	2014	NUM
ajlm-1964	90	31	ebola	ebola	PROPN
ajlm-1964	90	32	epidemic.61,122	epidemic.61,122	NOUN
ajlm-1964	90	33	while	while	SCONJ
ajlm-1964	90	34	the	the	DET
ajlm-1964	90	35	emergence	emergence	NOUN
ajlm-1964	90	36	of	of	ADP
ajlm-1964	90	37	new	new	ADJ
ajlm-1964	90	38	diseases	disease	NOUN
ajlm-1964	90	39	may	may	AUX
ajlm-1964	90	40	not	not	PART
ajlm-1964	90	41	have	have	VERB
ajlm-1964	90	42	a	a	DET
ajlm-1964	90	43	major	major	ADJ
ajlm-1964	90	44	repercussion	repercussion	NOUN
ajlm-1964	90	45	on	on	ADP
ajlm-1964	90	46	african	african	ADJ
ajlm-1964	90	47	population	population	NOUN
ajlm-1964	90	48	dynamics	dynamic	NOUN
ajlm-1964	90	49	,	,	PUNCT
ajlm-1964	90	50	it	it	PRON
ajlm-1964	90	51	may	may	AUX
ajlm-1964	90	52	have	have	VERB
ajlm-1964	90	53	serious	serious	ADJ
ajlm-1964	90	54	economic	economic	ADJ
ajlm-1964	90	55	and	and	CCONJ
ajlm-1964	90	56	social	social	ADJ
ajlm-1964	90	57	consequences	consequence	NOUN
ajlm-1964	90	58	.	.	PUNCT
ajlm-1964	91	1	when	when	SCONJ
ajlm-1964	91	2	these	these	DET
ajlm-1964	91	3	diseases	disease	NOUN
ajlm-1964	91	4	emerge	emerge	VERB
ajlm-1964	91	5	,	,	PUNCT
ajlm-1964	91	6	we	we	PRON
ajlm-1964	91	7	can	can	AUX
ajlm-1964	91	8	draw	draw	VERB
ajlm-1964	91	9	on	on	ADP
ajlm-1964	91	10	scientific	scientific	ADJ
ajlm-1964	91	11	advances	advance	NOUN
ajlm-1964	91	12	and	and	CCONJ
ajlm-1964	91	13	previous	previous	ADJ
ajlm-1964	91	14	experience	experience	NOUN
ajlm-1964	91	15	,	,	PUNCT
ajlm-1964	91	16	especially	especially	ADV
ajlm-1964	91	17	with	with	ADP
ajlm-1964	91	18	hiv	hiv	PROPN
ajlm-1964	91	19	/	/	SYM
ajlm-1964	91	20	aids	aids	PROPN
ajlm-1964	91	21	and	and	CCONJ
ajlm-1964	91	22	ebola	ebola	PROPN
ajlm-1964	91	23	,	,	PUNCT
ajlm-1964	91	24	to	to	PART
ajlm-1964	91	25	quickly	quickly	ADV
ajlm-1964	91	26	contain	contain	VERB
ajlm-1964	91	27	them	they	PRON
ajlm-1964	91	28	.	.	PUNCT
ajlm-1964	92	1	africa	africa	PROPN
ajlm-1964	92	2	might	might	AUX
ajlm-1964	92	3	be	be	AUX
ajlm-1964	92	4	able	able	ADJ
ajlm-1964	92	5	to	to	PART
ajlm-1964	92	6	withstand	withstand	VERB
ajlm-1964	92	7	some	some	PRON
ajlm-1964	92	8	of	of	ADP
ajlm-1964	92	9	these	these	DET
ajlm-1964	92	10	emerging	emerge	VERB
ajlm-1964	92	11	diseases	disease	NOUN
ajlm-1964	92	12	owing	owe	VERB
ajlm-1964	92	13	to	to	ADP
ajlm-1964	92	14	enhanced	enhance	VERB
ajlm-1964	92	15	immunity	immunity	NOUN
ajlm-1964	92	16	due	due	ADP
ajlm-1964	92	17	to	to	ADP
ajlm-1964	92	18	prior	prior	ADJ
ajlm-1964	92	19	exposure	exposure	NOUN
ajlm-1964	92	20	to	to	ADP
ajlm-1964	92	21	numerous	numerous	ADJ
ajlm-1964	92	22	pathogens	pathogen	NOUN
ajlm-1964	92	23	and	and	CCONJ
ajlm-1964	92	24	extensive	extensive	ADJ
ajlm-1964	92	25	vaccination	vaccination	NOUN
ajlm-1964	92	26	programmes	programme	NOUN
ajlm-1964	92	27	within	within	ADP
ajlm-1964	92	28	the	the	DET
ajlm-1964	92	29	continent	continent	NOUN
ajlm-1964	92	30	.	.	PUNCT
ajlm-1964	93	1	conclusion	conclusion	NOUN
ajlm-1964	93	2	this	this	DET
ajlm-1964	93	3	review	review	NOUN
ajlm-1964	93	4	has	have	AUX
ajlm-1964	93	5	shown	show	VERB
ajlm-1964	93	6	that	that	SCONJ
ajlm-1964	93	7	pre	pre	ADJ
ajlm-1964	93	8	-	-	ADJ
ajlm-1964	93	9	existing	exist	VERB
ajlm-1964	93	10	immunity	immunity	NOUN
ajlm-1964	93	11	against	against	ADP
ajlm-1964	93	12	sars	sar	NOUN
ajlm-1964	93	13	-	-	PUNCT
ajlm-1964	93	14	cov-2	cov-2	PART
ajlm-1964	93	15	is	be	AUX
ajlm-1964	93	16	widespread	widespread	ADJ
ajlm-1964	93	17	in	in	ADP
ajlm-1964	93	18	africa	africa	PROPN
ajlm-1964	93	19	and	and	CCONJ
ajlm-1964	93	20	higher	high	ADJ
ajlm-1964	93	21	than	than	ADP
ajlm-1964	93	22	in	in	ADP
ajlm-1964	93	23	western	western	ADJ
ajlm-1964	93	24	countries	country	NOUN
ajlm-1964	93	25	.	.	PUNCT
ajlm-1964	94	1	this	this	DET
ajlm-1964	94	2	immunity	immunity	NOUN
ajlm-1964	94	3	may	may	AUX
ajlm-1964	94	4	be	be	AUX
ajlm-1964	94	5	related	relate	VERB
ajlm-1964	94	6	to	to	ADP
ajlm-1964	94	7	previous	previous	ADJ
ajlm-1964	94	8	exposure	exposure	NOUN
ajlm-1964	94	9	to	to	ADP
ajlm-1964	94	10	endemic	endemic	ADJ
ajlm-1964	94	11	coronaviruses	coronaviruse	NOUN
ajlm-1964	94	12	or	or	CCONJ
ajlm-1964	94	13	other	other	ADJ
ajlm-1964	94	14	multiple	multiple	ADJ
ajlm-1964	94	15	pathogens	pathogen	NOUN
ajlm-1964	94	16	and	and	CCONJ
ajlm-1964	94	17	could	could	AUX
ajlm-1964	94	18	have	have	AUX
ajlm-1964	94	19	been	be	AUX
ajlm-1964	94	20	responsible	responsible	ADJ
ajlm-1964	94	21	for	for	ADP
ajlm-1964	94	22	the	the	DET
ajlm-1964	94	23	reduced	reduce	VERB
ajlm-1964	94	24	disease	disease	NOUN
ajlm-1964	94	25	transmission	transmission	NOUN
ajlm-1964	94	26	and	and	CCONJ
ajlm-1964	94	27	the	the	DET
ajlm-1964	94	28	limited	limited	ADJ
ajlm-1964	94	29	number	number	NOUN
ajlm-1964	94	30	of	of	ADP
ajlm-1964	94	31	cases	case	NOUN
ajlm-1964	94	32	and	and	CCONJ
ajlm-1964	94	33	mortality	mortality	NOUN
ajlm-1964	94	34	recorded	record	VERB
ajlm-1964	94	35	in	in	ADP
ajlm-1964	94	36	african	african	ADJ
ajlm-1964	94	37	countries	country	NOUN
ajlm-1964	94	38	.	.	PUNCT
ajlm-1964	95	1	the	the	DET
ajlm-1964	95	2	relatively	relatively	ADV
ajlm-1964	95	3	low	low	ADJ
ajlm-1964	95	4	number	number	NOUN
ajlm-1964	95	5	of	of	ADP
ajlm-1964	95	6	cases	case	NOUN
ajlm-1964	95	7	and	and	CCONJ
ajlm-1964	95	8	deaths	death	NOUN
ajlm-1964	95	9	in	in	ADP
ajlm-1964	95	10	africa	africa	PROPN
ajlm-1964	95	11	could	could	AUX
ajlm-1964	95	12	be	be	AUX
ajlm-1964	95	13	attributed	attribute	VERB
ajlm-1964	95	14	to	to	ADP
ajlm-1964	95	15	the	the	DET
ajlm-1964	95	16	activation	activation	NOUN
ajlm-1964	95	17	of	of	ADP
ajlm-1964	95	18	innate	innate	ADJ
ajlm-1964	95	19	immune	immune	NOUN
ajlm-1964	95	20	-	-	PUNCT
ajlm-1964	95	21	mediated	mediate	VERB
ajlm-1964	95	22	trained	train	VERB
ajlm-1964	95	23	immunity	immunity	NOUN
ajlm-1964	95	24	or	or	CCONJ
ajlm-1964	95	25	immune	immune	ADJ
ajlm-1964	95	26	tolerance	tolerance	NOUN
ajlm-1964	95	27	due	due	ADP
ajlm-1964	95	28	to	to	ADP
ajlm-1964	95	29	frequent	frequent	ADJ
ajlm-1964	95	30	exposure	exposure	NOUN
ajlm-1964	95	31	to	to	ADP
ajlm-1964	95	32	multiple	multiple	ADJ
ajlm-1964	95	33	pathogens	pathogen	NOUN
ajlm-1964	95	34	and	and	CCONJ
ajlm-1964	95	35	the	the	DET
ajlm-1964	95	36	impact	impact	NOUN
ajlm-1964	95	37	of	of	ADP
ajlm-1964	95	38	long	long	ADV
ajlm-1964	95	39	-	-	PUNCT
ajlm-1964	95	40	standing	stand	VERB
ajlm-1964	95	41	universal	universal	ADJ
ajlm-1964	95	42	bcg	bcg	PROPN
ajlm-1964	95	43	vaccination	vaccination	NOUN
ajlm-1964	95	44	policies	policy	NOUN
ajlm-1964	95	45	in	in	ADP
ajlm-1964	95	46	many	many	ADJ
ajlm-1964	95	47	african	african	ADJ
ajlm-1964	95	48	countries	country	NOUN
ajlm-1964	95	49	rather	rather	ADV
ajlm-1964	95	50	than	than	ADP
ajlm-1964	95	51	under	under	ADP
ajlm-1964	95	52	-	-	PUNCT
ajlm-1964	95	53	reporting	reporting	NOUN
ajlm-1964	95	54	or	or	CCONJ
ajlm-1964	95	55	diagnostic	diagnostic	ADJ
ajlm-1964	95	56	limitations	limitation	NOUN
ajlm-1964	95	57	.	.	PUNCT
ajlm-1964	96	1	acknowledgements	acknowledgement	NOUN
ajlm-1964	96	2	competing	compete	VERB
ajlm-1964	96	3	interests	interest	NOUN
ajlm-1964	96	4	the	the	DET
ajlm-1964	96	5	authors	author	NOUN
ajlm-1964	96	6	declare	declare	VERB
ajlm-1964	96	7	that	that	SCONJ
ajlm-1964	96	8	they	they	PRON
ajlm-1964	96	9	have	have	VERB
ajlm-1964	96	10	no	no	DET
ajlm-1964	96	11	financial	financial	ADJ
ajlm-1964	96	12	or	or	CCONJ
ajlm-1964	96	13	personal	personal	ADJ
ajlm-1964	96	14	relationships	relationship	NOUN
ajlm-1964	96	15	that	that	PRON
ajlm-1964	96	16	may	may	AUX
ajlm-1964	96	17	have	have	AUX
ajlm-1964	96	18	inappropriately	inappropriately	ADV
ajlm-1964	96	19	influenced	influence	VERB
ajlm-1964	96	20	them	they	PRON
ajlm-1964	96	21	in	in	ADP
ajlm-1964	96	22	writing	write	VERB
ajlm-1964	96	23	this	this	DET
ajlm-1964	96	24	article	article	NOUN
ajlm-1964	96	25	.	.	PUNCT
ajlm-1964	97	1	authors	author	NOUN
ajlm-1964	97	2	’	’	PART
ajlm-1964	97	3	contributions	contribution	NOUN
ajlm-1964	97	4	a.o.i	a.o.i	PROPN
ajlm-1964	97	5	.	.	PUNCT
ajlm-1964	97	6	did	do	VERB
ajlm-1964	97	7	extensive	extensive	ADJ
ajlm-1964	97	8	literature	literature	NOUN
ajlm-1964	97	9	work	work	NOUN
ajlm-1964	97	10	and	and	CCONJ
ajlm-1964	97	11	research	research	NOUN
ajlm-1964	97	12	to	to	PART
ajlm-1964	97	13	concretise	concretise	VERB
ajlm-1964	97	14	the	the	DET
ajlm-1964	97	15	review	review	NOUN
ajlm-1964	97	16	idea	idea	NOUN
ajlm-1964	97	17	and	and	CCONJ
ajlm-1964	97	18	drafted	draft	VERB
ajlm-1964	97	19	the	the	DET
ajlm-1964	97	20	manuscript	manuscript	NOUN
ajlm-1964	97	21	.	.	PUNCT
ajlm-1964	98	1	y.o.o	y.o.o	PROPN
ajlm-1964	98	2	.	.	PROPN
ajlm-1964	98	3	contributed	contribute	VERB
ajlm-1964	98	4	substantially	substantially	ADV
ajlm-1964	98	5	to	to	PART
ajlm-1964	98	6	revising	revise	VERB
ajlm-1964	98	7	the	the	DET
ajlm-1964	98	8	draft	draft	NOUN
ajlm-1964	98	9	.	.	PUNCT
ajlm-1964	99	1	j.u.i	j.u.i	PROPN
ajlm-1964	99	2	.	.	PROPN
ajlm-1964	99	3	contributed	contribute	VERB
ajlm-1964	99	4	to	to	ADP
ajlm-1964	99	5	revising	revise	VERB
ajlm-1964	99	6	the	the	DET
ajlm-1964	99	7	article	article	NOUN
ajlm-1964	99	8	.	.	PUNCT
ajlm-1964	100	1	a.a.a	a.a.a	PROPN
ajlm-1964	100	2	.	.	PROPN
ajlm-1964	100	3	conceived	conceive	VERB
ajlm-1964	100	4	the	the	DET
ajlm-1964	100	5	idea	idea	NOUN
ajlm-1964	100	6	,	,	PUNCT
ajlm-1964	100	7	designed	design	VERB
ajlm-1964	100	8	and	and	CCONJ
ajlm-1964	100	9	revised	revise	VERB
ajlm-1964	100	10	the	the	DET
ajlm-1964	100	11	draft	draft	NOUN
ajlm-1964	100	12	manuscript	manuscript	NOUN
ajlm-1964	100	13	.	.	PUNCT
ajlm-1964	101	1	ethical	ethical	ADJ
ajlm-1964	101	2	considerations	consideration	NOUN
ajlm-1964	101	3	this	this	DET
ajlm-1964	101	4	article	article	NOUN
ajlm-1964	101	5	followed	follow	VERB
ajlm-1964	101	6	all	all	DET
ajlm-1964	101	7	ethical	ethical	ADJ
ajlm-1964	101	8	standards	standard	NOUN
ajlm-1964	101	9	for	for	ADP
ajlm-1964	101	10	research	research	NOUN
ajlm-1964	101	11	without	without	ADP
ajlm-1964	101	12	direct	direct	ADJ
ajlm-1964	101	13	contact	contact	NOUN
ajlm-1964	101	14	with	with	ADP
ajlm-1964	101	15	human	human	ADJ
ajlm-1964	101	16	or	or	CCONJ
ajlm-1964	101	17	animal	animal	NOUN
ajlm-1964	101	18	subjects	subject	NOUN
ajlm-1964	101	19	.	.	PUNCT
ajlm-1964	102	1	sources	source	NOUN
ajlm-1964	102	2	of	of	ADP
ajlm-1964	102	3	support	support	NOUN
ajlm-1964	102	4	this	this	DET
ajlm-1964	102	5	research	research	NOUN
ajlm-1964	102	6	received	receive	VERB
ajlm-1964	102	7	no	no	DET
ajlm-1964	102	8	specific	specific	ADJ
ajlm-1964	102	9	grant	grant	NOUN
ajlm-1964	102	10	from	from	ADP
ajlm-1964	102	11	any	any	DET
ajlm-1964	102	12	funding	funding	NOUN
ajlm-1964	102	13	agency	agency	NOUN
ajlm-1964	102	14	in	in	ADP
ajlm-1964	102	15	the	the	DET
ajlm-1964	102	16	public	public	ADJ
ajlm-1964	102	17	,	,	PUNCT
ajlm-1964	102	18	commercial	commercial	ADJ
ajlm-1964	102	19	,	,	PUNCT
ajlm-1964	102	20	or	or	CCONJ
ajlm-1964	102	21	not	not	PART
ajlm-1964	102	22	-	-	PUNCT
ajlm-1964	102	23	for	for	ADP
ajlm-1964	102	24	-	-	PUNCT
ajlm-1964	102	25	profit	profit	NOUN
ajlm-1964	102	26	sectors	sector	NOUN
ajlm-1964	102	27	.	.	PUNCT
ajlm-1964	103	1	data	datum	NOUN
ajlm-1964	103	2	availability	availability	NOUN
ajlm-1964	103	3	data	datum	NOUN
ajlm-1964	103	4	sharing	sharing	NOUN
ajlm-1964	103	5	is	be	AUX
ajlm-1964	103	6	not	not	PART
ajlm-1964	103	7	applicable	applicable	ADJ
ajlm-1964	103	8	to	to	ADP
ajlm-1964	103	9	this	this	DET
ajlm-1964	103	10	article	article	NOUN
ajlm-1964	103	11	as	as	SCONJ
ajlm-1964	103	12	no	no	DET
ajlm-1964	103	13	new	new	ADJ
ajlm-1964	103	14	data	datum	NOUN
ajlm-1964	103	15	were	be	AUX
ajlm-1964	103	16	created	create	VERB
ajlm-1964	103	17	or	or	CCONJ
ajlm-1964	103	18	analysed	analyse	VERB
ajlm-1964	103	19	in	in	ADP
ajlm-1964	103	20	this	this	DET
ajlm-1964	103	21	study	study	NOUN
ajlm-1964	103	22	.	.	PUNCT
ajlm-1964	104	1	disclaimer	disclaimer	VERB
ajlm-1964	104	2	the	the	DET
ajlm-1964	104	3	views	view	NOUN
ajlm-1964	104	4	and	and	CCONJ
ajlm-1964	104	5	opinions	opinion	NOUN
ajlm-1964	104	6	expressed	express	VERB
ajlm-1964	104	7	in	in	ADP
ajlm-1964	104	8	this	this	DET
ajlm-1964	104	9	article	article	NOUN
ajlm-1964	104	10	are	be	AUX
ajlm-1964	104	11	those	those	PRON
ajlm-1964	104	12	of	of	ADP
ajlm-1964	104	13	the	the	DET
ajlm-1964	104	14	authors	author	NOUN
ajlm-1964	104	15	and	and	CCONJ
ajlm-1964	104	16	do	do	AUX
ajlm-1964	104	17	not	not	PART
ajlm-1964	104	18	necessarily	necessarily	ADV
ajlm-1964	104	19	reflect	reflect	VERB
ajlm-1964	104	20	the	the	DET
ajlm-1964	104	21	official	official	ADJ
ajlm-1964	104	22	policy	policy	NOUN
ajlm-1964	104	23	position	position	NOUN
ajlm-1964	104	24	of	of	ADP
ajlm-1964	104	25	any	any	DET
ajlm-1964	104	26	affiliated	affiliated	ADJ
ajlm-1964	104	27	agency	agency	NOUN
ajlm-1964	104	28	of	of	ADP
ajlm-1964	104	29	the	the	DET
ajlm-1964	104	30	authors	author	NOUN
ajlm-1964	104	31	.	.	PUNCT
ajlm-1964	105	1	references	reference	NOUN
ajlm-1964	105	2	world	world	PROPN
ajlm-1964	105	3	health	health	NOUN
ajlm-1964	105	4	organization	organization	NOUN
ajlm-1964	105	5	(	(	PUNCT
ajlm-1964	105	6	who	who	PRON
ajlm-1964	105	7	)	)	PUNCT
ajlm-1964	105	8	.	.	PUNCT
ajlm-1964	106	1	novel	novel	ADJ
ajlm-1964	106	2	coronavirus	coronavirus	NOUN
ajlm-1964	106	3	–	–	PUNCT
ajlm-1964	106	4	china	china	PROPN
ajlm-1964	107	1	[	[	X
ajlm-1964	107	2	homepage	homepage	NOUN
ajlm-1964	107	3	on	on	ADP
ajlm-1964	107	4	the	the	DET
ajlm-1964	107	5	internet	internet	NOUN
ajlm-1964	107	6	]	]	PUNCT
ajlm-1964	107	7	.	.	PUNCT
ajlm-1964	107	8	2020	2020	NUM
ajlm-1964	108	1	[	[	X
ajlm-1964	108	2	cited	cite	VERB
ajlm-1964	108	3	2021	2021	NUM
ajlm-1964	108	4	sept	sept	PROPN
ajlm-1964	108	5	21	21	NUM
ajlm-1964	108	6	]	]	PUNCT
ajlm-1964	108	7	.	.	PUNCT
ajlm-1964	109	1	available	available	ADJ
ajlm-1964	109	2	from	from	ADP
ajlm-1964	109	3	:	:	PUNCT
ajlm-1964	109	4	https://www.who.int/emergencies/disease-outbreak-news/item/2020-don233	https://www.who.int/emergencies/disease-outbreak-news/item/2020-don233	PROPN
ajlm-1964	109	5	gorbalenya	gorbalenya	PROPN
ajlm-1964	109	6	ae	ae	PROPN
ajlm-1964	109	7	,	,	PUNCT
ajlm-1964	109	8	baker	baker	PROPN
ajlm-1964	109	9	sc	sc	PROPN
ajlm-1964	109	10	,	,	PUNCT
ajlm-1964	109	11	baric	baric	ADJ
ajlm-1964	109	12	rs	rs	NOUN
ajlm-1964	109	13	,	,	PUNCT
ajlm-1964	109	14	et	et	PROPN
ajlm-1964	109	15	al	al	PROPN
ajlm-1964	109	16	.	.	PUNCT
ajlm-1964	110	1	the	the	DET
ajlm-1964	110	2	species	specie	NOUN
ajlm-1964	110	3	severe	severe	ADJ
ajlm-1964	110	4	acute	acute	ADJ
ajlm-1964	110	5	respiratory	respiratory	ADJ
ajlm-1964	110	6	syndrome	syndrome	NOUN
ajlm-1964	110	7	-	-	PUNCT
ajlm-1964	110	8	related	relate	VERB
ajlm-1964	110	9	coronavirus	coronavirus	NOUN
ajlm-1964	110	10	:	:	PUNCT
ajlm-1964	110	11	classifying	classify	VERB
ajlm-1964	110	12	2019	2019	NUM
ajlm-1964	110	13	-	-	PUNCT
ajlm-1964	110	14	ncov	ncov	ADV
ajlm-1964	110	15	and	and	CCONJ
ajlm-1964	110	16	naming	name	VERB
ajlm-1964	110	17	it	it	PRON
ajlm-1964	110	18	sars	sar	NOUN
ajlm-1964	110	19	-	-	PUNCT
ajlm-1964	110	20	cov-2	cov-2	NOUN
ajlm-1964	110	21	.	.	PUNCT
ajlm-1964	111	1	nat	nat	PROPN
ajlm-1964	111	2	microbiol	microbiol	PROPN
ajlm-1964	111	3	.	.	PUNCT
ajlm-1964	112	1	2020;5(4):536–544	2020;5(4):536–544	NUM
ajlm-1964	112	2	.	.	PUNCT
ajlm-1964	113	1	https://doi.org/10.1038/s41564-020-0695-z	https://doi.org/10.1038/s41564-020-0695-z	PROPN
ajlm-1964	113	2	world	world	PROPN
ajlm-1964	113	3	health	health	PROPN
ajlm-1964	113	4	organization	organization	NOUN
ajlm-1964	113	5	(	(	PUNCT
ajlm-1964	113	6	who	who	PRON
ajlm-1964	113	7	)	)	PUNCT
ajlm-1964	113	8	.	.	PUNCT
ajlm-1964	114	1	who	who	PRON
ajlm-1964	114	2	coronavirus	coronavirus	PROPN
ajlm-1964	114	3	(	(	PUNCT
ajlm-1964	114	4	covid-19	covid-19	PROPN
ajlm-1964	114	5	)	)	PUNCT
ajlm-1964	114	6	dashboard	dashboard	NOUN
ajlm-1964	115	1	[	[	X
ajlm-1964	115	2	homepage	homepage	NOUN
ajlm-1964	115	3	on	on	ADP
ajlm-1964	115	4	the	the	DET
ajlm-1964	115	5	internet	internet	NOUN
ajlm-1964	115	6	]	]	PUNCT
ajlm-1964	115	7	.	.	PUNCT
ajlm-1964	116	1	2020	2020	NUM
ajlm-1964	117	1	[	[	X
ajlm-1964	117	2	cited	cite	VERB
ajlm-1964	117	3	2021	2021	NUM
ajlm-1964	117	4	sept	sept	PROPN
ajlm-1964	117	5	21	21	NUM
ajlm-1964	117	6	]	]	PUNCT
ajlm-1964	117	7	.	.	PUNCT
ajlm-1964	118	1	available	available	ADJ
ajlm-1964	118	2	from	from	ADP
ajlm-1964	118	3	:	:	PUNCT
ajlm-1964	118	4	https://covid19.who.int	https://covid19.who.int	PROPN
ajlm-1964	118	5	chen	chen	PROPN
ajlm-1964	118	6	n	n	CCONJ
ajlm-1964	118	7	,	,	PUNCT
ajlm-1964	118	8	zhou	zhou	PROPN
ajlm-1964	118	9	m	m	PROPN
ajlm-1964	118	10	,	,	PUNCT
ajlm-1964	118	11	dong	dong	PROPN
ajlm-1964	118	12	x	x	PROPN
ajlm-1964	118	13	,	,	PUNCT
ajlm-1964	118	14	et	et	PROPN
ajlm-1964	118	15	al	al	PROPN
ajlm-1964	118	16	.	.	PROPN
ajlm-1964	118	17	epidemiological	epidemiological	ADJ
ajlm-1964	118	18	and	and	CCONJ
ajlm-1964	118	19	clinical	clinical	ADJ
ajlm-1964	118	20	characteristics	characteristic	NOUN
ajlm-1964	118	21	of	of	ADP
ajlm-1964	118	22	99	99	NUM
ajlm-1964	118	23	cases	case	NOUN
ajlm-1964	118	24	of	of	ADP
ajlm-1964	118	25	2019	2019	NUM
ajlm-1964	118	26	novel	novel	ADJ
ajlm-1964	118	27	coronavirus	coronavirus	NOUN
ajlm-1964	118	28	pneumonia	pneumonia	NOUN
ajlm-1964	118	29	in	in	ADP
ajlm-1964	118	30	wuhan	wuhan	PROPN
ajlm-1964	118	31	,	,	PUNCT
ajlm-1964	118	32	china	china	PROPN
ajlm-1964	118	33	:	:	PUNCT
ajlm-1964	118	34	a	a	DET
ajlm-1964	118	35	descriptive	descriptive	ADJ
ajlm-1964	118	36	study	study	NOUN
ajlm-1964	118	37	.	.	PUNCT
ajlm-1964	119	1	lancet	lancet	NOUN
ajlm-1964	119	2	.	.	PUNCT
ajlm-1964	120	1	2020;395(10223):507–513	2020;395(10223):507–513	NUM
ajlm-1964	120	2	.	.	PUNCT
ajlm-1964	121	1	https://doi.org/10.1016/s0140-6736(20)30211-7	https://doi.org/10.1016/s0140-6736(20)30211-7	VERB
ajlm-1964	121	2	huang	huang	PROPN
ajlm-1964	121	3	c	c	PROPN
ajlm-1964	121	4	,	,	PUNCT
ajlm-1964	121	5	wang	wang	PROPN
ajlm-1964	121	6	y	y	PROPN
ajlm-1964	121	7	,	,	PUNCT
ajlm-1964	121	8	li	li	PROPN
ajlm-1964	121	9	x	x	PROPN
ajlm-1964	121	10	,	,	PUNCT
ajlm-1964	121	11	et	et	PROPN
ajlm-1964	121	12	al	al	PROPN
ajlm-1964	121	13	.	.	PUNCT
ajlm-1964	122	1	clinical	clinical	ADJ
ajlm-1964	122	2	features	feature	NOUN
ajlm-1964	122	3	of	of	ADP
ajlm-1964	122	4	patients	patient	NOUN
ajlm-1964	122	5	infected	infect	VERB
ajlm-1964	122	6	with	with	ADP
ajlm-1964	122	7	2019	2019	NUM
ajlm-1964	122	8	novel	novel	ADJ
ajlm-1964	122	9	coronavirus	coronavirus	NOUN
ajlm-1964	122	10	in	in	ADP
ajlm-1964	122	11	wuhan	wuhan	PROPN
ajlm-1964	122	12	,	,	PUNCT
ajlm-1964	122	13	china	china	PROPN
ajlm-1964	122	14	.	.	PUNCT
ajlm-1964	123	1	lancet	lancet	PROPN
ajlm-1964	123	2	.	.	PUNCT
ajlm-1964	124	1	2020;395(10223):497–506	2020;395(10223):497–506	NOUN
ajlm-1964	124	2	.	.	PUNCT
ajlm-1964	125	1	https://doi.org/10.1016/s0140-6736(20)30183-5	https://doi.org/10.1016/s0140-6736(20)30183-5	PROPN
ajlm-1964	125	2	hu	hu	PROPN
ajlm-1964	126	1	b	b	PROPN
ajlm-1964	126	2	,	,	PUNCT
ajlm-1964	126	3	guo	guo	PROPN
ajlm-1964	126	4	h	h	NOUN
ajlm-1964	126	5	,	,	PUNCT
ajlm-1964	127	1	zhou	zhou	PROPN
ajlm-1964	127	2	p	p	PROPN
ajlm-1964	127	3	,	,	PUNCT
ajlm-1964	127	4	shi	shi	PROPN
ajlm-1964	127	5	z	z	PROPN
ajlm-1964	127	6	-	-	PUNCT
ajlm-1964	127	7	l.	l.	PROPN
ajlm-1964	127	8	characteristics	characteristics	PROPN
ajlm-1964	127	9	of	of	ADP
ajlm-1964	127	10	sars	sar	NOUN
ajlm-1964	127	11	-	-	PUNCT
ajlm-1964	127	12	cov-2	cov-2	NOUN
ajlm-1964	127	13	and	and	CCONJ
ajlm-1964	127	14	covid-19	covid-19	PROPN
ajlm-1964	127	15	.	.	PUNCT
ajlm-1964	128	1	nat	nat	PROPN
ajlm-1964	128	2	rev	rev	VERB
ajlm-1964	128	3	microbiol	microbiol	PROPN
ajlm-1964	128	4	.	.	PUNCT
ajlm-1964	129	1	2020;19:141–154	2020;19:141–154	NOUN
ajlm-1964	129	2	.	.	PUNCT
ajlm-1964	130	1	https://doi.org/10.1038/s41579-020-00459-7	https://doi.org/10.1038/s41579-020-00459-7	PROPN
ajlm-1964	130	2	chan	chan	PROPN
ajlm-1964	130	3	jf	jf	PROPN
ajlm-1964	130	4	-	-	PUNCT
ajlm-1964	130	5	w	w	PROPN
ajlm-1964	130	6	,	,	PUNCT
ajlm-1964	130	7	yuan	yuan	PROPN
ajlm-1964	130	8	s	s	PROPN
ajlm-1964	130	9	,	,	PUNCT
ajlm-1964	130	10	kok	kok	PROPN
ajlm-1964	130	11	k	k	PROPN
ajlm-1964	130	12	-	-	PROPN
ajlm-1964	130	13	h	h	PROPN
ajlm-1964	130	14	,	,	PUNCT
ajlm-1964	130	15	et	et	PROPN
ajlm-1964	130	16	al	al	PROPN
ajlm-1964	130	17	.	.	PUNCT
ajlm-1964	131	1	a	a	DET
ajlm-1964	131	2	familial	familial	ADJ
ajlm-1964	131	3	cluster	cluster	NOUN
ajlm-1964	131	4	of	of	ADP
ajlm-1964	131	5	pneumonia	pneumonia	NOUN
ajlm-1964	131	6	associated	associate	VERB
ajlm-1964	131	7	with	with	ADP
ajlm-1964	131	8	the	the	DET
ajlm-1964	131	9	2019	2019	NUM
ajlm-1964	131	10	novel	novel	ADJ
ajlm-1964	131	11	coronavirus	coronavirus	NOUN
ajlm-1964	131	12	indicating	indicate	VERB
ajlm-1964	131	13	person	person	NOUN
ajlm-1964	131	14	-	-	PUNCT
ajlm-1964	131	15	to	to	ADP
ajlm-1964	131	16	-	-	PUNCT
ajlm-1964	131	17	person	person	NOUN
ajlm-1964	131	18	transmission	transmission	NOUN
ajlm-1964	131	19	:	:	PUNCT
ajlm-1964	131	20	a	a	DET
ajlm-1964	131	21	study	study	NOUN
ajlm-1964	131	22	of	of	ADP
ajlm-1964	131	23	a	a	DET
ajlm-1964	131	24	family	family	NOUN
ajlm-1964	131	25	cluster	cluster	NOUN
ajlm-1964	131	26	.	.	PUNCT
ajlm-1964	132	1	lancet	lancet	NOUN
ajlm-1964	132	2	.	.	PUNCT
ajlm-1964	133	1	2020;395(10223):514–523	2020;395(10223):514–523	NUM
ajlm-1964	133	2	.	.	PUNCT
ajlm-1964	134	1	https://doi.org/10.1016/s0140-6736(20)30154-9	https://doi.org/10.1016/s0140-6736(20)30154-9	ADJ
ajlm-1964	134	2	nishiura	nishiura	PROPN
ajlm-1964	134	3	h	h	PROPN
ajlm-1964	134	4	,	,	PUNCT
ajlm-1964	134	5	kobayashi	kobayashi	PROPN
ajlm-1964	134	6	t	t	PROPN
ajlm-1964	134	7	,	,	PUNCT
ajlm-1964	134	8	miyama	miyama	PROPN
ajlm-1964	134	9	t	t	PROPN
ajlm-1964	134	10	,	,	PUNCT
ajlm-1964	135	1	et	et	PROPN
ajlm-1964	135	2	al	al	PROPN
ajlm-1964	135	3	.	.	PUNCT
ajlm-1964	135	4	estimation	estimation	NOUN
ajlm-1964	135	5	of	of	ADP
ajlm-1964	135	6	the	the	DET
ajlm-1964	135	7	asymptomatic	asymptomatic	ADJ
ajlm-1964	135	8	ratio	ratio	NOUN
ajlm-1964	135	9	of	of	ADP
ajlm-1964	135	10	novel	novel	ADJ
ajlm-1964	135	11	coronavirus	coronavirus	NOUN
ajlm-1964	135	12	infections	infection	NOUN
ajlm-1964	135	13	(	(	PUNCT
ajlm-1964	135	14	covid-19	covid-19	PROPN
ajlm-1964	135	15	)	)	PUNCT
ajlm-1964	135	16	.	.	PUNCT
ajlm-1964	136	1	int	int	PROPN
ajlm-1964	136	2	j	j	PROPN
ajlm-1964	136	3	infect	infect	VERB
ajlm-1964	136	4	dis	dis	PROPN
ajlm-1964	136	5	.	.	PUNCT
ajlm-1964	136	6	2020;94:154–155	2020;94:154–155	NOUN
ajlm-1964	136	7	.	.	PUNCT
ajlm-1964	137	1	https://doi.org/10.1016/j.ijid.2020.03.020	https://doi.org/10.1016/j.ijid.2020.03.020	NOUN
ajlm-1964	137	2	mizumoto	mizumoto	NOUN
ajlm-1964	137	3	k	k	PROPN
ajlm-1964	137	4	,	,	PUNCT
ajlm-1964	137	5	kagaya	kagaya	PROPN
ajlm-1964	137	6	k	k	NOUN
ajlm-1964	137	7	,	,	PUNCT
ajlm-1964	137	8	zarebski	zarebski	PROPN
ajlm-1964	137	9	a	a	X
ajlm-1964	137	10	,	,	PUNCT
ajlm-1964	137	11	chowell	chowell	PROPN
ajlm-1964	137	12	g.	g.	PROPN
ajlm-1964	137	13	estimating	estimate	VERB
ajlm-1964	137	14	the	the	DET
ajlm-1964	137	15	asymptomatic	asymptomatic	ADJ
ajlm-1964	137	16	proportion	proportion	NOUN
ajlm-1964	137	17	of	of	ADP
ajlm-1964	137	18	coronavirus	coronavirus	NOUN
ajlm-1964	137	19	disease	disease	NOUN
ajlm-1964	137	20	2019	2019	NUM
ajlm-1964	137	21	(	(	PUNCT
ajlm-1964	137	22	covid-19	covid-19	PROPN
ajlm-1964	137	23	)	)	PUNCT
ajlm-1964	137	24	cases	case	NOUN
ajlm-1964	137	25	on	on	ADP
ajlm-1964	137	26	board	board	NOUN
ajlm-1964	137	27	the	the	DET
ajlm-1964	137	28	diamond	diamond	PROPN
ajlm-1964	137	29	princess	princess	PROPN
ajlm-1964	137	30	cruise	cruise	NOUN
ajlm-1964	137	31	ship	ship	NOUN
ajlm-1964	137	32	,	,	PUNCT
ajlm-1964	137	33	yokohama	yokohama	PROPN
ajlm-1964	137	34	,	,	PUNCT
ajlm-1964	137	35	japan	japan	PROPN
ajlm-1964	137	36	,	,	PUNCT
ajlm-1964	137	37	2020	2020	NUM
ajlm-1964	137	38	.	.	PUNCT
ajlm-1964	138	1	euro	euro	PROPN
ajlm-1964	138	2	surveill	surveill	PROPN
ajlm-1964	138	3	bull	bull	PROPN
ajlm-1964	138	4	eur	eur	PROPN
ajlm-1964	138	5	sur	sur	PROPN
ajlm-1964	138	6	mal	mal	ADJ
ajlm-1964	138	7	transm	transm	PROPN
ajlm-1964	138	8	eur	eur	PROPN
ajlm-1964	138	9	commun	commun	PROPN
ajlm-1964	138	10	dis	dis	PROPN
ajlm-1964	138	11	bull	bull	PROPN
ajlm-1964	138	12	.	.	PUNCT
ajlm-1964	139	1	2020;25(10):2000180	2020;25(10):2000180	X
ajlm-1964	139	2	.	.	PUNCT
ajlm-1964	140	1	https://doi.org/10.2807/1560-7917.es.2020.25.10.2000180	https://doi.org/10.2807/1560-7917.es.2020.25.10.2000180	PROPN
ajlm-1964	140	2	wang	wang	PROPN
ajlm-1964	140	3	f	f	PROPN
ajlm-1964	140	4	,	,	PUNCT
ajlm-1964	140	5	nie	nie	PROPN
ajlm-1964	140	6	j	j	PROPN
ajlm-1964	140	7	,	,	PUNCT
ajlm-1964	140	8	wang	wang	PROPN
ajlm-1964	140	9	h	h	PROPN
ajlm-1964	140	10	,	,	PUNCT
ajlm-1964	140	11	et	et	PROPN
ajlm-1964	140	12	al	al	PROPN
ajlm-1964	140	13	.	.	PROPN
ajlm-1964	141	1	characteristics	characteristic	NOUN
ajlm-1964	141	2	of	of	ADP
ajlm-1964	141	3	peripheral	peripheral	ADJ
ajlm-1964	141	4	lymphocyte	lymphocyte	NOUN
ajlm-1964	141	5	subset	subset	NOUN
ajlm-1964	141	6	alteration	alteration	NOUN
ajlm-1964	141	7	in	in	ADP
ajlm-1964	141	8	covid-19	covid-19	PROPN
ajlm-1964	141	9	pneumonia	pneumonia	NOUN
ajlm-1964	141	10	.	.	PUNCT
ajlm-1964	142	1	j	j	PROPN
ajlm-1964	142	2	infect	infect	VERB
ajlm-1964	142	3	dis	dis	PROPN
ajlm-1964	142	4	.	.	PUNCT
ajlm-1964	143	1	2020;221(11):1762–1769	2020;221(11):1762–1769	NUM
ajlm-1964	143	2	.	.	PUNCT
ajlm-1964	144	1	https://doi.org/10.1093/infdis/jiaa150	https://doi.org/10.1093/infdis/jiaa150	PROPN
ajlm-1964	144	2	bai	bai	PROPN
ajlm-1964	144	3	y	y	PROPN
ajlm-1964	144	4	,	,	PUNCT
ajlm-1964	144	5	yao	yao	PROPN
ajlm-1964	144	6	l	l	PROPN
ajlm-1964	144	7	,	,	PUNCT
ajlm-1964	144	8	wei	wei	PROPN
ajlm-1964	144	9	t	t	PROPN
ajlm-1964	144	10	,	,	PUNCT
ajlm-1964	144	11	et	et	PROPN
ajlm-1964	144	12	al	al	PROPN
ajlm-1964	144	13	.	.	PROPN
ajlm-1964	144	14	presumed	presume	VERB
ajlm-1964	144	15	asymptomatic	asymptomatic	ADJ
ajlm-1964	144	16	carrier	carrier	NOUN
ajlm-1964	144	17	transmission	transmission	NOUN
ajlm-1964	144	18	of	of	ADP
ajlm-1964	144	19	covid-19	covid-19	PROPN
ajlm-1964	144	20	.	.	PUNCT
ajlm-1964	144	21	jama	jama	PROPN
ajlm-1964	144	22	.	.	PUNCT
ajlm-1964	145	1	2020;323(14):1406–1407	2020;323(14):1406–1407	NUM
ajlm-1964	145	2	.	.	PUNCT
ajlm-1964	146	1	https://doi.org/10.1001/jama.2020.2565	https://doi.org/10.1001/jama.2020.2565	PROPN
ajlm-1964	146	2	weiss	weiss	PROPN
ajlm-1964	146	3	sr	sr	PROPN
ajlm-1964	146	4	,	,	PUNCT
ajlm-1964	146	5	leibowitz	leibowitz	PROPN
ajlm-1964	146	6	jl	jl	PROPN
ajlm-1964	146	7	.	.	PUNCT
ajlm-1964	146	8	coronavirus	coronavirus	PROPN
ajlm-1964	146	9	pathogenesis	pathogenesis	PROPN
ajlm-1964	146	10	.	.	PUNCT
ajlm-1964	147	1	adv	adv	PROPN
ajlm-1964	147	2	virus	virus	NOUN
ajlm-1964	147	3	res	re	NOUN
ajlm-1964	147	4	.	.	PUNCT
ajlm-1964	147	5	2011	2011	NUM
ajlm-1964	147	6	;	;	PUNCT
ajlm-1964	147	7	81:85–164	81:85–164	NUM
ajlm-1964	147	8	.	.	PUNCT
ajlm-1964	148	1	https://doi.org/10.1016/b978-0-12-385885-6.00009-2	https://doi.org/10.1016/b978-0-12-385885-6.00009-2	NOUN
ajlm-1964	148	2	knipe	knipe	NOUN
ajlm-1964	148	3	dm	dm	PROPN
ajlm-1964	148	4	,	,	PUNCT
ajlm-1964	148	5	howley	howley	PROPN
ajlm-1964	148	6	pm	pm	PROPN
ajlm-1964	148	7	.	.	PUNCT
ajlm-1964	149	1	fields	field	NOUN
ajlm-1964	149	2	virology	virology	NOUN
ajlm-1964	149	3	:	:	PUNCT
ajlm-1964	149	4	editors	editor	NOUN
ajlm-1964	149	5	-	-	PUNCT
ajlm-1964	149	6	in	in	ADP
ajlm-1964	149	7	-	-	PUNCT
ajlm-1964	149	8	chief	chief	NOUN
ajlm-1964	149	9	,	,	PUNCT
ajlm-1964	149	10	david	david	PROPN
ajlm-1964	149	11	m.	m.	PROPN
ajlm-1964	149	12	knipe	knipe	PROPN
ajlm-1964	149	13	,	,	PUNCT
ajlm-1964	149	14	peter	peter	PROPN
ajlm-1964	149	15	m.	m.	PROPN
ajlm-1964	149	16	howley	howley	PROPN
ajlm-1964	149	17	.	.	PUNCT
ajlm-1964	150	1	philadelphia	philadelphia	PROPN
ajlm-1964	150	2	,	,	PUNCT
ajlm-1964	150	3	pa	pa	PROPN
ajlm-1964	150	4	:	:	PUNCT
ajlm-1964	150	5	wolters	wolters	PROPN
ajlm-1964	150	6	kluwer	kluwer	PROPN
ajlm-1964	150	7	/	/	SYM
ajlm-1964	150	8	lippincott	lippincott	PROPN
ajlm-1964	150	9	williams	williams	PROPN
ajlm-1964	150	10	&	&	CCONJ
ajlm-1964	150	11	wilkins	wilkins	PROPN
ajlm-1964	150	12	health	health	PROPN
ajlm-1964	150	13	;	;	PUNCT
ajlm-1964	150	14	2013	2013	NUM
ajlm-1964	150	15	.	.	PUNCT
ajlm-1964	151	1	su	su	PROPN
ajlm-1964	151	2	s	s	PROPN
ajlm-1964	151	3	,	,	PUNCT
ajlm-1964	151	4	wong	wong	PROPN
ajlm-1964	151	5	g	g	PROPN
ajlm-1964	151	6	,	,	PUNCT
ajlm-1964	151	7	shi	shi	PROPN
ajlm-1964	151	8	w	w	PROPN
ajlm-1964	151	9	,	,	PUNCT
ajlm-1964	151	10	et	et	PROPN
ajlm-1964	151	11	al	al	PROPN
ajlm-1964	151	12	.	.	PUNCT
ajlm-1964	152	1	epidemiology	epidemiology	NOUN
ajlm-1964	152	2	,	,	PUNCT
ajlm-1964	152	3	genetic	genetic	ADJ
ajlm-1964	152	4	recombination	recombination	NOUN
ajlm-1964	152	5	,	,	PUNCT
ajlm-1964	152	6	and	and	CCONJ
ajlm-1964	152	7	pathogenesis	pathogenesis	NOUN
ajlm-1964	152	8	of	of	ADP
ajlm-1964	152	9	coronaviruses	coronaviruse	NOUN
ajlm-1964	152	10	.	.	PUNCT
ajlm-1964	153	1	trends	trend	NOUN
ajlm-1964	153	2	microbiol	microbiol	PROPN
ajlm-1964	153	3	.	.	PUNCT
ajlm-1964	154	1	2016;24(6):490–502	2016;24(6):490–502	NUM
ajlm-1964	154	2	.	.	PUNCT
ajlm-1964	155	1	https://doi.org/10.1016/j.tim.2016.03.003	https://doi.org/10.1016/j.tim.2016.03.003	PROPN
ajlm-1964	155	2	zhong	zhong	PROPN
ajlm-1964	155	3	ns	ns	PROPN
ajlm-1964	155	4	,	,	PUNCT
ajlm-1964	155	5	zheng	zheng	PROPN
ajlm-1964	155	6	bj	bj	PROPN
ajlm-1964	155	7	,	,	PUNCT
ajlm-1964	155	8	li	li	PROPN
ajlm-1964	155	9	ym	ym	PROPN
ajlm-1964	155	10	,	,	PUNCT
ajlm-1964	155	11	et	et	PROPN
ajlm-1964	155	12	al	al	PROPN
ajlm-1964	155	13	.	.	PUNCT
ajlm-1964	155	14	epidemiology	epidemiology	NOUN
ajlm-1964	155	15	and	and	CCONJ
ajlm-1964	155	16	cause	cause	NOUN
ajlm-1964	155	17	of	of	ADP
ajlm-1964	155	18	severe	severe	ADJ
ajlm-1964	155	19	acute	acute	ADJ
ajlm-1964	155	20	respiratory	respiratory	ADJ
ajlm-1964	155	21	syndrome	syndrome	NOUN
ajlm-1964	155	22	(	(	PUNCT
ajlm-1964	155	23	sars	sars	PROPN
ajlm-1964	155	24	)	)	PUNCT
ajlm-1964	155	25	in	in	ADP
ajlm-1964	155	26	guangdong	guangdong	PROPN
ajlm-1964	155	27	,	,	PUNCT
ajlm-1964	155	28	people	people	NOUN
ajlm-1964	155	29	’s	’s	PART
ajlm-1964	155	30	republic	republic	NOUN
ajlm-1964	155	31	of	of	ADP
ajlm-1964	155	32	china	china	PROPN
ajlm-1964	155	33	,	,	PUNCT
ajlm-1964	155	34	in	in	ADP
ajlm-1964	155	35	february	february	PROPN
ajlm-1964	155	36	,	,	PUNCT
ajlm-1964	155	37	2003	2003	NUM
ajlm-1964	155	38	.	.	PUNCT
ajlm-1964	156	1	lancet	lancet	NOUN
ajlm-1964	156	2	.	.	PUNCT
ajlm-1964	157	1	2003;362(9393):1353–1358	2003;362(9393):1353–1358	X
ajlm-1964	157	2	.	.	PUNCT
ajlm-1964	158	1	https://doi.org/10.1016/s0140-6736(03)14630-2	https://doi.org/10.1016/s0140-6736(03)14630-2	PROPN
ajlm-1964	158	2	ksiazek	ksiazek	PROPN
ajlm-1964	158	3	tg	tg	PROPN
ajlm-1964	158	4	,	,	PUNCT
ajlm-1964	158	5	erdman	erdman	PROPN
ajlm-1964	158	6	d	d	PROPN
ajlm-1964	158	7	,	,	PUNCT
ajlm-1964	158	8	goldsmith	goldsmith	PROPN
ajlm-1964	158	9	cs	cs	PROPN
ajlm-1964	158	10	,	,	PUNCT
ajlm-1964	158	11	et	et	PROPN
ajlm-1964	158	12	al	al	PROPN
ajlm-1964	158	13	.	.	PUNCT
ajlm-1964	159	1	a	a	DET
ajlm-1964	159	2	novel	novel	ADJ
ajlm-1964	159	3	coronavirus	coronavirus	NOUN
ajlm-1964	159	4	associated	associate	VERB
ajlm-1964	159	5	with	with	ADP
ajlm-1964	159	6	severe	severe	ADJ
ajlm-1964	159	7	acute	acute	ADJ
ajlm-1964	159	8	respiratory	respiratory	ADJ
ajlm-1964	159	9	syndrome	syndrome	NOUN
ajlm-1964	159	10	.	.	PUNCT
ajlm-1964	160	1	n	n	PROPN
ajlm-1964	160	2	engl	engl	PROPN
ajlm-1964	160	3	j	j	PROPN
ajlm-1964	160	4	med	med	PROPN
ajlm-1964	160	5	.	.	PUNCT
ajlm-1964	160	6	2003;348(20):1953–1366	2003;348(20):1953–1366	NUM
ajlm-1964	160	7	.	.	PUNCT
ajlm-1964	161	1	https://doi.org/10.1056/nejmoa030781	https://doi.org/10.1056/nejmoa030781	PROPN
ajlm-1964	161	2	drosten	drosten	PROPN
ajlm-1964	161	3	c	c	PROPN
ajlm-1964	161	4	,	,	PUNCT
ajlm-1964	161	5	günther	günther	NOUN
ajlm-1964	161	6	s	s	PROPN
ajlm-1964	161	7	,	,	PUNCT
ajlm-1964	161	8	preiser	preiser	PROPN
ajlm-1964	161	9	w	w	PROPN
ajlm-1964	161	10	,	,	PUNCT
ajlm-1964	161	11	et	et	PROPN
ajlm-1964	161	12	al	al	PROPN
ajlm-1964	161	13	.	.	PUNCT
ajlm-1964	161	14	identification	identification	NOUN
ajlm-1964	161	15	of	of	ADP
ajlm-1964	161	16	a	a	DET
ajlm-1964	161	17	novel	novel	ADJ
ajlm-1964	161	18	coronavirus	coronavirus	NOUN
ajlm-1964	161	19	in	in	ADP
ajlm-1964	161	20	patients	patient	NOUN
ajlm-1964	161	21	with	with	ADP
ajlm-1964	161	22	severe	severe	ADJ
ajlm-1964	161	23	acute	acute	ADJ
ajlm-1964	161	24	respiratory	respiratory	ADJ
ajlm-1964	161	25	syndrome	syndrome	NOUN
ajlm-1964	161	26	.	.	PUNCT
ajlm-1964	162	1	n	n	PROPN
ajlm-1964	162	2	engl	engl	PROPN
ajlm-1964	162	3	j	j	PROPN
ajlm-1964	162	4	med	med	PROPN
ajlm-1964	162	5	.	.	PUNCT
ajlm-1964	163	1	2003;348(20):1967–1976	2003;348(20):1967–1976	NUM
ajlm-1964	163	2	.	.	PUNCT
ajlm-1964	164	1	https://doi.org/10.1056/nejmoa030747	https://doi.org/10.1056/nejmoa030747	PROPN
ajlm-1964	164	2	zaki	zaki	PROPN
ajlm-1964	164	3	am	be	AUX
ajlm-1964	164	4	,	,	PUNCT
ajlm-1964	164	5	van	van	PROPN
ajlm-1964	164	6	boheemen	boheeman	NOUN
ajlm-1964	164	7	s	s	PROPN
ajlm-1964	164	8	,	,	PUNCT
ajlm-1964	164	9	bestebroer	bestebroer	PROPN
ajlm-1964	164	10	tm	tm	PROPN
ajlm-1964	164	11	,	,	PUNCT
ajlm-1964	164	12	osterhaus	osterhaus	PROPN
ajlm-1964	164	13	adme	adme	NOUN
ajlm-1964	164	14	,	,	PUNCT
ajlm-1964	164	15	fouchier	fouchier	ADJ
ajlm-1964	164	16	ram	ram	NOUN
ajlm-1964	164	17	.	.	PUNCT
ajlm-1964	165	1	isolation	isolation	NOUN
ajlm-1964	165	2	of	of	ADP
ajlm-1964	165	3	a	a	DET
ajlm-1964	165	4	novel	novel	ADJ
ajlm-1964	165	5	coronavirus	coronavirus	NOUN
ajlm-1964	165	6	from	from	ADP
ajlm-1964	165	7	a	a	DET
ajlm-1964	165	8	man	man	NOUN
ajlm-1964	165	9	with	with	ADP
ajlm-1964	165	10	pneumonia	pneumonia	NOUN
ajlm-1964	165	11	in	in	ADP
ajlm-1964	165	12	saudi	saudi	PROPN
ajlm-1964	165	13	arabia	arabia	PROPN
ajlm-1964	165	14	.	.	PUNCT
ajlm-1964	166	1	n	n	PROPN
ajlm-1964	166	2	engl	engl	PROPN
ajlm-1964	166	3	j	j	PROPN
ajlm-1964	166	4	med	med	PROPN
ajlm-1964	166	5	.	.	PUNCT
ajlm-1964	166	6	2012;367(19):1814–1820	2012;367(19):1814–1820	NUM
ajlm-1964	166	7	.	.	PUNCT
ajlm-1964	167	1	https://doi.org/10.1056/nejmoa1211721	https://doi.org/10.1056/nejmoa1211721	PROPN
ajlm-1964	167	2	cui	cui	PROPN
ajlm-1964	167	3	j	j	PROPN
ajlm-1964	167	4	,	,	PUNCT
ajlm-1964	167	5	li	li	PROPN
ajlm-1964	167	6	f	f	PROPN
ajlm-1964	167	7	,	,	PUNCT
ajlm-1964	167	8	shi	shi	PROPN
ajlm-1964	167	9	z	z	PROPN
ajlm-1964	167	10	-	-	PUNCT
ajlm-1964	167	11	l.	l.	PROPN
ajlm-1964	167	12	origin	origin	NOUN
ajlm-1964	167	13	and	and	CCONJ
ajlm-1964	167	14	evolution	evolution	NOUN
ajlm-1964	167	15	of	of	ADP
ajlm-1964	167	16	pathogenic	pathogenic	ADJ
ajlm-1964	167	17	coronaviruses	coronaviruse	NOUN
ajlm-1964	167	18	.	.	PUNCT
ajlm-1964	168	1	nat	nat	PROPN
ajlm-1964	168	2	rev	rev	VERB
ajlm-1964	168	3	microbiol	microbiol	PROPN
ajlm-1964	168	4	.	.	PUNCT
ajlm-1964	169	1	2019;17(3):181–192	2019;17(3):181–192	X
ajlm-1964	169	2	.	.	PUNCT
ajlm-1964	170	1	https://doi.org/10.1038/s41579-018-0118-9	https://doi.org/10.1038/s41579-018-0118-9	PROPN
ajlm-1964	170	2	wong	wong	PROPN
ajlm-1964	170	3	g	g	PROPN
ajlm-1964	170	4	,	,	PUNCT
ajlm-1964	170	5	liu	liu	PROPN
ajlm-1964	170	6	w	w	PROPN
ajlm-1964	170	7	,	,	PUNCT
ajlm-1964	170	8	liu	liu	PROPN
ajlm-1964	170	9	y	y	PROPN
ajlm-1964	170	10	,	,	PUNCT
ajlm-1964	170	11	zhou	zhou	PROPN
ajlm-1964	170	12	b	b	PROPN
ajlm-1964	170	13	,	,	PUNCT
ajlm-1964	170	14	bi	bi	PROPN
ajlm-1964	170	15	y	y	PROPN
ajlm-1964	170	16	,	,	PUNCT
ajlm-1964	170	17	gao	gao	PROPN
ajlm-1964	170	18	gf	gf	PROPN
ajlm-1964	170	19	.	.	PUNCT
ajlm-1964	170	20	mers	mers	PROPN
ajlm-1964	170	21	,	,	PUNCT
ajlm-1964	170	22	sars	sar	NOUN
ajlm-1964	170	23	,	,	PUNCT
ajlm-1964	170	24	and	and	CCONJ
ajlm-1964	170	25	ebola	ebola	NOUN
ajlm-1964	170	26	:	:	PUNCT
ajlm-1964	170	27	the	the	DET
ajlm-1964	170	28	role	role	NOUN
ajlm-1964	170	29	of	of	ADP
ajlm-1964	170	30	super	super	NOUN
ajlm-1964	170	31	-	-	NOUN
ajlm-1964	170	32	spreaders	spreader	NOUN
ajlm-1964	170	33	in	in	ADP
ajlm-1964	170	34	infectious	infectious	ADJ
ajlm-1964	170	35	disease	disease	NOUN
ajlm-1964	170	36	.	.	PUNCT
ajlm-1964	171	1	cell	cell	NOUN
ajlm-1964	171	2	host	host	NOUN
ajlm-1964	171	3	microbe	microbe	NOUN
ajlm-1964	171	4	.	.	PUNCT
ajlm-1964	172	1	2015;18(4):398–401	2015;18(4):398–401	X
ajlm-1964	172	2	.	.	PROPN
ajlm-1964	172	3	https://doi.org/10.1016/j.chom.2015.09.013	https://doi.org/10.1016/j.chom.2015.09.013	PROPN
ajlm-1964	172	4	dan	dan	PROPN
ajlm-1964	172	5	jm	jm	PROPN
ajlm-1964	172	6	,	,	PUNCT
ajlm-1964	172	7	mateus	mateus	PROPN
ajlm-1964	172	8	j	j	PROPN
ajlm-1964	172	9	,	,	PUNCT
ajlm-1964	172	10	kato	kato	PROPN
ajlm-1964	172	11	y	y	PROPN
ajlm-1964	172	12	,	,	PUNCT
ajlm-1964	172	13	et	et	PROPN
ajlm-1964	172	14	al	al	PROPN
ajlm-1964	172	15	.	.	PUNCT
ajlm-1964	173	1	immunological	immunological	ADJ
ajlm-1964	173	2	memory	memory	NOUN
ajlm-1964	173	3	to	to	ADP
ajlm-1964	173	4	sars	sar	NOUN
ajlm-1964	173	5	-	-	PUNCT
ajlm-1964	173	6	cov-2	cov-2	NOUN
ajlm-1964	173	7	assessed	assess	VERB
ajlm-1964	173	8	for	for	ADP
ajlm-1964	173	9	up	up	ADP
ajlm-1964	173	10	to	to	PART
ajlm-1964	173	11	8	8	NUM
ajlm-1964	173	12	months	month	NOUN
ajlm-1964	173	13	after	after	ADP
ajlm-1964	173	14	infection	infection	NOUN
ajlm-1964	173	15	.	.	PUNCT
ajlm-1964	174	1	science	science	NOUN
ajlm-1964	174	2	.	.	PUNCT
ajlm-1964	175	1	2021;371(6529	2021;371(6529	ADV
ajlm-1964	175	2	):	):	PUNCT
ajlm-1964	175	3	eabf4063	eabf4063	PROPN
ajlm-1964	175	4	.	.	PUNCT
ajlm-1964	176	1	https://doi.org/10.1126/science.abf4063	https://doi.org/10.1126/science.abf4063	PROPN
ajlm-1964	176	2	grifoni	grifoni	VERB
ajlm-1964	176	3	a	a	PRON
ajlm-1964	176	4	,	,	PUNCT
ajlm-1964	176	5	weiskopf	weiskopf	ADJ
ajlm-1964	176	6	d	d	NOUN
ajlm-1964	176	7	,	,	PUNCT
ajlm-1964	176	8	ramirez	ramirez	PROPN
ajlm-1964	176	9	si	si	PROPN
ajlm-1964	176	10	,	,	PUNCT
ajlm-1964	176	11	et	et	PROPN
ajlm-1964	176	12	al	al	PROPN
ajlm-1964	176	13	.	.	PROPN
ajlm-1964	176	14	targets	target	NOUN
ajlm-1964	176	15	of	of	ADP
ajlm-1964	176	16	t	t	NOUN
ajlm-1964	176	17	cell	cell	NOUN
ajlm-1964	176	18	responses	response	NOUN
ajlm-1964	176	19	to	to	ADP
ajlm-1964	176	20	sars	sar	NOUN
ajlm-1964	176	21	-	-	PUNCT
ajlm-1964	176	22	cov-2	cov-2	NOUN
ajlm-1964	176	23	coronavirus	coronavirus	NOUN
ajlm-1964	176	24	in	in	ADP
ajlm-1964	176	25	humans	human	NOUN
ajlm-1964	176	26	with	with	ADP
ajlm-1964	176	27	covid-19	covid-19	PROPN
ajlm-1964	176	28	disease	disease	NOUN
ajlm-1964	176	29	and	and	CCONJ
ajlm-1964	176	30	unexposed	unexposed	ADJ
ajlm-1964	176	31	individuals	individual	NOUN
ajlm-1964	176	32	.	.	PUNCT
ajlm-1964	177	1	cell	cell	NOUN
ajlm-1964	177	2	.	.	PUNCT
ajlm-1964	178	1	2020;181(7):1489–1501.e15	2020;181(7):1489–1501.e15	X
ajlm-1964	178	2	.	.	PUNCT
ajlm-1964	179	1	https://doi.org/10.1016/j.cell.2020.05.015	https://doi.org/10.1016/j.cell.2020.05.015	NOUN
ajlm-1964	179	2	weiskopf	weiskopf	PUNCT
ajlm-1964	180	1	d	d	PROPN
ajlm-1964	180	2	,	,	PUNCT
ajlm-1964	180	3	schmitz	schmitz	PROPN
ajlm-1964	180	4	ks	ks	PROPN
ajlm-1964	180	5	,	,	PUNCT
ajlm-1964	180	6	raadsen	raadsen	PROPN
ajlm-1964	180	7	mp	mp	PROPN
ajlm-1964	180	8	,	,	PUNCT
ajlm-1964	180	9	et	et	PROPN
ajlm-1964	180	10	al	al	PROPN
ajlm-1964	180	11	.	.	PROPN
ajlm-1964	180	12	phenotype	phenotype	NOUN
ajlm-1964	180	13	and	and	CCONJ
ajlm-1964	180	14	kinetics	kinetic	NOUN
ajlm-1964	180	15	of	of	ADP
ajlm-1964	180	16	sars	sar	NOUN
ajlm-1964	180	17	-	-	PUNCT
ajlm-1964	180	18	cov-2	cov-2	NOUN
ajlm-1964	180	19	-	-	PUNCT
ajlm-1964	180	20	specific	specific	ADJ
ajlm-1964	180	21	t	t	NOUN
ajlm-1964	180	22	cells	cell	NOUN
ajlm-1964	180	23	in	in	ADP
ajlm-1964	180	24	covid-19	covid-19	PROPN
ajlm-1964	180	25	patients	patient	NOUN
ajlm-1964	180	26	with	with	ADP
ajlm-1964	180	27	acute	acute	ADJ
ajlm-1964	180	28	respiratory	respiratory	ADJ
ajlm-1964	180	29	distress	distress	NOUN
ajlm-1964	180	30	syndrome	syndrome	NOUN
ajlm-1964	180	31	.	.	PUNCT
ajlm-1964	181	1	sci	sci	PROPN
ajlm-1964	181	2	immunol	immunol	NOUN
ajlm-1964	181	3	.	.	PUNCT
ajlm-1964	182	1	2020;5(48	2020;5(48	NOUN
ajlm-1964	182	2	):	):	PUNCT
ajlm-1964	183	1	eabd2071	eabd2071	PROPN
ajlm-1964	183	2	.	.	PUNCT
ajlm-1964	184	1	https://doi.org/10.1126/sciimmunol.abd2071	https://doi.org/10.1126/sciimmunol.abd2071	ADJ
ajlm-1964	184	2	braun	braun	PROPN
ajlm-1964	184	3	j	j	PROPN
ajlm-1964	184	4	,	,	PUNCT
ajlm-1964	184	5	loyal	loyal	ADJ
ajlm-1964	184	6	l	l	NOUN
ajlm-1964	184	7	,	,	PUNCT
ajlm-1964	184	8	frentsch	frentsch	PROPN
ajlm-1964	184	9	m	m	PROPN
ajlm-1964	184	10	,	,	PUNCT
ajlm-1964	184	11	et	et	PROPN
ajlm-1964	184	12	al	al	PROPN
ajlm-1964	184	13	.	.	PUNCT
ajlm-1964	185	1	sars	sars	PROPN
ajlm-1964	185	2	-	-	PUNCT
ajlm-1964	185	3	cov-2	cov-2	NOUN
ajlm-1964	185	4	-	-	ADJ
ajlm-1964	185	5	reactive	reactive	ADJ
ajlm-1964	185	6	t	t	NOUN
ajlm-1964	185	7	cells	cell	NOUN
ajlm-1964	185	8	in	in	ADP
ajlm-1964	185	9	healthy	healthy	ADJ
ajlm-1964	185	10	donors	donor	NOUN
ajlm-1964	185	11	and	and	CCONJ
ajlm-1964	185	12	patients	patient	NOUN
ajlm-1964	185	13	with	with	ADP
ajlm-1964	185	14	covid-19	covid-19	PROPN
ajlm-1964	185	15	.	.	PUNCT
ajlm-1964	185	16	nature	nature	PROPN
ajlm-1964	185	17	.	.	PUNCT
ajlm-1964	186	1	2020;587(7833):270–274	2020;587(7833):270–274	X
ajlm-1964	186	2	.	.	PUNCT
ajlm-1964	187	1	https://doi.org/10.1038/s41586-020-2598-9	https://doi.org/10.1038/s41586-020-2598-9	PROPN
ajlm-1964	187	2	liu	liu	PROPN
ajlm-1964	187	3	w	w	PROPN
ajlm-1964	187	4	,	,	PUNCT
ajlm-1964	187	5	liu	liu	PROPN
ajlm-1964	187	6	l	l	PROPN
ajlm-1964	187	7	,	,	PUNCT
ajlm-1964	187	8	kou	kou	PROPN
ajlm-1964	187	9	g	g	PROPN
ajlm-1964	187	10	,	,	PUNCT
ajlm-1964	187	11	et	et	PROPN
ajlm-1964	187	12	al	al	PROPN
ajlm-1964	187	13	.	.	PUNCT
ajlm-1964	187	14	evaluation	evaluation	NOUN
ajlm-1964	187	15	of	of	ADP
ajlm-1964	187	16	nucleocapsid	nucleocapsid	ADJ
ajlm-1964	187	17	and	and	CCONJ
ajlm-1964	187	18	spike	spike	ADJ
ajlm-1964	187	19	protein	protein	NOUN
ajlm-1964	187	20	-	-	PUNCT
ajlm-1964	187	21	based	base	VERB
ajlm-1964	187	22	enzyme	enzyme	NOUN
ajlm-1964	187	23	-	-	PUNCT
ajlm-1964	187	24	linked	link	VERB
ajlm-1964	187	25	immunosorbent	immunosorbent	ADJ
ajlm-1964	187	26	assays	assay	NOUN
ajlm-1964	187	27	for	for	ADP
ajlm-1964	187	28	detecting	detect	VERB
ajlm-1964	187	29	antibodies	antibody	NOUN
ajlm-1964	187	30	against	against	ADP
ajlm-1964	187	31	sars	sar	NOUN
ajlm-1964	187	32	-	-	PUNCT
ajlm-1964	187	33	cov-2	cov-2	NOUN
ajlm-1964	187	34	.	.	PUNCT
ajlm-1964	188	1	j	j	PROPN
ajlm-1964	188	2	clin	clin	PROPN
ajlm-1964	188	3	microbiol	microbiol	PROPN
ajlm-1964	188	4	.	.	PUNCT
ajlm-1964	189	1	2020;58(6	2020;58(6	NUM
ajlm-1964	189	2	):	):	PUNCT
ajlm-1964	189	3	e00461	e00461	PROPN
ajlm-1964	189	4	-	-	SYM
ajlm-1964	189	5	20	20	NUM
ajlm-1964	189	6	.	.	PUNCT
ajlm-1964	190	1	https://doi.org/10.1128/jcm.00461-20	https://doi.org/10.1128/jcm.00461-20	PROPN
ajlm-1964	190	2	zhao	zhao	PROPN
ajlm-1964	190	3	j	j	PROPN
ajlm-1964	190	4	,	,	PUNCT
ajlm-1964	190	5	yuan	yuan	PROPN
ajlm-1964	190	6	q	q	PROPN
ajlm-1964	190	7	,	,	PUNCT
ajlm-1964	190	8	wang	wang	PROPN
ajlm-1964	190	9	h	h	PROPN
ajlm-1964	190	10	,	,	PUNCT
ajlm-1964	190	11	et	et	PROPN
ajlm-1964	190	12	al	al	PROPN
ajlm-1964	190	13	.	.	PUNCT
ajlm-1964	191	1	antibody	antibody	NOUN
ajlm-1964	191	2	responses	response	NOUN
ajlm-1964	191	3	to	to	ADP
ajlm-1964	191	4	sars	sar	NOUN
ajlm-1964	191	5	-	-	PUNCT
ajlm-1964	191	6	cov-2	cov-2	NOUN
ajlm-1964	191	7	in	in	ADP
ajlm-1964	191	8	patients	patient	NOUN
ajlm-1964	191	9	of	of	ADP
ajlm-1964	191	10	novel	novel	ADJ
ajlm-1964	191	11	coronavirus	coronavirus	NOUN
ajlm-1964	191	12	disease	disease	NOUN
ajlm-1964	191	13	2019	2019	NUM
ajlm-1964	191	14	.	.	PUNCT
ajlm-1964	192	1	clin	clin	PROPN
ajlm-1964	192	2	infect	infect	PROPN
ajlm-1964	192	3	dis	dis	PROPN
ajlm-1964	192	4	.	.	PUNCT
ajlm-1964	193	1	2020;71(16):2027–2034	2020;71(16):2027–2034	X
ajlm-1964	193	2	.	.	PUNCT
ajlm-1964	194	1	https://doi.org/10.1101/2020.03.02.20030189	https://doi.org/10.1101/2020.03.02.20030189	NOUN
ajlm-1964	194	2	okba	okba	NOUN
ajlm-1964	194	3	nma	nma	PROPN
ajlm-1964	194	4	,	,	PUNCT
ajlm-1964	194	5	müller	müller	PROPN
ajlm-1964	194	6	ma	ma	PROPN
ajlm-1964	194	7	,	,	PUNCT
ajlm-1964	194	8	li	li	PROPN
ajlm-1964	194	9	w	w	PROPN
ajlm-1964	194	10	,	,	PUNCT
ajlm-1964	194	11	et	et	PROPN
ajlm-1964	194	12	al	al	PROPN
ajlm-1964	194	13	.	.	PROPN
ajlm-1964	195	1	severe	severe	ADJ
ajlm-1964	195	2	acute	acute	ADJ
ajlm-1964	195	3	respiratory	respiratory	ADJ
ajlm-1964	195	4	syndrome	syndrome	NOUN
ajlm-1964	195	5	coronavirus	coronavirus	NOUN
ajlm-1964	195	6	2	2	NUM
ajlm-1964	195	7	-	-	PUNCT
ajlm-1964	195	8	specific	specific	ADJ
ajlm-1964	195	9	antibody	antibody	NOUN
ajlm-1964	195	10	responses	response	NOUN
ajlm-1964	195	11	in	in	ADP
ajlm-1964	195	12	coronavirus	coronavirus	NOUN
ajlm-1964	195	13	disease	disease	NOUN
ajlm-1964	195	14	patients	patient	NOUN
ajlm-1964	195	15	.	.	PUNCT
ajlm-1964	196	1	emerg	emerg	PROPN
ajlm-1964	196	2	infect	infect	PROPN
ajlm-1964	196	3	dis	dis	PROPN
ajlm-1964	196	4	.	.	PUNCT
ajlm-1964	197	1	2020;26(7):1478–1488	2020;26(7):1478–1488	NUM
ajlm-1964	197	2	.	.	PUNCT
ajlm-1964	198	1	https://doi.org/10.3201/eid2607.200841	https://doi.org/10.3201/eid2607.200841	AUX
ajlm-1964	198	2	long	long	ADJ
ajlm-1964	198	3	q	q	NOUN
ajlm-1964	198	4	-	-	PUNCT
ajlm-1964	198	5	x	x	NOUN
ajlm-1964	198	6	,	,	PUNCT
ajlm-1964	198	7	liu	liu	PROPN
ajlm-1964	198	8	b	b	PROPN
ajlm-1964	198	9	-	-	PUNCT
ajlm-1964	198	10	z	z	PROPN
ajlm-1964	198	11	,	,	PUNCT
ajlm-1964	198	12	deng	deng	PROPN
ajlm-1964	198	13	h	h	PROPN
ajlm-1964	198	14	-	-	PUNCT
ajlm-1964	198	15	j	j	PROPN
ajlm-1964	198	16	,	,	PUNCT
ajlm-1964	198	17	et	et	PROPN
ajlm-1964	198	18	al	al	PROPN
ajlm-1964	198	19	.	.	PUNCT
ajlm-1964	198	20	antibody	antibody	NOUN
ajlm-1964	198	21	responses	response	NOUN
ajlm-1964	198	22	to	to	ADP
ajlm-1964	198	23	sars	sar	NOUN
ajlm-1964	198	24	-	-	PUNCT
ajlm-1964	198	25	cov-2	cov-2	NOUN
ajlm-1964	198	26	in	in	ADP
ajlm-1964	198	27	patients	patient	NOUN
ajlm-1964	198	28	with	with	ADP
ajlm-1964	198	29	covid-19	covid-19	PROPN
ajlm-1964	198	30	.	.	PUNCT
ajlm-1964	199	1	nat	nat	PROPN
ajlm-1964	199	2	med	me	VERB
ajlm-1964	199	3	.	.	PUNCT
ajlm-1964	200	1	2020;26(6):845–848	2020;26(6):845–848	NUM
ajlm-1964	200	2	.	.	PUNCT
ajlm-1964	201	1	https://doi.org/10.1038/s41591-020-0897-1	https://doi.org/10.1038/s41591-020-0897-1	PROPN
ajlm-1964	201	2	wölfel	wölfel	PROPN
ajlm-1964	201	3	r	r	NOUN
ajlm-1964	201	4	,	,	PUNCT
ajlm-1964	201	5	corman	corman	PROPN
ajlm-1964	201	6	vm	vm	PROPN
ajlm-1964	201	7	,	,	PUNCT
ajlm-1964	201	8	guggemos	guggemos	PROPN
ajlm-1964	201	9	w	w	PROPN
ajlm-1964	201	10	,	,	PUNCT
ajlm-1964	201	11	et	et	PROPN
ajlm-1964	201	12	al	al	PROPN
ajlm-1964	201	13	.	.	PROPN
ajlm-1964	202	1	virological	virological	ADJ
ajlm-1964	202	2	assessment	assessment	NOUN
ajlm-1964	202	3	of	of	ADP
ajlm-1964	202	4	hospitalized	hospitalize	VERB
ajlm-1964	202	5	patients	patient	NOUN
ajlm-1964	202	6	with	with	ADP
ajlm-1964	202	7	covid-2019	covid-2019	NOUN
ajlm-1964	202	8	.	.	PUNCT
ajlm-1964	203	1	nature	nature	NOUN
ajlm-1964	203	2	.	.	PUNCT
ajlm-1964	204	1	2020;581(7809):465–469	2020;581(7809):465–469	X
ajlm-1964	204	2	.	.	X
ajlm-1964	204	3	https://doi.org/10.1038/s41586-020-2196-x	https://doi.org/10.1038/s41586-020-2196-x	PROPN
ajlm-1964	204	4	orenstein	orenstein	PROPN
ajlm-1964	204	5	wa	wa	PROPN
ajlm-1964	204	6	,	,	PUNCT
ajlm-1964	204	7	ahmed	ahmed	PROPN
ajlm-1964	204	8	r.	r.	PROPN
ajlm-1964	204	9	simply	simply	ADV
ajlm-1964	204	10	put	put	VERB
ajlm-1964	204	11	:	:	PUNCT
ajlm-1964	204	12	vaccination	vaccination	NOUN
ajlm-1964	204	13	saves	save	VERB
ajlm-1964	204	14	lives	life	NOUN
ajlm-1964	204	15	.	.	PUNCT
ajlm-1964	205	1	proc	proc	PROPN
ajlm-1964	205	2	natl	natl	PROPN
ajlm-1964	205	3	acad	acad	PROPN
ajlm-1964	205	4	sci	sci	PROPN
ajlm-1964	205	5	u	u	PROPN
ajlm-1964	205	6	s	s	NOUN
ajlm-1964	205	7	a.	a.	NOUN
ajlm-1964	205	8	2017;114(16):4031–4033	2017;114(16):4031–4033	NUM
ajlm-1964	205	9	.	.	PUNCT
ajlm-1964	206	1	https://doi.org/10.1073/pnas.1704507114	https://doi.org/10.1073/pnas.1704507114	PROPN
ajlm-1964	206	2	plotkin	plotkin	PROPN
ajlm-1964	206	3	s	s	PROPN
ajlm-1964	206	4	,	,	PUNCT
ajlm-1964	206	5	orenstein	orenstein	PROPN
ajlm-1964	206	6	wa	wa	PROPN
ajlm-1964	206	7	,	,	PUNCT
ajlm-1964	206	8	offit	offit	VERB
ajlm-1964	206	9	p	p	X
ajlm-1964	206	10	,	,	PUNCT
ajlm-1964	206	11	edwards	edwards	PROPN
ajlm-1964	206	12	km	km	PROPN
ajlm-1964	206	13	.	.	PUNCT
ajlm-1964	207	1	plotkin	plotkin	PROPN
ajlm-1964	207	2	’s	’s	PART
ajlm-1964	207	3	vaccines	vaccine	NOUN
ajlm-1964	207	4	.	.	PUNCT
ajlm-1964	208	1	7th	7th	ADJ
ajlm-1964	208	2	ed	ed	NOUN
ajlm-1964	208	3	.	.	PUNCT
ajlm-1964	209	1	[	[	X
ajlm-1964	209	2	homepage	homepage	NOUN
ajlm-1964	209	3	on	on	ADP
ajlm-1964	209	4	the	the	DET
ajlm-1964	209	5	internet	internet	NOUN
ajlm-1964	209	6	]	]	PUNCT
ajlm-1964	209	7	.	.	PUNCT
ajlm-1964	210	1	2017	2017	NUM
ajlm-1964	211	1	[	[	X
ajlm-1964	211	2	cited	cite	VERB
ajlm-1964	211	3	2021	2021	NUM
ajlm-1964	211	4	sept	sept	PROPN
ajlm-1964	211	5	22	22	NUM
ajlm-1964	211	6	]	]	PUNCT
ajlm-1964	211	7	.	.	PUNCT
ajlm-1964	212	1	available	available	ADJ
ajlm-1964	212	2	from	from	ADP
ajlm-1964	212	3	:	:	PUNCT
ajlm-1964	212	4	https://www.elsevier.com/books/t/a/9780323357616	https://www.elsevier.com/books/t/a/9780323357616	PROPN
ajlm-1964	212	5	piot	piot	NOUN
ajlm-1964	212	6	p	p	X
ajlm-1964	212	7	,	,	PUNCT
ajlm-1964	212	8	larson	larson	PROPN
ajlm-1964	212	9	hj	hj	PROPN
ajlm-1964	212	10	,	,	PUNCT
ajlm-1964	212	11	o’brien	o’brien	PROPN
ajlm-1964	212	12	kl	kl	PROPN
ajlm-1964	212	13	,	,	PUNCT
ajlm-1964	212	14	et	et	PROPN
ajlm-1964	212	15	al	al	PROPN
ajlm-1964	212	16	.	.	PUNCT
ajlm-1964	213	1	immunization	immunization	NOUN
ajlm-1964	213	2	:	:	PUNCT
ajlm-1964	213	3	vital	vital	ADJ
ajlm-1964	213	4	progress	progress	NOUN
ajlm-1964	213	5	,	,	PUNCT
ajlm-1964	213	6	unfinished	unfinished	ADJ
ajlm-1964	213	7	agenda	agenda	NOUN
ajlm-1964	213	8	.	.	PUNCT
ajlm-1964	214	1	nature	nature	NOUN
ajlm-1964	214	2	.	.	PUNCT
ajlm-1964	215	1	2019;575(7781):119–129	2019;575(7781):119–129	NUM
ajlm-1964	215	2	.	.	PUNCT
ajlm-1964	216	1	https://doi.org/10.1038/s41586-019-1656-7	https://doi.org/10.1038/s41586-019-1656-7	PROPN
ajlm-1964	216	2	kellam	kellam	PROPN
ajlm-1964	216	3	p	p	PROPN
ajlm-1964	216	4	,	,	PUNCT
ajlm-1964	216	5	barclay	barclay	PROPN
ajlm-1964	216	6	w.	w.	PROPN
ajlm-1964	216	7	the	the	DET
ajlm-1964	216	8	dynamics	dynamic	NOUN
ajlm-1964	216	9	of	of	ADP
ajlm-1964	216	10	humoral	humoral	ADJ
ajlm-1964	216	11	immune	immune	ADJ
ajlm-1964	216	12	responses	response	NOUN
ajlm-1964	216	13	following	follow	VERB
ajlm-1964	216	14	sars	sar	NOUN
ajlm-1964	216	15	-	-	PUNCT
ajlm-1964	216	16	cov-2	cov-2	PART
ajlm-1964	216	17	infection	infection	NOUN
ajlm-1964	216	18	and	and	CCONJ
ajlm-1964	216	19	the	the	DET
ajlm-1964	216	20	potential	potential	NOUN
ajlm-1964	216	21	for	for	ADP
ajlm-1964	216	22	reinfection	reinfection	NOUN
ajlm-1964	216	23	.	.	PUNCT
ajlm-1964	217	1	j	j	PROPN
ajlm-1964	217	2	gen	gen	PROPN
ajlm-1964	217	3	virol	virol	NOUN
ajlm-1964	217	4	.	.	PUNCT
ajlm-1964	218	1	2020;101(8):791–797	2020;101(8):791–797	X
ajlm-1964	218	2	.	.	PUNCT
ajlm-1964	218	3	https://doi.org/10.1099/jgv.0.001439	https://doi.org/10.1099/jgv.0.001439	PROPN
ajlm-1964	218	4	wu	wu	PROPN
ajlm-1964	218	5	l	l	PROPN
ajlm-1964	218	6	-	-	PROPN
ajlm-1964	218	7	p	p	PROPN
ajlm-1964	218	8	,	,	PUNCT
ajlm-1964	218	9	wang	wang	PROPN
ajlm-1964	218	10	n	n	PROPN
ajlm-1964	218	11	-	-	PUNCT
ajlm-1964	218	12	c	c	PROPN
ajlm-1964	218	13	,	,	PUNCT
ajlm-1964	218	14	chang	chang	PROPN
ajlm-1964	218	15	y	y	PROPN
ajlm-1964	218	16	-	-	PUNCT
ajlm-1964	218	17	h	h	PROPN
ajlm-1964	218	18	,	,	PUNCT
ajlm-1964	218	19	et	et	PROPN
ajlm-1964	218	20	al	al	PROPN
ajlm-1964	218	21	.	.	PUNCT
ajlm-1964	219	1	duration	duration	NOUN
ajlm-1964	219	2	of	of	ADP
ajlm-1964	219	3	antibody	antibody	NOUN
ajlm-1964	219	4	responses	response	NOUN
ajlm-1964	219	5	after	after	ADP
ajlm-1964	219	6	severe	severe	ADJ
ajlm-1964	219	7	acute	acute	ADJ
ajlm-1964	219	8	respiratory	respiratory	ADJ
ajlm-1964	219	9	syndrome	syndrome	NOUN
ajlm-1964	219	10	.	.	PUNCT
ajlm-1964	220	1	emerg	emerg	PROPN
ajlm-1964	220	2	infect	infect	PROPN
ajlm-1964	220	3	dis	dis	PROPN
ajlm-1964	220	4	.	.	PUNCT
ajlm-1964	221	1	2007;13(10):1562–1564	2007;13(10):1562–1564	NUM
ajlm-1964	221	2	.	.	PUNCT
ajlm-1964	221	3	https://doi.org/10.3201/eid1310.070576	https://doi.org/10.3201/eid1310.070576	PROPN
ajlm-1964	222	1	xiao	xiao	PROPN
ajlm-1964	222	2	at	at	ADP
ajlm-1964	222	3	,	,	PUNCT
ajlm-1964	222	4	gao	gao	PROPN
ajlm-1964	222	5	c	c	PROPN
ajlm-1964	222	6	,	,	PUNCT
ajlm-1964	222	7	zhang	zhang	PROPN
ajlm-1964	222	8	s.	s.	PROPN
ajlm-1964	222	9	profile	profile	PROPN
ajlm-1964	222	10	of	of	ADP
ajlm-1964	222	11	specific	specific	ADJ
ajlm-1964	222	12	antibodies	antibody	NOUN
ajlm-1964	222	13	to	to	ADP
ajlm-1964	222	14	sars	sar	NOUN
ajlm-1964	222	15	-	-	PUNCT
ajlm-1964	222	16	cov-2	cov-2	NUM
ajlm-1964	222	17	:	:	PUNCT
ajlm-1964	222	18	the	the	DET
ajlm-1964	222	19	first	first	ADJ
ajlm-1964	222	20	report	report	NOUN
ajlm-1964	222	21	.	.	PUNCT
ajlm-1964	223	1	j	j	PROPN
ajlm-1964	223	2	infect	infect	VERB
ajlm-1964	223	3	.	.	PUNCT
ajlm-1964	224	1	2020;81(1):147–178	2020;81(1):147–178	X
ajlm-1964	224	2	.	.	PUNCT
ajlm-1964	225	1	https://doi.org/10.1016/j.jinf.2020.03.012	https://doi.org/10.1016/j.jinf.2020.03.012	NOUN
ajlm-1964	225	2	zeng	zeng	PROPN
ajlm-1964	225	3	h	h	PROPN
ajlm-1964	225	4	,	,	PUNCT
ajlm-1964	225	5	xu	xu	PROPN
ajlm-1964	226	1	c	c	X
ajlm-1964	226	2	,	,	PUNCT
ajlm-1964	226	3	fan	fan	PROPN
ajlm-1964	226	4	j	j	PROPN
ajlm-1964	226	5	,	,	PUNCT
ajlm-1964	226	6	et	et	PROPN
ajlm-1964	226	7	al	al	PROPN
ajlm-1964	226	8	.	.	PROPN
ajlm-1964	226	9	antibodies	antibodie	VERB
ajlm-1964	226	10	in	in	ADP
ajlm-1964	226	11	infants	infant	NOUN
ajlm-1964	226	12	born	bear	VERB
ajlm-1964	226	13	to	to	ADP
ajlm-1964	226	14	mothers	mother	NOUN
ajlm-1964	226	15	with	with	ADP
ajlm-1964	226	16	covid-19	covid-19	PROPN
ajlm-1964	226	17	pneumonia	pneumonia	NOUN
ajlm-1964	226	18	.	.	PUNCT
ajlm-1964	227	1	jama	jama	PROPN
ajlm-1964	227	2	.	.	PUNCT
ajlm-1964	228	1	2020;323(18):1848–1849	2020;323(18):1848–1849	NUM
ajlm-1964	228	2	.	.	PUNCT
ajlm-1964	229	1	https://doi.org/10.1001/jama.2020.4861	https://doi.org/10.1001/jama.2020.4861	PROPN
ajlm-1964	229	2	africa	africa	PROPN
ajlm-1964	229	3	cdc	cdc	PROPN
ajlm-1964	229	4	.	.	PUNCT
ajlm-1964	229	5	outbreak	outbreak	PROPN
ajlm-1964	229	6	brief	brief	VERB
ajlm-1964	229	7	86	86	NUM
ajlm-1964	229	8	:	:	PUNCT
ajlm-1964	229	9	coronavirus	coronavirus	NOUN
ajlm-1964	229	10	disease	disease	NOUN
ajlm-1964	229	11	2019	2019	NUM
ajlm-1964	229	12	(	(	PUNCT
ajlm-1964	229	13	covid-19	covid-19	PROPN
ajlm-1964	229	14	)	)	PUNCT
ajlm-1964	229	15	pandemic	pandemic	ADJ
ajlm-1964	229	16	[	[	X
ajlm-1964	229	17	homepage	homepage	NOUN
ajlm-1964	229	18	on	on	ADP
ajlm-1964	229	19	the	the	DET
ajlm-1964	229	20	internet	internet	NOUN
ajlm-1964	229	21	]	]	PUNCT
ajlm-1964	229	22	.	.	PUNCT
ajlm-1964	230	1	africa	africa	PROPN
ajlm-1964	230	2	cdc	cdc	PROPN
ajlm-1964	230	3	;	;	PUNCT
ajlm-1964	230	4	2021	2021	NUM
ajlm-1964	230	5	[	[	X
ajlm-1964	230	6	cited	cite	VERB
ajlm-1964	230	7	2022	2022	NUM
ajlm-1964	230	8	sept	sept	PROPN
ajlm-1964	230	9	27	27	NUM
ajlm-1964	230	10	]	]	PUNCT
ajlm-1964	230	11	.	.	PUNCT
ajlm-1964	231	1	available	available	ADJ
ajlm-1964	231	2	from	from	ADP
ajlm-1964	231	3	:	:	PUNCT
ajlm-1964	231	4	https://africacdc.org/download/outbreak-brief-86-coronavirus-disease-2019-covid-19-pandemic/	https://africacdc.org/download/outbreak-brief-86-coronavirus-disease-2019-covid-19-pandemic/	PROPN
ajlm-1964	231	5	embrett	embrett	PROPN
ajlm-1964	231	6	m	m	PROPN
ajlm-1964	231	7	,	,	PUNCT
ajlm-1964	231	8	sim	sim	ADJ
ajlm-1964	231	9	sm	sm	PROPN
ajlm-1964	231	10	,	,	PUNCT
ajlm-1964	231	11	caldwell	caldwell	PROPN
ajlm-1964	231	12	hat	hat	PROPN
ajlm-1964	231	13	,	,	PUNCT
ajlm-1964	231	14	et	et	PROPN
ajlm-1964	231	15	al	al	PROPN
ajlm-1964	231	16	.	.	PUNCT
ajlm-1964	232	1	barriers	barrier	NOUN
ajlm-1964	232	2	to	to	ADP
ajlm-1964	232	3	and	and	CCONJ
ajlm-1964	232	4	strategies	strategy	NOUN
ajlm-1964	232	5	to	to	PART
ajlm-1964	232	6	address	address	VERB
ajlm-1964	232	7	covid-19	covid-19	PROPN
ajlm-1964	232	8	testing	testing	NOUN
ajlm-1964	232	9	hesitancy	hesitancy	NOUN
ajlm-1964	232	10	:	:	PUNCT
ajlm-1964	232	11	a	a	DET
ajlm-1964	232	12	rapid	rapid	ADJ
ajlm-1964	232	13	scoping	scoping	NOUN
ajlm-1964	232	14	review	review	NOUN
ajlm-1964	232	15	.	.	PUNCT
ajlm-1964	233	1	bmc	bmc	ADJ
ajlm-1964	233	2	public	public	ADJ
ajlm-1964	233	3	health	health	NOUN
ajlm-1964	233	4	.	.	PUNCT
ajlm-1964	234	1	2022;22(1):750	2022;22(1):750	NUM
ajlm-1964	234	2	.	.	PUNCT
ajlm-1964	235	1	https://doi.org/10.1186/s12889-022-13127-7	https://doi.org/10.1186/s12889-022-13127-7	VERB
ajlm-1964	235	2	kaseje	kaseje	PROPN
ajlm-1964	235	3	n.	n.	PROPN
ajlm-1964	235	4	why	why	SCONJ
ajlm-1964	235	5	sub	sub	ADJ
ajlm-1964	235	6	-	-	ADJ
ajlm-1964	235	7	saharan	saharan	ADJ
ajlm-1964	235	8	africa	africa	PROPN
ajlm-1964	235	9	needs	need	VERB
ajlm-1964	235	10	a	a	DET
ajlm-1964	235	11	unique	unique	ADJ
ajlm-1964	235	12	response	response	NOUN
ajlm-1964	235	13	to	to	ADP
ajlm-1964	235	14	covid-19	covid-19	PROPN
ajlm-1964	236	1	[	[	X
ajlm-1964	236	2	homepage	homepage	NOUN
ajlm-1964	236	3	on	on	ADP
ajlm-1964	236	4	the	the	DET
ajlm-1964	236	5	internet	internet	NOUN
ajlm-1964	236	6	]	]	PUNCT
ajlm-1964	236	7	.	.	PUNCT
ajlm-1964	237	1	world	world	PROPN
ajlm-1964	237	2	economic	economic	PROPN
ajlm-1964	237	3	forum	forum	PROPN
ajlm-1964	237	4	;	;	PUNCT
ajlm-1964	237	5	2020	2020	NUM
ajlm-1964	238	1	[	[	X
ajlm-1964	238	2	cited	cite	VERB
ajlm-1964	238	3	2021	2021	NUM
ajlm-1964	238	4	nov	nov	NOUN
ajlm-1964	238	5	24	24	NUM
ajlm-1964	238	6	]	]	PUNCT
ajlm-1964	238	7	.	.	PUNCT
ajlm-1964	239	1	available	available	ADJ
ajlm-1964	239	2	from	from	ADP
ajlm-1964	239	3	:	:	PUNCT
ajlm-1964	239	4	https://www.weforum.org/agenda/2020/03/why-sub-saharan-africa-needs-a-unique-response-to-covid-19/	https://www.weforum.org/agenda/2020/03/why-sub-saharan-africa-needs-a-unique-response-to-covid-19/	X
ajlm-1964	239	5	centers	centers	AUX
ajlm-1964	239	6	for	for	ADP
ajlm-1964	239	7	disease	disease	NOUN
ajlm-1964	239	8	control	control	NOUN
ajlm-1964	239	9	and	and	CCONJ
ajlm-1964	239	10	prevention	prevention	NOUN
ajlm-1964	239	11	(	(	PUNCT
ajlm-1964	239	12	cdc	cdc	PROPN
ajlm-1964	239	13	)	)	PUNCT
ajlm-1964	239	14	.	.	PUNCT
ajlm-1964	240	1	covid-19	covid-19	PROPN
ajlm-1964	240	2	and	and	CCONJ
ajlm-1964	240	3	your	your	PRON
ajlm-1964	240	4	health	health	NOUN
ajlm-1964	241	1	[	[	X
ajlm-1964	241	2	homepage	homepage	NOUN
ajlm-1964	241	3	on	on	ADP
ajlm-1964	241	4	the	the	DET
ajlm-1964	241	5	internet	internet	NOUN
ajlm-1964	241	6	]	]	PUNCT
ajlm-1964	241	7	.	.	PUNCT
ajlm-1964	242	1	centers	center	NOUN
ajlm-1964	242	2	for	for	ADP
ajlm-1964	242	3	disease	disease	NOUN
ajlm-1964	242	4	control	control	NOUN
ajlm-1964	242	5	and	and	CCONJ
ajlm-1964	242	6	prevention	prevention	NOUN
ajlm-1964	242	7	;	;	PUNCT
ajlm-1964	242	8	2020	2020	NUM
ajlm-1964	242	9	[	[	X
ajlm-1964	242	10	cited	cite	VERB
ajlm-1964	242	11	2021	2021	NUM
ajlm-1964	242	12	nov	nov	NOUN
ajlm-1964	242	13	24	24	NUM
ajlm-1964	242	14	]	]	PUNCT
ajlm-1964	242	15	.	.	PUNCT
ajlm-1964	243	1	available	available	ADJ
ajlm-1964	243	2	from	from	ADP
ajlm-1964	243	3	:	:	PUNCT
ajlm-1964	243	4	https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html	https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html	PROPN
ajlm-1964	243	5	kaneda	kaneda	PROPN
ajlm-1964	243	6	t	t	PROPN
ajlm-1964	243	7	,	,	PUNCT
ajlm-1964	243	8	ashford	ashford	PROPN
ajlm-1964	243	9	ls	ls	PROPN
ajlm-1964	243	10	.	.	PUNCT
ajlm-1964	244	1	sub	sub	ADJ
ajlm-1964	244	2	-	-	ADJ
ajlm-1964	244	3	saharan	saharan	ADJ
ajlm-1964	244	4	africa	africa	PROPN
ajlm-1964	244	5	’s	’s	PART
ajlm-1964	244	6	demographic	demographic	ADJ
ajlm-1964	244	7	and	and	CCONJ
ajlm-1964	244	8	health	health	NOUN
ajlm-1964	244	9	characteristics	characteristic	NOUN
ajlm-1964	244	10	will	will	AUX
ajlm-1964	244	11	influence	influence	VERB
ajlm-1964	244	12	the	the	DET
ajlm-1964	244	13	course	course	NOUN
ajlm-1964	244	14	of	of	ADP
ajlm-1964	244	15	the	the	DET
ajlm-1964	244	16	covid-19	covid-19	PROPN
ajlm-1964	244	17	pandemic	pandemic	ADJ
ajlm-1964	244	18	–	–	PUNCT
ajlm-1964	244	19	population	population	NOUN
ajlm-1964	244	20	reference	reference	NOUN
ajlm-1964	244	21	bureau	bureau	NOUN
ajlm-1964	245	1	[	[	X
ajlm-1964	245	2	homepage	homepage	NOUN
ajlm-1964	245	3	on	on	ADP
ajlm-1964	245	4	the	the	DET
ajlm-1964	245	5	internet	internet	NOUN
ajlm-1964	245	6	]	]	PUNCT
ajlm-1964	245	7	.	.	PUNCT
ajlm-1964	245	8	2020	2020	NUM
ajlm-1964	246	1	[	[	X
ajlm-1964	246	2	cited	cite	VERB
ajlm-1964	246	3	2020	2020	NUM
ajlm-1964	246	4	aug	aug	PROPN
ajlm-1964	246	5	14	14	NUM
ajlm-1964	246	6	]	]	PUNCT
ajlm-1964	246	7	.	.	PUNCT
ajlm-1964	247	1	available	available	ADJ
ajlm-1964	247	2	from	from	ADP
ajlm-1964	247	3	:	:	PUNCT
ajlm-1964	247	4	https://www.prb.org/sub-saharan-africas-demographic-and-health-characteristics-will-influence-the-course-of-the-covid-19-pandemic/	https://www.prb.org/sub-saharan-africas-demographic-and-health-characteristics-will-influence-the-course-of-the-covid-19-pandemic/	PROPN
ajlm-1964	247	5	gona	gona	PROPN
ajlm-1964	247	6	pn	pn	PROPN
ajlm-1964	247	7	,	,	PUNCT
ajlm-1964	247	8	gona	gona	PROPN
ajlm-1964	247	9	cm	cm	PROPN
ajlm-1964	247	10	,	,	PUNCT
ajlm-1964	247	11	ballout	ballout	NOUN
ajlm-1964	247	12	s	s	PART
ajlm-1964	247	13	,	,	PUNCT
ajlm-1964	247	14	et	et	PROPN
ajlm-1964	247	15	al	al	PROPN
ajlm-1964	247	16	.	.	PUNCT
ajlm-1964	247	17	burden	burden	NOUN
ajlm-1964	247	18	and	and	CCONJ
ajlm-1964	247	19	changes	change	NOUN
ajlm-1964	247	20	in	in	ADP
ajlm-1964	247	21	hiv	hiv	PROPN
ajlm-1964	247	22	/	/	SYM
ajlm-1964	247	23	aids	aids	PROPN
ajlm-1964	247	24	morbidity	morbidity	NOUN
ajlm-1964	247	25	and	and	CCONJ
ajlm-1964	247	26	mortality	mortality	NOUN
ajlm-1964	247	27	in	in	ADP
ajlm-1964	247	28	southern	southern	PROPN
ajlm-1964	247	29	africa	africa	PROPN
ajlm-1964	247	30	development	development	PROPN
ajlm-1964	247	31	community	community	NOUN
ajlm-1964	247	32	countries	country	NOUN
ajlm-1964	247	33	,	,	PUNCT
ajlm-1964	247	34	1990–2017	1990–2017	NUM
ajlm-1964	247	35	.	.	PUNCT
ajlm-1964	248	1	bmc	bmc	ADJ
ajlm-1964	248	2	public	public	ADJ
ajlm-1964	248	3	health	health	NOUN
ajlm-1964	248	4	.	.	PUNCT
ajlm-1964	249	1	2020;20(1):867	2020;20(1):867	NUM
ajlm-1964	249	2	.	.	PUNCT
ajlm-1964	250	1	https://doi.org/10.1186/s12889-020-08988-9	https://doi.org/10.1186/s12889-020-08988-9	PROPN
ajlm-1964	250	2	dye	dye	NOUN
ajlm-1964	250	3	c	c	X
ajlm-1964	250	4	,	,	PUNCT
ajlm-1964	250	5	harries	harries	PROPN
ajlm-1964	250	6	ad	ad	NOUN
ajlm-1964	250	7	,	,	PUNCT
ajlm-1964	250	8	maher	maher	PROPN
ajlm-1964	250	9	d	d	PROPN
ajlm-1964	250	10	,	,	PUNCT
ajlm-1964	250	11	hosseini	hosseini	PROPN
ajlm-1964	250	12	sm	sm	PROPN
ajlm-1964	250	13	,	,	PUNCT
ajlm-1964	250	14	nkhoma	nkhoma	PROPN
ajlm-1964	250	15	w	w	PROPN
ajlm-1964	250	16	,	,	PUNCT
ajlm-1964	250	17	salaniponi	salaniponi	PROPN
ajlm-1964	250	18	fm	fm	PROPN
ajlm-1964	250	19	.	.	PROPN
ajlm-1964	250	20	tuberculosis	tuberculosis	NOUN
ajlm-1964	250	21	.	.	PUNCT
ajlm-1964	251	1	in	in	ADP
ajlm-1964	251	2	:	:	PUNCT
ajlm-1964	251	3	jamison	jamison	PROPN
ajlm-1964	251	4	dt	dt	PROPN
ajlm-1964	251	5	,	,	PUNCT
ajlm-1964	251	6	feachem	feachem	PROPN
ajlm-1964	251	7	rg	rg	PROPN
ajlm-1964	251	8	,	,	PUNCT
ajlm-1964	251	9	makgoba	makgoba	PROPN
ajlm-1964	251	10	mw	mw	PROPN
ajlm-1964	251	11	,	,	PUNCT
ajlm-1964	251	12	et	et	PROPN
ajlm-1964	251	13	al	al	PROPN
ajlm-1964	251	14	.	.	PROPN
ajlm-1964	251	15	,	,	PUNCT
ajlm-1964	251	16	editors	editor	NOUN
ajlm-1964	251	17	.	.	PUNCT
ajlm-1964	252	1	disease	disease	NOUN
ajlm-1964	252	2	and	and	CCONJ
ajlm-1964	252	3	mortality	mortality	NOUN
ajlm-1964	252	4	in	in	ADP
ajlm-1964	252	5	sub	sub	ADJ
ajlm-1964	252	6	-	-	ADJ
ajlm-1964	252	7	saharan	saharan	ADJ
ajlm-1964	252	8	africa	africa	PROPN
ajlm-1964	253	1	[	[	X
ajlm-1964	253	2	homepage	homepage	NOUN
ajlm-1964	253	3	on	on	ADP
ajlm-1964	253	4	the	the	DET
ajlm-1964	253	5	internet	internet	NOUN
ajlm-1964	253	6	]	]	PUNCT
ajlm-1964	253	7	.	.	PUNCT
ajlm-1964	254	1	2nd	2nd	ADJ
ajlm-1964	254	2	ed	ed	NOUN
ajlm-1964	254	3	.	.	PUNCT
ajlm-1964	255	1	washington	washington	PROPN
ajlm-1964	255	2	,	,	PUNCT
ajlm-1964	255	3	dc	dc	PROPN
ajlm-1964	255	4	:	:	PUNCT
ajlm-1964	255	5	world	world	PROPN
ajlm-1964	255	6	bank	bank	PROPN
ajlm-1964	255	7	;	;	PUNCT
ajlm-1964	255	8	2006	2006	NUM
ajlm-1964	255	9	[	[	X
ajlm-1964	255	10	cited	cite	VERB
ajlm-1964	255	11	2021	2021	NUM
ajlm-1964	255	12	nov	nov	NOUN
ajlm-1964	255	13	23	23	NUM
ajlm-1964	255	14	]	]	PUNCT
ajlm-1964	255	15	.	.	PUNCT
ajlm-1964	256	1	available	available	ADJ
ajlm-1964	256	2	from	from	ADP
ajlm-1964	256	3	:	:	PUNCT
ajlm-1964	256	4	http://www.ncbi.nlm.nih.gov/books/nbk2285/	http://www.ncbi.nlm.nih.gov/books/nbk2285/	PROPN
ajlm-1964	256	5	young	young	ADJ
ajlm-1964	256	6	f	f	NOUN
ajlm-1964	256	7	,	,	PUNCT
ajlm-1964	256	8	critchley	critchley	PROPN
ajlm-1964	256	9	ja	ja	PROPN
ajlm-1964	256	10	,	,	PUNCT
ajlm-1964	256	11	johnstone	johnstone	PROPN
ajlm-1964	256	12	lk	lk	PROPN
ajlm-1964	256	13	,	,	PUNCT
ajlm-1964	256	14	unwin	unwin	PROPN
ajlm-1964	256	15	nc	nc	PROPN
ajlm-1964	256	16	.	.	PROPN
ajlm-1964	257	1	a	a	DET
ajlm-1964	257	2	review	review	NOUN
ajlm-1964	257	3	of	of	ADP
ajlm-1964	257	4	co	co	NOUN
ajlm-1964	257	5	-	-	NOUN
ajlm-1964	257	6	morbidity	morbidity	NOUN
ajlm-1964	257	7	between	between	ADP
ajlm-1964	257	8	infectious	infectious	ADJ
ajlm-1964	257	9	and	and	CCONJ
ajlm-1964	257	10	chronic	chronic	ADJ
ajlm-1964	257	11	disease	disease	NOUN
ajlm-1964	257	12	in	in	ADP
ajlm-1964	257	13	sub	sub	PROPN
ajlm-1964	257	14	saharan	saharan	PROPN
ajlm-1964	257	15	africa	africa	PROPN
ajlm-1964	257	16	:	:	PUNCT
ajlm-1964	258	1	tb	tb	NOUN
ajlm-1964	258	2	and	and	CCONJ
ajlm-1964	258	3	diabetes	diabete	VERB
ajlm-1964	258	4	mellitus	mellitus	NOUN
ajlm-1964	258	5	,	,	PUNCT
ajlm-1964	258	6	hiv	hiv	PROPN
ajlm-1964	258	7	and	and	CCONJ
ajlm-1964	258	8	metabolic	metabolic	NOUN
ajlm-1964	258	9	syndrome	syndrome	NOUN
ajlm-1964	258	10	,	,	PUNCT
ajlm-1964	258	11	and	and	CCONJ
ajlm-1964	258	12	the	the	DET
ajlm-1964	258	13	impact	impact	NOUN
ajlm-1964	258	14	of	of	ADP
ajlm-1964	258	15	globalization	globalization	NOUN
ajlm-1964	258	16	.	.	PUNCT
ajlm-1964	259	1	glob	glob	NOUN
ajlm-1964	259	2	health	health	NOUN
ajlm-1964	259	3	.	.	PUNCT
ajlm-1964	260	1	2009;5:9	2009;5:9	X
ajlm-1964	260	2	.	.	PUNCT
ajlm-1964	260	3	https://doi.org/10.1186/1744-8603-5-9	https://doi.org/10.1186/1744-8603-5-9	PROPN
ajlm-1964	260	4	corburn	corburn	PROPN
ajlm-1964	260	5	j	j	PROPN
ajlm-1964	260	6	,	,	PUNCT
ajlm-1964	260	7	hildebrand	hildebrand	PROPN
ajlm-1964	260	8	c.	c.	PROPN
ajlm-1964	260	9	slum	slum	PROPN
ajlm-1964	260	10	sanitation	sanitation	NOUN
ajlm-1964	260	11	and	and	CCONJ
ajlm-1964	260	12	the	the	DET
ajlm-1964	260	13	social	social	ADJ
ajlm-1964	260	14	determinants	determinant	NOUN
ajlm-1964	260	15	of	of	ADP
ajlm-1964	260	16	women	woman	NOUN
ajlm-1964	260	17	’s	’s	PART
ajlm-1964	260	18	health	health	NOUN
ajlm-1964	260	19	in	in	ADP
ajlm-1964	260	20	nairobi	nairobi	PROPN
ajlm-1964	260	21	,	,	PUNCT
ajlm-1964	260	22	kenya	kenya	PROPN
ajlm-1964	260	23	.	.	PUNCT
ajlm-1964	261	1	j	j	PROPN
ajlm-1964	261	2	environ	environ	PROPN
ajlm-1964	261	3	public	public	ADJ
ajlm-1964	261	4	health	health	NOUN
ajlm-1964	261	5	.	.	PUNCT
ajlm-1964	262	1	2015;2015	2015;2015	NUM
ajlm-1964	262	2	:	:	PUNCT
ajlm-1964	262	3	e209505	e209505	NOUN
ajlm-1964	262	4	.	.	PROPN
ajlm-1964	262	5	https://doi.org/10.1155/2015/209505	https://doi.org/10.1155/2015/209505	PROPN
ajlm-1964	262	6	united	united	PROPN
ajlm-1964	262	7	nations	nations	PROPN
ajlm-1964	262	8	human	human	PROPN
ajlm-1964	262	9	settlements	settlement	NOUN
ajlm-1964	262	10	programme	programme	NOUN
ajlm-1964	262	11	(	(	PUNCT
ajlm-1964	262	12	un	un	NOUN
ajlm-1964	262	13	-	-	NOUN
ajlm-1964	262	14	habitat	habitat	NOUN
ajlm-1964	262	15	)	)	PUNCT
ajlm-1964	262	16	.	.	PUNCT
ajlm-1964	263	1	covid-19	covid-19	PROPN
ajlm-1964	263	2	in	in	ADP
ajlm-1964	263	3	african	african	ADJ
ajlm-1964	263	4	cities	city	NOUN
ajlm-1964	263	5	:	:	PUNCT
ajlm-1964	263	6	impacts	impact	NOUN
ajlm-1964	263	7	,	,	PUNCT
ajlm-1964	263	8	responses	response	NOUN
ajlm-1964	263	9	and	and	CCONJ
ajlm-1964	263	10	policies	policy	NOUN
ajlm-1964	263	11	2020	2020	NUM
ajlm-1964	263	12	.	.	PUNCT
ajlm-1964	264	1	available	available	ADJ
ajlm-1964	264	2	from	from	ADP
ajlm-1964	264	3	:	:	PUNCT
ajlm-1964	264	4	https://unhabitat.org/covid-19-in-africa-cities-impacts-responses-and-policies	https://unhabitat.org/covid-19-in-africa-cities-impacts-responses-and-policies	PROPN
ajlm-1964	264	5	unicef	unicef	PROPN
ajlm-1964	264	6	.	.	PUNCT
ajlm-1964	265	1	water	water	NOUN
ajlm-1964	265	2	,	,	PUNCT
ajlm-1964	265	3	sanitation	sanitation	NOUN
ajlm-1964	265	4	and	and	CCONJ
ajlm-1964	265	5	hygiene	hygiene	NOUN
ajlm-1964	266	1	[	[	X
ajlm-1964	266	2	home	home	NOUN
ajlm-1964	266	3	on	on	ADP
ajlm-1964	266	4	the	the	DET
ajlm-1964	266	5	internet	internet	NOUN
ajlm-1964	266	6	]	]	PUNCT
ajlm-1964	266	7	.	.	PUNCT
ajlm-1964	267	1	2021	2021	NUM
ajlm-1964	268	1	[	[	X
ajlm-1964	268	2	cited	cite	VERB
ajlm-1964	268	3	2021	2021	NUM
ajlm-1964	268	4	nov	nov	NOUN
ajlm-1964	268	5	23	23	NUM
ajlm-1964	268	6	]	]	PUNCT
ajlm-1964	268	7	.	.	PUNCT
ajlm-1964	269	1	available	available	ADJ
ajlm-1964	269	2	from	from	ADP
ajlm-1964	269	3	:	:	PUNCT
ajlm-1964	269	4	https://www.unicef.org/wca/what-we-do/wash	https://www.unicef.org/wca/what-we-do/wash	PROPN
ajlm-1964	269	5	boutayeb	boutayeb	ADJ
ajlm-1964	269	6	a.	a.	NOUN
ajlm-1964	269	7	the	the	DET
ajlm-1964	269	8	impact	impact	NOUN
ajlm-1964	269	9	of	of	ADP
ajlm-1964	269	10	infectious	infectious	ADJ
ajlm-1964	269	11	diseases	disease	NOUN
ajlm-1964	269	12	on	on	ADP
ajlm-1964	269	13	the	the	DET
ajlm-1964	269	14	development	development	NOUN
ajlm-1964	269	15	of	of	ADP
ajlm-1964	269	16	africa	africa	PROPN
ajlm-1964	269	17	.	.	PUNCT
ajlm-1964	270	1	in	in	ADP
ajlm-1964	270	2	:	:	PUNCT
ajlm-1964	270	3	preedy	preedy	PROPN
ajlm-1964	270	4	vr	vr	PROPN
ajlm-1964	270	5	,	,	PUNCT
ajlm-1964	270	6	watson	watson	PROPN
ajlm-1964	270	7	rr	rr	PROPN
ajlm-1964	270	8	,	,	PUNCT
ajlm-1964	270	9	editors	editor	NOUN
ajlm-1964	270	10	.	.	PUNCT
ajlm-1964	271	1	handbook	handbook	NOUN
ajlm-1964	271	2	of	of	ADP
ajlm-1964	271	3	disease	disease	NOUN
ajlm-1964	271	4	burdens	burden	NOUN
ajlm-1964	271	5	and	and	CCONJ
ajlm-1964	271	6	quality	quality	NOUN
ajlm-1964	271	7	of	of	ADP
ajlm-1964	271	8	life	life	NOUN
ajlm-1964	271	9	measures	measure	NOUN
ajlm-1964	271	10	.	.	PUNCT
ajlm-1964	272	1	new	new	PROPN
ajlm-1964	272	2	york	york	PROPN
ajlm-1964	272	3	,	,	PUNCT
ajlm-1964	272	4	ny	ny	PROPN
ajlm-1964	272	5	:	:	PUNCT
ajlm-1964	272	6	springer	springer	NOUN
ajlm-1964	272	7	;	;	PUNCT
ajlm-1964	272	8	2010	2010	NUM
ajlm-1964	272	9	,	,	PUNCT
ajlm-1964	272	10	pp	pp	ADJ
ajlm-1964	272	11	.	.	PUNCT
ajlm-1964	273	1	1171–1188	1171–1188	NUM
ajlm-1964	273	2	.	.	PUNCT
ajlm-1964	274	1	world	world	PROPN
ajlm-1964	274	2	health	health	PROPN
ajlm-1964	274	3	organization	organization	NOUN
ajlm-1964	274	4	(	(	PUNCT
ajlm-1964	274	5	who	who	PRON
ajlm-1964	274	6	)	)	PUNCT
ajlm-1964	274	7	.	.	PUNCT
ajlm-1964	275	1	global	global	ADJ
ajlm-1964	275	2	health	health	NOUN
ajlm-1964	275	3	estimates	estimate	NOUN
ajlm-1964	275	4	:	:	PUNCT
ajlm-1964	275	5	leading	lead	VERB
ajlm-1964	275	6	causes	cause	NOUN
ajlm-1964	275	7	of	of	ADP
ajlm-1964	275	8	dalys	daly	NOUN
ajlm-1964	276	1	[	[	X
ajlm-1964	276	2	internet	internet	NOUN
ajlm-1964	276	3	]	]	PUNCT
ajlm-1964	276	4	.	.	PUNCT
ajlm-1964	276	5	2020	2020	NUM
ajlm-1964	277	1	[	[	X
ajlm-1964	277	2	cited	cite	VERB
ajlm-1964	277	3	2022	2022	NUM
ajlm-1964	277	4	oct	oct	NOUN
ajlm-1964	277	5	31	31	NUM
ajlm-1964	277	6	]	]	PUNCT
ajlm-1964	277	7	.	.	PUNCT
ajlm-1964	278	1	available	available	ADJ
ajlm-1964	278	2	from	from	ADP
ajlm-1964	278	3	:	:	PUNCT
ajlm-1964	278	4	https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/global-health-estimates-leading-causes-of-dalys	https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/global-health-estimates-leading-causes-of-dalys	PROPN
ajlm-1964	278	5	world	world	PROPN
ajlm-1964	278	6	health	health	PROPN
ajlm-1964	278	7	organization	organization	NOUN
ajlm-1964	278	8	(	(	PUNCT
ajlm-1964	278	9	who	who	PRON
ajlm-1964	278	10	)	)	PUNCT
ajlm-1964	278	11	.	.	PUNCT
ajlm-1964	279	1	world	world	NOUN
ajlm-1964	279	2	malaria	malaria	PROPN
ajlm-1964	279	3	report	report	NOUN
ajlm-1964	279	4	2020	2020	NUM
ajlm-1964	280	1	[	[	X
ajlm-1964	280	2	homepage	homepage	NOUN
ajlm-1964	280	3	on	on	ADP
ajlm-1964	280	4	the	the	DET
ajlm-1964	280	5	internet	internet	NOUN
ajlm-1964	280	6	]	]	PUNCT
ajlm-1964	280	7	.	.	PUNCT
ajlm-1964	281	1	2020	2020	NUM
ajlm-1964	282	1	[	[	X
ajlm-1964	282	2	cited	cite	VERB
ajlm-1964	282	3	2021	2021	NUM
ajlm-1964	282	4	sept	sept	PROPN
ajlm-1964	282	5	23	23	NUM
ajlm-1964	282	6	]	]	PUNCT
ajlm-1964	282	7	.	.	PUNCT
ajlm-1964	283	1	available	available	ADJ
ajlm-1964	283	2	from	from	ADP
ajlm-1964	283	3	:	:	PUNCT
ajlm-1964	283	4	https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2020	https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2020	PROPN
ajlm-1964	283	5	picker	picker	NOUN
ajlm-1964	283	6	lj	lj	PROPN
ajlm-1964	283	7	,	,	PUNCT
ajlm-1964	283	8	watkins	watkins	PROPN
ajlm-1964	283	9	di	di	PROPN
ajlm-1964	283	10	.	.	PROPN
ajlm-1964	284	1	hiv	hiv	PROPN
ajlm-1964	284	2	pathogenesis	pathogenesis	PROPN
ajlm-1964	284	3	:	:	PUNCT
ajlm-1964	284	4	the	the	DET
ajlm-1964	284	5	first	first	ADJ
ajlm-1964	284	6	cut	cut	NOUN
ajlm-1964	284	7	is	be	AUX
ajlm-1964	284	8	the	the	DET
ajlm-1964	284	9	deepest	deep	ADJ
ajlm-1964	284	10	.	.	PUNCT
ajlm-1964	285	1	nat	nat	PROPN
ajlm-1964	285	2	immunol	immunol	NOUN
ajlm-1964	285	3	.	.	PUNCT
ajlm-1964	286	1	2005;6(5):430–432	2005;6(5):430–432	X
ajlm-1964	286	2	.	.	PUNCT
ajlm-1964	286	3	https://doi.org/10.1038/ni0505-430	https://doi.org/10.1038/ni0505-430	PROPN
ajlm-1964	286	4	naif	naif	NOUN
ajlm-1964	287	1	hm	hm	INTJ
ajlm-1964	287	2	.	.	PUNCT
ajlm-1964	287	3	pathogenesis	pathogenesis	NOUN
ajlm-1964	287	4	of	of	ADP
ajlm-1964	287	5	hiv	hiv	PROPN
ajlm-1964	287	6	infection	infection	NOUN
ajlm-1964	287	7	.	.	PUNCT
ajlm-1964	288	1	infect	infect	VERB
ajlm-1964	288	2	dis	dis	PROPN
ajlm-1964	288	3	rep	rep	PROPN
ajlm-1964	288	4	.	.	PROPN
ajlm-1964	288	5	2013;5(suppl	2013;5(suppl	PROPN
ajlm-1964	288	6	.	.	PUNCT
ajlm-1964	288	7	1):e6	1):e6	NUM
ajlm-1964	288	8	.	.	PUNCT
ajlm-1964	289	1	https://doi.org/10.4081/idr.2013.s1.e6	https://doi.org/10.4081/idr.2013.s1.e6	PROPN
ajlm-1964	289	2	unaids	unaid	NOUN
ajlm-1964	289	3	.	.	PUNCT
ajlm-1964	290	1	global	global	PROPN
ajlm-1964	290	2	hiv	hiv	PROPN
ajlm-1964	290	3	&	&	CCONJ
ajlm-1964	290	4	aids	aids	PROPN
ajlm-1964	290	5	statistics	statistic	NOUN
ajlm-1964	290	6	–	–	PUNCT
ajlm-1964	290	7	fact	fact	NOUN
ajlm-1964	290	8	sheet	sheet	NOUN
ajlm-1964	291	1	[	[	X
ajlm-1964	291	2	home	home	NOUN
ajlm-1964	291	3	on	on	ADP
ajlm-1964	291	4	the	the	DET
ajlm-1964	291	5	internet	internet	NOUN
ajlm-1964	291	6	]	]	PUNCT
ajlm-1964	291	7	.	.	PUNCT
ajlm-1964	292	1	2020	2020	NUM
ajlm-1964	293	1	[	[	X
ajlm-1964	293	2	cited	cite	VERB
ajlm-1964	293	3	2021	2021	NUM
ajlm-1964	293	4	sept	sept	PROPN
ajlm-1964	293	5	23	23	NUM
ajlm-1964	293	6	]	]	PUNCT
ajlm-1964	293	7	.	.	PUNCT
ajlm-1964	294	1	available	available	ADJ
ajlm-1964	294	2	from	from	ADP
ajlm-1964	294	3	:	:	PUNCT
ajlm-1964	294	4	https://www.unaids.org/en/resources/fact-sheet	https://www.unaids.org/en/resources/fact-sheet	PROPN
ajlm-1964	294	5	world	world	PROPN
ajlm-1964	294	6	health	health	NOUN
ajlm-1964	294	7	organization	organization	NOUN
ajlm-1964	294	8	(	(	PUNCT
ajlm-1964	294	9	who	who	PRON
ajlm-1964	294	10	)	)	PUNCT
ajlm-1964	294	11	.	.	PUNCT
ajlm-1964	295	1	tuberculosis	tuberculosis	NOUN
ajlm-1964	296	1	[	[	X
ajlm-1964	296	2	homepage	homepage	NOUN
ajlm-1964	296	3	on	on	ADP
ajlm-1964	296	4	the	the	DET
ajlm-1964	296	5	internet	internet	NOUN
ajlm-1964	296	6	]	]	PUNCT
ajlm-1964	296	7	.	.	PUNCT
ajlm-1964	296	8	2018	2018	NUM
ajlm-1964	297	1	[	[	X
ajlm-1964	297	2	cited	cite	VERB
ajlm-1964	297	3	2021	2021	NUM
ajlm-1964	297	4	nov	nov	NOUN
ajlm-1964	297	5	07	07	NUM
ajlm-1964	297	6	]	]	PUNCT
ajlm-1964	297	7	.	.	PUNCT
ajlm-1964	298	1	available	available	ADJ
ajlm-1964	298	2	from	from	ADP
ajlm-1964	298	3	:	:	PUNCT
ajlm-1964	298	4	https://www.who.int/news-room/q-a-detail/tuberculosis	https://www.who.int/news-room/q-a-detail/tuberculosis	ADV
ajlm-1964	298	5	toth	toth	PROPN
ajlm-1964	298	6	a	a	PROPN
ajlm-1964	298	7	,	,	PUNCT
ajlm-1964	298	8	fackelmann	fackelmann	PROPN
ajlm-1964	298	9	j	j	PROPN
ajlm-1964	298	10	,	,	PUNCT
ajlm-1964	298	11	pigott	pigott	PROPN
ajlm-1964	298	12	w	w	PROPN
ajlm-1964	298	13	,	,	PUNCT
ajlm-1964	298	14	tolomeo	tolomeo	NOUN
ajlm-1964	298	15	o.	o.	NOUN
ajlm-1964	298	16	tuberculosis	tuberculosis	NOUN
ajlm-1964	298	17	prevention	prevention	NOUN
ajlm-1964	298	18	and	and	CCONJ
ajlm-1964	298	19	treatment	treatment	NOUN
ajlm-1964	298	20	.	.	PUNCT
ajlm-1964	299	1	can	can	AUX
ajlm-1964	299	2	nurse	nurse	VERB
ajlm-1964	299	3	.	.	PUNCT
ajlm-1964	300	1	2004;100(9):27–30	2004;100(9):27–30	PROPN
ajlm-1964	300	2	.	.	PUNCT
ajlm-1964	301	1	world	world	PROPN
ajlm-1964	301	2	health	health	PROPN
ajlm-1964	301	3	organization	organization	NOUN
ajlm-1964	301	4	(	(	PUNCT
ajlm-1964	301	5	who	who	PRON
ajlm-1964	301	6	)	)	PUNCT
ajlm-1964	301	7	.	.	PUNCT
ajlm-1964	302	1	global	global	ADJ
ajlm-1964	302	2	tuberculosis	tuberculosis	NOUN
ajlm-1964	302	3	report	report	NOUN
ajlm-1964	302	4	2020	2020	NUM
ajlm-1964	303	1	[	[	X
ajlm-1964	303	2	homepage	homepage	NOUN
ajlm-1964	303	3	on	on	ADP
ajlm-1964	303	4	the	the	DET
ajlm-1964	303	5	internet	internet	NOUN
ajlm-1964	303	6	]	]	PUNCT
ajlm-1964	303	7	.	.	PUNCT
ajlm-1964	303	8	2020	2020	NUM
ajlm-1964	304	1	[	[	X
ajlm-1964	304	2	cited	cite	VERB
ajlm-1964	304	3	2021	2021	NUM
ajlm-1964	304	4	sept	sept	PROPN
ajlm-1964	304	5	23	23	NUM
ajlm-1964	304	6	]	]	PUNCT
ajlm-1964	304	7	.	.	PUNCT
ajlm-1964	305	1	available	available	ADJ
ajlm-1964	305	2	from	from	ADP
ajlm-1964	305	3	:	:	PUNCT
ajlm-1964	305	4	https://www.who.int/publications/i/item/9789240013131	https://www.who.int/publications/i/item/9789240013131	PROPN
ajlm-1964	305	5	world	world	PROPN
ajlm-1964	305	6	health	health	PROPN
ajlm-1964	305	7	organization	organization	NOUN
ajlm-1964	305	8	(	(	PUNCT
ajlm-1964	305	9	who	who	PRON
ajlm-1964	305	10	)	)	PUNCT
ajlm-1964	305	11	.	.	PUNCT
ajlm-1964	306	1	ebola	ebola	PROPN
ajlm-1964	306	2	virus	virus	NOUN
ajlm-1964	306	3	disease	disease	NOUN
ajlm-1964	306	4	[	[	X
ajlm-1964	306	5	home	home	NOUN
ajlm-1964	306	6	on	on	ADP
ajlm-1964	306	7	the	the	DET
ajlm-1964	306	8	internet	internet	NOUN
ajlm-1964	306	9	]	]	PUNCT
ajlm-1964	306	10	.	.	PUNCT
ajlm-1964	307	1	2021	2021	NUM
ajlm-1964	308	1	[	[	X
ajlm-1964	308	2	cited	cite	VERB
ajlm-1964	308	3	2021	2021	NUM
ajlm-1964	308	4	sept	sept	PROPN
ajlm-1964	308	5	23	23	NUM
ajlm-1964	308	6	]	]	PUNCT
ajlm-1964	308	7	.	.	PUNCT
ajlm-1964	309	1	available	available	ADJ
ajlm-1964	309	2	from	from	ADP
ajlm-1964	309	3	:	:	PUNCT
ajlm-1964	309	4	https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease	https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease	ADJ
ajlm-1964	309	5	baseler	baseler	NOUN
ajlm-1964	309	6	l	l	PROPN
ajlm-1964	309	7	,	,	PUNCT
ajlm-1964	309	8	chertow	chertow	NOUN
ajlm-1964	309	9	ds	ds	PROPN
ajlm-1964	309	10	,	,	PUNCT
ajlm-1964	309	11	johnson	johnson	PROPN
ajlm-1964	309	12	km	km	PROPN
ajlm-1964	309	13	,	,	PUNCT
ajlm-1964	309	14	feldmann	feldmann	PROPN
ajlm-1964	309	15	h	h	NOUN
ajlm-1964	309	16	,	,	PUNCT
ajlm-1964	309	17	morens	moren	NOUN
ajlm-1964	309	18	dm	dm	PROPN
ajlm-1964	309	19	.	.	PUNCT
ajlm-1964	310	1	the	the	DET
ajlm-1964	310	2	pathogenesis	pathogenesis	NOUN
ajlm-1964	310	3	of	of	ADP
ajlm-1964	310	4	ebola	ebola	PROPN
ajlm-1964	310	5	virus	virus	NOUN
ajlm-1964	310	6	disease	disease	NOUN
ajlm-1964	310	7	.	.	PUNCT
ajlm-1964	311	1	ann	ann	PROPN
ajlm-1964	311	2	rev	rev	PROPN
ajlm-1964	311	3	pathol	pathol	PROPN
ajlm-1964	311	4	.	.	PUNCT
ajlm-1964	312	1	2017;12:387–418	2017;12:387–418	NOUN
ajlm-1964	312	2	.	.	PUNCT
ajlm-1964	313	1	https://doi.org/10.1146/annurev-pathol-052016-100506	https://doi.org/10.1146/annurev-pathol-052016-100506	PROPN
ajlm-1964	313	2	world	world	PROPN
ajlm-1964	313	3	health	health	NOUN
ajlm-1964	313	4	organization	organization	NOUN
ajlm-1964	313	5	(	(	PUNCT
ajlm-1964	313	6	who	who	PRON
ajlm-1964	313	7	)	)	PUNCT
ajlm-1964	313	8	.	.	PUNCT
ajlm-1964	314	1	ebola	ebola	PROPN
ajlm-1964	314	2	haemorrhagic	haemorrhagic	ADJ
ajlm-1964	314	3	fever	fever	NOUN
ajlm-1964	314	4	in	in	ADP
ajlm-1964	314	5	zaire	zaire	PROPN
ajlm-1964	314	6	,	,	PUNCT
ajlm-1964	314	7	1976	1976	NUM
ajlm-1964	314	8	.	.	PUNCT
ajlm-1964	315	1	bull	bull	PROPN
ajlm-1964	315	2	world	world	PROPN
ajlm-1964	315	3	health	health	NOUN
ajlm-1964	315	4	organ	organ	NOUN
ajlm-1964	315	5	.	.	PUNCT
ajlm-1964	316	1	1978;56(2):271–293	1978;56(2):271–293	X
ajlm-1964	316	2	.	.	NUM
ajlm-1964	316	3	rouquet	rouquet	VERB
ajlm-1964	316	4	p	p	PRON
ajlm-1964	316	5	,	,	PUNCT
ajlm-1964	316	6	froment	froment	PROPN
ajlm-1964	316	7	j	j	PROPN
ajlm-1964	316	8	-	-	PROPN
ajlm-1964	316	9	m	m	PROPN
ajlm-1964	316	10	,	,	PUNCT
ajlm-1964	316	11	bermejo	bermejo	PROPN
ajlm-1964	316	12	m	m	PROPN
ajlm-1964	316	13	,	,	PUNCT
ajlm-1964	316	14	et	et	PROPN
ajlm-1964	316	15	al	al	PROPN
ajlm-1964	316	16	.	.	PUNCT
ajlm-1964	317	1	wild	wild	ADJ
ajlm-1964	317	2	animal	animal	NOUN
ajlm-1964	317	3	mortality	mortality	NOUN
ajlm-1964	317	4	monitoring	monitoring	NOUN
ajlm-1964	317	5	and	and	CCONJ
ajlm-1964	317	6	human	human	ADJ
ajlm-1964	317	7	ebola	ebola	PROPN
ajlm-1964	317	8	outbreaks	outbreak	NOUN
ajlm-1964	317	9	,	,	PUNCT
ajlm-1964	317	10	gabon	gabon	PROPN
ajlm-1964	317	11	and	and	CCONJ
ajlm-1964	317	12	republic	republic	NOUN
ajlm-1964	317	13	of	of	ADP
ajlm-1964	317	14	congo	congo	PROPN
ajlm-1964	317	15	,	,	PUNCT
ajlm-1964	317	16	2001–2003	2001–2003	NUM
ajlm-1964	317	17	.	.	PROPN
ajlm-1964	317	18	emerg	emerg	PROPN
ajlm-1964	317	19	infect	infect	ADJ
ajlm-1964	317	20	dis	dis	PROPN
ajlm-1964	317	21	.	.	PUNCT
ajlm-1964	318	1	2005;11(2):283–290	2005;11(2):283–290	X
ajlm-1964	318	2	.	.	PROPN
ajlm-1964	318	3	https://doi.org/10.3201/eid1102.040533	https://doi.org/10.3201/eid1102.040533	PROPN
ajlm-1964	318	4	cdc	cdc	PROPN
ajlm-1964	318	5	.	.	PUNCT
ajlm-1964	319	1	2014–2016	2014–2016	NUM
ajlm-1964	319	2	ebola	ebola	PROPN
ajlm-1964	319	3	outbreak	outbreak	NOUN
ajlm-1964	319	4	in	in	ADP
ajlm-1964	319	5	west	west	PROPN
ajlm-1964	319	6	africa	africa	PROPN
ajlm-1964	320	1	|	|	ADV
ajlm-1964	320	2	history	history	NOUN
ajlm-1964	321	1	|	|	ADV
ajlm-1964	321	2	ebola	ebola	PROPN
ajlm-1964	321	3	(	(	PUNCT
ajlm-1964	321	4	ebola	ebola	NOUN
ajlm-1964	321	5	virus	virus	NOUN
ajlm-1964	321	6	disease	disease	NOUN
ajlm-1964	321	7	)	)	PUNCT
ajlm-1964	322	1	|	|	ADV
ajlm-1964	322	2	cdc	cdc	PROPN
ajlm-1964	323	1	[	[	X
ajlm-1964	323	2	home	home	NOUN
ajlm-1964	323	3	on	on	ADP
ajlm-1964	323	4	the	the	DET
ajlm-1964	323	5	internet	internet	NOUN
ajlm-1964	323	6	]	]	PUNCT
ajlm-1964	323	7	.	.	PUNCT
ajlm-1964	324	1	2016	2016	NUM
ajlm-1964	325	1	[	[	X
ajlm-1964	325	2	cited	cite	VERB
ajlm-1964	325	3	2021	2021	NUM
ajlm-1964	325	4	sept	sept	PROPN
ajlm-1964	325	5	23	23	NUM
ajlm-1964	325	6	]	]	PUNCT
ajlm-1964	325	7	.	.	PUNCT
ajlm-1964	326	1	available	available	ADJ
ajlm-1964	326	2	from	from	ADP
ajlm-1964	326	3	:	:	PUNCT
ajlm-1964	326	4	https://www.cdc.gov/vhf/ebola/history/2014-2016-outbreak/index.html	https://www.cdc.gov/vhf/ebola/history/2014-2016-outbreak/index.html	PROPN
ajlm-1964	326	5	coltart	coltart	NOUN
ajlm-1964	326	6	cem	cem	NOUN
ajlm-1964	326	7	,	,	PUNCT
ajlm-1964	326	8	lindsey	lindsey	PROPN
ajlm-1964	326	9	b	b	PROPN
ajlm-1964	326	10	,	,	PUNCT
ajlm-1964	326	11	ghinai	ghinai	ADJ
ajlm-1964	326	12	i	i	PROPN
ajlm-1964	326	13	,	,	PUNCT
ajlm-1964	326	14	johnson	johnson	PROPN
ajlm-1964	326	15	am	be	AUX
ajlm-1964	326	16	,	,	PUNCT
ajlm-1964	326	17	heymann	heymann	PROPN
ajlm-1964	326	18	dl	dl	PROPN
ajlm-1964	326	19	.	.	PUNCT
ajlm-1964	327	1	the	the	DET
ajlm-1964	327	2	ebola	ebola	PROPN
ajlm-1964	327	3	outbreak	outbreak	NOUN
ajlm-1964	327	4	,	,	PUNCT
ajlm-1964	327	5	2013–2016	2013–2016	NUM
ajlm-1964	327	6	:	:	PUNCT
ajlm-1964	327	7	old	old	ADJ
ajlm-1964	327	8	lessons	lesson	NOUN
ajlm-1964	327	9	for	for	ADP
ajlm-1964	327	10	new	new	ADJ
ajlm-1964	327	11	epidemics	epidemic	NOUN
ajlm-1964	327	12	.	.	PUNCT
ajlm-1964	328	1	philos	philos	PROPN
ajlm-1964	328	2	trans	trans	PROPN
ajlm-1964	328	3	r	r	PROPN
ajlm-1964	328	4	soc	soc	PROPN
ajlm-1964	328	5	b	b	PROPN
ajlm-1964	328	6	biol	biol	PROPN
ajlm-1964	328	7	sci	sci	PROPN
ajlm-1964	328	8	.	.	PROPN
ajlm-1964	328	9	2017;372(1721):20160297	2017;372(1721):20160297	PROPN
ajlm-1964	328	10	.	.	PUNCT
ajlm-1964	329	1	https://doi.org/10.1098/rstb.2016.0297	https://doi.org/10.1098/rstb.2016.0297	PROPN
ajlm-1964	329	2	rojek	rojek	VERB
ajlm-1964	329	3	a	a	PRON
ajlm-1964	329	4	,	,	PUNCT
ajlm-1964	329	5	horby	horby	VERB
ajlm-1964	329	6	p	p	PRON
ajlm-1964	329	7	,	,	PUNCT
ajlm-1964	329	8	dunning	dun	VERB
ajlm-1964	329	9	j.	j.	PROPN
ajlm-1964	329	10	insights	insight	NOUN
ajlm-1964	329	11	from	from	ADP
ajlm-1964	329	12	clinical	clinical	ADJ
ajlm-1964	329	13	research	research	NOUN
ajlm-1964	329	14	completed	complete	VERB
ajlm-1964	329	15	during	during	ADP
ajlm-1964	329	16	the	the	DET
ajlm-1964	329	17	west	west	PROPN
ajlm-1964	329	18	africa	africa	PROPN
ajlm-1964	329	19	ebola	ebola	PROPN
ajlm-1964	329	20	virus	virus	PROPN
ajlm-1964	329	21	disease	disease	NOUN
ajlm-1964	329	22	epidemic	epidemic	NOUN
ajlm-1964	329	23	.	.	PUNCT
ajlm-1964	330	1	lancet	lancet	PROPN
ajlm-1964	330	2	infect	infect	PROPN
ajlm-1964	330	3	dis	dis	PROPN
ajlm-1964	330	4	.	.	PUNCT
ajlm-1964	331	1	2017;17(9	2017;17(9	NUM
ajlm-1964	331	2	):	):	PUNCT
ajlm-1964	331	3	e280	e280	PROPN
ajlm-1964	331	4	–	–	PUNCT
ajlm-1964	331	5	e292	e292	NUM
ajlm-1964	331	6	.	.	PUNCT
ajlm-1964	332	1	https://doi.org/10.1016/s1473-3099(17)30234-7	https://doi.org/10.1016/s1473-3099(17)30234-7	PROPN
ajlm-1964	332	2	iwasaki	iwasaki	PROPN
ajlm-1964	332	3	a	a	PROPN
ajlm-1964	332	4	,	,	PUNCT
ajlm-1964	332	5	medzhitov	medzhitov	PROPN
ajlm-1964	332	6	r.	r.	PROPN
ajlm-1964	332	7	control	control	PROPN
ajlm-1964	332	8	of	of	ADP
ajlm-1964	332	9	adaptive	adaptive	ADJ
ajlm-1964	332	10	immunity	immunity	NOUN
ajlm-1964	332	11	by	by	ADP
ajlm-1964	332	12	the	the	DET
ajlm-1964	332	13	innate	innate	ADJ
ajlm-1964	332	14	immune	immune	ADJ
ajlm-1964	332	15	system	system	NOUN
ajlm-1964	332	16	.	.	PUNCT
ajlm-1964	333	1	nat	nat	PROPN
ajlm-1964	333	2	immunol	immunol	NOUN
ajlm-1964	333	3	.	.	PUNCT
ajlm-1964	334	1	2015;16(4):343–353	2015;16(4):343–353	NUM
ajlm-1964	334	2	.	.	PUNCT
ajlm-1964	335	1	https://doi.org/10.1038/ni.3123	https://doi.org/10.1038/ni.3123	X
ajlm-1964	335	2	schenten	schenten	ADJ
ajlm-1964	335	3	d	d	PROPN
ajlm-1964	335	4	,	,	PUNCT
ajlm-1964	335	5	medzhitov	medzhitov	PROPN
ajlm-1964	335	6	r.	r.	PROPN
ajlm-1964	335	7	the	the	DET
ajlm-1964	335	8	control	control	NOUN
ajlm-1964	335	9	of	of	ADP
ajlm-1964	335	10	adaptive	adaptive	ADJ
ajlm-1964	335	11	immune	immune	ADJ
ajlm-1964	335	12	responses	response	NOUN
ajlm-1964	335	13	by	by	ADP
ajlm-1964	335	14	the	the	DET
ajlm-1964	335	15	innate	innate	ADJ
ajlm-1964	335	16	immune	immune	ADJ
ajlm-1964	335	17	system	system	NOUN
ajlm-1964	335	18	.	.	PUNCT
ajlm-1964	336	1	adv	adv	PROPN
ajlm-1964	336	2	immunol	immunol	NOUN
ajlm-1964	336	3	.	.	PUNCT
ajlm-1964	337	1	2011;109:87–124	2011;109:87–124	X
ajlm-1964	337	2	.	.	PUNCT
ajlm-1964	337	3	https://doi.org/10.1016/b978-0-12-387664-5.00003-0	https://doi.org/10.1016/b978-0-12-387664-5.00003-0	PROPN
ajlm-1964	337	4	dianzani	dianzani	PROPN
ajlm-1964	337	5	f	f	PROPN
ajlm-1964	337	6	,	,	PUNCT
ajlm-1964	337	7	baron	baron	PROPN
ajlm-1964	337	8	s.	s.	PROPN
ajlm-1964	337	9	nonspecific	nonspecific	PROPN
ajlm-1964	337	10	defenses	defense	NOUN
ajlm-1964	337	11	.	.	PUNCT
ajlm-1964	338	1	in	in	ADP
ajlm-1964	338	2	:	:	PUNCT
ajlm-1964	338	3	baron	baron	PROPN
ajlm-1964	338	4	s	s	PROPN
ajlm-1964	338	5	,	,	PUNCT
ajlm-1964	338	6	editor	editor	NOUN
ajlm-1964	338	7	.	.	PUNCT
ajlm-1964	339	1	medical	medical	ADJ
ajlm-1964	339	2	microbiology	microbiology	NOUN
ajlm-1964	340	1	[	[	X
ajlm-1964	340	2	homepage	homepage	NOUN
ajlm-1964	340	3	on	on	ADP
ajlm-1964	340	4	the	the	DET
ajlm-1964	340	5	internet	internet	NOUN
ajlm-1964	340	6	]	]	PUNCT
ajlm-1964	340	7	.	.	PUNCT
ajlm-1964	341	1	4th	4th	ADJ
ajlm-1964	341	2	ed	ed	NOUN
ajlm-1964	341	3	.	.	PUNCT
ajlm-1964	342	1	galveston	galveston	PROPN
ajlm-1964	342	2	,	,	PUNCT
ajlm-1964	342	3	tx	tx	PROPN
ajlm-1964	342	4	:	:	PUNCT
ajlm-1964	342	5	university	university	PROPN
ajlm-1964	342	6	of	of	ADP
ajlm-1964	342	7	texas	texas	PROPN
ajlm-1964	342	8	medical	medical	PROPN
ajlm-1964	342	9	branch	branch	PROPN
ajlm-1964	342	10	at	at	ADP
ajlm-1964	342	11	galveston	galveston	PROPN
ajlm-1964	342	12	;	;	PUNCT
ajlm-1964	342	13	1996	1996	NUM
ajlm-1964	342	14	[	[	X
ajlm-1964	342	15	cited	cite	VERB
ajlm-1964	342	16	2021	2021	NUM
ajlm-1964	342	17	nov	nov	NOUN
ajlm-1964	342	18	21	21	NUM
ajlm-1964	342	19	]	]	PUNCT
ajlm-1964	342	20	.	.	PUNCT
ajlm-1964	343	1	available	available	ADJ
ajlm-1964	343	2	from	from	ADP
ajlm-1964	343	3	:	:	PUNCT
ajlm-1964	343	4	http://www.ncbi.nlm.nih.gov/books/nbk8348/	http://www.ncbi.nlm.nih.gov/books/nbk8348/	PROPN
ajlm-1964	343	5	klimpel	klimpel	PROPN
ajlm-1964	343	6	gr	gr	PROPN
ajlm-1964	343	7	.	.	PROPN
ajlm-1964	343	8	immune	immune	ADJ
ajlm-1964	343	9	defenses	defense	NOUN
ajlm-1964	343	10	.	.	PUNCT
ajlm-1964	344	1	in	in	ADP
ajlm-1964	344	2	:	:	PUNCT
ajlm-1964	344	3	baron	baron	PROPN
ajlm-1964	344	4	s	s	PROPN
ajlm-1964	344	5	,	,	PUNCT
ajlm-1964	344	6	editor	editor	NOUN
ajlm-1964	344	7	.	.	PUNCT
ajlm-1964	345	1	medical	medical	ADJ
ajlm-1964	345	2	microbiology	microbiology	NOUN
ajlm-1964	346	1	[	[	X
ajlm-1964	346	2	homepage	homepage	NOUN
ajlm-1964	346	3	on	on	ADP
ajlm-1964	346	4	the	the	DET
ajlm-1964	346	5	internet	internet	NOUN
ajlm-1964	346	6	]	]	PUNCT
ajlm-1964	346	7	.	.	PUNCT
ajlm-1964	347	1	4th	4th	ADJ
ajlm-1964	347	2	ed	ed	NOUN
ajlm-1964	347	3	.	.	PUNCT
ajlm-1964	348	1	galveston	galveston	PROPN
ajlm-1964	348	2	,	,	PUNCT
ajlm-1964	348	3	tx	tx	PROPN
ajlm-1964	348	4	:	:	PUNCT
ajlm-1964	348	5	university	university	PROPN
ajlm-1964	348	6	of	of	ADP
ajlm-1964	348	7	texas	texas	PROPN
ajlm-1964	348	8	medical	medical	PROPN
ajlm-1964	348	9	branch	branch	PROPN
ajlm-1964	348	10	at	at	ADP
ajlm-1964	348	11	galveston	galveston	PROPN
ajlm-1964	348	12	;	;	PUNCT
ajlm-1964	348	13	1996	1996	NUM
ajlm-1964	348	14	[	[	X
ajlm-1964	348	15	cited	cite	VERB
ajlm-1964	348	16	2021	2021	NUM
ajlm-1964	348	17	nov	nov	NOUN
ajlm-1964	348	18	21	21	NUM
ajlm-1964	348	19	]	]	PUNCT
ajlm-1964	348	20	.	.	PUNCT
ajlm-1964	349	1	available	available	ADJ
ajlm-1964	349	2	from	from	ADP
ajlm-1964	349	3	:	:	PUNCT
ajlm-1964	349	4	http://www.ncbi.nlm.nih.gov/books/nbk8423/	http://www.ncbi.nlm.nih.gov/books/nbk8423/	PROPN
ajlm-1964	349	5	netea	netea	NOUN
ajlm-1964	349	6	mg	mg	PROPN
ajlm-1964	349	7	,	,	PUNCT
ajlm-1964	349	8	domínguez	domínguez	NOUN
ajlm-1964	349	9	-	-	PUNCT
ajlm-1964	349	10	andrés	andrés	PROPN
ajlm-1964	349	11	j	j	PROPN
ajlm-1964	349	12	,	,	PUNCT
ajlm-1964	349	13	barreiro	barreiro	PROPN
ajlm-1964	349	14	lb	lb	PROPN
ajlm-1964	349	15	,	,	PUNCT
ajlm-1964	349	16	et	et	PROPN
ajlm-1964	349	17	al	al	PROPN
ajlm-1964	349	18	.	.	PUNCT
ajlm-1964	350	1	defining	define	VERB
ajlm-1964	350	2	trained	train	VERB
ajlm-1964	350	3	immunity	immunity	NOUN
ajlm-1964	350	4	and	and	CCONJ
ajlm-1964	350	5	its	its	PRON
ajlm-1964	350	6	role	role	NOUN
ajlm-1964	350	7	in	in	ADP
ajlm-1964	350	8	health	health	NOUN
ajlm-1964	350	9	and	and	CCONJ
ajlm-1964	350	10	disease	disease	NOUN
ajlm-1964	350	11	.	.	PUNCT
ajlm-1964	351	1	nat	nat	PROPN
ajlm-1964	351	2	rev	rev	VERB
ajlm-1964	351	3	immunol	immunol	NOUN
ajlm-1964	351	4	.	.	PUNCT
ajlm-1964	352	1	2020;20(6):375–388	2020;20(6):375–388	NUM
ajlm-1964	352	2	.	.	NOUN
ajlm-1964	352	3	https://doi.org/10.1038/s41577-020-0285-6	https://doi.org/10.1038/s41577-020-0285-6	NUM
ajlm-1964	353	1	netea	netea	NOUN
ajlm-1964	353	2	mg	mg	PROPN
ajlm-1964	353	3	,	,	PUNCT
ajlm-1964	353	4	quintin	quintin	PROPN
ajlm-1964	353	5	j	j	PROPN
ajlm-1964	353	6	,	,	PUNCT
ajlm-1964	353	7	van	van	PROPN
ajlm-1964	353	8	der	der	PROPN
ajlm-1964	353	9	meer	meer	PROPN
ajlm-1964	353	10	jwm	jwm	PROPN
ajlm-1964	353	11	.	.	PUNCT
ajlm-1964	354	1	trained	train	VERB
ajlm-1964	354	2	immunity	immunity	NOUN
ajlm-1964	354	3	:	:	PUNCT
ajlm-1964	354	4	a	a	DET
ajlm-1964	354	5	memory	memory	NOUN
ajlm-1964	354	6	for	for	ADP
ajlm-1964	354	7	innate	innate	ADJ
ajlm-1964	354	8	host	host	NOUN
ajlm-1964	354	9	defense	defense	NOUN
ajlm-1964	354	10	.	.	PUNCT
ajlm-1964	355	1	cell	cell	NOUN
ajlm-1964	355	2	host	host	NOUN
ajlm-1964	355	3	microbe	microbe	NOUN
ajlm-1964	355	4	.	.	PUNCT
ajlm-1964	356	1	2011;9(5):355–361	2011;9(5):355–361	X
ajlm-1964	356	2	.	.	PROPN
ajlm-1964	356	3	https://doi.org/10.1016/j.chom.2011.04.006	https://doi.org/10.1016/j.chom.2011.04.006	VERB
ajlm-1964	356	4	divangahi	divangahi	PROPN
ajlm-1964	356	5	m	m	PROPN
ajlm-1964	356	6	,	,	PUNCT
ajlm-1964	356	7	aaby	aaby	NOUN
ajlm-1964	356	8	p	p	NOUN
ajlm-1964	356	9	,	,	PUNCT
ajlm-1964	356	10	khader	khader	PROPN
ajlm-1964	356	11	sa	sa	PROPN
ajlm-1964	356	12	,	,	PUNCT
ajlm-1964	356	13	et	et	PROPN
ajlm-1964	356	14	al	al	PROPN
ajlm-1964	356	15	.	.	PROPN
ajlm-1964	356	16	trained	train	VERB
ajlm-1964	356	17	immunity	immunity	NOUN
ajlm-1964	356	18	,	,	PUNCT
ajlm-1964	356	19	tolerance	tolerance	NOUN
ajlm-1964	356	20	,	,	PUNCT
ajlm-1964	356	21	priming	priming	NOUN
ajlm-1964	356	22	and	and	CCONJ
ajlm-1964	356	23	differentiation	differentiation	NOUN
ajlm-1964	356	24	:	:	PUNCT
ajlm-1964	356	25	distinct	distinct	ADJ
ajlm-1964	356	26	immunological	immunological	ADJ
ajlm-1964	356	27	processes	process	NOUN
ajlm-1964	356	28	.	.	PUNCT
ajlm-1964	357	1	nat	nat	PROPN
ajlm-1964	357	2	immunol	immunol	NOUN
ajlm-1964	357	3	.	.	PUNCT
ajlm-1964	358	1	2021;22(1):2–6	2021;22(1):2–6	X
ajlm-1964	358	2	.	.	PUNCT
ajlm-1964	359	1	https://doi.org/10.1038/s41590-020-00845-6	https://doi.org/10.1038/s41590-020-00845-6	PROPN
ajlm-1964	359	2	peignier	peignier	NOUN
ajlm-1964	359	3	a	a	NOUN
ajlm-1964	359	4	,	,	PUNCT
ajlm-1964	359	5	parker	parker	PROPN
ajlm-1964	359	6	d.	d.	PROPN
ajlm-1964	359	7	trained	train	VERB
ajlm-1964	359	8	immunity	immunity	NOUN
ajlm-1964	359	9	and	and	CCONJ
ajlm-1964	359	10	host	host	NOUN
ajlm-1964	359	11	-	-	PUNCT
ajlm-1964	359	12	pathogen	pathogen	NOUN
ajlm-1964	359	13	interactions	interaction	NOUN
ajlm-1964	359	14	.	.	PUNCT
ajlm-1964	360	1	cell	cell	NOUN
ajlm-1964	360	2	microbiol	microbiol	PROPN
ajlm-1964	360	3	.	.	PUNCT
ajlm-1964	361	1	2020;22(12	2020;22(12	NUM
ajlm-1964	361	2	):	):	PUNCT
ajlm-1964	361	3	e13261	e13261	NOUN
ajlm-1964	361	4	.	.	PUNCT
ajlm-1964	361	5	https://doi.org/10.1111/cmi.13261	https://doi.org/10.1111/cmi.13261	PROPN
ajlm-1964	361	6	ifrim	ifrim	PROPN
ajlm-1964	361	7	dc	dc	PROPN
ajlm-1964	361	8	,	,	PUNCT
ajlm-1964	361	9	quintin	quintin	PROPN
ajlm-1964	361	10	j	j	PROPN
ajlm-1964	361	11	,	,	PUNCT
ajlm-1964	361	12	joosten	joosten	VERB
ajlm-1964	361	13	lab	lab	NOUN
ajlm-1964	361	14	,	,	PUNCT
ajlm-1964	361	15	et	et	PROPN
ajlm-1964	361	16	al	al	PROPN
ajlm-1964	361	17	.	.	PROPN
ajlm-1964	362	1	trained	train	VERB
ajlm-1964	362	2	immunity	immunity	NOUN
ajlm-1964	362	3	or	or	CCONJ
ajlm-1964	362	4	tolerance	tolerance	NOUN
ajlm-1964	362	5	:	:	PUNCT
ajlm-1964	362	6	opposing	oppose	VERB
ajlm-1964	362	7	functional	functional	ADJ
ajlm-1964	362	8	programs	program	NOUN
ajlm-1964	362	9	induced	induce	VERB
ajlm-1964	362	10	in	in	ADP
ajlm-1964	362	11	human	human	ADJ
ajlm-1964	362	12	monocytes	monocyte	NOUN
ajlm-1964	362	13	after	after	ADP
ajlm-1964	362	14	engagement	engagement	NOUN
ajlm-1964	362	15	of	of	ADP
ajlm-1964	362	16	various	various	ADJ
ajlm-1964	362	17	pattern	pattern	NOUN
ajlm-1964	362	18	recognition	recognition	NOUN
ajlm-1964	362	19	receptors	receptor	NOUN
ajlm-1964	362	20	.	.	PUNCT
ajlm-1964	363	1	clin	clin	PROPN
ajlm-1964	363	2	vaccine	vaccine	NOUN
ajlm-1964	363	3	immunol	immunol	NOUN
ajlm-1964	363	4	.	.	PUNCT
ajlm-1964	364	1	2014;21(4):534–545	2014;21(4):534–545	X
ajlm-1964	364	2	.	.	PUNCT
ajlm-1964	365	1	https://doi.org/10.1128/cvi.00688-13	https://doi.org/10.1128/cvi.00688-13	PROPN
ajlm-1964	365	2	kleinnijenhuis	kleinnijenhuis	PROPN
ajlm-1964	365	3	j	j	PROPN
ajlm-1964	365	4	,	,	PUNCT
ajlm-1964	365	5	quintin	quintin	PROPN
ajlm-1964	365	6	j	j	PROPN
ajlm-1964	365	7	,	,	PUNCT
ajlm-1964	365	8	preijers	preijer	NOUN
ajlm-1964	365	9	f	f	PROPN
ajlm-1964	365	10	,	,	PUNCT
ajlm-1964	365	11	et	et	PROPN
ajlm-1964	365	12	al	al	PROPN
ajlm-1964	365	13	.	.	PUNCT
ajlm-1964	365	14	bacille	bacille	PROPN
ajlm-1964	365	15	calmette	calmette	PROPN
ajlm-1964	365	16	-	-	PUNCT
ajlm-1964	365	17	guerin	guerin	PROPN
ajlm-1964	365	18	induces	induce	VERB
ajlm-1964	365	19	nod2	nod2	NOUN
ajlm-1964	365	20	-	-	PUNCT
ajlm-1964	365	21	dependent	dependent	ADJ
ajlm-1964	365	22	nonspecific	nonspecific	ADJ
ajlm-1964	365	23	protection	protection	NOUN
ajlm-1964	365	24	from	from	ADP
ajlm-1964	365	25	reinfection	reinfection	NOUN
ajlm-1964	365	26	via	via	ADP
ajlm-1964	365	27	epigenetic	epigenetic	ADJ
ajlm-1964	365	28	reprogramming	reprogramming	NOUN
ajlm-1964	365	29	of	of	ADP
ajlm-1964	365	30	monocytes	monocyte	NOUN
ajlm-1964	365	31	.	.	PUNCT
ajlm-1964	366	1	proc	proc	PROPN
ajlm-1964	366	2	natl	natl	PROPN
ajlm-1964	366	3	acad	acad	PROPN
ajlm-1964	366	4	sci	sci	PROPN
ajlm-1964	366	5	u	u	PROPN
ajlm-1964	366	6	s	s	NOUN
ajlm-1964	366	7	a.	a.	NOUN
ajlm-1964	366	8	2012;109(43):17537–17542	2012;109(43):17537–17542	NUM
ajlm-1964	366	9	.	.	PUNCT
ajlm-1964	367	1	https://doi.org/10.1073/pnas.1202870109	https://doi.org/10.1073/pnas.1202870109	VERB
ajlm-1964	367	2	lerm	lerm	PROPN
ajlm-1964	367	3	m	m	PROPN
ajlm-1964	367	4	,	,	PUNCT
ajlm-1964	367	5	netea	netea	NOUN
ajlm-1964	367	6	mg	mg	PROPN
ajlm-1964	367	7	.	.	PUNCT
ajlm-1964	368	1	trained	train	VERB
ajlm-1964	368	2	immunity	immunity	NOUN
ajlm-1964	368	3	:	:	PUNCT
ajlm-1964	368	4	a	a	DET
ajlm-1964	368	5	new	new	ADJ
ajlm-1964	368	6	avenue	avenue	NOUN
ajlm-1964	368	7	for	for	ADP
ajlm-1964	368	8	tuberculosis	tuberculosis	NOUN
ajlm-1964	368	9	vaccine	vaccine	NOUN
ajlm-1964	368	10	development	development	NOUN
ajlm-1964	368	11	.	.	PUNCT
ajlm-1964	369	1	j	j	PROPN
ajlm-1964	369	2	intern	intern	PROPN
ajlm-1964	369	3	med	me	VERB
ajlm-1964	369	4	.	.	PUNCT
ajlm-1964	370	1	2016;279(4):337–346	2016;279(4):337–346	NUM
ajlm-1964	370	2	.	.	PROPN
ajlm-1964	370	3	https://doi.org/10.1111/joim.12449	https://doi.org/10.1111/joim.12449	PROPN
ajlm-1964	370	4	sánchez	sánchez	PROPN
ajlm-1964	370	5	-	-	PUNCT
ajlm-1964	370	6	ramón	ramón	PROPN
ajlm-1964	370	7	s	s	PROPN
ajlm-1964	370	8	,	,	PUNCT
ajlm-1964	370	9	conejero	conejero	PROPN
ajlm-1964	370	10	l	l	NOUN
ajlm-1964	370	11	,	,	PUNCT
ajlm-1964	370	12	netea	netea	NOUN
ajlm-1964	370	13	mg	mg	PROPN
ajlm-1964	370	14	,	,	PUNCT
ajlm-1964	370	15	sancho	sancho	PROPN
ajlm-1964	370	16	d	d	PROPN
ajlm-1964	370	17	,	,	PUNCT
ajlm-1964	370	18	palomares	palomares	PROPN
ajlm-1964	370	19	ó	ó	PROPN
ajlm-1964	370	20	,	,	PUNCT
ajlm-1964	370	21	subiza	subiza	PROPN
ajlm-1964	370	22	jl	jl	PROPN
ajlm-1964	370	23	.	.	PUNCT
ajlm-1964	371	1	trained	train	VERB
ajlm-1964	371	2	immunity	immunity	NOUN
ajlm-1964	371	3	-	-	PUNCT
ajlm-1964	371	4	based	base	VERB
ajlm-1964	371	5	vaccines	vaccine	NOUN
ajlm-1964	371	6	:	:	PUNCT
ajlm-1964	371	7	a	a	DET
ajlm-1964	371	8	new	new	ADJ
ajlm-1964	371	9	paradigm	paradigm	NOUN
ajlm-1964	371	10	for	for	ADP
ajlm-1964	371	11	the	the	DET
ajlm-1964	371	12	development	development	NOUN
ajlm-1964	371	13	of	of	ADP
ajlm-1964	371	14	broad	broad	ADJ
ajlm-1964	371	15	-	-	PUNCT
ajlm-1964	371	16	spectrum	spectrum	NOUN
ajlm-1964	371	17	anti	anti	ADJ
ajlm-1964	371	18	-	-	ADJ
ajlm-1964	371	19	infectious	infectious	ADJ
ajlm-1964	371	20	formulations	formulation	NOUN
ajlm-1964	371	21	.	.	PUNCT
ajlm-1964	372	1	front	front	ADJ
ajlm-1964	372	2	immunol	immunol	NOUN
ajlm-1964	372	3	.	.	PUNCT
ajlm-1964	373	1	2018;9:2936	2018;9:2936	NOUN
ajlm-1964	373	2	.	.	PUNCT
ajlm-1964	374	1	https://doi.org/10.3389/fimmu.2018.02936	https://doi.org/10.3389/fimmu.2018.02936	PROPN
ajlm-1964	374	2	arts	arts	PROPN
ajlm-1964	374	3	rjw	rjw	PROPN
ajlm-1964	374	4	,	,	PUNCT
ajlm-1964	374	5	joosten	joosten	VERB
ajlm-1964	374	6	lab	lab	NOUN
ajlm-1964	374	7	,	,	PUNCT
ajlm-1964	374	8	netea	netea	NOUN
ajlm-1964	374	9	mg	mg	PROPN
ajlm-1964	374	10	.	.	PUNCT
ajlm-1964	375	1	the	the	DET
ajlm-1964	375	2	potential	potential	ADJ
ajlm-1964	375	3	role	role	NOUN
ajlm-1964	375	4	of	of	ADP
ajlm-1964	375	5	trained	train	VERB
ajlm-1964	375	6	immunity	immunity	NOUN
ajlm-1964	375	7	in	in	ADP
ajlm-1964	375	8	autoimmune	autoimmune	ADJ
ajlm-1964	375	9	and	and	CCONJ
ajlm-1964	375	10	auto	auto	NOUN
ajlm-1964	375	11	inflammatory	inflammatory	ADJ
ajlm-1964	375	12	disorders	disorder	NOUN
ajlm-1964	375	13	.	.	PUNCT
ajlm-1964	376	1	front	front	ADJ
ajlm-1964	376	2	immunol	immunol	NOUN
ajlm-1964	376	3	.	.	PUNCT
ajlm-1964	377	1	2018;9:298	2018;9:298	NOUN
ajlm-1964	377	2	.	.	PUNCT
ajlm-1964	378	1	https://doi.org/10.3389/fimmu.2018.00298	https://doi.org/10.3389/fimmu.2018.00298	PROPN
ajlm-1964	378	2	yuki	yuki	PROPN
ajlm-1964	378	3	k	k	PROPN
ajlm-1964	378	4	,	,	PUNCT
ajlm-1964	378	5	fujiogi	fujiogi	PROPN
ajlm-1964	378	6	m	m	PROPN
ajlm-1964	378	7	,	,	PUNCT
ajlm-1964	378	8	koutsogiannaki	koutsogiannaki	PROPN
ajlm-1964	378	9	s.	s.	PROPN
ajlm-1964	378	10	covid-19	covid-19	PROPN
ajlm-1964	378	11	pathophysiology	pathophysiology	NOUN
ajlm-1964	378	12	:	:	PUNCT
ajlm-1964	378	13	a	a	DET
ajlm-1964	378	14	review	review	NOUN
ajlm-1964	378	15	.	.	PUNCT
ajlm-1964	379	1	clin	clin	PROPN
ajlm-1964	379	2	immunol	immunol	NOUN
ajlm-1964	379	3	.	.	PUNCT
ajlm-1964	380	1	2020;215:108427	2020;215:108427	NUM
ajlm-1964	380	2	.	.	PUNCT
ajlm-1964	381	1	https://doi.org/10.1016/j.clim.2020.108427	https://doi.org/10.1016/j.clim.2020.108427	NOUN
ajlm-1964	381	2	chakrabarti	chakrabarti	VERB
ajlm-1964	381	3	ss	ss	PROPN
ajlm-1964	381	4	,	,	PUNCT
ajlm-1964	381	5	kaur	kaur	PROPN
ajlm-1964	381	6	u	u	PROPN
ajlm-1964	381	7	,	,	PUNCT
ajlm-1964	381	8	singh	singh	PROPN
ajlm-1964	381	9	a	a	X
ajlm-1964	381	10	,	,	PUNCT
ajlm-1964	381	11	et	et	PROPN
ajlm-1964	381	12	al	al	PROPN
ajlm-1964	381	13	.	.	PROPN
ajlm-1964	381	14	of	of	ADP
ajlm-1964	381	15	cross	cross	NOUN
ajlm-1964	381	16	-	-	NOUN
ajlm-1964	381	17	immunity	immunity	ADJ
ajlm-1964	381	18	,	,	PUNCT
ajlm-1964	381	19	herd	herd	NOUN
ajlm-1964	381	20	immunity	immunity	NOUN
ajlm-1964	381	21	and	and	CCONJ
ajlm-1964	381	22	country	country	NOUN
ajlm-1964	381	23	-	-	PUNCT
ajlm-1964	381	24	specific	specific	ADJ
ajlm-1964	381	25	plans	plan	NOUN
ajlm-1964	381	26	:	:	PUNCT
ajlm-1964	381	27	experiences	experience	NOUN
ajlm-1964	381	28	from	from	ADP
ajlm-1964	381	29	covid-19	covid-19	PROPN
ajlm-1964	381	30	in	in	ADP
ajlm-1964	381	31	india	india	PROPN
ajlm-1964	381	32	.	.	PUNCT
ajlm-1964	382	1	aging	age	VERB
ajlm-1964	382	2	dis	dis	PROPN
ajlm-1964	382	3	.	.	PUNCT
ajlm-1964	383	1	2020;11(6):1339	2020;11(6):1339	NUM
ajlm-1964	383	2	.	.	PUNCT
ajlm-1964	384	1	https://doi.org/10.14336/ad.2020.1104	https://doi.org/10.14336/ad.2020.1104	PROPN
ajlm-1964	384	2	gorse	gorse	PROPN
ajlm-1964	384	3	gj	gj	PROPN
ajlm-1964	384	4	,	,	PUNCT
ajlm-1964	384	5	patel	patel	PROPN
ajlm-1964	384	6	gb	gb	PROPN
ajlm-1964	384	7	,	,	PUNCT
ajlm-1964	384	8	vitale	vitale	PROPN
ajlm-1964	384	9	jn	jn	PROPN
ajlm-1964	384	10	,	,	PUNCT
ajlm-1964	384	11	o’connor	o’connor	ADV
ajlm-1964	384	12	tz	tz	PROPN
ajlm-1964	384	13	.	.	PUNCT
ajlm-1964	385	1	prevalence	prevalence	NOUN
ajlm-1964	385	2	of	of	ADP
ajlm-1964	385	3	antibodies	antibody	NOUN
ajlm-1964	385	4	to	to	ADP
ajlm-1964	385	5	four	four	NUM
ajlm-1964	385	6	human	human	ADJ
ajlm-1964	385	7	coronaviruses	coronaviruse	NOUN
ajlm-1964	385	8	is	be	AUX
ajlm-1964	385	9	lower	low	ADJ
ajlm-1964	385	10	in	in	ADP
ajlm-1964	385	11	nasal	nasal	ADJ
ajlm-1964	385	12	secretions	secretion	NOUN
ajlm-1964	385	13	than	than	ADP
ajlm-1964	385	14	in	in	ADP
ajlm-1964	385	15	serum	serum	NOUN
ajlm-1964	385	16	.	.	PUNCT
ajlm-1964	386	1	clin	clin	PROPN
ajlm-1964	386	2	vaccine	vaccine	NOUN
ajlm-1964	386	3	immunol	immunol	NOUN
ajlm-1964	386	4	.	.	PUNCT
ajlm-1964	387	1	2010;17(12):1875–1880	2010;17(12):1875–1880	NUM
ajlm-1964	387	2	.	.	PUNCT
ajlm-1964	388	1	https://doi.org/10.1128/cvi.00278-10	https://doi.org/10.1128/cvi.00278-10	PROPN
ajlm-1964	388	2	lipsitch	lipsitch	VERB
ajlm-1964	388	3	m	m	PROPN
ajlm-1964	388	4	,	,	PUNCT
ajlm-1964	388	5	grad	grad	PROPN
ajlm-1964	388	6	yh	yh	PROPN
ajlm-1964	388	7	,	,	PUNCT
ajlm-1964	388	8	sette	sette	PROPN
ajlm-1964	388	9	a	a	PROPN
ajlm-1964	388	10	,	,	PUNCT
ajlm-1964	388	11	crotty	crotty	PROPN
ajlm-1964	388	12	s.	s.	PROPN
ajlm-1964	388	13	cross	cross	PROPN
ajlm-1964	388	14	-	-	ADJ
ajlm-1964	388	15	reactive	reactive	ADJ
ajlm-1964	388	16	memory	memory	NOUN
ajlm-1964	388	17	t	t	NOUN
ajlm-1964	388	18	cells	cell	NOUN
ajlm-1964	388	19	and	and	CCONJ
ajlm-1964	388	20	herd	herd	NOUN
ajlm-1964	388	21	immunity	immunity	NOUN
ajlm-1964	388	22	to	to	ADP
ajlm-1964	388	23	sars	sar	NOUN
ajlm-1964	388	24	-	-	PUNCT
ajlm-1964	388	25	cov-2	cov-2	NOUN
ajlm-1964	388	26	.	.	PUNCT
ajlm-1964	389	1	nat	nat	PROPN
ajlm-1964	389	2	rev	rev	PROPN
ajlm-1964	389	3	immunol	immunol	NOUN
ajlm-1964	389	4	.	.	PUNCT
ajlm-1964	390	1	2020;20(11):709–713	2020;20(11):709–713	NUM
ajlm-1964	390	2	.	.	PUNCT
ajlm-1964	390	3	https://doi.org/10.1038/s41577-020-00460-4	https://doi.org/10.1038/s41577-020-00460-4	PROPN
ajlm-1964	390	4	le	le	PROPN
ajlm-1964	390	5	bert	bert	PROPN
ajlm-1964	390	6	n	n	PROPN
ajlm-1964	390	7	,	,	PUNCT
ajlm-1964	390	8	tan	tan	PROPN
ajlm-1964	390	9	at	at	ADP
ajlm-1964	390	10	,	,	PUNCT
ajlm-1964	390	11	kunasegaran	kunasegaran	PROPN
ajlm-1964	390	12	k	k	PROPN
ajlm-1964	390	13	,	,	PUNCT
ajlm-1964	390	14	et	et	PROPN
ajlm-1964	390	15	al	al	PROPN
ajlm-1964	390	16	.	.	PUNCT
ajlm-1964	391	1	sars	sars	PROPN
ajlm-1964	391	2	-	-	PUNCT
ajlm-1964	391	3	cov-2	cov-2	NOUN
ajlm-1964	391	4	-	-	PUNCT
ajlm-1964	391	5	specific	specific	ADJ
ajlm-1964	391	6	t	t	NOUN
ajlm-1964	391	7	cell	cell	NOUN
ajlm-1964	391	8	immunity	immunity	NOUN
ajlm-1964	391	9	in	in	ADP
ajlm-1964	391	10	cases	case	NOUN
ajlm-1964	391	11	of	of	ADP
ajlm-1964	391	12	covid-19	covid-19	PROPN
ajlm-1964	391	13	and	and	CCONJ
ajlm-1964	391	14	sars	sar	NOUN
ajlm-1964	391	15	,	,	PUNCT
ajlm-1964	391	16	and	and	CCONJ
ajlm-1964	391	17	uninfected	uninfected	ADJ
ajlm-1964	391	18	controls	control	NOUN
ajlm-1964	391	19	.	.	PUNCT
ajlm-1964	392	1	nature	nature	NOUN
ajlm-1964	392	2	.	.	PUNCT
ajlm-1964	393	1	2020;584(7821):457–462	2020;584(7821):457–462	X
ajlm-1964	393	2	.	.	PUNCT
ajlm-1964	394	1	https://doi.org/10.1038/s41586-020-2550-z	https://doi.org/10.1038/s41586-020-2550-z	PROPN
ajlm-1964	394	2	stefano	stefano	PROPN
ajlm-1964	394	3	gb	gb	PROPN
ajlm-1964	394	4	,	,	PUNCT
ajlm-1964	394	5	kream	kream	PROPN
ajlm-1964	394	6	rm	rm	PROPN
ajlm-1964	394	7	.	.	PUNCT
ajlm-1964	394	8	convalescent	convalescent	PROPN
ajlm-1964	394	9	memory	memory	NOUN
ajlm-1964	394	10	t	t	PROPN
ajlm-1964	394	11	cell	cell	NOUN
ajlm-1964	394	12	immunity	immunity	NOUN
ajlm-1964	394	13	in	in	ADP
ajlm-1964	394	14	individuals	individual	NOUN
ajlm-1964	394	15	with	with	ADP
ajlm-1964	394	16	mild	mild	ADJ
ajlm-1964	394	17	or	or	CCONJ
ajlm-1964	394	18	asymptomatic	asymptomatic	ADJ
ajlm-1964	394	19	sars	sar	NOUN
ajlm-1964	394	20	-	-	PUNCT
ajlm-1964	394	21	cov-2	cov-2	PART
ajlm-1964	394	22	infection	infection	NOUN
ajlm-1964	394	23	may	may	AUX
ajlm-1964	394	24	result	result	VERB
ajlm-1964	394	25	from	from	ADP
ajlm-1964	394	26	an	an	DET
ajlm-1964	394	27	evolutionarily	evolutionarily	ADV
ajlm-1964	394	28	adapted	adapt	VERB
ajlm-1964	394	29	immune	immune	ADJ
ajlm-1964	394	30	response	response	NOUN
ajlm-1964	394	31	to	to	ADP
ajlm-1964	394	32	coronavirus	coronavirus	NOUN
ajlm-1964	394	33	and	and	CCONJ
ajlm-1964	394	34	the	the	DET
ajlm-1964	394	35	“	"	PUNCT
ajlm-1964	394	36	common	common	ADJ
ajlm-1964	394	37	cold	cold	NOUN
ajlm-1964	394	38	.	.	PUNCT
ajlm-1964	394	39	”	"	PUNCT
ajlm-1964	395	1	int	int	PROPN
ajlm-1964	395	2	med	med	PROPN
ajlm-1964	395	3	j	j	PROPN
ajlm-1964	395	4	exp	exp	NOUN
ajlm-1964	395	5	clin	clin	PROPN
ajlm-1964	395	6	res	re	NOUN
ajlm-1964	395	7	.	.	PUNCT
ajlm-1964	396	1	2020;26	2020;26	NUM
ajlm-1964	396	2	:	:	PUNCT
ajlm-1964	396	3	e929789	e929789	ADV
ajlm-1964	396	4	.	.	PUNCT
ajlm-1964	397	1	https://doi.org/10.12659/msm.929789	https://doi.org/10.12659/msm.929789	ADJ
ajlm-1964	397	2	woldemeskel	woldemeskel	PROPN
ajlm-1964	397	3	ba	ba	PROPN
ajlm-1964	397	4	,	,	PUNCT
ajlm-1964	397	5	kwaa	kwaa	PROPN
ajlm-1964	397	6	ak	ak	PROPN
ajlm-1964	397	7	,	,	PUNCT
ajlm-1964	397	8	garliss	garliss	PROPN
ajlm-1964	397	9	cc	cc	PROPN
ajlm-1964	397	10	,	,	PUNCT
ajlm-1964	397	11	laeyendecker	laeyendecker	PROPN
ajlm-1964	397	12	o	o	NOUN
ajlm-1964	397	13	,	,	PUNCT
ajlm-1964	397	14	ray	ray	PROPN
ajlm-1964	397	15	sc	sc	PROPN
ajlm-1964	397	16	,	,	PUNCT
ajlm-1964	397	17	blankson	blankson	PROPN
ajlm-1964	397	18	jn	jn	PROPN
ajlm-1964	397	19	.	.	PROPN
ajlm-1964	397	20	healthy	healthy	ADJ
ajlm-1964	397	21	donor	donor	NOUN
ajlm-1964	397	22	t	t	PROPN
ajlm-1964	397	23	cell	cell	NOUN
ajlm-1964	397	24	responses	response	NOUN
ajlm-1964	397	25	to	to	ADP
ajlm-1964	397	26	common	common	ADJ
ajlm-1964	397	27	cold	cold	ADJ
ajlm-1964	397	28	coronaviruses	coronaviruse	NOUN
ajlm-1964	397	29	and	and	CCONJ
ajlm-1964	397	30	sars	sar	NOUN
ajlm-1964	397	31	-	-	PUNCT
ajlm-1964	397	32	cov-2	cov-2	NOUN
ajlm-1964	397	33	.	.	PUNCT
ajlm-1964	398	1	j	j	PROPN
ajlm-1964	398	2	clin	clin	PROPN
ajlm-1964	398	3	invest	invest	PROPN
ajlm-1964	398	4	.	.	PUNCT
ajlm-1964	399	1	2020;130(12):6631–6638	2020;130(12):6631–6638	NUM
ajlm-1964	399	2	.	.	PUNCT
ajlm-1964	400	1	https://doi.org/10.12659/msm.929789	https://doi.org/10.12659/msm.929789	PROPN
ajlm-1964	400	2	chakrabarti	chakrabarti	PROPN
ajlm-1964	400	3	s	s	PART
ajlm-1964	400	4	,	,	PUNCT
ajlm-1964	400	5	chakrabarti	chakrabarti	PROPN
ajlm-1964	400	6	ss	ss	PROPN
ajlm-1964	400	7	,	,	PUNCT
ajlm-1964	400	8	kaur	kaur	PROPN
ajlm-1964	400	9	u	u	PROPN
ajlm-1964	400	10	,	,	PUNCT
ajlm-1964	400	11	agrawal	agrawal	PROPN
ajlm-1964	400	12	bk	bk	PROPN
ajlm-1964	400	13	,	,	PUNCT
ajlm-1964	400	14	ganguly	ganguly	NOUN
ajlm-1964	400	15	u	u	PROPN
ajlm-1964	400	16	,	,	PUNCT
ajlm-1964	400	17	jin	jin	PROPN
ajlm-1964	400	18	k.	k.	PROPN
ajlm-1964	400	19	cross	cross	PROPN
ajlm-1964	400	20	-	-	NOUN
ajlm-1964	400	21	immunity	immunity	NOUN
ajlm-1964	400	22	and	and	CCONJ
ajlm-1964	400	23	trained	train	VERB
ajlm-1964	400	24	immunity	immunity	NOUN
ajlm-1964	400	25	in	in	ADP
ajlm-1964	400	26	explaining	explain	VERB
ajlm-1964	400	27	variable	variable	ADJ
ajlm-1964	400	28	covid-19	covid-19	PROPN
ajlm-1964	400	29	mortality	mortality	NOUN
ajlm-1964	400	30	–	–	PUNCT
ajlm-1964	400	31	guidance	guidance	NOUN
ajlm-1964	400	32	for	for	ADP
ajlm-1964	400	33	future	future	ADJ
ajlm-1964	400	34	pandemics	pandemic	NOUN
ajlm-1964	400	35	.	.	PUNCT
ajlm-1964	401	1	j	j	PROPN
ajlm-1964	401	2	med	med	PROPN
ajlm-1964	401	3	virol	virol	NOUN
ajlm-1964	401	4	.	.	PUNCT
ajlm-1964	402	1	2021;93(7):4094–4096	2021;93(7):4094–4096	NUM
ajlm-1964	402	2	.	.	PUNCT
ajlm-1964	403	1	https://doi.org/10.1002/jmv.26958	https://doi.org/10.1002/jmv.26958	PROPN
ajlm-1964	403	2	zhao	zhao	PROPN
ajlm-1964	403	3	j	j	PROPN
ajlm-1964	403	4	,	,	PUNCT
ajlm-1964	403	5	zhao	zhao	PROPN
ajlm-1964	403	6	j	j	PROPN
ajlm-1964	403	7	,	,	PUNCT
ajlm-1964	403	8	mangalam	mangalam	PROPN
ajlm-1964	403	9	ak	ak	PROPN
ajlm-1964	403	10	,	,	PUNCT
ajlm-1964	403	11	et	et	PROPN
ajlm-1964	403	12	al	al	PROPN
ajlm-1964	403	13	.	.	PROPN
ajlm-1964	403	14	airway	airway	PROPN
ajlm-1964	403	15	memory	memory	NOUN
ajlm-1964	403	16	cd4(+	cd4(+	PROPN
ajlm-1964	403	17	)	)	PUNCT
ajlm-1964	403	18	t	t	NOUN
ajlm-1964	403	19	cells	cell	NOUN
ajlm-1964	403	20	mediate	mediate	VERB
ajlm-1964	403	21	protective	protective	ADJ
ajlm-1964	403	22	immunity	immunity	NOUN
ajlm-1964	403	23	against	against	ADP
ajlm-1964	403	24	emerging	emerge	VERB
ajlm-1964	403	25	respiratory	respiratory	ADJ
ajlm-1964	403	26	coronaviruses	coronaviruse	NOUN
ajlm-1964	403	27	.	.	PUNCT
ajlm-1964	404	1	immunity	immunity	NOUN
ajlm-1964	404	2	.	.	PUNCT
ajlm-1964	405	1	2016;44(6):1379–1391	2016;44(6):1379–1391	NUM
ajlm-1964	405	2	.	.	PUNCT
ajlm-1964	406	1	https://doi.org/10.1016/j.immuni.2016.05.006	https://doi.org/10.1016/j.immuni.2016.05.006	NUM
ajlm-1964	406	2	pedersen	pedersen	PROPN
ajlm-1964	406	3	j	j	PROPN
ajlm-1964	406	4	,	,	PUNCT
ajlm-1964	406	5	koumakpayi	koumakpayi	VERB
ajlm-1964	406	6	ih	ih	X
ajlm-1964	406	7	,	,	PUNCT
ajlm-1964	406	8	babuadze	babuadze	ADJ
ajlm-1964	406	9	g	g	PROPN
ajlm-1964	406	10	,	,	PUNCT
ajlm-1964	406	11	et	et	PROPN
ajlm-1964	406	12	al	al	PROPN
ajlm-1964	406	13	.	.	PUNCT
ajlm-1964	407	1	cross	cross	ADJ
ajlm-1964	407	2	-	-	ADJ
ajlm-1964	407	3	reactive	reactive	ADJ
ajlm-1964	407	4	immunity	immunity	NOUN
ajlm-1964	407	5	against	against	ADP
ajlm-1964	407	6	sars	sar	NOUN
ajlm-1964	407	7	-	-	PUNCT
ajlm-1964	407	8	cov-2	cov-2	NOUN
ajlm-1964	407	9	n	n	PRON
ajlm-1964	407	10	protein	protein	NOUN
ajlm-1964	407	11	in	in	ADP
ajlm-1964	407	12	central	central	ADJ
ajlm-1964	407	13	and	and	CCONJ
ajlm-1964	407	14	west	west	PROPN
ajlm-1964	407	15	africa	africa	PROPN
ajlm-1964	407	16	precedes	precede	VERB
ajlm-1964	407	17	the	the	DET
ajlm-1964	407	18	covid-19	covid-19	PROPN
ajlm-1964	407	19	pandemic	pandemic	NOUN
ajlm-1964	407	20	.	.	PUNCT
ajlm-1964	408	1	sci	sci	PROPN
ajlm-1964	408	2	rep.;12(1):12962	rep.;12(1):12962	PROPN
ajlm-1964	408	3	.	.	PROPN
ajlm-1964	409	1	https://doi.org/10.1038/s41598-022-17241-9	https://doi.org/10.1038/s41598-022-17241-9	ADP
ajlm-1964	409	2	tso	tso	PROPN
ajlm-1964	409	3	fy	fy	PROPN
ajlm-1964	409	4	,	,	PUNCT
ajlm-1964	409	5	lidenge	lidenge	NOUN
ajlm-1964	409	6	sj	sj	PROPN
ajlm-1964	409	7	,	,	PUNCT
ajlm-1964	409	8	peña	peña	PROPN
ajlm-1964	409	9	pb	pb	PROPN
ajlm-1964	409	10	,	,	PUNCT
ajlm-1964	409	11	et	et	PROPN
ajlm-1964	409	12	al	al	PROPN
ajlm-1964	409	13	.	.	PROPN
ajlm-1964	410	1	high	high	ADJ
ajlm-1964	410	2	prevalence	prevalence	NOUN
ajlm-1964	410	3	of	of	ADP
ajlm-1964	410	4	pre	pre	ADJ
ajlm-1964	410	5	-	-	ADJ
ajlm-1964	410	6	existing	existing	ADJ
ajlm-1964	410	7	serological	serological	ADJ
ajlm-1964	410	8	cross	cross	NOUN
ajlm-1964	410	9	-	-	NOUN
ajlm-1964	410	10	reactivity	reactivity	NOUN
ajlm-1964	410	11	against	against	ADP
ajlm-1964	410	12	severe	severe	ADJ
ajlm-1964	410	13	acute	acute	ADJ
ajlm-1964	410	14	respiratory	respiratory	ADJ
ajlm-1964	410	15	syndrome	syndrome	NOUN
ajlm-1964	410	16	coronavirus-2	coronavirus-2	NUM
ajlm-1964	410	17	(	(	PUNCT
ajlm-1964	410	18	sars	sar	NOUN
ajlm-1964	410	19	-	-	PUNCT
ajlm-1964	410	20	cov-2	cov-2	NOUN
ajlm-1964	410	21	)	)	PUNCT
ajlm-1964	410	22	in	in	ADP
ajlm-1964	410	23	sub	sub	ADJ
ajlm-1964	410	24	-	-	ADJ
ajlm-1964	410	25	saharan	saharan	ADJ
ajlm-1964	410	26	africa	africa	PROPN
ajlm-1964	410	27	.	.	PUNCT
ajlm-1964	411	1	int	int	PROPN
ajlm-1964	411	2	j	j	PROPN
ajlm-1964	411	3	infect	infect	VERB
ajlm-1964	411	4	dis	dis	PROPN
ajlm-1964	411	5	.	.	PUNCT
ajlm-1964	411	6	2021;102:577–583	2021;102:577–583	NUM
ajlm-1964	411	7	.	.	PUNCT
ajlm-1964	412	1	https://doi.org/10.1016/j.ijid.2020.10.104	https://doi.org/10.1016/j.ijid.2020.10.104	PROPN
ajlm-1964	412	2	emmerich	emmerich	PROPN
ajlm-1964	412	3	p	p	NOUN
ajlm-1964	412	4	,	,	PUNCT
ajlm-1964	412	5	murawski	murawski	NOUN
ajlm-1964	412	6	c	c	NOUN
ajlm-1964	412	7	,	,	PUNCT
ajlm-1964	412	8	ehmen	ehman	NOUN
ajlm-1964	412	9	c	c	VERB
ajlm-1964	412	10	,	,	PUNCT
ajlm-1964	412	11	et	et	PROPN
ajlm-1964	412	12	al	al	PROPN
ajlm-1964	412	13	.	.	PROPN
ajlm-1964	412	14	limited	limited	ADJ
ajlm-1964	412	15	specificity	specificity	NOUN
ajlm-1964	412	16	of	of	ADP
ajlm-1964	412	17	commercially	commercially	ADV
ajlm-1964	412	18	available	available	ADJ
ajlm-1964	412	19	sars	sar	NOUN
ajlm-1964	412	20	-	-	PUNCT
ajlm-1964	412	21	cov-2	cov-2	NOUN
ajlm-1964	412	22	igg	igg	PROPN
ajlm-1964	412	23	elisas	elisas	PROPN
ajlm-1964	412	24	in	in	ADP
ajlm-1964	412	25	serum	serum	NOUN
ajlm-1964	412	26	samples	sample	NOUN
ajlm-1964	412	27	of	of	ADP
ajlm-1964	412	28	african	african	ADJ
ajlm-1964	412	29	origin	origin	NOUN
ajlm-1964	412	30	.	.	PUNCT
ajlm-1964	413	1	trop	trop	PROPN
ajlm-1964	413	2	med	med	ADJ
ajlm-1964	413	3	int	int	PROPN
ajlm-1964	413	4	health	health	NOUN
ajlm-1964	413	5	.	.	PUNCT
ajlm-1964	414	1	2021;26(6):621–631	2021;26(6):621–631	X
ajlm-1964	414	2	.	.	PUNCT
ajlm-1964	415	1	https://doi.org/10.1111/tmi.13569	https://doi.org/10.1111/tmi.13569	PROPN
ajlm-1964	415	2	mveang	mveang	INTJ
ajlm-1964	415	3	nzoghe	nzoghe	PROPN
ajlm-1964	416	1	a	a	PRON
ajlm-1964	416	2	,	,	PUNCT
ajlm-1964	416	3	essone	essone	PROPN
ajlm-1964	416	4	pn	pn	PROPN
ajlm-1964	416	5	,	,	PUNCT
ajlm-1964	416	6	leboueny	leboueny	PROPN
ajlm-1964	416	7	m	m	PROPN
ajlm-1964	416	8	,	,	PUNCT
ajlm-1964	416	9	et	et	PROPN
ajlm-1964	416	10	al	al	PROPN
ajlm-1964	416	11	.	.	PROPN
ajlm-1964	416	12	evidence	evidence	NOUN
ajlm-1964	416	13	and	and	CCONJ
ajlm-1964	416	14	implications	implication	NOUN
ajlm-1964	416	15	of	of	ADP
ajlm-1964	416	16	pre	pre	ADJ
ajlm-1964	416	17	-	-	ADJ
ajlm-1964	416	18	existing	exist	VERB
ajlm-1964	416	19	humoral	humoral	ADJ
ajlm-1964	416	20	cross	cross	ADJ
ajlm-1964	416	21	-	-	ADJ
ajlm-1964	416	22	reactive	reactive	ADJ
ajlm-1964	416	23	immunity	immunity	NOUN
ajlm-1964	416	24	to	to	ADP
ajlm-1964	416	25	sars	sar	NOUN
ajlm-1964	416	26	-	-	PUNCT
ajlm-1964	416	27	cov-2	cov-2	NOUN
ajlm-1964	416	28	.	.	PUNCT
ajlm-1964	417	1	immun	immun	PROPN
ajlm-1964	417	2	inflamm	inflamm	PROPN
ajlm-1964	417	3	dis	dis	PROPN
ajlm-1964	417	4	.	.	PUNCT
ajlm-1964	418	1	2021;9(1):128–133	2021;9(1):128–133	NUM
ajlm-1964	418	2	.	.	PUNCT
ajlm-1964	419	1	https://doi.org/10.1002/iid3.367	https://doi.org/10.1002/iid3.367	PROPN
ajlm-1964	419	2	yadouleton	yadouleton	PROPN
ajlm-1964	419	3	a	a	PRON
ajlm-1964	419	4	,	,	PUNCT
ajlm-1964	419	5	sander	sander	PROPN
ajlm-1964	419	6	al	al	PROPN
ajlm-1964	419	7	,	,	PUNCT
ajlm-1964	419	8	moreira	moreira	PROPN
ajlm-1964	419	9	-	-	PUNCT
ajlm-1964	419	10	soto	soto	PROPN
ajlm-1964	419	11	a	a	X
ajlm-1964	419	12	,	,	PUNCT
ajlm-1964	419	13	et	et	PROPN
ajlm-1964	419	14	al	al	PROPN
ajlm-1964	419	15	.	.	PROPN
ajlm-1964	419	16	limited	limited	ADJ
ajlm-1964	419	17	specificity	specificity	NOUN
ajlm-1964	419	18	of	of	ADP
ajlm-1964	419	19	serologic	serologic	ADJ
ajlm-1964	419	20	tests	test	NOUN
ajlm-1964	419	21	for	for	ADP
ajlm-1964	419	22	sars	sar	NOUN
ajlm-1964	419	23	-	-	PUNCT
ajlm-1964	419	24	cov-2	cov-2	NOUN
ajlm-1964	419	25	antibody	antibody	NOUN
ajlm-1964	419	26	detection	detection	NOUN
ajlm-1964	419	27	,	,	PUNCT
ajlm-1964	419	28	benin	benin	PROPN
ajlm-1964	419	29	.	.	PUNCT
ajlm-1964	420	1	emerg	emerg	PROPN
ajlm-1964	420	2	infect	infect	PROPN
ajlm-1964	420	3	dis	dis	PROPN
ajlm-1964	420	4	.	.	PUNCT
ajlm-1964	421	1	2021;27(1	2021;27(1	NUM
ajlm-1964	421	2	)	)	PUNCT
ajlm-1964	421	3	.	.	PUNCT
ajlm-1964	422	1	https://doi.org/10.3201/eid2701.203281	https://doi.org/10.3201/eid2701.203281	NUM
ajlm-1964	422	2	grzelak	grzelak	NOUN
ajlm-1964	422	3	l	l	NOUN
ajlm-1964	422	4	,	,	PUNCT
ajlm-1964	422	5	temmam	temmam	NOUN
ajlm-1964	422	6	s	s	NOUN
ajlm-1964	422	7	,	,	PUNCT
ajlm-1964	422	8	planchais	planchais	NOUN
ajlm-1964	422	9	c	c	NOUN
ajlm-1964	422	10	,	,	PUNCT
ajlm-1964	422	11	et	et	PROPN
ajlm-1964	422	12	al	al	PROPN
ajlm-1964	422	13	.	.	PUNCT
ajlm-1964	423	1	a	a	DET
ajlm-1964	423	2	comparison	comparison	NOUN
ajlm-1964	423	3	of	of	ADP
ajlm-1964	423	4	four	four	NUM
ajlm-1964	423	5	serological	serological	ADJ
ajlm-1964	423	6	assays	assay	NOUN
ajlm-1964	423	7	for	for	ADP
ajlm-1964	423	8	detecting	detect	VERB
ajlm-1964	423	9	anti	anti	ADJ
ajlm-1964	423	10	-	-	ADJ
ajlm-1964	423	11	sars	sar	NOUN
ajlm-1964	423	12	-	-	PUNCT
ajlm-1964	423	13	cov-2	cov-2	NOUN
ajlm-1964	423	14	antibodies	antibody	NOUN
ajlm-1964	423	15	in	in	ADP
ajlm-1964	423	16	human	human	ADJ
ajlm-1964	423	17	serum	serum	NOUN
ajlm-1964	423	18	samples	sample	NOUN
ajlm-1964	423	19	from	from	ADP
ajlm-1964	423	20	different	different	ADJ
ajlm-1964	423	21	populations	population	NOUN
ajlm-1964	423	22	.	.	PUNCT
ajlm-1964	424	1	sci	sci	PROPN
ajlm-1964	424	2	transl	transl	PROPN
ajlm-1964	424	3	med	med	PROPN
ajlm-1964	424	4	.	.	PUNCT
ajlm-1964	425	1	2020;12(559	2020;12(559	NUM
ajlm-1964	425	2	):	):	PUNCT
ajlm-1964	425	3	eabc3103	eabc3103	PROPN
ajlm-1964	425	4	.	.	PUNCT
ajlm-1964	426	1	https://doi.org/10.1126/scitranslmed.abc3103	https://doi.org/10.1126/scitranslmed.abc3103	PROPN
ajlm-1964	426	2	ng	ng	PROPN
ajlm-1964	426	3	kw	kw	PROPN
ajlm-1964	426	4	,	,	PUNCT
ajlm-1964	426	5	faulkner	faulkner	NOUN
ajlm-1964	426	6	n	n	CCONJ
ajlm-1964	426	7	,	,	PUNCT
ajlm-1964	426	8	cornish	cornish	PROPN
ajlm-1964	426	9	gh	gh	PROPN
ajlm-1964	426	10	,	,	PUNCT
ajlm-1964	426	11	et	et	PROPN
ajlm-1964	426	12	al	al	PROPN
ajlm-1964	426	13	.	.	PUNCT
ajlm-1964	427	1	preexisting	preexist	VERB
ajlm-1964	427	2	and	and	CCONJ
ajlm-1964	427	3	de	de	ADP
ajlm-1964	427	4	novo	novo	NOUN
ajlm-1964	427	5	humoral	humoral	ADJ
ajlm-1964	427	6	immunity	immunity	NOUN
ajlm-1964	427	7	to	to	ADP
ajlm-1964	427	8	sars	sar	NOUN
ajlm-1964	427	9	-	-	PUNCT
ajlm-1964	427	10	cov-2	cov-2	NOUN
ajlm-1964	427	11	in	in	ADP
ajlm-1964	427	12	humans	human	NOUN
ajlm-1964	427	13	.	.	PUNCT
ajlm-1964	428	1	science	science	NOUN
ajlm-1964	428	2	.	.	PUNCT
ajlm-1964	429	1	2020;370(6522):1339–1343	2020;370(6522):1339–1343	NOUN
ajlm-1964	429	2	.	.	PUNCT
ajlm-1964	430	1	https://doi.org/10.1126/science.abe1107	https://doi.org/10.1126/science.abe1107	PROPN
ajlm-1964	430	2	song	song	NOUN
ajlm-1964	430	3	g	g	PROPN
ajlm-1964	430	4	,	,	PUNCT
ajlm-1964	430	5	he	he	PRON
ajlm-1964	430	6	w	w	NOUN
ajlm-1964	430	7	-	-	PUNCT
ajlm-1964	430	8	t.	t.	PROPN
ajlm-1964	430	9	,	,	PUNCT
ajlm-1964	430	10	callaghan	callaghan	PROPN
ajlm-1964	430	11	s	s	PROPN
ajlm-1964	430	12	,	,	PUNCT
ajlm-1964	430	13	et	et	PROPN
ajlm-1964	430	14	al	al	PROPN
ajlm-1964	430	15	.	.	PUNCT
ajlm-1964	431	1	cross	cross	ADJ
ajlm-1964	431	2	-	-	ADJ
ajlm-1964	431	3	reactive	reactive	ADJ
ajlm-1964	431	4	serum	serum	NOUN
ajlm-1964	431	5	and	and	CCONJ
ajlm-1964	431	6	memory	memory	NOUN
ajlm-1964	431	7	b	b	NOUN
ajlm-1964	431	8	-	-	PUNCT
ajlm-1964	431	9	cell	cell	NOUN
ajlm-1964	431	10	responses	response	NOUN
ajlm-1964	431	11	to	to	PART
ajlm-1964	431	12	spike	spike	VERB
ajlm-1964	431	13	protein	protein	NOUN
ajlm-1964	431	14	in	in	ADP
ajlm-1964	431	15	sars	sar	NOUN
ajlm-1964	431	16	-	-	PUNCT
ajlm-1964	431	17	cov-2	cov-2	PART
ajlm-1964	431	18	and	and	CCONJ
ajlm-1964	431	19	endemic	endemic	ADJ
ajlm-1964	431	20	coronavirus	coronavirus	NOUN
ajlm-1964	431	21	infection	infection	NOUN
ajlm-1964	431	22	.	.	PUNCT
ajlm-1964	432	1	nat	nat	PROPN
ajlm-1964	432	2	commun	commun	PROPN
ajlm-1964	432	3	.	.	PUNCT
ajlm-1964	433	1	2021;12(1):2938	2021;12(1):2938	NUM
ajlm-1964	433	2	.	.	PUNCT
ajlm-1964	434	1	https://doi.org/10.1038/s41467-021-23074-3	https://doi.org/10.1038/s41467-021-23074-3	NUM
ajlm-1964	434	2	netea	netea	NOUN
ajlm-1964	434	3	mg	mg	PROPN
ajlm-1964	434	4	,	,	PUNCT
ajlm-1964	434	5	joosten	joosten	VERB
ajlm-1964	434	6	lab	lab	NOUN
ajlm-1964	434	7	,	,	PUNCT
ajlm-1964	434	8	latz	latz	ADJ
ajlm-1964	434	9	e	e	NOUN
ajlm-1964	434	10	,	,	PUNCT
ajlm-1964	434	11	et	et	PROPN
ajlm-1964	434	12	al	al	PROPN
ajlm-1964	434	13	.	.	PROPN
ajlm-1964	435	1	trained	train	VERB
ajlm-1964	435	2	immunity	immunity	NOUN
ajlm-1964	435	3	:	:	PUNCT
ajlm-1964	435	4	a	a	DET
ajlm-1964	435	5	program	program	NOUN
ajlm-1964	435	6	of	of	ADP
ajlm-1964	435	7	innate	innate	ADJ
ajlm-1964	435	8	immune	immune	ADJ
ajlm-1964	435	9	memory	memory	NOUN
ajlm-1964	435	10	in	in	ADP
ajlm-1964	435	11	health	health	NOUN
ajlm-1964	435	12	and	and	CCONJ
ajlm-1964	435	13	disease	disease	NOUN
ajlm-1964	435	14	.	.	PUNCT
ajlm-1964	436	1	science	science	NOUN
ajlm-1964	436	2	.	.	PUNCT
ajlm-1964	437	1	2016;352(6284	2016;352(6284	NUM
ajlm-1964	437	2	):	):	PUNCT
ajlm-1964	437	3	aaf1098	aaf1098	NOUN
ajlm-1964	437	4	.	.	PUNCT
ajlm-1964	438	1	https://doi.org/10.1126/science.aaf1098	https://doi.org/10.1126/science.aaf1098	PROPN
ajlm-1964	438	2	van’t	van’t	NUM
ajlm-1964	438	3	wout	wout	PROPN
ajlm-1964	438	4	jw	jw	PROPN
ajlm-1964	438	5	,	,	PUNCT
ajlm-1964	438	6	poell	poell	NOUN
ajlm-1964	438	7	r	r	PROPN
ajlm-1964	438	8	,	,	PUNCT
ajlm-1964	438	9	van	van	PROPN
ajlm-1964	438	10	furth	furth	PROPN
ajlm-1964	438	11	r.	r.	PROPN
ajlm-1964	438	12	the	the	DET
ajlm-1964	438	13	role	role	NOUN
ajlm-1964	438	14	of	of	ADP
ajlm-1964	438	15	bcg	bcg	PROPN
ajlm-1964	438	16	/	/	SYM
ajlm-1964	438	17	ppd	ppd	NOUN
ajlm-1964	438	18	-	-	PUNCT
ajlm-1964	438	19	activated	activate	VERB
ajlm-1964	438	20	macrophages	macrophage	NOUN
ajlm-1964	438	21	in	in	ADP
ajlm-1964	438	22	resistance	resistance	NOUN
ajlm-1964	438	23	against	against	ADP
ajlm-1964	438	24	systemic	systemic	ADJ
ajlm-1964	438	25	candidiasis	candidiasis	NOUN
ajlm-1964	438	26	in	in	ADP
ajlm-1964	438	27	mice	mouse	NOUN
ajlm-1964	438	28	.	.	PUNCT
ajlm-1964	439	1	scand	scand	PROPN
ajlm-1964	439	2	j	j	PROPN
ajlm-1964	439	3	immunol	immunol	NOUN
ajlm-1964	439	4	.	.	PUNCT
ajlm-1964	440	1	1992;36(5):713–719	1992;36(5):713–719	X
ajlm-1964	440	2	.	.	PUNCT
ajlm-1964	441	1	https://doi.org/10.1111/j.1365-3083.1992.tb03132.x	https://doi.org/10.1111/j.1365-3083.1992.tb03132.x	PROPN
ajlm-1964	441	2	kaufmann	kaufmann	PROPN
ajlm-1964	441	3	e	e	PROPN
ajlm-1964	441	4	,	,	PUNCT
ajlm-1964	441	5	sanz	sanz	PROPN
ajlm-1964	441	6	j	j	PROPN
ajlm-1964	441	7	,	,	PUNCT
ajlm-1964	441	8	dunn	dunn	PROPN
ajlm-1964	441	9	jl	jl	PROPN
ajlm-1964	441	10	,	,	PUNCT
ajlm-1964	441	11	et	et	PROPN
ajlm-1964	441	12	al	al	PROPN
ajlm-1964	441	13	.	.	PROPN
ajlm-1964	442	1	bcg	bcg	PROPN
ajlm-1964	442	2	educates	educate	VERB
ajlm-1964	442	3	hematopoietic	hematopoietic	ADJ
ajlm-1964	442	4	stem	stem	NOUN
ajlm-1964	442	5	cells	cell	NOUN
ajlm-1964	442	6	to	to	PART
ajlm-1964	442	7	generate	generate	VERB
ajlm-1964	442	8	protective	protective	ADJ
ajlm-1964	442	9	innate	innate	ADJ
ajlm-1964	442	10	immunity	immunity	NOUN
ajlm-1964	442	11	against	against	ADP
ajlm-1964	442	12	tuberculosis	tuberculosis	NOUN
ajlm-1964	442	13	.	.	PUNCT
ajlm-1964	443	1	cell	cell	NOUN
ajlm-1964	443	2	.	.	PUNCT
ajlm-1964	444	1	2018;172(1–2):176–190.e19	2018;172(1–2):176–190.e19	NUM
ajlm-1964	444	2	.	.	PUNCT
ajlm-1964	445	1	https://doi.org/10.1016/j.cell.2017.12.031	https://doi.org/10.1016/j.cell.2017.12.031	PROPN
ajlm-1964	445	2	arts	arts	PROPN
ajlm-1964	445	3	rjw	rjw	PROPN
ajlm-1964	445	4	,	,	PUNCT
ajlm-1964	445	5	moorlag	moorlag	PROPN
ajlm-1964	445	6	sjcfm	sjcfm	PROPN
ajlm-1964	445	7	,	,	PUNCT
ajlm-1964	445	8	novakovic	novakovic	PROPN
ajlm-1964	445	9	b	b	NOUN
ajlm-1964	445	10	,	,	PUNCT
ajlm-1964	445	11	et	et	PROPN
ajlm-1964	445	12	al	al	PROPN
ajlm-1964	445	13	.	.	PROPN
ajlm-1964	446	1	bcg	bcg	PROPN
ajlm-1964	446	2	vaccination	vaccination	NOUN
ajlm-1964	446	3	protects	protect	VERB
ajlm-1964	446	4	against	against	ADP
ajlm-1964	446	5	experimental	experimental	ADJ
ajlm-1964	446	6	viral	viral	ADJ
ajlm-1964	446	7	infection	infection	NOUN
ajlm-1964	446	8	in	in	ADP
ajlm-1964	446	9	humans	human	NOUN
ajlm-1964	446	10	through	through	ADP
ajlm-1964	446	11	the	the	DET
ajlm-1964	446	12	induction	induction	NOUN
ajlm-1964	446	13	of	of	ADP
ajlm-1964	446	14	cytokines	cytokine	NOUN
ajlm-1964	446	15	associated	associate	VERB
ajlm-1964	446	16	with	with	ADP
ajlm-1964	446	17	trained	train	VERB
ajlm-1964	446	18	immunity	immunity	NOUN
ajlm-1964	446	19	.	.	PUNCT
ajlm-1964	447	1	cell	cell	NOUN
ajlm-1964	447	2	host	host	NOUN
ajlm-1964	447	3	microbe	microbe	NOUN
ajlm-1964	447	4	.	.	PUNCT
ajlm-1964	448	1	2018;23(1):89–100.e5	2018;23(1):89–100.e5	X
ajlm-1964	448	2	.	.	PUNCT
ajlm-1964	449	1	https://doi.org/10.1016/j.chom.2017.12.010	https://doi.org/10.1016/j.chom.2017.12.010	PROPN
ajlm-1964	449	2	walk	walk	PROPN
ajlm-1964	449	3	j	j	PROPN
ajlm-1964	449	4	,	,	PUNCT
ajlm-1964	449	5	de	de	PROPN
ajlm-1964	449	6	bree	bree	PROPN
ajlm-1964	449	7	lcj	lcj	NOUN
ajlm-1964	449	8	,	,	PUNCT
ajlm-1964	449	9	graumans	grauman	VERB
ajlm-1964	449	10	w	w	PROPN
ajlm-1964	449	11	,	,	PUNCT
ajlm-1964	449	12	et	et	PROPN
ajlm-1964	449	13	al	al	PROPN
ajlm-1964	449	14	.	.	PUNCT
ajlm-1964	450	1	outcomes	outcome	NOUN
ajlm-1964	450	2	of	of	ADP
ajlm-1964	450	3	controlled	control	VERB
ajlm-1964	450	4	human	human	ADJ
ajlm-1964	450	5	malaria	malaria	NOUN
ajlm-1964	450	6	infection	infection	NOUN
ajlm-1964	450	7	after	after	ADP
ajlm-1964	450	8	bcg	bcg	PROPN
ajlm-1964	450	9	vaccination	vaccination	NOUN
ajlm-1964	450	10	.	.	PUNCT
ajlm-1964	451	1	nat	nat	PROPN
ajlm-1964	451	2	commun	commun	PROPN
ajlm-1964	451	3	.	.	PUNCT
ajlm-1964	452	1	2019;10(1):874	2019;10(1):874	NUM
ajlm-1964	452	2	.	.	PUNCT
ajlm-1964	453	1	https://doi.org/10.1038/s41467-019-08659-3	https://doi.org/10.1038/s41467-019-08659-3	NOUN
ajlm-1964	453	2	tanner	tanner	NOUN
ajlm-1964	453	3	r	r	NOUN
ajlm-1964	453	4	,	,	PUNCT
ajlm-1964	453	5	villarreal	villarreal	NOUN
ajlm-1964	453	6	-	-	PUNCT
ajlm-1964	453	7	ramos	ramos	PROPN
ajlm-1964	453	8	b	b	PROPN
ajlm-1964	453	9	,	,	PUNCT
ajlm-1964	453	10	vordermeier	vordermeier	PROPN
ajlm-1964	453	11	hm	hm	PROPN
ajlm-1964	453	12	,	,	PUNCT
ajlm-1964	453	13	mcshane	mcshane	PROPN
ajlm-1964	453	14	h.	h.	PROPN
ajlm-1964	453	15	the	the	DET
ajlm-1964	453	16	humoral	humoral	ADJ
ajlm-1964	453	17	immune	immune	ADJ
ajlm-1964	453	18	response	response	NOUN
ajlm-1964	453	19	to	to	ADP
ajlm-1964	453	20	bcg	bcg	NOUN
ajlm-1964	453	21	vaccination	vaccination	NOUN
ajlm-1964	453	22	.	.	PUNCT
ajlm-1964	454	1	front	front	ADJ
ajlm-1964	454	2	immunol	immunol	NOUN
ajlm-1964	454	3	.	.	PUNCT
ajlm-1964	455	1	2019;10:1317	2019;10:1317	NUM
ajlm-1964	455	2	.	.	X
ajlm-1964	456	1	https://doi.org/10.3389/fimmu.2019.01317	https://doi.org/10.3389/fimmu.2019.01317	PROPN
ajlm-1964	456	2	moorlag	moorlag	NOUN
ajlm-1964	456	3	sjcfm	sjcfm	PROPN
ajlm-1964	456	4	,	,	PUNCT
ajlm-1964	456	5	arts	art	NOUN
ajlm-1964	456	6	rjw	rjw	PROPN
ajlm-1964	456	7	,	,	PUNCT
ajlm-1964	456	8	van	van	PROPN
ajlm-1964	456	9	crevel	crevel	PROPN
ajlm-1964	456	10	r	r	NOUN
ajlm-1964	456	11	,	,	PUNCT
ajlm-1964	456	12	netea	netea	NOUN
ajlm-1964	456	13	mg	mg	PROPN
ajlm-1964	456	14	.	.	PUNCT
ajlm-1964	457	1	non	non	ADJ
ajlm-1964	457	2	-	-	ADJ
ajlm-1964	457	3	specific	specific	ADJ
ajlm-1964	457	4	effects	effect	NOUN
ajlm-1964	457	5	of	of	ADP
ajlm-1964	457	6	bcg	bcg	NOUN
ajlm-1964	457	7	vaccine	vaccine	NOUN
ajlm-1964	457	8	on	on	ADP
ajlm-1964	457	9	viral	viral	ADJ
ajlm-1964	457	10	infections	infection	NOUN
ajlm-1964	457	11	.	.	PUNCT
ajlm-1964	458	1	clin	clin	PROPN
ajlm-1964	458	2	microbiol	microbiol	PROPN
ajlm-1964	458	3	infect	infect	PROPN
ajlm-1964	458	4	.	.	PUNCT
ajlm-1964	459	1	2019;25(12):1473–1478	2019;25(12):1473–1478	X
ajlm-1964	459	2	.	.	PUNCT
ajlm-1964	460	1	https://doi.org/10.1016/j.cmi.2019.04.020	https://doi.org/10.1016/j.cmi.2019.04.020	PROPN
ajlm-1964	460	2	arnoldussen	arnoldussen	PROPN
ajlm-1964	460	3	dl	dl	PROPN
ajlm-1964	460	4	,	,	PUNCT
ajlm-1964	460	5	linehan	linehan	PROPN
ajlm-1964	460	6	m	m	PROPN
ajlm-1964	460	7	,	,	PUNCT
ajlm-1964	460	8	sheikh	sheikh	PROPN
ajlm-1964	460	9	a.	a.	PROPN
ajlm-1964	460	10	bcg	bcg	PROPN
ajlm-1964	460	11	vaccination	vaccination	NOUN
ajlm-1964	460	12	and	and	CCONJ
ajlm-1964	460	13	allergy	allergy	NOUN
ajlm-1964	460	14	:	:	PUNCT
ajlm-1964	460	15	a	a	DET
ajlm-1964	460	16	systematic	systematic	ADJ
ajlm-1964	460	17	review	review	NOUN
ajlm-1964	460	18	and	and	CCONJ
ajlm-1964	460	19	meta	meta	ADJ
ajlm-1964	460	20	-	-	PUNCT
ajlm-1964	460	21	analysis	analysis	NOUN
ajlm-1964	460	22	.	.	PUNCT
ajlm-1964	461	1	j	j	PROPN
ajlm-1964	461	2	allergy	allergy	PROPN
ajlm-1964	461	3	clin	clin	PROPN
ajlm-1964	461	4	immunol	immunol	PROPN
ajlm-1964	461	5	.	.	PUNCT
ajlm-1964	462	1	2011;127(1):246–53	2011;127(1):246–53	NUM
ajlm-1964	462	2	,	,	PUNCT
ajlm-1964	462	3	253.e1	253.e1	NUM
ajlm-1964	462	4	–	–	PUNCT
ajlm-1964	462	5	e21	e21	PROPN
ajlm-1964	462	6	.	.	PUNCT
ajlm-1964	463	1	https://doi.org/10.1016/j.jaci.2010.07.039	https://doi.org/10.1016/j.jaci.2010.07.039	NOUN
ajlm-1964	463	2	nakayama	nakayama	PROPN
ajlm-1964	463	3	k	k	PROPN
ajlm-1964	463	4	,	,	PUNCT
ajlm-1964	463	5	monma	monma	PROPN
ajlm-1964	463	6	m	m	PROPN
ajlm-1964	463	7	,	,	PUNCT
ajlm-1964	463	8	fukushima	fukushima	PROPN
ajlm-1964	463	9	t	t	PROPN
ajlm-1964	463	10	,	,	PUNCT
ajlm-1964	463	11	ohrui	ohrui	PROPN
ajlm-1964	463	12	t	t	PROPN
ajlm-1964	463	13	,	,	PUNCT
ajlm-1964	463	14	sasaki	sasaki	PROPN
ajlm-1964	463	15	h.	h.	PROPN
ajlm-1964	463	16	tuberculin	tuberculin	PROPN
ajlm-1964	463	17	responses	response	NOUN
ajlm-1964	463	18	and	and	CCONJ
ajlm-1964	463	19	risk	risk	NOUN
ajlm-1964	463	20	of	of	ADP
ajlm-1964	463	21	pneumonia	pneumonia	NOUN
ajlm-1964	463	22	in	in	ADP
ajlm-1964	463	23	immobile	immobile	ADJ
ajlm-1964	463	24	elderly	elderly	ADJ
ajlm-1964	463	25	patients	patient	NOUN
ajlm-1964	463	26	.	.	PUNCT
ajlm-1964	464	1	thorax	thorax	NOUN
ajlm-1964	464	2	.	.	PUNCT
ajlm-1964	465	1	2000;55(10):867–869	2000;55(10):867–869	NUM
ajlm-1964	465	2	.	.	PUNCT
ajlm-1964	466	1	https://doi.org/10.1136/thorax.55.10.867	https://doi.org/10.1136/thorax.55.10.867	PROPN
ajlm-1964	466	2	ohrui	ohrui	PROPN
ajlm-1964	466	3	t	t	PROPN
ajlm-1964	466	4	,	,	PUNCT
ajlm-1964	466	5	nakayama	nakayama	PROPN
ajlm-1964	466	6	k	k	PROPN
ajlm-1964	466	7	,	,	PUNCT
ajlm-1964	466	8	fukushima	fukushima	PROPN
ajlm-1964	466	9	t	t	PROPN
ajlm-1964	466	10	,	,	PUNCT
ajlm-1964	466	11	chiba	chiba	PROPN
ajlm-1964	466	12	h	h	PROPN
ajlm-1964	466	13	,	,	PUNCT
ajlm-1964	466	14	sasaki	sasaki	PROPN
ajlm-1964	466	15	h.	h.	PROPN
ajlm-1964	467	1	[	[	X
ajlm-1964	467	2	prevention	prevention	NOUN
ajlm-1964	467	3	of	of	ADP
ajlm-1964	467	4	elderly	elderly	ADJ
ajlm-1964	467	5	pneumonia	pneumonia	NOUN
ajlm-1964	467	6	by	by	ADP
ajlm-1964	467	7	pneumococcal	pneumococcal	ADJ
ajlm-1964	467	8	,	,	PUNCT
ajlm-1964	467	9	influenza	influenza	NOUN
ajlm-1964	467	10	and	and	CCONJ
ajlm-1964	467	11	bcg	bcg	PROPN
ajlm-1964	467	12	vaccinations	vaccination	NOUN
ajlm-1964	467	13	]	]	PUNCT
ajlm-1964	467	14	.	.	PUNCT
ajlm-1964	468	1	nihon	nihon	PROPN
ajlm-1964	468	2	ronen	ronen	PROPN
ajlm-1964	468	3	igakkai	igakkai	PROPN
ajlm-1964	468	4	zasshi	zasshi	PROPN
ajlm-1964	468	5	jpn	jpn	PROPN
ajlm-1964	468	6	j	j	PROPN
ajlm-1964	468	7	geriatr	geriatr	PROPN
ajlm-1964	468	8	.	.	PUNCT
ajlm-1964	469	1	2005;42(1):34–36	2005;42(1):34–36	NUM
ajlm-1964	469	2	.	.	NOUN
ajlm-1964	469	3	https://doi.org/10.3143/geriatrics.42.34	https://doi.org/10.3143/geriatrics.42.34	NOUN
ajlm-1964	469	4	giamarellos	giamarello	NOUN
ajlm-1964	469	5	-	-	PUNCT
ajlm-1964	469	6	bourboulis	bourboulis	PROPN
ajlm-1964	469	7	ej	ej	PROPN
ajlm-1964	469	8	,	,	PUNCT
ajlm-1964	469	9	tsilika	tsilika	X
ajlm-1964	469	10	m	m	PROPN
ajlm-1964	469	11	,	,	PUNCT
ajlm-1964	469	12	moorlag	moorlag	PROPN
ajlm-1964	469	13	s	s	PART
ajlm-1964	469	14	,	,	PUNCT
ajlm-1964	469	15	et	et	PROPN
ajlm-1964	469	16	al	al	PROPN
ajlm-1964	469	17	.	.	PROPN
ajlm-1964	469	18	activate	activate	PROPN
ajlm-1964	469	19	:	:	PUNCT
ajlm-1964	469	20	randomized	randomize	VERB
ajlm-1964	469	21	clinical	clinical	ADJ
ajlm-1964	469	22	trial	trial	NOUN
ajlm-1964	469	23	of	of	ADP
ajlm-1964	469	24	bcg	bcg	NOUN
ajlm-1964	469	25	vaccination	vaccination	NOUN
ajlm-1964	469	26	against	against	ADP
ajlm-1964	469	27	infection	infection	NOUN
ajlm-1964	469	28	in	in	ADP
ajlm-1964	469	29	the	the	DET
ajlm-1964	469	30	elderly	elderly	ADJ
ajlm-1964	469	31	.	.	PUNCT
ajlm-1964	470	1	cell	cell	NOUN
ajlm-1964	470	2	.	.	PUNCT
ajlm-1964	471	1	2020;183(2):315–323.e9	2020;183(2):315–323.e9	NOUN
ajlm-1964	471	2	.	.	PUNCT
ajlm-1964	472	1	https://doi.org/10.1016/j.cell.2020.08.051	https://doi.org/10.1016/j.cell.2020.08.051	ADJ
ajlm-1964	472	2	nguipdop	nguipdop	PROPN
ajlm-1964	472	3	-	-	PUNCT
ajlm-1964	472	4	djomo	djomo	NOUN
ajlm-1964	472	5	p	p	NOUN
ajlm-1964	472	6	,	,	PUNCT
ajlm-1964	472	7	heldal	heldal	NOUN
ajlm-1964	472	8	e	e	NOUN
ajlm-1964	472	9	,	,	PUNCT
ajlm-1964	472	10	rodrigues	rodrigues	PROPN
ajlm-1964	472	11	lc	lc	PROPN
ajlm-1964	472	12	,	,	PUNCT
ajlm-1964	472	13	abubakar	abubakar	PROPN
ajlm-1964	472	14	i	i	PRON
ajlm-1964	472	15	,	,	PUNCT
ajlm-1964	472	16	mangtani	mangtani	ADJ
ajlm-1964	472	17	p.	p.	NOUN
ajlm-1964	472	18	duration	duration	NOUN
ajlm-1964	472	19	of	of	ADP
ajlm-1964	472	20	bcg	bcg	PROPN
ajlm-1964	472	21	protection	protection	NOUN
ajlm-1964	472	22	against	against	ADP
ajlm-1964	472	23	tuberculosis	tuberculosis	NOUN
ajlm-1964	472	24	and	and	CCONJ
ajlm-1964	472	25	change	change	VERB
ajlm-1964	472	26	in	in	ADP
ajlm-1964	472	27	effectiveness	effectiveness	NOUN
ajlm-1964	472	28	with	with	ADP
ajlm-1964	472	29	time	time	NOUN
ajlm-1964	472	30	since	since	SCONJ
ajlm-1964	472	31	vaccination	vaccination	NOUN
ajlm-1964	472	32	in	in	ADP
ajlm-1964	472	33	norway	norway	PROPN
ajlm-1964	472	34	:	:	PUNCT
ajlm-1964	472	35	a	a	DET
ajlm-1964	472	36	retrospective	retrospective	ADJ
ajlm-1964	472	37	population	population	NOUN
ajlm-1964	472	38	-	-	PUNCT
ajlm-1964	472	39	based	base	VERB
ajlm-1964	472	40	cohort	cohort	NOUN
ajlm-1964	472	41	study	study	NOUN
ajlm-1964	472	42	.	.	PUNCT
ajlm-1964	473	1	lancet	lancet	PROPN
ajlm-1964	473	2	infect	infect	PROPN
ajlm-1964	473	3	dis	dis	PROPN
ajlm-1964	473	4	.	.	PUNCT
ajlm-1964	474	1	2016;16(2):219–226	2016;16(2):219–226	NUM
ajlm-1964	474	2	.	.	PUNCT
ajlm-1964	475	1	https://doi.org/10.1016/s1473-3099(15)00400-4	https://doi.org/10.1016/s1473-3099(15)00400-4	PROPN
ajlm-1964	475	2	aronson	aronson	PROPN
ajlm-1964	475	3	ne	ne	PROPN
ajlm-1964	475	4	,	,	PUNCT
ajlm-1964	475	5	santosham	santosham	PROPN
ajlm-1964	475	6	m	m	PROPN
ajlm-1964	475	7	,	,	PUNCT
ajlm-1964	475	8	comstock	comstock	PROPN
ajlm-1964	475	9	gw	gw	PROPN
ajlm-1964	475	10	,	,	PUNCT
ajlm-1964	475	11	et	et	PROPN
ajlm-1964	475	12	al	al	PROPN
ajlm-1964	475	13	.	.	PUNCT
ajlm-1964	476	1	long	long	ADJ
ajlm-1964	476	2	-	-	PUNCT
ajlm-1964	476	3	term	term	NOUN
ajlm-1964	476	4	efficacy	efficacy	NOUN
ajlm-1964	476	5	of	of	ADP
ajlm-1964	476	6	bcg	bcg	PROPN
ajlm-1964	476	7	vaccine	vaccine	NOUN
ajlm-1964	476	8	in	in	ADP
ajlm-1964	476	9	american	american	PROPN
ajlm-1964	476	10	indians	indians	PROPN
ajlm-1964	476	11	and	and	CCONJ
ajlm-1964	476	12	alaska	alaska	PROPN
ajlm-1964	476	13	natives	native	NOUN
ajlm-1964	476	14	:	:	PUNCT
ajlm-1964	476	15	a	a	DET
ajlm-1964	476	16	60	60	NUM
ajlm-1964	476	17	-	-	PUNCT
ajlm-1964	476	18	year	year	NOUN
ajlm-1964	476	19	follow	follow	NOUN
ajlm-1964	476	20	-	-	PUNCT
ajlm-1964	476	21	up	up	ADP
ajlm-1964	476	22	study	study	NOUN
ajlm-1964	476	23	.	.	PUNCT
ajlm-1964	477	1	jama	jama	PROPN
ajlm-1964	477	2	.	.	PUNCT
ajlm-1964	478	1	2004;291(17):2086–2091	2004;291(17):2086–2091	NUM
ajlm-1964	478	2	.	.	PUNCT
ajlm-1964	479	1	https://doi.org/10.1001/jama.291.17.2086	https://doi.org/10.1001/jama.291.17.2086	PROPN
ajlm-1964	479	2	menzies	menzies	PROPN
ajlm-1964	479	3	d.	d.	PROPN
ajlm-1964	479	4	interpretation	interpretation	PROPN
ajlm-1964	479	5	of	of	ADP
ajlm-1964	479	6	repeated	repeat	VERB
ajlm-1964	479	7	tuberculin	tuberculin	NOUN
ajlm-1964	479	8	tests	test	NOUN
ajlm-1964	479	9	.	.	PUNCT
ajlm-1964	480	1	boosting	boost	VERB
ajlm-1964	480	2	,	,	PUNCT
ajlm-1964	480	3	conversion	conversion	NOUN
ajlm-1964	480	4	,	,	PUNCT
ajlm-1964	480	5	and	and	CCONJ
ajlm-1964	480	6	reversion	reversion	NOUN
ajlm-1964	480	7	.	.	PUNCT
ajlm-1964	481	1	am	be	AUX
ajlm-1964	481	2	j	j	PROPN
ajlm-1964	481	3	respir	respir	NOUN
ajlm-1964	481	4	crit	crit	PROPN
ajlm-1964	481	5	care	care	NOUN
ajlm-1964	481	6	med	me	VERB
ajlm-1964	481	7	.	.	PUNCT
ajlm-1964	482	1	1999;159(1):15–21	1999;159(1):15–21	X
ajlm-1964	482	2	.	.	PUNCT
ajlm-1964	483	1	https://doi.org/10.1164/ajrccm.159.1.9801120	https://doi.org/10.1164/ajrccm.159.1.9801120	ADV
ajlm-1964	483	2	miller	miller	PROPN
ajlm-1964	483	3	a	a	PRON
ajlm-1964	483	4	,	,	PUNCT
ajlm-1964	483	5	reandelar	reandelar	ADJ
ajlm-1964	483	6	mj	mj	NOUN
ajlm-1964	483	7	,	,	PUNCT
ajlm-1964	483	8	fasciglione	fasciglione	PROPN
ajlm-1964	483	9	k	k	PROPN
ajlm-1964	483	10	,	,	PUNCT
ajlm-1964	483	11	roumenova	roumenova	VERB
ajlm-1964	483	12	v	v	PROPN
ajlm-1964	483	13	,	,	PUNCT
ajlm-1964	483	14	li	li	PROPN
ajlm-1964	483	15	y	y	PROPN
ajlm-1964	483	16	,	,	PUNCT
ajlm-1964	484	1	otazu	otazu	PROPN
ajlm-1964	484	2	gh	gh	PROPN
ajlm-1964	484	3	.	.	PUNCT
ajlm-1964	484	4	correlation	correlation	NOUN
ajlm-1964	484	5	between	between	ADP
ajlm-1964	484	6	universal	universal	ADJ
ajlm-1964	484	7	bcg	bcg	PROPN
ajlm-1964	484	8	vaccination	vaccination	NOUN
ajlm-1964	484	9	policy	policy	NOUN
ajlm-1964	484	10	and	and	CCONJ
ajlm-1964	484	11	reduced	reduced	ADJ
ajlm-1964	484	12	morbidity	morbidity	NOUN
ajlm-1964	484	13	and	and	CCONJ
ajlm-1964	484	14	mortality	mortality	NOUN
ajlm-1964	484	15	for	for	ADP
ajlm-1964	484	16	covid-19	covid-19	PROPN
ajlm-1964	484	17	:	:	PUNCT
ajlm-1964	484	18	an	an	DET
ajlm-1964	484	19	epidemiological	epidemiological	ADJ
ajlm-1964	484	20	study	study	NOUN
ajlm-1964	484	21	[	[	X
ajlm-1964	484	22	serial	serial	ADJ
ajlm-1964	484	23	online	online	NOUN
ajlm-1964	484	24	]	]	PUNCT
ajlm-1964	484	25	.	.	PUNCT
ajlm-1964	485	1	2020	2020	NUM
ajlm-1964	486	1	[	[	X
ajlm-1964	486	2	cited	cite	VERB
ajlm-1964	486	3	2021	2021	NUM
ajlm-1964	486	4	nov	nov	NOUN
ajlm-1964	486	5	16]:20042937	16]:20042937	NUM
ajlm-1964	486	6	.	.	PUNCT
ajlm-1964	487	1	available	available	ADJ
ajlm-1964	487	2	from	from	ADP
ajlm-1964	487	3	:	:	PUNCT
ajlm-1964	487	4	https://www.medrxiv.org/content/10.1101/2020.03.24.20042937v1	https://www.medrxiv.org/content/10.1101/2020.03.24.20042937v1	PROPN
ajlm-1964	487	5	levine	levine	PROPN
ajlm-1964	487	6	di	di	PROPN
ajlm-1964	487	7	.	.	PUNCT
ajlm-1964	488	1	a	a	DET
ajlm-1964	488	2	shred	shred	NOUN
ajlm-1964	488	3	of	of	ADP
ajlm-1964	488	4	evidence	evidence	NOUN
ajlm-1964	488	5	that	that	SCONJ
ajlm-1964	488	6	bcg	bcg	PROPN
ajlm-1964	488	7	vaccine	vaccine	NOUN
ajlm-1964	488	8	may	may	AUX
ajlm-1964	488	9	protect	protect	VERB
ajlm-1964	488	10	against	against	ADP
ajlm-1964	488	11	covid-19	covid-19	PROPN
ajlm-1964	488	12	:	:	PUNCT
ajlm-1964	488	13	comparing	compare	VERB
ajlm-1964	488	14	cohorts	cohort	NOUN
ajlm-1964	488	15	in	in	ADP
ajlm-1964	488	16	spain	spain	PROPN
ajlm-1964	488	17	and	and	CCONJ
ajlm-1964	488	18	italy	italy	PROPN
ajlm-1964	489	1	[	[	X
ajlm-1964	489	2	serial	serial	VERB
ajlm-1964	489	3	online	online	NOUN
ajlm-1964	489	4	]	]	PUNCT
ajlm-1964	489	5	.	.	PUNCT
ajlm-1964	489	6	2020	2020	NUM
ajlm-1964	490	1	[	[	X
ajlm-1964	490	2	cited	cite	VERB
ajlm-1964	490	3	2021	2021	NUM
ajlm-1964	490	4	nov	nov	NOUN
ajlm-1964	490	5	17]:20123539	17]:20123539	NUM
ajlm-1964	490	6	.	.	PUNCT
ajlm-1964	491	1	available	available	ADJ
ajlm-1964	491	2	from	from	ADP
ajlm-1964	491	3	:	:	PUNCT
ajlm-1964	491	4	https://www.medrxiv.org/content/10.1101/2020.06.05.20123539v1	https://www.medrxiv.org/content/10.1101/2020.06.05.20123539v1	PROPN
ajlm-1964	491	5	curtis	curtis	PROPN
ajlm-1964	491	6	n	n	CCONJ
ajlm-1964	491	7	,	,	PUNCT
ajlm-1964	491	8	sparrow	sparrow	VERB
ajlm-1964	491	9	a	a	PRON
ajlm-1964	491	10	,	,	PUNCT
ajlm-1964	491	11	ghebreyesus	ghebreyesus	PROPN
ajlm-1964	491	12	ta	ta	PROPN
ajlm-1964	491	13	,	,	PUNCT
ajlm-1964	491	14	netea	netea	NOUN
ajlm-1964	491	15	mg	mg	PROPN
ajlm-1964	491	16	.	.	PUNCT
ajlm-1964	492	1	considering	consider	VERB
ajlm-1964	492	2	bcg	bcg	NOUN
ajlm-1964	492	3	vaccination	vaccination	NOUN
ajlm-1964	492	4	to	to	PART
ajlm-1964	492	5	reduce	reduce	VERB
ajlm-1964	492	6	the	the	DET
ajlm-1964	492	7	impact	impact	NOUN
ajlm-1964	492	8	of	of	ADP
ajlm-1964	492	9	covid-19	covid-19	PROPN
ajlm-1964	492	10	.	.	PUNCT
ajlm-1964	492	11	lancet	lancet	PROPN
ajlm-1964	492	12	.	.	PUNCT
ajlm-1964	493	1	2020;395(10236):1545–1546	2020;395(10236):1545–1546	PROPN
ajlm-1964	493	2	.	.	PUNCT
ajlm-1964	494	1	https://doi.org/10.1016/s0140-6736(20)31025-4	https://doi.org/10.1016/s0140-6736(20)31025-4	PROPN
ajlm-1964	494	2	brooks	brooks	PROPN
ajlm-1964	494	3	na	na	PROPN
ajlm-1964	494	4	,	,	PUNCT
ajlm-1964	494	5	puri	puri	PROPN
ajlm-1964	494	6	a	a	PROPN
ajlm-1964	494	7	,	,	PUNCT
ajlm-1964	494	8	garg	garg	PROPN
ajlm-1964	494	9	s	s	PROPN
ajlm-1964	494	10	,	,	PUNCT
ajlm-1964	494	11	et	et	PROPN
ajlm-1964	494	12	al	al	PROPN
ajlm-1964	494	13	.	.	PUNCT
ajlm-1964	495	1	the	the	DET
ajlm-1964	495	2	association	association	PROPN
ajlm-1964	495	3	of	of	ADP
ajlm-1964	495	4	coronavirus	coronavirus	NOUN
ajlm-1964	495	5	disease-19	disease-19	PROPN
ajlm-1964	495	6	mortality	mortality	NOUN
ajlm-1964	495	7	and	and	CCONJ
ajlm-1964	495	8	prior	prior	ADJ
ajlm-1964	495	9	bacille	bacille	NOUN
ajlm-1964	495	10	calmette	calmette	PROPN
ajlm-1964	495	11	-	-	PUNCT
ajlm-1964	495	12	guerin	guerin	PROPN
ajlm-1964	495	13	vaccination	vaccination	NOUN
ajlm-1964	495	14	:	:	PUNCT
ajlm-1964	495	15	a	a	DET
ajlm-1964	495	16	robust	robust	ADJ
ajlm-1964	495	17	ecological	ecological	ADJ
ajlm-1964	495	18	analysis	analysis	NOUN
ajlm-1964	495	19	using	use	VERB
ajlm-1964	495	20	unsupervised	unsupervised	ADJ
ajlm-1964	495	21	machine	machine	NOUN
ajlm-1964	495	22	learning	learning	NOUN
ajlm-1964	495	23	.	.	PUNCT
ajlm-1964	496	1	sci	sci	PROPN
ajlm-1964	496	2	rep	rep	PROPN
ajlm-1964	496	3	.	.	PROPN
ajlm-1964	496	4	2021;11(1):774	2021;11(1):774	NUM
ajlm-1964	496	5	.	.	PUNCT
ajlm-1964	497	1	https://doi.org/10.1038/s41598-020-80787-z	https://doi.org/10.1038/s41598-020-80787-z	PROPN
ajlm-1964	497	2	hensel	hensel	PROPN
ajlm-1964	497	3	j	j	PROPN
ajlm-1964	497	4	,	,	PUNCT
ajlm-1964	497	5	mcandrews	mcandrews	PROPN
ajlm-1964	497	6	km	km	PROPN
ajlm-1964	497	7	,	,	PUNCT
ajlm-1964	497	8	mcgrail	mcgrail	NOUN
ajlm-1964	497	9	dj	dj	NOUN
ajlm-1964	497	10	,	,	PUNCT
ajlm-1964	497	11	dowlatshahi	dowlatshahi	ADJ
ajlm-1964	497	12	dp	dp	NOUN
ajlm-1964	497	13	,	,	PUNCT
ajlm-1964	497	14	lebleu	lebleu	NOUN
ajlm-1964	497	15	vs	vs	ADP
ajlm-1964	497	16	,	,	PUNCT
ajlm-1964	497	17	kalluri	kalluri	PROPN
ajlm-1964	497	18	r.	r.	PROPN
ajlm-1964	497	19	protection	protection	PROPN
ajlm-1964	497	20	against	against	ADP
ajlm-1964	497	21	sars	sar	NOUN
ajlm-1964	497	22	-	-	PUNCT
ajlm-1964	497	23	cov-2	cov-2	NUM
ajlm-1964	497	24	by	by	ADP
ajlm-1964	497	25	bcg	bcg	NOUN
ajlm-1964	497	26	vaccination	vaccination	NOUN
ajlm-1964	497	27	is	be	AUX
ajlm-1964	497	28	not	not	PART
ajlm-1964	497	29	supported	support	VERB
ajlm-1964	497	30	by	by	ADP
ajlm-1964	497	31	epidemiological	epidemiological	ADJ
ajlm-1964	497	32	analyses	analysis	NOUN
ajlm-1964	497	33	.	.	PUNCT
ajlm-1964	498	1	sci	sci	PROPN
ajlm-1964	498	2	rep	rep	PROPN
ajlm-1964	498	3	.	.	PROPN
ajlm-1964	498	4	2020;10(1):18377	2020;10(1):18377	PROPN
ajlm-1964	498	5	.	.	PUNCT
ajlm-1964	499	1	https://doi.org/10.1038/s41598-020-75491-x	https://doi.org/10.1038/s41598-020-75491-x	PROPN
ajlm-1964	499	2	seeley	seeley	PROPN
ajlm-1964	499	3	jj	jj	PROPN
ajlm-1964	499	4	,	,	PUNCT
ajlm-1964	499	5	ghosh	ghosh	PROPN
ajlm-1964	499	6	s.	s.	PROPN
ajlm-1964	499	7	molecular	molecular	ADJ
ajlm-1964	499	8	mechanisms	mechanism	NOUN
ajlm-1964	499	9	of	of	ADP
ajlm-1964	499	10	innate	innate	ADJ
ajlm-1964	499	11	memory	memory	NOUN
ajlm-1964	499	12	and	and	CCONJ
ajlm-1964	499	13	tolerance	tolerance	NOUN
ajlm-1964	499	14	to	to	ADP
ajlm-1964	499	15	lps	lps	PROPN
ajlm-1964	499	16	.	.	PUNCT
ajlm-1964	500	1	j	j	PROPN
ajlm-1964	500	2	leukoc	leukoc	VERB
ajlm-1964	500	3	biol	biol	PROPN
ajlm-1964	500	4	.	.	PUNCT
ajlm-1964	501	1	2017;101(1):107–119	2017;101(1):107–119	NUM
ajlm-1964	501	2	.	.	PROPN
ajlm-1964	501	3	https://doi.org/10.1189/jlb.3mr0316-118rr	https://doi.org/10.1189/jlb.3mr0316-118rr	PROPN
ajlm-1964	501	4	world	world	PROPN
ajlm-1964	501	5	health	health	NOUN
ajlm-1964	501	6	organization	organization	NOUN
ajlm-1964	501	7	(	(	PUNCT
ajlm-1964	501	8	who	who	PRON
ajlm-1964	501	9	)	)	PUNCT
ajlm-1964	501	10	.	.	PUNCT
ajlm-1964	502	1	tracking	track	VERB
ajlm-1964	502	2	sars	sar	NOUN
ajlm-1964	502	3	-	-	PUNCT
ajlm-1964	502	4	cov-2	cov-2	PART
ajlm-1964	502	5	variants	variant	NOUN
ajlm-1964	502	6	[	[	X
ajlm-1964	502	7	homepage	homepage	NOUN
ajlm-1964	502	8	on	on	ADP
ajlm-1964	502	9	the	the	DET
ajlm-1964	502	10	internet	internet	NOUN
ajlm-1964	502	11	]	]	PUNCT
ajlm-1964	502	12	.	.	PUNCT
ajlm-1964	502	13	2021	2021	NUM
ajlm-1964	503	1	[	[	X
ajlm-1964	503	2	cited	cite	VERB
ajlm-1964	503	3	2021	2021	NUM
ajlm-1964	503	4	dec	dec	PROPN
ajlm-1964	503	5	25	25	NUM
ajlm-1964	503	6	]	]	PUNCT
ajlm-1964	503	7	.	.	PUNCT
ajlm-1964	504	1	available	available	ADJ
ajlm-1964	504	2	from	from	ADP
ajlm-1964	504	3	:	:	PUNCT
ajlm-1964	504	4	https://www.who.int/en/activities/tracking-sars-cov-2-variants/	https://www.who.int/en/activities/tracking-sars-cov-2-variants/	NOUN
ajlm-1964	504	5	parums	parums	PROPN
ajlm-1964	504	6	dv	dv	PROPN
ajlm-1964	504	7	.	.	PROPN
ajlm-1964	504	8	revised	revise	VERB
ajlm-1964	504	9	world	world	PROPN
ajlm-1964	504	10	health	health	NOUN
ajlm-1964	504	11	organization	organization	NOUN
ajlm-1964	504	12	(	(	PUNCT
ajlm-1964	504	13	who	who	PRON
ajlm-1964	504	14	)	)	PUNCT
ajlm-1964	504	15	terminology	terminology	NOUN
ajlm-1964	504	16	for	for	ADP
ajlm-1964	504	17	variants	variant	NOUN
ajlm-1964	504	18	of	of	ADP
ajlm-1964	504	19	concern	concern	NOUN
ajlm-1964	504	20	and	and	CCONJ
ajlm-1964	504	21	variants	variant	NOUN
ajlm-1964	504	22	of	of	ADP
ajlm-1964	504	23	interest	interest	NOUN
ajlm-1964	504	24	of	of	ADP
ajlm-1964	504	25	sars	sar	NOUN
ajlm-1964	504	26	-	-	PUNCT
ajlm-1964	504	27	cov-2	cov-2	NOUN
ajlm-1964	504	28	.	.	PUNCT
ajlm-1964	504	29	med	med	PROPN
ajlm-1964	504	30	sci	sci	PROPN
ajlm-1964	504	31	monit	monit	PROPN
ajlm-1964	504	32	.	.	PUNCT
ajlm-1964	505	1	2021;27	2021;27	NUM
ajlm-1964	505	2	:	:	PUNCT
ajlm-1964	506	1	e933622	e933622	X
ajlm-1964	506	2	.	.	PUNCT
ajlm-1964	507	1	https://doi.org/10.12659/msm.933622	https://doi.org/10.12659/msm.933622	PROPN
ajlm-1964	507	2	zahradník	zahradník	PROPN
ajlm-1964	507	3	j	j	PROPN
ajlm-1964	507	4	,	,	PUNCT
ajlm-1964	507	5	marciano	marciano	PROPN
ajlm-1964	507	6	s	s	PROPN
ajlm-1964	507	7	,	,	PUNCT
ajlm-1964	507	8	shemesh	shemesh	PROPN
ajlm-1964	507	9	m	m	PROPN
ajlm-1964	507	10	,	,	PUNCT
ajlm-1964	507	11	et	et	PROPN
ajlm-1964	507	12	al	al	PROPN
ajlm-1964	507	13	.	.	PUNCT
ajlm-1964	508	1	sars	sars	PROPN
ajlm-1964	508	2	-	-	PUNCT
ajlm-1964	508	3	cov-2	cov-2	NOUN
ajlm-1964	508	4	variant	variant	ADJ
ajlm-1964	508	5	prediction	prediction	NOUN
ajlm-1964	508	6	and	and	CCONJ
ajlm-1964	508	7	antiviral	antiviral	ADJ
ajlm-1964	508	8	drug	drug	NOUN
ajlm-1964	508	9	design	design	NOUN
ajlm-1964	508	10	are	be	AUX
ajlm-1964	508	11	enabled	enable	VERB
ajlm-1964	508	12	by	by	ADP
ajlm-1964	508	13	rbd	rbd	NOUN
ajlm-1964	508	14	in	in	ADP
ajlm-1964	508	15	vitro	vitro	X
ajlm-1964	508	16	evolution	evolution	NOUN
ajlm-1964	508	17	.	.	PUNCT
ajlm-1964	509	1	nat	nat	PROPN
ajlm-1964	509	2	microbiol	microbiol	PROPN
ajlm-1964	509	3	.	.	PUNCT
ajlm-1964	510	1	2021;6:1188–1198	2021;6:1188–1198	NUM
ajlm-1964	510	2	.	.	PUNCT
ajlm-1964	510	3	https://doi.org/10.1038/s41564-021-00954-4	https://doi.org/10.1038/s41564-021-00954-4	NUM
ajlm-1964	511	1	ren	ren	PROPN
ajlm-1964	511	2	sy	sy	PROPN
ajlm-1964	511	3	,	,	PUNCT
ajlm-1964	511	4	wang	wang	PROPN
ajlm-1964	511	5	wb	wb	PROPN
ajlm-1964	511	6	,	,	PUNCT
ajlm-1964	511	7	gao	gao	PROPN
ajlm-1964	511	8	rd	rd	PROPN
ajlm-1964	511	9	,	,	PUNCT
ajlm-1964	511	10	zhou	zhou	PROPN
ajlm-1964	511	11	am	be	AUX
ajlm-1964	511	12	.	.	PUNCT
ajlm-1964	512	1	omicron	omicron	PROPN
ajlm-1964	512	2	variant	variant	NOUN
ajlm-1964	512	3	(	(	PUNCT
ajlm-1964	512	4	b.1.1.529	b.1.1.529	ADV
ajlm-1964	512	5	)	)	PUNCT
ajlm-1964	512	6	of	of	ADP
ajlm-1964	512	7	sars	sar	NOUN
ajlm-1964	512	8	-	-	PUNCT
ajlm-1964	512	9	cov-2	cov-2	NOUN
ajlm-1964	512	10	:	:	PUNCT
ajlm-1964	512	11	mutation	mutation	NOUN
ajlm-1964	512	12	,	,	PUNCT
ajlm-1964	512	13	infectivity	infectivity	NOUN
ajlm-1964	512	14	,	,	PUNCT
ajlm-1964	512	15	transmission	transmission	NOUN
ajlm-1964	512	16	,	,	PUNCT
ajlm-1964	512	17	and	and	CCONJ
ajlm-1964	512	18	vaccine	vaccine	NOUN
ajlm-1964	512	19	resistance	resistance	NOUN
ajlm-1964	512	20	.	.	PUNCT
ajlm-1964	513	1	world	world	PROPN
ajlm-1964	513	2	j	j	PROPN
ajlm-1964	513	3	clin	clin	PROPN
ajlm-1964	513	4	cases	case	NOUN
ajlm-1964	513	5	.	.	PUNCT
ajlm-1964	514	1	2022;10(1):1–11	2022;10(1):1–11	NUM
ajlm-1964	514	2	.	.	PUNCT
ajlm-1964	515	1	https://doi.org/10.12998/wjcc.v10.i1.1	https://doi.org/10.12998/wjcc.v10.i1.1	PROPN
ajlm-1964	515	2	hku	hku	PROPN
ajlm-1964	515	3	med	med	PROPN
ajlm-1964	515	4	.	.	PUNCT
ajlm-1964	516	1	hkumed	hkumed	PROPN
ajlm-1964	516	2	finds	find	VERB
ajlm-1964	516	3	omicron	omicron	PROPN
ajlm-1964	516	4	sars	sar	NOUN
ajlm-1964	516	5	-	-	PUNCT
ajlm-1964	516	6	cov-2	cov-2	NUM
ajlm-1964	516	7	can	can	AUX
ajlm-1964	516	8	infect	infect	VERB
ajlm-1964	516	9	faster	fast	ADV
ajlm-1964	516	10	and	and	CCONJ
ajlm-1964	516	11	better	well	ADJ
ajlm-1964	516	12	than	than	ADP
ajlm-1964	516	13	delta	delta	NOUN
ajlm-1964	516	14	in	in	ADP
ajlm-1964	516	15	human	human	ADJ
ajlm-1964	516	16	bronchus	bronchu	NOUN
ajlm-1964	516	17	but	but	CCONJ
ajlm-1964	516	18	with	with	ADP
ajlm-1964	516	19	less	less	ADV
ajlm-1964	516	20	severe	severe	ADJ
ajlm-1964	516	21	infection	infection	NOUN
ajlm-1964	516	22	in	in	ADP
ajlm-1964	516	23	lung	lung	PROPN
ajlm-1964	516	24	.	.	PUNCT
ajlm-1964	517	1	hong	hong	PROPN
ajlm-1964	517	2	kong	kong	PROPN
ajlm-1964	517	3	:	:	PUNCT
ajlm-1964	518	1	hku	hku	PROPN
ajlm-1964	518	2	med	med	PROPN
ajlm-1964	518	3	.	.	PROPN
ajlm-1964	518	4	callaway	callaway	PROPN
ajlm-1964	518	5	e.	e.	PROPN
ajlm-1964	518	6	omicron	omicron	PROPN
ajlm-1964	518	7	likely	likely	ADJ
ajlm-1964	518	8	to	to	PART
ajlm-1964	518	9	weaken	weaken	VERB
ajlm-1964	518	10	covid	covid	PROPN
ajlm-1964	518	11	vaccine	vaccine	NOUN
ajlm-1964	518	12	protection	protection	NOUN
ajlm-1964	518	13	.	.	PUNCT
ajlm-1964	519	1	nature	nature	NOUN
ajlm-1964	519	2	.	.	PUNCT
ajlm-1964	520	1	2021;600:367–368	2021;600:367–368	NUM
ajlm-1964	520	2	.	.	PUNCT
ajlm-1964	521	1	https://doi.org/10.1038/d41586-021-03672-3	https://doi.org/10.1038/d41586-021-03672-3	NUM
ajlm-1964	522	1	callaway	callaway	PROPN
ajlm-1964	522	2	e	e	PROPN
ajlm-1964	522	3	,	,	PUNCT
ajlm-1964	522	4	ledford	ledford	PROPN
ajlm-1964	522	5	h.	h.	PROPN
ajlm-1964	523	1	how	how	SCONJ
ajlm-1964	523	2	bad	bad	ADJ
ajlm-1964	523	3	is	be	AUX
ajlm-1964	523	4	omicron	omicron	PROPN
ajlm-1964	523	5	?	?	PUNCT
ajlm-1964	523	6	nature	nature	NOUN
ajlm-1964	523	7	.	.	PUNCT
ajlm-1964	524	1	2021;600:197–199	2021;600:197–199	X
ajlm-1964	524	2	.	.	PUNCT
ajlm-1964	525	1	https://doi.org/10.1038/d41586-021-03614-z	https://doi.org/10.1038/d41586-021-03614-z	PROPN
ajlm-1964	525	2	pfizer	pfizer	PROPN
ajlm-1964	525	3	inc	inc	PROPN
ajlm-1964	525	4	.	.	PROPN
ajlm-1964	525	5	pfizer	pfizer	PROPN
ajlm-1964	525	6	and	and	CCONJ
ajlm-1964	525	7	biontech	biontech	NOUN
ajlm-1964	525	8	provide	provide	VERB
ajlm-1964	525	9	update	update	NOUN
ajlm-1964	525	10	on	on	ADP
ajlm-1964	525	11	omicron	omicron	PROPN
ajlm-1964	525	12	variant	variant	NOUN
ajlm-1964	526	1	[	[	X
ajlm-1964	526	2	homepage	homepage	NOUN
ajlm-1964	526	3	on	on	ADP
ajlm-1964	526	4	the	the	DET
ajlm-1964	526	5	internet	internet	NOUN
ajlm-1964	526	6	]	]	PUNCT
ajlm-1964	526	7	.	.	PUNCT
ajlm-1964	527	1	2021	2021	NUM
ajlm-1964	528	1	[	[	X
ajlm-1964	528	2	cited	cite	VERB
ajlm-1964	528	3	2021	2021	NUM
ajlm-1964	528	4	dec	dec	PROPN
ajlm-1964	528	5	09	09	NUM
ajlm-1964	528	6	]	]	PUNCT
ajlm-1964	528	7	.	.	PUNCT
ajlm-1964	529	1	available	available	ADJ
ajlm-1964	529	2	from	from	ADP
ajlm-1964	529	3	:	:	PUNCT
ajlm-1964	529	4	https://www.businesswire.com/news/home/20211208005542/en/pfizer-and-biontech-provide-update-on-omicron-variant	https://www.businesswire.com/news/home/20211208005542/en/pfizer-and-biontech-provide-update-on-omicron-variant	PROPN
ajlm-1964	529	5	wilhelm	wilhelm	PROPN
ajlm-1964	529	6	a	a	PROPN
ajlm-1964	529	7	,	,	PUNCT
ajlm-1964	529	8	widera	widera	NOUN
ajlm-1964	529	9	m	m	PROPN
ajlm-1964	529	10	,	,	PUNCT
ajlm-1964	529	11	grikscheit	grikscheit	PROPN
ajlm-1964	529	12	k	k	PROPN
ajlm-1964	529	13	,	,	PUNCT
ajlm-1964	529	14	et	et	PROPN
ajlm-1964	529	15	al	al	PROPN
ajlm-1964	529	16	.	.	PROPN
ajlm-1964	530	1	reduced	reduce	VERB
ajlm-1964	530	2	neutralization	neutralization	NOUN
ajlm-1964	530	3	of	of	ADP
ajlm-1964	530	4	sars	sars	PROPN
ajlm-1964	530	5	-	-	PUNCT
ajlm-1964	530	6	cov-2	cov-2	NOUN
ajlm-1964	530	7	omicron	omicron	NOUN
ajlm-1964	530	8	variant	variant	NOUN
ajlm-1964	530	9	by	by	ADP
ajlm-1964	530	10	vaccine	vaccine	NOUN
ajlm-1964	530	11	sera	sera	NOUN
ajlm-1964	530	12	and	and	CCONJ
ajlm-1964	530	13	monoclonal	monoclonal	NOUN
ajlm-1964	530	14	antibodies	antibody	NOUN
ajlm-1964	531	1	[	[	X
ajlm-1964	531	2	homepage	homepage	NOUN
ajlm-1964	531	3	on	on	ADP
ajlm-1964	531	4	the	the	DET
ajlm-1964	531	5	internet	internet	NOUN
ajlm-1964	531	6	]	]	PUNCT
ajlm-1964	531	7	.	.	PUNCT
ajlm-1964	531	8	2021	2021	NUM
ajlm-1964	531	9	,	,	PUNCT
ajlm-1964	531	10	p.	p.	NOUN
ajlm-1964	531	11	21267432	21267432	NUM
ajlm-1964	532	1	[	[	X
ajlm-1964	532	2	cited	cite	VERB
ajlm-1964	532	3	2021	2021	NUM
ajlm-1964	532	4	dec	dec	PROPN
ajlm-1964	532	5	09	09	NUM
ajlm-1964	532	6	]	]	PUNCT
ajlm-1964	532	7	.	.	PUNCT
ajlm-1964	533	1	available	available	ADJ
ajlm-1964	533	2	from	from	ADP
ajlm-1964	533	3	:	:	PUNCT
ajlm-1964	533	4	https://www.medrxiv.org/content/10.1101/2021.12.07.21267432v1	https://www.medrxiv.org/content/10.1101/2021.12.07.21267432v1	NOUN